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Abstract 
In residue analysis of antibiotics quantitative and qualitative aspects are involved 
in declaring a sample non-compliant. The quantitative aspect regards the 
determination of the amount of the compound present in the sample. Validation 
procedures are available to determine the uncertainty of this result, which is 
taken into account in the decision making process. The qualitative aspect regards 
the confirmation of the identity of the compound present. In this, selectivity is 
the main parameter which is defined as the ability of a method to discriminate 
the analyte being measured from other substances. A trend observed in residue 
analysis is towards more generic methods for the detection of a broad range of 
compounds in a single run. As a result, by definition, selectivity is compromised. 
Procedures to determine the uncertainty of the qualitative aspect are lacking 
and, as a result, whether or not a method is adequately selective is a matter of 
experts’ judgment. 
In this thesis a method is presented for grading selectivity of methods using liquid 
chromatography coupled to tandem mass spectrometry. Based on the outcome it 
can be stated if selectivity is adequate and thus if a confirmatory result stands 
strong when challenged in a court case. If selectivity is found inadequate, 
additional measures can be taken like the selection of another product ion or the 
use of a third product ion to obtain adequate selectivity.  
Furthermore, two examples of analyses are presented in which selectivity plays 
an important role. First, the analysis of the banned antibiotic chloramphenicol 
(CAP). CAP contains two chiral centers and the nitro-group can either be para- or 
meta-substituted. Therefore, eight different isomers of CAP occur of which only 
RR-p-CAP is antimicrobially active. In the analysis of CAP, extreme selectivity is 
needed to distinguish the antimicrobially active compound from its inactive 
isomers. A method applying chiral liquid chromatography with tandem mass 
spectrometry was developed to discriminate antimicrobially active CAP for its 
inactive isomers. Also the research for the possible natural occurrence of this 
drug is presented. It is shown that CAP can be produced in unamended soil by 
Streptomyces venezuelae in appreciable amounts and that crops can take up CAP 
from soils. Therefore, it is concluded that CAP can occur in crops and animal 
feed due to its natural production by soil bacteria. 
 
 
 
Second, the development of a multi-ß-lactam method is presented. In this 
method a derivatization is applied to be able to effectively detect off-label 
ceftiofur use. In this selectivity is intentionally compromised and no unequivocal 
confirmation can be carried out using this method. The developed method is 
applicable to a wide range of ß-lactam antibiotics including penicillins, 
cephalosporins and carbapenems and is the best method available today for 
effective monitoring of off-label ß-lactam usage in poultry breeding. 
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Introduction 
In animal breeding the use of antibiotics has become common practice. 
Antibiotics are used to treat bacterially infected animals but are also 
administered as a preventive measure. From an animal and human health 
perspective, responsible use of antibiotics is of importance and therefore 
extensive monitoring programs are in place within the European Union. The 
methods used for analysis of antibiotics aim for the detection, quantitation and 
confirmation of the antibiotic present in products of animal origin. In this 
chapter the use of antibiotics and its drawbacks are discussed followed by a 
description of the legal framework for antibiotic analysis and the methods 
employed. Finally some challenges are discussed that are subject of this thesis.  
Antibiotics and their veterinary usage 
Antibiotics 
Antibiotics are used to treat infections caused by bacteria and other micro-
organisms. Traditionally, the term “antibiotics” is used to describe any substance 
produced by a micro-organism that is effective against the growth of another 
micro-organism [1]. Nowadays the term “antibiotics” is used interchangeably 
with the term “antibacterials”, and includes synthetic substances like 
sulfonamides and quinolones as well.  
Definition: 
“Antibiotic ► noun, a medicine (such as penicillin or its derivatives) that 
inhibits the growth of or destroys micro-organisms.” [2] 
In 1928, Alexander Flemming discovered the antibiotic action of the fungus of the 
genus 'Penicillium' and attributed it to one of its constituents: penicillin [3,4]. In 
1932, the first antibiotic substance, developed by Gerhard Domagk, became 
commercially available: prontosil. This was the first commercially available 
synthetic antibiotic belonging to the sulfonamide group and has a broad activity 
against Gram-positive bacteria, but not against enterobacteria (Gram negative) 
[5]. In 1939, Howard Florey and Ernst Chain continued the study on penicillin [6] 
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and showed its activity against a broad spectrum of bacteria and proved it to be 
safe for use in humans. Later many chemically altered semi-synthetic penicillins 
were developed. The penicillins derive their activity from the 6-aminopenicillinic 
acid nucleus which is effective against mainly Gram positive bacteria [4,7,8]. 
Amoxicillin, ampicillin, penicillin G (benzylpenicillin), penicillin V 
(phenoxymethylpenicillin), cloxacillin, dicloxacillin, oxacillin and nafcillin (figure 
1.1) are nowadays registered for veterinary use [9].  
 
Figure 1.1. Molecular structure of the penicillins registered for use in animal 
practice. 
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The discovery of penicillin led to renewed interest in the search for antibiotic 
compounds with similar efficacy and safety. In 1956, the first cephalosporin 
antibiotic, closely related to the penicillins, was isolated from the Acremonium 
fungus species [10-12]. The six membered dihydrothiazine ring fused with a four 
membered ß-lactam ring (figure 1.2) is responsible for the biological activity of 
this group of compounds. Cephalosporins are highly effective antibiotics in the 
treatment of bacterial infections of the respiratory tract [4,13]. As for the 
penicillins, many semi-synthetic cephalosporins were developed which are 
nowadays distinguished in several generations based upon their time of discovery 
and their range of activity [14]. Cefacetril, cefalonium, cefazolin, cefalexin and 
cefapirin (all 1st generation), cefoperazone and ceftiofur (3rd generation), and 
cefquinome (4th generation) are all approved for veterinary use (figure 1.2) [9]. 
Another ß-lactam group consists of the carbapenems of which the first compound 
was isolated from Streptomyces cattleyain in 1971 [15]. The carbapenems are 
structurally very similar to the penicillins: the sulfur atom has been replaced by a 
carbon atom and an unsaturation has been introduced (figure 1.3) [16]. As a 
result the carbapenems possess the broadest antimicrobial activity amongst the 
ß-lactams [16]. The most common carbapenems are imipenem, meropenem, 
ertapenem, doripenem and biapenem (figure 1.3). The carbapenems are not 
registered for use in food-producing animals and are used off-label in companion 
animals [8]. 
Another important group of antibiotics was introduced by Benjamin Duggar: the 
tetracyclines, of which chlortetracycline, isolated from the soil bacteria 
Strepromyces aureofaciens, was the first [17]. In the same year, David Gottlieb 
reported the isolation of a new broad spectrum antibiotic from the soil bacterium 
Streptomyces venezuelae called chloramphenicol [18] (figure 1.4). 
Although, as these examples show, many antibiotics were first isolated from a 
natural source, most of them are now produced synthetically and new antibiotics 
are usually semisynthetic modifications thereof [19]. 
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Figure 1.2. Molecular structure of the cephalosporins registered for use in 
animal practice. 
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Figure 1.3. Molecular structure of the carbapenems: meropenem, imipenem, 
ertapenem, doripenem and biapenem. 
 
Figure 1.4. Molecular structure of chloramphenicol. 
Different antibiotics have different antibacterial mechanisms of activity. The 
main mechanisms of antimicrobial action are presented in appendix 1.1. ß-
lactams inhibit the bacteria cell wall synthesis by covalently binding with 
penicillin-binding proteins (PBP), which catalyse the synthesis of peptidoglycan, 
the major component of the cell wall [20]. Chloramphenicol binds to the active 
site of transfer ribonucleic acid (tRNA) and thus inhibits the protein synthesis at 
the ribosome [21]. 
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Antibiotic usage 
Nowadays, the use of antibiotic agents in animal breeding for food production is 
general practice. Antibiotics are used to treat bacterially infected animals but 
are also administered as a preventive measure. Furthermore, administration of 
antibiotics at sub-therapeutic doses has a growth promoting effects, making its 
use economically advantageous [22]. This is especially of interest since the ban 
of antimicrobial growth promoting substances in animal feed since 2006 [23,24]. 
Antibiotic usage in veterinary practice in the Netherlands is monitored to obtain 
insight in the exposure of farm animals to antibiotics. One way of monitoring 
antibiotic usage is registering antibiotic sales for therapeutic use. The antibiotic 
sales from 1999 to 2009 are presented in figure 1.5 [25]. 
 
Figure 1.5. Total veterinary therapeutic antibiotic sales 1999 – 2011. Reproduced 
with permission from [25]. 
The livestock population remained roughly constant over the years [25] and thus 
is concluded that sales by the pharmaceutical industry of antibiotics for 
veterinary therapeutic use increased from 1999 to 2007. An antibiotic sales 
decrease of over 30 % was observed in 2011 compared to 2007. In all years 
monitored, tetracyclines are sold the most followed by 
sulfonamides/trimethoprim and penicillins/cephalosporins. 
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The therapeutic antibiotic sales were determined for several species: pigs, 
broilers, veal calves and dairy cows. In 2009, for pigs a tendency to reintroduce 
traditional antibiotics like tetracyclines and sulfonamides/trimethoprim was 
observed, whereas for veal calves and dairy cows, besides the traditional 
antibiotics, newer antibiotics like 3rd and 4th generation cephalosporins and 
fluoroquinolones were more frequently used. For broilers a severe increase of the 
use of penicillin antibiotics was observed in 2009 compared to previous years, 
possibly because penicillin administration results in the enhancement of the feed 
conversion and growth rate [26]. 
Adverse effects of antibiotic usage 
Excessive antibiotic usage in veterinary practice in food producing animals can 
have adverse effects on human health [27-29]. Some antibiotics are banned for 
use in veterinary practice because of their negative effects on health, like bone 
marrow toxicity, aplastic anemia and carcinogenicity [28,30]. If these antibiotics 
are illegally administered, residues might occur in food products of animal origin. 
The adverse effects of the occurrence of these antibiotics in the food chain do 
not need any further elaboration. 
Less obvious is that also the irresponsible and excessive use of regulated 
antibiotics is a risk to human health [4,27,29,31]. About six to eight percent of 
the population show a hypersensitive reaction to covalent penicillin-protein 
conjugates that can be present in food products from animals that have been 
treated with penicillin antibiotics [32]. Furthermore, the use of antibiotics in 
veterinary practice can result in the occurrence of resistant bacteria that can be 
disseminated throughout the food chain and the environment and thus possibly 
be transferred from animals to humans [31]. Furthermore, low levels of these 
antibiotics can end up in the human food chain or the environment and do 
contribute to the evolvement of bacterial resistance as well [29,33]. 
Recent examples of the occurrence of resistant bacteria are: 
(1) methicillin-resistant Staphylococcus aureus (MRSA), a bacterium that is 
resistant to several β-lactam antibiotics. MRSA was found on swine in 2005 and 
transfer of the resistant bacteria from swine to man was observed [34,35]. 
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(2) extended spectrum beta-lactamase (ESBL) producing bacteria, resistant 
to, among others, pencillins and 3rd and 4th generation cephalosporin antibiotics 
[36,37]. The emergence of ESBL is linked to the excessive antibiotic use in 
poultry breeding and it was found that a majority of animals carry these resistant 
bacteria [38]. 
(3)  enterohaemorragic Escherichia coli (EHEC) is a toxin-producing bacteria of 
which certain strains have developed many antibiotic resistance genes [39-41]. 
An EHEC outbreak was reported by 9 countries in 2011 and cost the lives of at 
least 26 people [42]. 
Several mechanisms of bacterial resistance have been reported. The four main 
mechanisms of resistance are graphically presented in appendix 1.1 (page 52). 
Resistance development to ß-lactam antibiotics is caused by the expression of ß-
lactamases, which are enzymes that hydrolyse the four-membered ß-lactam ring 
and thus inactivates the antibiotics [4,43]. Widespread cephalosporin use is 
thought to have selected for ESBL resistance [44]. To prevent ß-lactam hydrolysis 
due to ESBLs, ß-lactam antibiotics are administered in combination with 
inhibitory substances like clavulanic acid and sulbactams that irreversibly bind to 
ß-lactamases and thus inactivate them [45]. Also chloramphenicol resistance is 
the result of the expression of an enzyme: chloramphenicol acetyltransferase 
modifies the drug by acetylation at the 3-hydroxyl group, thereby inactivating 
the drug's affinity for bacterial ribosomes [46]. 
Bacterial resistance is steadily increasing [47]. As an example, in 2009 it was 
found that the resistance of Escherichia coli (E. coli) against β-lactam antibiotics 
was disturbing: resistance against 3rd and 4th generation cephalosporins had 
further increased compared to 2008 and cefotaxime resistance was detected in 
all animal species ranging from 1.5 % in dairy cattle to 17.9 % in broiler chicken 
[48]. Steadily increasing antibiotic resistance and the lack of the development of 
new still effective antibiotics appear to result in a period during which treatment 
of infections will become increasingly difﬁcult [49,50]. Especially if one realises 
that many antibiotics applied in veterinary practice are the same antibiotics as 
used to treat bacterial infections in humans, it is clear that the occurrence of 
bacterial resistance is a serious healthcare issue [51-53].  
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Legal framework of antibiotic residue control 
Monitoring programs 
To detect off-label use of antibiotics and to prevent too high levels of antibiotics 
to occur in the food chain and thus to assure consumer safety, regulations were 
established within the European Union from 1986 starting with 86/469/EC [54], 
89/610/EC [55] and 2377/90/EEC [56]. More recently 2002/657/EC [57], 
2009/470/EC [58] and EU 2010/37 [9] have been established. 
In 89/610/EC [55], national reference laboratories were assigned in each EU 
member state which were made responsible for the analyses of residues of 
veterinary drugs in products of animal origin. For that purpose, within 
2377/90/EEC [56] veterinary medicinal products were divided into four 
categories which are generally referred to by their annex numbers: 
I: substances for which maximum residue levels (MRLs) have been established; 
II:  substances not subject to maximum residue levels; 
III:  substances for which provisional MRLs have been established; 
IV:  substances for which no maximum levels can be established. 
For simplification this was superseded by EU 2010/37 [9] which differentiates two 
groups: table 1 including all registered substances and table 2 including all 
banned substances. The established MRLs are included in this document and 
prohibition of substances for which no maximum levels can be established was 
laid down in 96/22/EC [59].  
Definition: 
“Maximum Residue Limit (MRL) ► the maximum concentration of 
residue resulting from the use of a veterinary medicinal product which 
may be accepted by the Community to be legally permitted or 
recognised as acceptable in or on a food. It is based on the type and 
amount of residue considered to be without any toxicological hazard for 
human health as expressed by the acceptable daily intake (ADI), or on 
the basis of a temporary ADI that utilises an additional safety factor. It 
also takes into account other relevant public health risks as well as food 
technology aspects.” [56] 
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Guidelines to monitor food and feed products according to these regulations 
were stated in 86/469/EC [54], which was later repealed by 96/23/EC [60] in 
which two main groups of substances that should be monitored in food and 
animal products were distinguished: 
Group A: substances having an anabolic effect and unauthorised substances 
as mentioned in table 2 of EU 2010/37 [9] respectively 96/22/EC 
[59]; 
Group B: Registered substances as mentioned in table 1 of EU 2010/37 [9]. 
An overview of substances per category is presented in table 1.1.  
Table 1.1. Overview of substances in group A and B [60]. 
Group A Group B 
(1) Stilbenes, stilbene derivatives, 
and their salts and esters 
(2) Antithyroid agents 
(3) Steroids 
(4) Resorcylic acid lactones 
including zeranol 
(5) Beta-agonists 
(6) Compounds included in Annex IV 
to Council Regulation (EEC) No 
2377/90 [56] 
 
(1) Antibacterial substances, including 
sulphonamides, quinolones 
(2) Other veterinary drugs 
     (a) Anthelmintics 
     (b) Anticoccidials, including nitroimidazoles 
     (c) Carbamates and pyrethroids 
     (d) Sedatives 
     (e) Non-steroidal anti-inflammatory drugs  
(NSAIDs) 
     (f) Other pharmacologically active substances 
(3) Other substances and environmental 
contaminants 
     (a) Organochlorine compounds including PCBs 
     (b) Organophosphorus compounds 
     (c) Chemical elements 
     (d) Mycotoxins 
     (e) Dyes 
     (f) Others 
 
Furthermore, 96/23/EC [60] further established the European laboratory  
infrastructure assigning, besides the national reference laboratories, community 
reference laboratories (CRL, nowadays called EU reference laboratories (EURL)) 
which were made responsible for development of methods and assisting NRLs in 
the analysis of specific substance groups. Last, this document very specifically 
describes requirements for monitoring plans for the detection of residues of the 
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mentioned substances in live animals, their excrements, body fluids, tissues, 
animal products, animal feed and drinking water. The establishment of 96/23/EC 
[60] has resulted in extensive control programs in each of the EU member states. 
In 1997, with the implementation of 97/78/EC [61] additional guidelines were 
established governing the veterinary control of products entering the EU from 
third countries. 
Within the Netherlands, the legal framework of 2009/470/EC [58], 96/22/EC 
[59], 96/23/EC [60] and the general food law (178/2002/EC [62]) is included in 
‘Wet dieren’ [63] which was effectuated on January 1st 2013 and is framework 
legislation integrating several other legal documents including ‘Regeling 
diergeneesmiddelen’ [64], ‘Besluit diergeneesmiddelen’ [65], ‘Diergenees-
middelenwet’ [66] and ‘Regeling verbod handel met bepaalde stoffen 
behandelde dieren en producten’ [67]. In Dutch legislation the focus is on self-
control in which producers are responsible for product quality. As surveillance, a 
‘national plan’ has been established by the Dutch Food and Consumer Product 
Safety Authority (NVWA), part of the Ministry of Economic Affairs, describing the 
exact type and number of samples that are controlled annually for specified 
substances or substance groups. More recently, legislation has been established 
on registration and justification of antibiotic use in poultry breeding [68] aiming 
for a decrease in antibiotic usage. General legislation on the obligation of 
keeping an administration on antibiotic usage in veterinary practice is in 
preparation [69] as well as additional legislation to prevent the unnecessary use 
of third and fourth generation cephalosporins and fluoroquinolones in veterinary 
practice. In this it is stated that these antibiotics are only allowed after 
demonstration of resistance against other antibiotic substances [69].  
Method criteria 
In 89/610/EC [55] the concept of reference methods was established indicating 
which analysis techniques and methods are considered suitable for the detection 
of specific residues. In this, screening and confirmatory methods can be 
distinguished. This concept was superseded by a criteria based approach as laid 
down in Commission Decision 2002/657/EC [57]. In this document the minimum 
requirements of analytical methods used in the analysis of veterinary drug 
residues, be it screening or confirmatory methods, were described.  
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Definition: 
Screening method ► methods that are used to detect the presence of a 
substance or class of substances at the level of interest. These methods 
have the capability for a high sample throughput and are used to sift 
large numbers of samples for potential non-compliant results. They are 
specifically designed to avoid false compliant results. [57] 
 
Definition: 
Confirmatory method ► methods that provide full or complementary 
information enabling the substance to be unequivocally identified and if 
necessary quantified at the level of interest. [57] 
This includes criteria for, amongst others, trueness, repeatability and within-
laboratory reproducibility. Besides criteria for the performance of analytical 
methods, the concepts of the minimum required performance limit (MRPL), the 
concept of the decision limit (CCα) and detection capability (CCβ), and 
regulations on the confirmation of an analytical result were introduced. 
Minimum required performance limit 
The concept of the minimum required performance limit (MRPL) was introduced 
to harmonise the analytical performance of analytical methods focusing on group 
A substances. Official MRPLs were established for chloramphenicol, nitrofuran 
residues and medroxyprogesterone acetate [70] and later for the sum of  
malachite green and its metabolite leuco-malachite green [71]. Provisional MRPLs 
for many other banned substances have been established since, but these did not 
obtain a legal status yet. 
Definition: 
“Minimum required performance limit (MRPL) ► minimum content of an 
analyte in a sample, which at least has to be detected and confirmed. It 
is intended to harmonise the analytical performance of methods for 
substances for which no permitted limited has been established.” [57] 
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In 2005, the interpretation of the established MRPLs changed. According to 
2005/34/EC [72] for all products entering the EU that are analysed for veterinary 
drugs and thus are within the scope of 97/78/EC [60], the MRPL should be 
regarded as a reference point of action. In other words, for banned substances, 
only concentration levels above the MRPL are considered being non-compliant 
results. If the result of an analytical test is below the MRPL “the competent 
authority has to retain a record of the findings in case of recurrence” [72] and 
appropriate measures should be taken in the case “results of analytical tests on 
products from the same origin show a recurrent pattern indicating a potential 
problem related to one or several prohibited or unauthorised substances” [72]. 
Due to the principle of equality this guideline is considered to apply not only for 
imported products but for all products tested [73,74]. 
Criteria for quantitative residue analysis 
For quantitative results, the measurement uncertainty expresses the dispersion 
of the quantitative value of a single analytical result. Validation procedures to 
determine the measurement uncertainty of quantitative methods are described 
in 2002/657/EC [57]. In this document the concept of measurement uncertainty 
is incorporated by the parameters CCα, the decision limit, and CCβ, the 
detection capability, allowing this uncertainty to be applied in the decision 
making process. This concept was already stated in ISO 11843-1 [75] but was 
adopted in the analysis of veterinary drugs residues in products of animal origin 
in 2002. These parameters are discussed in detail elsewhere [57,76,77]. 
Definition: 
“Decision limit(CCα) ► the limit at and above which it can be concluded 
with an error probability of α that a sample is non-compliant.” [57] 
 
Definition: 
“Detection capability (CCβ) ► the smallest content of the substance 
that may be detected, identified and/or quantified in a sample with an 
error probability of β. In the case of substances for which no permitted 
limit has been established, the detection capability is the lowest 
concentration at which a method is able to detect truly contaminated 
samples with a statistical certainty of 1 – β. In the case of substances 
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with an established permitted limit, this means that the detection 
capability is the concentration at which the method is able to detect 
permitted limit concentrations with a statistical certainty of 1 – β.” [57] 
Criteria for identification 
In 1977 the Food and Drug Administration was the first to publish criteria for 
regulatory assays for carcinogenic residues [78]. For confirmatory analysis a 
requirement is that “the observed response must without question be due to the 
compound being measured and only this compound” [79]. 
In 1978, for the first time mass spectrometry guidelines for confirmatory analysis 
using electron impact ionisation (EI) were reported by Sphon [79]. Based on a 
database containing the empirical results of over 30.000 compounds, using 
diethylstilbestrol as a model compound, it was concluded that the number of ions 
in an EI mass spectrum needed for confirmatory analysis depends on their 
uniqueness, but that three ions of the proper ratio can be regarded as the 
minimum number [79,80]. Although this was specifically reported as being a 
guideline instead of a rule, this observation became known as the “three-ion 
criterion” [81] and was applied in practice. An update of Sphon’s experiment was 
reported in 1997 [82] and again in 2008 [83], showing that the choice of ions used 
for confirmatory purposes is critical to prevent false positive findings. 
Sphon [79] only took the mass spectrometric detection into consideration and 
therefore in 1997 a method was suggested to determine the suitability of 
complete methods based on “selectivity indices” [82]. This was based on the fact 
that selectivity is directly related to the different steps of the method of analysis 
applied, including the extraction and the sample clean-up. In this approach 
different extraction, clean-up, and detection techniques were assigned a certain 
number of selectivity indices. By combining extraction, clean-up, separation 
(thin layer chromatography, LC or GC) and detection techniques to obtain a 
minimum number of selectivity indices, a method could be considered adequate 
for confirmatory analysis.  
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In 2002 the European Union established criteria concerning the performance of 
analytical methods and the interpretation of results [57]. According to this 
document, to obtain adequate identification power, confirmatory methods have 
to provide information on the chemical structure of the substance and thus only 
spectrometric detection techniques are considered to be sufficient, among which 
fluorescence detection (only for group B substances) and mass spectrometry, 
both in combination with chromatography. However, based on recent false 
positive findings, gas chromatography coupled to mass spectrometry (GC-MS) or 
liquid chromatography coupled to MS (LC-MS) are the preferred techniques for 
confirmatory analysis [84,85]. 
According to 2002/657/EC [57], if full scan single MS is used, a minimum number 
of four ions (group A substances) or three ions (group B substances) must be 
present in the spectrum having a relative intensity of > 10 % of the base peak. 
This is a more stringent criterion compared to the “three-ion criterion” [79]. If 
product ions are monitored using other than full scan techniques, the 
“identification points concept” applies, which was introduced in 2001 [86] and 
was later included in 2002/657/EC [57]. This approach is derived from the 
previously mentioned approach based on “selectivity indices”, but because 
selectivity was then predominantly considered a function of the measuring 
technique, the extraction and clean-up were not included.  
When using GC- or LC-MS a method should earn a minimum number of 
identification points for confirmatory analysis. For the identification of group B 
substances, three identification points were considered adequate and for group A 
substances, this is four identification points [57,87]. The number of points earned 
for each mass spectrometric technique is presented in table 1.2. It is stated that 
“(1) each ion may only be counted once, (2) GC-MS using electron impact 
ionisation is regarded as being a different technique to GC-MS using chemical 
ionisation, (3) different chemical derivatives of an analyte can be used to 
increase the number of identification points only if the derivatives employ 
different reaction chemistries and (4) transition products include both daughter 
and granddaughter products” [57]. 
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Table 1.2. Earned identification points per MS technique [57,87]. 
MS technique Identification points 
Low resolution mass spectrometry (LRMS) 1.0 
LRMSn precursor ion 1.0 
LRMSn transition products 1.5 
High resolution mass spectrometry (HRMS) 2.0 
HRMSn precursor ion 2.0 
HRMSn transition products 2.5 
 
As a result, when using GC or LC in combination with low resolution MSn a 
combination of one precursor ion and two product ions results in four 
identification point which is sufficient for confirmatory analysis. Another option 
is the monitoring of two precursor ions, each with one product ion, resulting in 
five identification points. In all cases a minimum of one ion ratio (relative ion 
abundance) must be determined and all determined ion ratios must comply with 
the criteria as presented in table 1.3 before the result can be considered as 
being non-compliant. Furthermore, in LC, the difference of the retention time of 
the unknown analyte and the reference standard should not exceed 5 %. This is 
2.5 % in the case a relative retention time is calculated based upon an internal 
standard. 
Parallel to the EU criteria, other guidelines stating confirmatory analysis criteria 
were established [88-94]. All are in agreement with the EU guidelines with regard 
to the requirement to use chromatography in line with either full scan MS or 
MS/MS in selected ion monitoring mode [95,96]. Furthermore, all state that in 
the case of MS/MS at least two transitions from precursor to a product ion should 
be monitored to obtain adequate selectivity and according to all documents 
confirmation of the identity should be carried out by comparing the ion ratio of 
the unknown compound in the sample with a known reference standard 
permitting maximum tolerance levels. Even though the approaches are very 
similar, the criteria for accepting or rejecting a match differ significantly. The 
different criteria that apply to LC-MS(/MS) are presented in table 1.3. 
Furthermore, criteria for the (relative) retention time in LC differ (table 1.3). 
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Table 1.3. Maximum allowed tolerance levels of relative ion abundances and 
retention time for confirmation of the identity based upon LC-MS/MS according 
to different guidelines [57]. 
Guideline Ion ratio (%) Maximum tolerance levels 
relative ion abundance 
Maximum tolerance levels 
for (relative) retention 
times 
EU [57] > 50 ± 20 % relative RT: 5 % 
RRT: 2.5 % 
 > 20 - 50 ± 25 % relative  
 > 10 - 20 ± 30 % relative  
 ≤ 10 ± 50 % relative  
SANCO 
12495 [88] 
Equal to EU   
SOFT/AAFS 
[89] 
All ± 20 – 30 % relative “Slightly larger than” 2 % 
AORC [91] All ± 20 % absolute or ± 40 % 
relative, whichever is 
larger 
RT: 2 % or 12 s, whichever 
is the larger 
RRT: 2 % 
CVM [92] All ± 10 % relative in case of 
two transitions 
± 20 % relative in case of 
three transitions 
5 % 
IOC [90] All ± 10 % absolute or ± 25 % 
relative, whichever is 
larger 
RT: 1% 
RRT: 1 % 
UK Drug 
testing [93] 
All ± 20 % relative 2 % or 3 s, whichever is the 
lower 
WADA [94] ≥ 50 - 100 ± 15 % absolute RT: 2 % or 24 s, whichever 
is the lower 
 ≥ 25 and < 50 ± 25 % relative  
 < 25 ± 10 % absolute  
SANCO = Directorate General for Health and Consumer Affairs 
SOFT/AAFS = Society of Forensic Toxicologists / American Academy of Forensic Sciences 
AORC = Associating of Official Racing Chemists 
CVM = Center for Veterinary Medicine 
EU = European Union 
IOC = International Olympic Committee 
WADA = World Anti-Doping Agency 
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Confirmation versus identification 
In ISO 17025 [97] general requirements for the competence of testing and 
calibration laboratories are laid down. This document states that “calibration 
certificates shall contain the measurement results including the measurement 
uncertainty”. Often, uncertainty is solely regarded as a parameter applicable to 
quantitative results. However, ‘uncertainty’ can be interpreted as a much 
broader concept which involves both the quantitative and the qualitative aspect. 
Definition: 
“Uncertainty (in statistics) ► noun, the estimated amount or percentage 
by which an observed or calculated value may differ from the true 
value.” [2] 
“Uncertainty ► noun, the state of being uncertain –Uncertain ► 
adjective, not able to be relied on; not known or definite.” [2] 
Although 2002/657/EC [57] does not specifically discuss the uncertainty of a 
qualitative result, it states that a result can only be considered non-compliant if 
“the decision limit of the confirmatory method for the analyte is exceeded”, 
indicating that the use of a confirmatory method is mandatory. 
Furthermore, the document defines confirmatory methods as “a method that 
provides full or complementary information enabling the substance to be 
unequivocally identified (…)” [57]. To obtain a clear view on the implications of 
this statement, a brief discussion on the concept of confirmation versus 
identification is needed, which is discussed in more detail elsewhere 
[80,81,95,98]. 
No universally-accepted definitions for confirmation and identification exist. In 
this thesis the term ‘confirmation’ presumes knowledge on the identity of the 
compound present, e.g. from previous analysis or from other information. A 
positive confirmation indicates that the result is not against the presumptions 
made: the compound shows the same characteristics as the reference compound 
selected, but it does not exclude the possibility of the presence of another 
compound showing the same characteristics. From this Lehotay et al. [80] 
concluded that for confirmation a second method (preferably having orthogonal 
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selectivity to the first method) is mandatory. At least one of both methods 
should meet the identification criteria [80]. However, neither in 96/23/EC [59] 
nor in 2002/657/EC [57] a second method is prescribed.  
Definition: 
“Confirmation ► noun. the action of confirming something or the state 
of being confirmed.” [2] 
“Confirm ► verb. Establish the truth or correctness of (something 
previously believed or suspected to)” [2] 
In contrast, in ‘identification’ no a priori presumption on the substance present is 
made and thus identification requires that all other substances are excluded, so 
that the reported substance is the only possible candidate [95]. 
Definition: 
“Identification ► noun, the action or process of identifying someone or 
something or the fact of being identified.” [2] 
“Identify ► verb, establish or indicate who or what (someone or 
something) is.” [2] 
In conclusion, although some uncertainty is allowed for a quantitative result, no 
uncertainty is specified for the qualitative result (the confirmation). When 
realising the indefinite number of substances that exist (also including substances 
not yet known to mankind), unequivocal identification is an impossible task [80] 
and therefore a degree of uncertainty of the qualitative result should be 
considered depending on the risks involved related to a false positive finding 
[81]. 
Selectivity 
The identification power and therefore the qualitative uncertainty of the 
confirmatory method is expressed in its selectivity. This term is often 
interchangeably used with ‘specificity’ [99], which is actually the ultimate of 
selectivity [100]. In contrast to specificity, selectivity can be graded (e.g. being 
high, excellent or extreme) but it is not clear what each gradation exactly 
reflects [101,102]. 
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Definition: 
“Specific ► adjective, clearly defined or identified.” [2] 
 
Definition: 
“Selective ► adjective, relating or involving the selection of the most 
suitable or best qualified.” [2] 
“Selectivity ► the ability of a method to distinguish between the 
analyte being measured and other substances.” [57] 
“Selectivity ► the extent to which a method can determine particular 
analyte(s) in a complex mixture without interference from other 
components in the mixture.” [103] 
Selectivity is a measure directly related to the chance of the occurrence of a 
false positive identification. In case of a false positive result the presence of a 
certain substance is reported whereas this specific substance is not present. The 
power of discrimination between the substance present and closely related 
substances (isomers, metabolites, degradation products, endogenous substances, 
matrix constituents, etc.) is key to prevent false positive results in confirmatory 
methods. When one realises that non-compliant analytical results in food product 
analysis can have a huge effect on personal lives and society as well as on 
economy this becomes more than evident. In case the presence of a banned 
substance is reported whereas it is not truly present in the sample, farmers may 
be falsely accused of using banned carcinogenic antibiotics and go bankrupt after 
prosecution; certain branches may get a bad reputation and people may choose 
to avoid buying certain products; shipments of perfect quality food products 
might be destroyed, affecting the economy, international relations and food 
security. From this it is clear that, especially for confirmatory methods, 
selectivity is a very important parameter. 
None of the established MS and LC criteria [57,89-94] are based on scientific 
data, but are a result of experts’ judgments and thus it cannot be concluded that 
one criterion is better than the other. This depends on the point of view taken: 
strict criteria result in an increased probability of false negative results whereas 
less strict criteria result in an increased possibility of obtaining a false positive 
result. This concerns respectively producer protection versus consumer safety. 
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A review on the fundamentals of the confirmation criteria was reported by Van 
Eenoo et al. [104] and Faber [105] who both observed that there is no fluent 
transition between the maximum allowed tolerances for the different ion ratio 
categories in the WADA and EU regulations. For instance, in the WADA 
regulations, in case the reference ion ratio is 24 %, the maximum allowed 
tolerance is 10 % (absolute), whereas for a reference ion ratio of 25 % the 
maximum allowed tolerance is 6.25 % (absolute). 
Although all of the ion ratio criteria were established based on experts’ 
judgment, it is not unlikely that incorrect identification takes place. Critical 
reviews of the ion ratio criteria were presented by Kaufmann et al. [76,106]. The 
influence of matrix constituents on the ion ratio was described and appointed as 
a possible cause of deviating ion abundances. In the described analysis of 
quinolone antibiotics in a marbofloxacin containing muscle sample, this resulted 
in deviating ion ratios and therefore the detected compound could not be 
identified as being marbofloxacin according to EU regulations [57] and would in 
practice result in a false negative result. Also, a case of a false positive 
identification was reported [107]. Sebuthylazine, a pesticide compound, was 
identified according to the EU criteria [57] in a tarragon (Artemisia dranunculus) 
sample whereas, after additional high resolution mass spectrometric analysis, the 
compound could be identified as the endogenous nepellitorine [107].  
In summary, maximum tolerance limits for ion ratio and retention time as 
established in several legal documents are very useful tools for the confirmation 
but not necessarily for the identification of compounds. However, some aspects 
that are not explicitly stated in the guidelines should be taken into account: 
- The selectivity of the whole procedure, including the sample 
preparation procedure. 
- The importance of LC: low resolution and high resolution LC are still 
considered equally selective. 
- The relative importance of certain transitions: EU legislation indicates 
that “the selected diagnostic ions should not exclusively originate from 
the same part of the molecule” [57], but the loss of water or ammonia 
during collision induced dissociation (CID) is considered equally 
selective to the loss of larger, more compound specific losses. The UK 
guidelines for urine drugs testing mention product ions that are 
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considered insufficiently selective, viz. m/z < 50, 58, 86, 91 and 105 
[93] and the Society of Forensic Toxicology indicated the low selectivity 
of the loss of water [102]. 
An alternative to the use of a priori established tolerance limits as indicated by 
the legal framework was presented by Van de Voet et al. [108] for GC-MS 
analysis. The applicability of constructing a confidence interval for the ion ratio 
based on empirical data was demonstrated using a multi-variate approach. This 
approach was found very useful to replace a priori established tolerance limits, 
especially at very low concentration levels. A simpler uni-variate approach was 
pointed out by Faber [105]. Using these approaches, the confidence needed for 
determination of the identity can be easily set by adjusting the confidence 
interval parameters. But the chance on false positives and false negatives is set 
based on empirical data (e.g. from a validation) and it does not give information 
on the selectivity of the applied method. 
Assessment of selectivity 
According to 2002/657/EC [57] a confirmatory method shall be able to distinguish 
between the analyte and other substances under the experimental conditions 
chosen. Two approaches are recommended to demonstrate the selectivity. First, 
potentially interfering substances that are likely to be encountered shall be 
evaluated. Representative blank samples shall be fortified at a relevant 
concentration with these substances to test for interferences. Second, at least 20 
representative blank samples shall be analysed under within-laboratory 
reproducibility conditions to detect the presence of possible interferences and to 
estimate the effect of these interferences.  
According to the regulations, from the combination of the ‘identification points 
concept’ and the recommendations to test for interferences, optimal selectivity 
should be obtained, even though the guidelines do not seem to originate from 
statistically supported data. At the same time the document states: “An estimate 
to which extent this (the occurrence of a false positive result) is possible has to 
be provided.” However, no guidelines are given to do this. How to determine and 
express the grade of selectivity? 
 
 
 
 32 
To express the grade of selectivity of chemical reactions, in 1965, the use of 
selectivity indices was suggested [102,109]. A selectivity number was assigned 
based on the number of compounds that would respond to the reaction in the  
most favorable circumstances possible. One compound would result in a 
selectivity index of I, two compounds in a selectivity index of II, three to five in a 
selectivity index of III, etc. It would not be necessary to have more than about 
six or seven groups because if several compounds respond in a reaction the term 
selectivity would become meaningless [102]. This approach was further improved 
in 1976 differentiating natural selectivity (under general conditions) and 
selectivity under the most favorable conditions [110].  
An approach for evaluation of the certainty of analytical methods, among which 
chromatography and mass spectrometry, was reported in 1989 [111]. An 
uncertainty factor was introduced representing the reciprocal value of the 
number of possibilities for an open set and the ratio of the number of 
indistinguishable items to the total number of items for a closed set. As a result, 
an uncertainty factor of 50-1 was found for LC. However, this is based upon the 
number of peaks fitting in a chromatogram and is not correlated to any 
parameters (e.g. polarity) of the compound detected. 
The same approach resulted in an uncertainty factor of 10-8 for low resolution 
MS. However, this is based upon equal probability of all ions in a mass spectrum. 
From 10,000 mass spectra, Van Marlen et al. [112], determined the probability of 
the presence of an ion in GC-MS. Binary coded mass spectra were used and thus 
the abundance of the ions was discarded. On this basis the information given by a 
specific ion was determined indicating that the presence of an ion at m/z 77 
gave the most information and is therefore the most selective. 
McLafferty et al. [113] and Pesyna et al. [114,115] carried out probability based 
mass spectra matching and regarded the probability of ions to occur in a mass 
spectrum. From a large collection of GC spectra, the occurrence of ions between 
m/z 29 – 400 were modeled indicating that ions at m/z 29, 39, 41, 43, 55, 57, 73, 
91 and 105 have a high probability in contrast to ions at m/z 37, 38, 49 – 53 and 
62 – 66, which have a low probability. Furthermore, a nearly linear correlation 
was found between the mass and the occurrence of ions above m/z 115. Based 
on this probability matching was carried out based upon the probability theory 
which states that if a number of events occur with a certain probability, the 
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probability of all these events to occur is the multiplication of all the individual 
probabilities. This overall probability is a measure for the uniqueness of a 
spectrum and thus for selectivity. 
Only limited data are available on the probability of the occurrence of ions in MS 
using electrospray ionisation (ESI) as is the most commonly applied ionisation 
technique in veterinary drug residue analysis [116]. 
Methods of analysis 
Methods are generally divided in screening and confirmatory methods. Screening 
methods are usually inexpensive, rapid and suitable for high-throughput analysis, 
but do not provide unequivocal identification and usually do not result in exact 
quantitative results. Confirmatory methods must be instrumental spectrometric 
techniques and therefore are more expensive and time-consuming, but are 
supposed to be highly selective in order to provide unequivocal identification. 
The combination of a bio-based screening method and an instrumental 
confirmatory method is very strong in residue analysis. With a bio-based 
screening a fast qualification (compliant or suspect) of samples can be made 
based on biological activity. Compliant samples can be reported right away and 
the usually few suspect samples can be subsequently analysed by a more 
elaborate confirmatory method based on chemical properties of the compound.  
Bio-based screening methods 
Several bio-based tests have been reported for the screening of antibiotic 
substances in different matrices. Bio-based screening methods used for the 
detection of antibiotics in products of animal origin have been reviewed recently 
[117-120]. The most commonly applied bio-based screening techniques for 
antibiotics are immunoassays, microbiological inhibition assays and reporter gene 
assays [120]. 
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Immunoassay 
Immunoassays are based upon a binding reaction between a compound and an 
antibody. The most commonly applied immunoassay in antibiotic analysis is the 
enzyme-linked immuno sorbent assay (ELISA) [117]. Different test formats exist 
in ELISA, but all tests are based upon the same principle. The sample that is 
screened for antibiotic content is incubated with antibodies, under the 
production of an analyte-antibody binding complex. Next, the degree of binding, 
which is related to the level of antibiotics present in the sample, is determined 
(e.g. by adding a fluorescent label) [117,118,121]. ELISA tests for analysis of ß-
lactam antibiotics have been reviewed recently [122] and immunoassay tests for 
the analysis of chloramphenicol were reported as well [123-128]. Note that apart 
from ELISA other platforms such as surface plasmon resonance (SPR) biosensors 
[121,129-136] and dipstick assays can be applied [137].  
An important advantage of immunoassays is that they are able to detect the 
presence of antibiotics at very low levels, which makes them even useful for 
screening of banned substances but the main challenge of immunoassays is the 
production and supply of antibodies, which should be selective towards the 
aimed antibiotic compound or group. 
Microbiological inhibition assays 
Microbiological inhibition assays are based on a reaction between a bacteria and 
the antibiotic present in the sample. The tube and plate test are the most 
common formats for this type of screening assays.  
The tube test consists of a growth medium inoculated with a bacterium, 
supplemented with a pH or redox indicator. If no specific antibiotics are present, 
the bacteria start to grow and produce acid, which will cause a detectable color 
change. If antibiotics are present that inhibit bacterial growth, no color change 
will occur [119,138]. Within Europe, the tube test is commonly applied for the 
analysis of milk. 
The plate test consists of a layer of inoculated nutrient agar and samples are 
brought onto the surface. If no specific antibiotics are present, the bacteria start 
to grow throughout the plate. If a specific antibiotic is present, no bacterial 
growth will occur around the sample, which can be observed from the bacteria-
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free inhibition zone. In Europe this has been the main test format since screening 
of slaughter animals for the presence of antibiotics started [119]. Many 
combinations of plates (up to seven within one test) containing different bacteria 
under varying environments are applied to cover the relevant spectrum of 
antibiotics at relevant levels [119,122]. A few critical comparisons of plate tests 
were reported in literature [139-141]. 
An important advantage, compared to immunoassays and instrumental methods is 
that microbiological tests can detect any antibiotic compound that shows 
antibacterial activity [142] and they have the potential to cover the entire 
antibiotic spectrum within one test [119]. The most important drawbacks of the 
microbiological tests are their lack of selectivity of especially the tube test, 
relatively high detection limits and the long incubation time. As a result 
microbiological inhibition assays are not suitable for detection of banned 
antibiotic compounds like chloramphenicol. 
Reporter gene assays 
Reporter gene assays consist of a genetically modified bacterium, containing an 
inducible promoter, responsive to a particular antibiotic, coupled to a reporter 
gene or operon [120]. Based on the presence or absence of responsive 
antibiotics, the reporter gene induces a fluorescent signal or the operon affects 
the transcription to produce or inhibit a signaling process.  
An example is the Tet-Lux which is based on specific, tetracycline-controlled 
expression of bacterial luciferase genes that code for enzymes responsible for 
light emission [143]. When tetracyclines enter the genetically engineered cell, it 
releases a repressor protein from the luciferase operon allowing synthesis of the 
luciferase reporter genes, resulting in a luminescence signal [120,144,145]. A 
comparable assay has been reported for the screening of macrolide antibiotics 
[146]. 
The tetracycline cell-biosensor was compared with the microbial inhibition test 
[147]. The cell-bioassay was found to be more sensitive and faster than the 
microbial assay. 
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Instrumental methods 
Until the last decade of the 20th century, the main instrumental techniques used 
for veterinary drug residue analysis were liquid chromatography (LC) using ultra 
violet detection (UV), diode array detection (DAD) and fluorescence detection 
(FLD), and gas chromatography (GC) using flame ionisation detection and 
electron capture detection [148]. 
Since 1992 LC coupled to mass spectrometry (MS) became more affordable and 
was gradually implemented for the analysis of compounds for which GC is 
unfavorable due to thermolability or insufficient volatility [149]. Since then 
numerous methods for the analysis of veterinary drug residues were developed 
using either LC or GC coupled to triple quadrupole (QqQ) MS [150,151] as can be 
concluded from the increase in peer-reviewed papers during the last decade 
(figure 1.6). 
 
Figure 1.6. The number of peer-reviewed papers in the last decade (found in 
SciFinder [152], using the key words ‘mass spectrometry’ AND ‘chromatography’ 
AND ‘residue’ AND ‘veterinary drugs’. 
The first generation QqQ-MS systems needed relatively long dwell times (> 100 
ms) in the multiple reaction monitoring (MRM) acquisition mode to obtain a 
sufficient number of ions for accurate detection of an ion transition [153]. This 
dwell time in combination with the low resolution of the LC system limited the 
number of compounds that could be detected within one run [154]. As a result 
Chapter 1 
 
37 
single-compound methods and multi-methods that included antibiotics belonging 
to a single compound group, were developed [155]. 
In the last decade fast switching (< 10 ms) triple quadrupole instruments became 
available. This facilitated the development of high performance liquid 
chromatography (HPLC) MS/MS methods in which a larger number of compounds 
were detected within one run. These methods include up to 120 compounds 
belonging to different antibiotic groups [155-168] and even to different classes 
like veterinary drugs and pesticides [154]. 
The development of high resolution LC (HRLC) featuring sub-2 µm stationary 
phase particles delivered a higher chromatographic resolution and higher sample 
throughput, because separation can be carried out with the same or better 
chromatographic resolution within a shorter time frame [169]. This innovation 
resulted in further development of multi-compound and multi-class methods 
containing over 250 compounds belonging to different compound groups [168-
177]. 
Meanwhile, with developments in the detection limits of time of flight mass 
spectrometry (TOF/MS) and the development of orbitrap instruments, highly 
selective, HR-MS detection techniques became routinely available [178]. Because 
HR-MS is a full scan technique, in theory, an indefinite number of compounds 
that can be ionised by the selected ionisation technique can be analysed 
simultaneously within a certain m/z range. Several methods using these 
techniques for the analysis of, among others, antibiotics have been published 
[179-186].   
Challenges in antibiotic residue analysis 
Mass spectrometry is considered a highly selective technique. It is often assumed 
that, when carrying out a confirmatory analysis according to the confirmation 
criteria, the identification is unequivocal. This suggests that the identity of the 
compound present is proven beyond any doubt. However, as discussed above, 
this depends on many factors including the measurement technique, sample 
preparation, and the number and nature of the (product) ions monitored. 
Therefore, the occurrence of false positive results cannot be entirely ruled out. 
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Challenge 1 
Legitimate questions are: 
- Is the reported substance truly the substance present? 
- What are the chances the observed signal is a result of the presence of 
an interfering substance rather than the reported substance? 
To be able to answer these questions, a method is needed to determine the 
uncertainty of the identification provided by confirmatory analysis. Whether 
or not the certainty of the identification of the compound present is adequate 
depends on the nature of the detected compound and the risks at stake.  
Challenge 2 
However, other aspects are also relevant before initiating enforcement measures 
or even a trial. Legitimate questions are: 
- Is the detected substance endogenous or exogenous? 
- Is the detection of a substance a result of off-label use? 
The issue of endogenous versus exogenous was first recognised in doping control. 
As an example 19-norandrosterone (NA) is used as a marker to detect misuse of 
the synthetic anabolic steroid 19-nortestosterone [187] in sports doping. 
However, small amounts of NA are biosynthesised by pregnant women and 
further evidence exists for physiological origin of this compound and thus WADA 
defined NA as endogenous in 2006 [187]. Examples in animals are the endogenous 
production of the banned anabolic steroid 17β-nortestosterone in intersex pigs 
[188,189], the banned thyreostat thiouracil that proved to occur endogenously in 
animals through a brassicaceae diet [190,191] and semicarbazide, a marker for 
the banned antibiotic nitrofurazone, that is not exclusively related to 
nitrofurazone use, but can occur naturally in shrimp [192].   
Note that many antibiotics, among which chloramphenicol and penicillin, were 
first isolated from bacteria and thus do occur naturally as well. Research is 
needed to determine whether these antibiotics can occur in products of 
animal origin via a natural route. 
Challenge 3 
Another challenge in antibiotic residue analysis is related to the emergence of 
antibiotic resistance. It is recognised only recently that antibiotic usage in 
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veterinary practice and the presence of low levels of antibiotics in food products 
and the environment contribute to the emergence of antibiotic resistance [29]. 
Therefore, methods capable of detecting off-label use of antibiotics should 
be developed. Legitimate questions are:  
- Are detection limits sufficient to detect off-label use? 
- Are adequate marker metabolites monitored to be able to detect off-
label use?  
- Are all relevant compounds, including metabolites, detected? 
A clear example is the analysis of ß-lactams in poultry production. A main 
difficulty in ß-lactam analysis is that some penicillin antibiotics are unstable 
(mainly ampicillin, amoxicillin, penicillin G and penicillin V) [4] and that some 
cephalosporins, including ceftiofur, are known to rapidly metabolise after intra-
muscular administration. To allow detection of off-label use, methods need to be 
developed that include a broad spectrum of ß-lactam antibiotics and that not 
only detect the administered drug, but also are able to detect metabolites 
thereof, including protein bound residues. 
Thesis outline 
This thesis is a result of research carried out within the field of antibiotic residue 
analysis. In chapter 2 a literature review is presented on the latest trends 
observed in the sample clean-up procedures in the field of veterinary drug 
residue analysis using LC-MS/MS. As a consequence of the advances in the 
available instruments the number of compounds that are analysed in a single run 
increased rapidly throughout the last decade. As a prerequisite, to be able to 
simultaneously analyse compounds having different physical and chemical 
properties, extraction and sample clean-up procedure had to change as well. This 
has resulted in the development of generic, non-selective sample preparation 
procedures. The most frequently reported generic sample preparation methods 
are a solvent extraction only, solid phase extraction and a QuEChERS (Quick, 
Easy, Cheap, Effective, Rugged, Safe) approach. 
In chapter 3 the selectivity of analytical LC-MS/MS methods based on the 
identification points concept is studied. The chance of an incorrect identification 
depends on parameters related to the LC separation like the polarity of a 
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compound. and parameters related to the MS detection, like the molecular mass 
and product ion mass. Based upon these parameters, models were established to 
determine the grade of selectivity obtained. If needed, additional measures can 
be taken to increase the selectivity of the method applied.  
In chapter 4 a major analytical challenge is discussed: the analysis of the banned 
antibiotic chloramphenicol (CAP). CAP is a broad-spectrum antibiotic with 
historical veterinary use in all major food-producing animals. CAP is a suspect 
carcinogen and can cause bone marrow toxicity and aplastic anemia, and for this 
reason the drug is banned for use in food-producing animals in the EU and in 
many other countries. In recent years, findings of CAP residues in food products 
such as poultry, honey and sheep casings had a major impact on international 
trade [193]. CAP can occur in the meta-configuration and in the para-
configuration and has two chiral centers, resulting in eight different isomeric 
configurations. Only for RR-p-CAP regulations were established because this is 
the active isomer. The challenges related to the analysis of CAP are introduced in 
more detail in section 4.1. 
A complicating factor in the analysis of CAP is that it is biosynthesised by the soil 
organism Streptomyces venezuelae and chemically synthesised for commercial 
use as well [194]. Evidence of the natural occurrence of CAP in plants and soil is 
presented in section 4.2. 
In section 4.3 research is presented in which the selectivity of generally applied 
LC-MS/MS methods for the confirmatory analysis of CAP in relation to its isomers 
was determined. Furthermore, a chiral LC-MS/MS system was developed to be 
able to discriminate the eight CAP isomers. Using this method, it was studied if 
the comparison of the isomeric patterns of non-compliant samples with the 
isomeric pattern of CAP formulations yields information on the origin of CAP 
residues. 
In section 4.4 a new method to distinguish the presence of the active 
configuration of CAP from the other configurations at trace level in urine is 
presented. In this especially the development of the sample clean-up was 
challenging to obtain a robust separation of the isomers on the chiral LC column. 
The hypotheses was suggested that CAP, present in soil, is taken up by plants and 
accumulates there. This would explain the positive findings of CAP in plants, 
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herbs, straw and corn silage. A model plant experiment was set-up to investigate 
this hypothesis of which the work is presented in section 4.5.  
In chapter 5 the analysis of ß-lactam antibiotics in tissue is discussed. The β-
lactam antibiotics consist of three main groups: penicillins, cephalosporins and 
carbapenems. Apart from their human medicinal use, penicillins are the most 
frequently used antibiotics in poultry breeding [25], which is likely to have 
contributed to the emergence of extended-spectrum-ß-lactamase-producing 
bacteria. Cephalosporins are assigned as critically important antibiotics in human 
medicine [195] and should be used sparingly. Nevertheless, bacterial resistance 
against this group has been reported as well. To prevent further evolvement and 
dissemination of bacterial resistance, effective analytical methods are needed to 
detect off-label use of ß-lactams in animal breeding. The challenges related to ß-
lactam analysis are introduced in more detail in section 5.1. 
A main difficulty in ß-lactam analysis is that some penicillins are unstable and 
that some cephalosporins, including ceftiofur, are known to rapidly metabolise 
after intramuscular administration. In section 5.2 the work on the degradation 
study of ceftiofur and cefapirin under several conditions is presented and the 
impact of the results on the monitoring of these drugs is discussed. 
The ceftiofur MRL was defined as the sum of all active metabolites expressed as 
DFC [9] and thus all metabolites should be included in the methods. In section 
5.3 a new approach for ceftiofur analysis is described which is compared to 
routinely applied approaches. To allow detection of not only the administered 
drug but also metabolites thereof, including protein bound residues, the 
selectivity was intentionally compromised. 
Based on the new approach a method was developed for the analysis of a broad 
range of ß-lactam antibiotics including penicillins, cephalosporins (including their 
relevant metabolites) and carbapenems. This work is presented in section 5.4. 
Finally, in chapter 6 general conclusions on selectivity, antibiotic residue 
analysis, and chrloramphenicol and ß-lactam analysis specifically are summarised 
and future perspectives are discussed. 
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Abstract 
Sample preparation is a critical process in relation to analysis time, sample 
through-put and therefore analysis costs. Due to recent advances in liquid 
chromatography mass spectrometry instrumentation the detection of many 
compounds within one run became possible and methods for the simultaneous 
analysis of different compound groups were developed. To be able to 
simultaneously analyse such compounds having different physical and chemical 
properties, generic, non-selective sample preparation procedures are applied. 
The most frequently reported generic sample preparation methods are a solvent 
extraction only, solid phase extraction and a QuEChERS approach. These multi-
analyte methods - sometimes including more than 150 different compounds in 
one method – are of much interest for analytical laboratories due to the 
reduction of costs. A clear drawback of generic sample preparation procedures is 
the occurrence of abundant matrix effects which compromise detection limits, 
quantitative aspects, method selectivity and maintenance frequency. In contrast 
to the trend towards non-selective sample preparation, an opposite trend 
towards more selective sample preparation methods is expected to be able to 
unambiguously confirm the identity of compounds, e.g. stereoisomers. This 
review gives an overview of generic sample preparation procedures in the field of 
the analysis of veterinary drug residues in products of animal origin using liquid 
chromatography coupled to mass spectrometry as a detection technique and an 
outlook towards expected future trends.  
Introduction 
Sample preparation is the process of extracting chemical residues from the 
matrix, removing interfering substances and, if needed, the subsequent 
concentration of the extract and the deconjugation or derivatisation of the 
compounds of interest. The sample preparation in the field of residue analysis of 
veterinary drugs in products of animal origin is of critical importance. Since the 
composition of the final extract introduced into the instrumental system, mainly 
depends on the sample preparation procedure, it highly impacts the final results 
in terms of detection limits, reproducibility, ruggedness and selectivity. 
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Furthermore, sample preparation is a critical process in relation to analysis time, 
sample throughput and therefore analysis costs. 
Sample preparation is not a goal by itself but merely a logical consequence of the 
detection technique applied. Therefore a clear relation between the selectivity 
of applied sample preparation procedures and the selectivity of detection 
techniques available is observed. Until the end of the 20th century mainly liquid 
chromatography (LC) was used coupled to triple quadrupole (QqQ) mass 
spectrometers that needed relatively long dwell times (> 100 ms) in the multiple 
reaction monitoring (MRM) acquisition mode in order to obtain a sufficient 
number of ions for accurate detection of an ion transition [1]. This dwell time in 
combination with the low resolution of the LC system limited the number of 
compounds that could be detected within one run. As a result multi- methods 
that included compounds belonging to a single compound group, were developed 
[2]. In the last decade, high resolution LC (HRLC) featuring sub-2 µm stationary 
phase particles, and fast scanning (< 10 ms) triple quadrupole instruments 
became available facilitating the detection of a larger number of compounds 
within one run. Meanwhile, with developments in the detection limits of time of 
flight mass spectrometry (TOF-MS) and the development of orbitrap instruments, 
highly selective, high resolution MS (HRMS) detection techniques became 
routinely available [3]. Because HRMS is a full scan technique, in theory, an 
indefinite number of compounds can be analysed simultaneously. Both HRLC and 
HRMS resulted in the development of new analytical strategies that included over 
a hundred compounds belonging to different compound groups, including 
antibiotics, growth promoters, pesticides and natural toxins. As a consequence of 
the advances in the available instruments the number of compounds that are 
analysed in a single run increased rapidly throughout the last decade. 
With the increasing number of compounds that are analysed simultaneously, 
analytical methods, including the sample preparation procedure, have to be 
applicable to compounds having very different physical and chemical properties. 
Therefore multi-residue protocols include very generic sample preparation 
procedures to obtain sufficient recovery for all compounds. However, as a result 
of applying a generic and inherently non-selective sample preparation procedure, 
the final extract contains a significant amount of matrix constituents that might 
interfere in the detection and overall method selectivity can be compromised. 
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Therefore, one should be aware of the pronounced matrix effects and the limited 
selectivity of the sample preparation procedure, which might result in higher 
detection limits, interfering signals and more variation in the quantitative result 
[2,4-7]. 
Reviews on sample preparation techniques applied since 2004 have been 
published previously [2,8-10]. Reviews mainly covered new analytical techniques 
[8-16], automation [8,9,17], miniaturization [8,18], regulations for confirmatory 
methods [2,6] or specific matrices [2]. 
The scope of the current review is limited to the trend observed towards more 
generic sample preparation procedures in the field of the analysis of veterinary 
drug residues in products of animal origin using liquid chromatography coupled to 
mass spectrometry as a detection technique and thus the focus is on multi-
compound methods. This includes the use of solvent extraction only, solid phase 
extraction and QuEChER-based approaches. Furthermore, expected future trends 
are discussed. The scientific literature was evaluated covering 2008 – mid 2012 
based on the SciFinder and Scopus databases using the following keywords and 
combinations thereof: veterinary drugs, antibiotics, multi compound analysis, 
residues, sample preparation, liquid chromatography, solid phase extraction, 
QuEChERS. 
Generic sample preparation techniques 
As a generic sample preparation procedure solvent extraction only, very generic 
solid phase extraction (SPE) procedures and modifications on the QuEChERS 
(Quick, Easy, Cheap, Effective, Rugged, Safe) approach are most frequently 
reported and discussed in the following sections. 
Solvent extraction 
In the simultaneous analysis of multiple classes of veterinary drugs in products of 
animal origin, solvent extraction without further purification is frequently 
reported as the method of choice. Here solvent extraction includes conventional 
liquid-liquid extraction as well as the liquid extraction of homogenised tissues 
such as muscle, liver and kidney. A summary of the applications reported since 
2008, giving a good overview of the current trends in sample preparation 
procedures, is presented in table 2.1. 
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Table 2.1. Summary of applications using solvent extraction without further 
clean-up for the analysis of multi-class veterinary drugs in products of animal 
origin. 
Compound 
groups 
Matrix Method Ref. 
A, AVM, B, 
Q, T, TMP  
Meat-based 
baby food, 
powdered milk 
Soak with water. Extraction with acidic ACN. 
Filtration (nylon). HRLC-QqQ-MS. 
[19] 
Q, S, T Kidney, liver Extraction with acidic ACN/water (7:2 v/v). 
Partly evaporation of solvent and dilute with 
water/ACN (95:5 v/v). Filtration. HRLC-
Orbitrap-MS 
[7] 
AG, C, L, 
M, P, Q, 
morantel  
Milk Extraction with ACN. Evaporation of solvent and 
dissolve in water/ACN (1:1 v/v). Filtration 
(PVDF). HRLC-QqQ-MS. 
[20] 
C, P, M, S Milk Extraction with ACN. Evaporation of solvent and 
dissolve in NH4Ac. Filtration. LC-QqQ-MS 
[21] 
A, AG, M, 
P, S, T 
Honey Extraction with ACN. Extraction of the pellet 
with 10 % TCA. Extraction of the pellet with 
nonafluoropropionic acid in ACN followed by 
neutralisation. Hydrolysis of the pellet followed 
by extraction with ACN. Evaporation of the 
individual extracts and dissolve in water/MeOH 
(8:2 v/v). 
LC-QqQ-MS. 
[22] 
B, COC, M, 
N, NIZ, Q, 
S, T, TQ 
Honey, egg, 
milk, meat 
Soak the sample with water. Extraction with 
acidic ACN, MeOH or acetone (ACE). HRLC-QqQ-
MS. 
[23,24] 
A, AG, C, 
M, NSAID, 
P, Q, T, S  
Muscle Extraction with ACN/water (86:14 v/v) at 60 °C. 
Second extraction with water. Dilution of the 
combined extracts with water. Fat removal with 
hexane. LC-QqQ-MS. 
[25] 
AG, COC, 
L, M, P, Q, 
S, T 
Muscle Extraction with 2 % TCA/ACN (1:1 v/v). fat 
removal using hexane. Dilution with acidic 
water/ACN (1:9 v/v). Filtration (Nylon). HILIC-
LC-QqQ-MS 
[26] 
AG, L, Q, T Milk Extraction with 5 % TCA. Filtration (PVDF). LC-
QqQ-MS. 
[21] 
S, TMP, 
TPM 
Shrimp Extraction with 6 mL 20 % TCA in ultrasonic 
bath. Evaporation of solvent and dissolve in 
MeOH/water (1:4 v/v). Filtration (PTFE). LC-
TOF-MS. 
[27] 
M, P, Q, S, 
T 
Muscle Add EDTA solution. Extraction with MeOH/water 
(7:3 v/v). Dilution with water. LC-QqQ-MS 
[28] 
M, P, Q, S, 
T 
Muscle Extraction with MeOH/water (7:3 v/v), EDTA. 
Dilution with water. Filtration. HRLC-QqQ-MS. 
[29] 
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C, L, M, 
NIZ, P, Q, 
S, T, TMP 
Muscle PLE with water and EDTA. Evaporation of 
solvent. LC-QqQ-MS. 
[30] 
M, NIZ, P, 
Q, S 
Muscle PLE with water and EDTA. Evaporation of the 
solvent. LC-QqQ-MS 
[31] 
A:amphenicols, AG:aminoglycosides, AVM:avermectins, ßA:ß-agonists, 
B:benzimidazoles, C:cephalosporins, COC:coccidiostats, L:lincosamides, M:macrolides, 
NIZ:nitroimidazoles, P:penicillins, Q: quinolones, S:sulfonamides, T:tetracyclines, 
TMP:trimethoprim, TPM:triphenylmethanes, TQ:tranquilizers. 
To obtain optimal results, the extraction solvent has to be selected in such a way 
that efficient extraction of the target compounds is obtained, whereas the 
extraction of matrix constituents remains limited in order to prevent excessive 
matrix effects to occur. Therefore the selection of the solvent not only depends 
on the target compounds, but also on the matrix. Mol et al. [23] compared the 
use of ACN, MeOH and acetone (ACE) for the extraction of veterinary drugs, 
pesticides and toxins from honey, milk, eggs and muscle. For milk, MeOH showed 
the highest extraction recoveries, but the final extracts were turbid, probably 
due to insufficient protein precipitation [23,32] and the amount of fat present in 
the final extract [33]. Nevertheless, MeOH proved to be a quick alternative for 
the extraction of veterinary drugs from muscle [28,29]. In terms of extraction 
recoveries, ACE was found to be the most suitable extraction solvent across all 
tested matrices [23]. ACE did not show undesired side-effects like phase 
separation or turbid extracts but it showed sub-optimal performance in terms of 
co-extraction of matrix interferences and as a result ion suppression during 
detection. ACN typically provides high extraction recoveries, minimises co-
extraction of lipids [26] and is efficient for denaturation of proteins. Mol et al. 
[23] reported that when using ACN for the extraction of veterinary drug, 
pesticide and toxins the overall matrix effects decrease from muscle > milk > egg 
> honey, although for veterinary drugs specifically the matrix effect of honey 
seems worse and for muscle less. Furthermore, it was reported that MeOH 
performed worst in term of matrix effects and that although ACE showed the 
highest recovery overall, it also showed more severe matrix effects compared to 
ACN. As a result ACN was selected as the solvent for extraction of muscle and 
ACE for the extraction of milk, egg and honey [23]. For the analysis of veterinary 
drugs in products of animal origin ACN is the most frequently reported extraction 
solvent. However, it is reported that ACN does not sufficiently extract polar 
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analytes [32] as was demonstrated for the extraction of some quinolones from 
meat-based baby food and powdered milk [19]. Also low recoveries were 
observed for the ACN extraction of tetracyclines, which was most likely caused 
by complex formation of the analytes. As a result Kaufmann et al. [4] proposed a 
bipolar extraction combining an extraction with ACN and an extraction using a 
McIlvain buffer containing complexing agents. A double extraction using ACN 
significantly improved the extraction recoveries [33] but this enhances matrix 
effects as well [28]. 
Another frequently applied extraction solvent is trichloroacetic acid (TCA), which 
is an efficient solvent for protein removal [26,32] but might cause degradation of 
pH sensitive compounds such as ß-lactams and some macrolides [26,32]. In 
contrast Chiaochan et al. [26] reported that TCA is favorable for releasing 
protein bound compounds and stabilises basic aminoglycosides. As a result, 
Gaugain-Juhel et al. [21] reported two parallel solvent extraction methods to 
cover the complete range of antibiotics in the analysis of milk: ACN was used for 
the extraction of ß-lactams, macrolides and sulfonamides, whereas 5 % TCA 
proved to be better for the extraction of tetracyclines, aminoglycosides, 
lincosamides and quinolones. TCA (20 %) was reported not to be applicable for 
the extraction of shrimp, because it results in turbid extracts [27].  
Hammel et al. [22] studied the effect of subsequent extraction of antibiotics 
from honey with (1) ACN, (2) 10 % TCA/ACN (1:2 v/v), (3) nonafluoropentanoic 
acid (NFPA) in ACN and (4) a hydrolysis during 1 hour at 65 °C followed by 
extraction with ACN. The results are presented in figure 2.1. The amphenicols, 
macrolides, all sulfonamides except sulfanilamide and the penicillins except 
ampicillin and amoxicillin were extracted in the first extraction step using ACN 
with recoveries > 50 %. The extraction using TCA was necessary to effectively 
extract the tetracyclines, ampicillin and amoxicillin (recoveries > 50 %) and 
proved to be beneficial for all compounds except the aminoglycosides and 
sulfanilamide. NFPA was needed to extract sulfanilamide and the 
aminoglycosides for 90-100 % and to increase the recovery for the tetracyclins by 
20-40 %. The subsequent hydrolysis did not significantly increase the extraction 
recovery of any of the compounds. However, Sheridan et al. [34] stated that an 
acid hydrolysis is needed for the extraction of sulfonamides from honey and  
ound that this is disadvantageous for the analysis of ß-lactams and some 
macrolides, which are instable at low pH [4,26]. 
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Figure 2.1. Relative recovery (estimation based on 
an area normalization) of each analyte based on the 
four liquid-liquid extraction fractions analysed 
separately. Blank honey sample was spiked at a 
concentration of 50 μg kg-1. Reproduced from [22] 
with permission from the author. 
Frequently, the addition of a complexing agent like EDTA 
(ethylenediaminetetraacetic acid) is used during extraction [4,28-32,35-38]. 
Complexing agents are reported to be mandatory for the extraction of 
tetracyclins and some macrolides because these compounds have a strong 
tendency to form chelates with divalent metallic cations present in food samples 
[26,31,35,39]. The use of EDTA negatively affects the extraction of benzanthine, 
which is a marker residue for penicillin use [40]. 
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The use of pressurised liquid extraction (PLE) instead of regular solvent 
extraction using either water or an organic solvent was reported [30, 31] and 
proved to be beneficial for the recovery of most veterinary drugs at 70 °C and 
elevated pressure. For all compounds included, recoveries between 64 and 122 % 
were obtained. Another advantage is that also when using heated water instead 
of an organic solvent, acceptable extraction recoveries can be obtained which is 
environmental friendly and compatible with clean-up procedures like SPE.   
Methods that only consist of a solvent extraction procedure usually result in final 
extracts containing a large amount of matrix interferences and thus matrix 
effects are pronounced [7,19-23,26,30,41,42]. Ion suppression is a well-known 
matrix effect, which can result in an increase in the detection limits, negatively 
influences the quantitation and increases maintenance frequency. Suppression 
effects are usually related to the retention time of the compounds and are most 
pronounced for early and late eluting compounds [41,43] due to co-elution of 
e.g. salts, sugars, fatty acids and proteins. Also ionisation effects occurring in the 
orbitrap system, and therefore post-ionisation, were observed for low m/z 
compounds eluting within a particular retention time period when using orbitrap-
MS as the detection technique [7].  
An approach to reduce matrix effects is the addition of tungsten ions to further 
remove proteins [32]. Unfortunately tungsten ions covalently bind to organic 
amines and thus lead to low recovery for some target compounds like 
sulphonamides. Saturated ammonium sulphate was reported to be as efficient for 
protein precipitation, but co-precipitation of target compounds was observed. 
Kaufmann et al. [32] reported an optimum concentration of ammonium sulphate 
to facilitate additional protein precipitation for the extraction of honey and 
tissue, whereas Peters et al. [44] reported no improvement using ammonium 
sulfate in the extraction of egg, fish and muscle.  
Another approach to reduce matrix effects without additional clean-up 
procedure, is to dilute the final extract to counteract suppression [28,29,32,36]. 
If matrix effects cannot be eliminated, the use of isotopically labeled internal 
standards and, to some extent, the use of matrix matched calibrants are useful 
tools to still obtain reproducible quantitative results.  
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Besides the occurrence of ion suppression effects, another risk of a limited clean-
up is a drop in overall method selectivity due to the appearance of interfering 
peaks in the chromatogram. Granelli et al. [28] observed an interfering peak in 
one of both traces for tylosin when analysing muscle, ChiaoChan et al. [26] 
reported matrix interferences that eluted close to tylosin and amprolium, and 
Schürmann et al. [45] reported false positive findings when applying a generic 
sample preparation procedure in combination with MS detection according to 
2002/657/EC [46] for the pesticide sebuthylazine. 
Solid phase extraction 
A procedure that is frequently used as a clean-up technique in the simultaneous 
analysis of multiple classes of veterinary drugs in products of animal origin is SPE. 
Three types of SPE can be distinguished (figure 2.2): (1) regular SPE in which the 
extract is applied onto an SPE cartridge to retain the compounds of interest, 
followed by a wash step to remove matrix interferences and a subsequent elution 
of the compounds from the cartridge; (2) SPE applying a highly organic raw 
extract onto an SPE cartridge and immediately collecting the eluent for further 
analysis; (3) Dispersive SPE (dSPE) by adding sorbent material to a raw extract, 
followed by shaking and centrifugation and subsequent isolation of the 
supernatant. dSPE is usually included in the QuEChERS approach and is discussed 
in 2.3. A summary of the SPE applications in cartridge format reported since 
2008, giving a good overview of the current trends in sample preparation 
procedures, is presented in table 2.2. 
 
 
Figure 2.2. Schematic presentation of (a) regular SPE, (b) pass-through SPE and 
(c) dSPE. 
a b c 
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Table 2.2. Summary of applications using SPE for the analysis of multi-class 
veterinary drugs in products of animal origin. 
Compound 
groups 
Matrix Method Ref. 
S, TMP, TPM Shrimp Extraction with metaphosphoric acid in ACN (6:4 v/v). 
Filtrate (PTFE). Partially evaporate the solvent. SPE 
Oasis HLB, wash with ACN/water (1:4 v/v), elute with 
ACN. Partially evaporation of solvent. Filtration (PTFE). 
LC-TOF-MS. 
[27] 
B, M, Q, S Egg Extraction with 0.1 M Na2EDTA (pH=4). Oasis HLB, wash 
with n-hexane, elution with ACN, MeOH, alkaline MeOH. 
Evaporation of solvent and dissolve in acidic 
MeOH/water (1:1 v/v). Filtration (nylon). HRLC-QqQ-MS. 
[36] 
B, C, NIZ, P, 
Q, S, TMP, 
TQ 
Meat Extraction with water/ACN (1:1 v/v), EDTA, (NH4)2SO4. 
Add (NH4)2SO4. Evaporation of organic solvent. Adjust to 
pH=6.5. SPE Oasis HLB, wash with water, elution with 
ACN and succinate buffer/ACN (1:1 v/v). Add DMSO. 
Evaporation of the organic solvent. Dilution with water. 
HRLC-TOF-MS. 
[4] 
L, M, Q, T, 
TMP 
Honey Extraction with McIlvain, Na2EDTA. Filtration. SPE Oasis 
HLB, wash with water/MeOH (95:5 v/v), elution with 
MeOH. Evaporation of the solvent. Dissolve in 0.2 % 
formic acid. 
[38] 
C, M, P, Q, 
S, T, 
bacitracin 
Milk Extraction with ACN. Dilution in 0.1 % formic acid. SPE 
Oasis HLB, wash with 0.1 % formic acid, elution with 
ACN/MeOH (7:3 v/v). Add 0.1 % formic acid. Partial 
evaporation of solvent. Ultrafiltration 30 kD. 
[47] 
M, Q, S, T Honey Extraction with Na2EDTA (pH=4). SPE Oasis HLB [39] 
A, B, COC, 
I, M, P, NIZ, 
NSAID, Q, S, 
T, TMP, TQ  
Egg, 
fish, 
meat 
Extraction with ACN/water (6:4 v/v). Dilution of 
supernatant in water. SPE Strata-X RP, wash with water. 
Egg: elution with MeOH/ethyl acetate (EtAc) (1:1 v/v). 
Fish/meat: elution MeOH/ACN (1:1 v/v). Evaporation of 
solvent and dissolve in ACN, dilute in acidic water. 
HRLC-TOF-MS. 
[44] 
A, AG, I, L, 
M, S, T, 
fumagillin 
Honey Extraction with water. Aliquot for streptomycin analysis. 
Filtration (nylon). SPE Strata-X RP, wash with water and 
hexane, elute with MeOH, ACN and alkaline MeOH. 
Partial evaporation of solvent. Dilution with water. LC-
QqQ-MS. 
[42] 
A, B, I, M, 
NIZ, NSAID,  
P, Q, S, T, 
TMP, TQ 
Milk Extraction with ACN. Dilution with water. SPE Strata-X 
RP, wash with water, elution with MeOH. Evaporation of 
the solvent. Dissolve in ACN. Dilute in acidic water. 
HRLC-TOF-MS. 
[48] 
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COC, CS, Q, 
S, TMP, 
griseofulvin  
Milk Extraction with ACN. Dilution with water. SPE Strata-X 
RP, elution with MeOH. Evaporation of the solvent. 
Dissolve in acidic MeOH.  
[33] 
B, C, I, NIZ, 
P, Q, S, 
TMP, TPM, 
TQ 
Honey, 
fish 
Extraction with water/ACN (35:45 v/v), EDTA, (NH4)2SO4. 
Add (NH4)2SO4. Evaporation of organic solvent. Adjust to 
pH=6.5. SPE Evolute ABN, wash with water, elution with 
ACN and succinate buffer/ACN (1:1 v/v). Partial 
evaporation of the solvent. Dissolve in water. HRLC-
Oribtrap-MS. 
[32] 
ßA, CS, 
stimulants, 
narcotics 
Urine Hydrolysis at pH=4.8 with ß-glucuronidase/aryl 
sulphatase. SPE Oasis MCX, wash with 1 M acetic acid 
and NaAc buffer/ACE (85:15 v/v), elution with alkaline 
ethyl acetate. Evaporation of the solvent. Dissolve in 
water/ACN (5:95 v/v). HRLC-TOF-MS. 
[49] 
B, ßA, BDP, 
CS, NIZ, Q, 
S, T, TPM 
Meat, 
milk, 
egg 
Mix with anhydrous Na2SO4. Double extraction with 
acidic ACN. Extraction EtAc. Evaporate combined extract 
and dissolve in alkaline MeOH. Pass through SPE Oasis 
HLB, elute with alkaline MeOH. Evaporation of solvent 
and dissolve in water/ACN (7:3 v/v). HRLC-QTOF-MS. 
[50] 
AVM, B, M, 
Q, T, S 
Egg Extraction with ACN, citric acid (pH=4), 0.1 M Na2EDTA. 
Pass through Oasis HLB cartridge, Partial evaporation of 
solvent and dilute with acidic MeOH/water (1:1 v/v). 
Filtrate (nylon). HRLC-QqQ-MS. 
[36] 
A:amphenicols, AG:aminoglycosides, AVM:avermectins, ßA:ß-agonists, 
B:benzimidazoles, BDP:benzodiazepams, COC:coccidiostats, CS:corticosteroids, 
I:ionophores, L:lincosamides, M:macrolides, NIZ:nitroimidazoles, NSAID:non-steroidal 
anti-inflammatory drugs, P:penicillins, Q:quinolones, S:sulfonamides, T:tetracyclines, 
TMP:trimethoprim, TPM:triphenylmethanes, TQ:tranquilizers. 
In general, matrix effects can be significantly reduced by using an SPE procedure 
[50]. However, in order to use an SPE approach for a broad range of compounds, 
having different physical and chemical properties, the choice of the interaction 
mechanism is limited. Peters et al. [49] used a mixed mode cation exchange 
material for the clean-up of hydrolysed urine samples for the analysis of multi-
class prohibited small substances. Others use C18, Oasis HLB, Strata-X RP or 
Evolute ABN which are all based upon hydrophilic-lipophilic interaction. To retain 
even the polar target compounds, a low organic content of the extract that is 
applied onto the SPE cartridge is mandatory. Therefore, the extraction solvent 
should have a high water content or additional procedures have to be applied to 
change the solvent of the raw extract prior to SPE [44]. Even though the use of 
an high organic extraction solvent like ACN or ACE is favorable for high solvent 
extraction recoveries (2.1), aqueous solvents are frequently applied if the 
extraction is followed by an SPE procedure [36,38,39,42]. In other cases the 
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organic solvent is evaporated before SPE [4,32,50], which is time-consuming or 
the organic phase is diluted with an aqueous solvent [33,44,47,48].  
In single-compound methods selective wash steps and a selective elution can be 
used to effectively separate the target compounds from matrix interferences. 
Because the chemical properties of the target compounds in multi-class methods 
are usually very diverse, the options for clean-up in SPE are limited. Water, 
formic acid, water/methanol (95:5 v/v) and hexane [36,42] are used for washing 
the SPE cartridges to remove highly hydrophilic and highly lipophilic matrix 
interferences. Elution of the target compounds, which are mostly polar or semi-
polar, is carried out by pure organic solvents or mixtures thereof at neutral or 
alkaline conditions. The analytical separation is usually based on the same 
separation principle (reversed phase (RP)) and therefore the additional 
selectivity obtained by SPE is limited. Therefore, co-elution with interfering 
compounds and thus ion suppression effects remain [33,42] but surprisingly, in 
some cases lower matrix effects and lower detection limits are reported [48]. An 
evaluation of the matrix effects of milk samples after SPE is reported by Ortelli 
et al. [43]. It is shown that matrix effects especially occur during the first and 
last part of the chromatogram and therefore influence the analysis of the most 
hydrophilic and lipophilic compounds. For milk the matrix effects after SPE are 
relatively variable throughout different samples [43], complicating quantitative 
analysis when no isotopically labeled internal standards are available. 
RP SPE is somewhat limited towards polar compounds [44,48]. As an example the 
aminoglycosides, which are highly polar compounds, are usually not included in 
procedures that use SPE as a clean-up technique. Lopez et al. [42] included the 
aminoglycosides in their multi-class method, but a fraction of the raw extract 
was isolated before SPE to be able to detect the aminoglycosides. Another 
example is the low recovery found for tetracyclins in the generic SPE procedure 
applied by Frenich et al. [36]. They also show the limitations of SPE towards 
highly lipophilic compounds like ivermectin.  
Kaufmann et al. [32] presented the use of an Evolute ABN cartridge which has a 
smaller pore size (40 Å) compared to other commercially available polymeric 
reversed phase materials (60 Å). As a result, interfering high molecular weight 
compounds are more effectively removed and the protein content of the final 
extract dropped by a factor two to three compared to the use of Oasis HLB 
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cartridges. On the other hand the ABN material shows slightly lower retention 
power which negatively affects its performance towards polar compounds due to 
the increase of break-through. 
Deng et al. [50] and Frenich et al. [36] developed a procedure in which an 
organic extract is passed through a reversed phase SPE cartridge. This is effective 
for removal of lipophilic matrix interferences and is comparable to dSPE. 
QuEChERS approach 
A third frequently applied clean-up technique in the multi-class analysis of 
veterinary drugs in products of animal origin is a QuEChERS procedure which 
consists of the extraction with an organic solvent and phase separation using a 
high salt content, in some cases followed by dSPE. This procedure is considered 
to be quick, easy, cheap, efficient, robust and safe and found its origin in 
pesticide analysis [51]. Since a few years QuEChERS approaches are also applied 
in the analysis of multi-class veterinary drugs in products of animal origin; a 
summary, giving a good overview of the current trends in sample preparation 
procedures, is presented in table 2.3. 
Table 2.3. Summary of applications using QuEChERS for the analysis of multi-
class veterinary drugs in products of animal origin. 
Compound 
groups 
Matrix Method Ref. 
AVM, B, M, 
Q, S, T 
Egg Extraction with acidic ACN and 0.1 M Na2EDTA. 
Shake with anhydrous MgSO4 and NaAc. Dilution 
with acidic MeOH/water (1:1 v/v). Filtration 
(nylon). HRLC-QqQ-MS. 
[36] 
B, COC, M, 
NSAID, NIZ, 
Q, S, T, TQ 
Honey, egg, 
milk, meat 
Soak with water. Extraction with acidic ACN, 
MgSO4, NaAc. HRLC-QqQ-MS.  
[23] 
A, AVM, B, 
Q, T, TMP  
Meat-based 
baby food, 
powdered 
milk 
Extraction with acidic ACN. Shake with 
anhydrous MgSO4 and NaAc. Filtration (Nylon). 
HRLC-QqQ-MS. 
[19] 
B, M, Q, S, 
T 
Milk Extraction with acidic ACN and EDTA. Shake with 
anhydrous MgSO4 and NaAc. Filtration (nylon). 
Dilution with acidic MeOH/water (1:1 v/v). 
HRLC-QqQ-MS. 
[35] 
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AVM, B, M, 
Q, S, T  
Milk Extraction with acidic ACN and EDTA. Shake 
with anhydrous MgSO4 and NaAc. Filtration 
(nylon). Dilution with acidic MeOH/water (1:1 
v/v). HRLC-QqQ-MS. HRLC-TOF-MS. HRLC-
Orbitrap-MS. 
[52] 
P, S, T Muscle Extraction with acidic ACN. Shake with 
anhydrous MgSO4 and NaAc. Evaporation of 
solvent. Dissolve in MeOH and dilute in water. 
HRLC-Orbitrap-MS. 
[53] 
P, S, T Milk Extraction with acidic ACN/water (5:6 v/v). 
Shake with anhydrous MgSO4 and NaAc. 
Evaporation of solvent. Dissolve in MeOH and 
dilute in water. HRLC-Orbitrap-MS. 
[53] 
I, DNC, NIZ, 
Q, S 
Tissue Extraction with ACN, acidic ACN, ACN/water 
(7:15 v/v) or acidic ACN/water (7:15 v/v). Shake 
with anhydrous NaSO4 or MgSO4. For NIZ 
additional SPE Oasis MCX. LC-QqQ-MS. 
[54] 
AVM, B, M, 
Q, S, T 
Milk Extraction with acidic ACN and Na2EDTA. Shake 
with anhydrous MgSO4 and NaAc. Dilution with 
acidic MeOH/water (1:1 v/v). HRLC-QqQ-MS. 
[37] 
S, TMP, TPM Shrimp Extraction with acidic ACN. Shake with 
anhydrous MgSO4 and g NaCl. dSPE PSA and 
anhydrous MgSO4. Evaporation of solvent and 
dissolve in MeOH/water (1:4 v/v). Filtration 
(PTFE). LC-TOF-MS. 
[27] 
P, S, T Liver Extraction with acidic ACN. Shake with 
anhydrous MgSO4 and NaAc. pSPE with PSA, C18 
and anhydrous MgSO4. Evaporation of solvent. 
Dissolve in MeOH and dilute in water. HRLC-
Orbitrap-MS. 
[53] 
AVM, B, F Milk, liver Extraction with ACN. Shake with anhydrous 
MgSO4 and NaCl. pSPE with C18 or PSA and MgSO4. 
LC-QqQ-MS. 
[55] 
AVM, B, M, 
Q, S 
Muscle Add water and extraction with ACN/water (8:2 
v/v). Shake with anhydrous MgSO4, sodium 
citrate dibasic sesquihydrate and sodium citrate 
dehydrate. dSPE with PSA. Filtration (nylon). 
Dilution with acidic water/ACN (1:1 v/v). HRLC-
QqQ-MS. 
[40] 
M, NIZ, P, 
Q, S 
Muscle Extraction with acidic ACN. Shake with 
anhydrous MgSO4. dSPE with PSA. Evaporation of 
the solvent. Dissolve in water/ACN (9:1 v/v).  
[31] 
A:amphenicols, AVM:avermectins, B:benzimidazoles, COC:coccidiostats, 
DNC:dinitrocarbanilide, F:flukicides, M:macrolides, NSAID:non-steroidal anti-
inflammatory drugs, NIZ:nitroimidazoles, P:penicillins, Q:quinolones, S:sulfonamides, 
T:tetracyclines, TMP:trimethoprim, TPM:triphenylmethanes, TQ:tranquilizers. 
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The majority of methods based on the QuEChERS approach consist of a solvent 
extraction with acidic ACN in the presence or absence of EDTA followed by phase 
separation using anhydrous magnesium sulphate as a drying agent. A few 
methods include a subsequent dSPE procedure using C18 [55], primary secondary 
amine (PSA) [27,31,40,55] or a combination of both [53].  
The preferred extraction solvent when using a QuEChERS approach is acidic ACN, 
whereas the preference for acidic solvents is not as clear for solvent extraction 
methods without further clean-up. It is demonstrated that recoveries in a 
QuEChERS approach significantly improve for especially quinolones when using 
acidic ACN [31].  
Several drying agents have been compared. Low recoveries for especially 
quinolones when using silica due to adsorption were reported [31]. No 
differences in terms of recovery were observed when using anhydrous MgSO4 or 
Na2SO4 [31,54], but MgSO4 was selected for its better dispersion characteristics 
[31]. It is observed that the amount of drying agent is an important parameter. 
Too low amounts result in incomplete water removal and therefore a less 
efficient clean-up during dSPE. A too high amount results in lower recoveries for 
the quinolones [31], probably caused by adsorption to the drying agent. 
Also the sorbent used for subsequent dSPE is critical. Carbon is not suited 
because it results in low recoveries or complete loss for a broad range of 
compounds [31]. Blasco et al. [31] reported that recoveries for PSA and C18 were 
similar, whereas others reported lower recoveries for especially the flukicides 
[55], for polar compounds [31,50] and spiramycin [31] when using PSA. PSA 
resulted in cleaner extracts for muscle [31] and milk [55] and is thus favourable 
for these matrices. For the analysis of liver, because of its high fat content, the 
use of C18 is reported to be beneficial [53,55]. The amount of sorbent is not a 
critical factor, but too high amounts can result in cloudy extracts [31]. In dSPE 
(as well as in regular SPE) the organic content of the extract has to be critically 
reviewed: when using C18 sorbent, if the aqueous phase is not completely 
removed by phase separation and thus an excess of water is present, immediate 
loss of lipophilic compounds onto the sorbent material will occur.  
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Blasco et al. [31] reported that the QuEChERS approach resulted in more severe 
matrix effects for bovine muscle compared to PLE. Matrix effects were primarily 
observed for early eluting compounds. As a result the detection limits for some 
compounds are higher using QuEChERS compared to PLE. Others observed 
significant matrix effects for the QuEChERS procedure as well [35,40]. 
Other generic clean-up procedures 
Some other clean-up techniques that have shown to be applicable for multi-class 
analysis of veterinary drugs in products of animal origin were reported. These 
include ultrafiltration and ultra-low temperature phase separation. A summary of 
such methods published since 2008 is presented in table 2.4.  
Ultrafiltration is a very quick technique and is applied in the analysis of samples 
with a high protein content. It was reported that using an ultrafiltration 
procedure, some compounds show low recoveries when using a 30 kD filter [48]. 
Low recoveries and high variation for the avermectins were specifically observed 
when using a 3D cut-off filter, which was contributed to the voluminosity of 
these compounds [43]. 
As expected, a cut-off filter of 3 kD clearly showed cleaner extracts compared to 
a 10 and 30 kD filters [43]. Ortelli et al. [43] showed that ultrafiltration removes 
more lipophilic matrix interferences compared to SPE, but that the removal of 
hydrophilic interferences is worse. The matrix effects of different milk samples 
after ultrafiltration are very comparable, facilitating quantitative analysis by 
using matrix match calibrants.  
A method for the analysis of muscle based upon phase partitioning at ultra-low 
temperatures was reported by Lopes et al. [57]. This method consists of a solvent 
extraction using ACN and phase partitioning by freezing the aqueous fraction by 
immersing the test tube in liquid nitrogen. This approach is fast and selective, 
but proved to be problematic for ampicillin, clindamycin and erythromycin. 
Extracts were reported to be clean, but matrix effects were not specifically 
reported. 
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Table 2.4. Summary of applications of other generic sample preparation 
procedures for the analysis of multi-class veterinary drugs in products of animal 
origin.   
Compound 
groups 
Matrix Method Ref. 
GCS, 
designer 
drugs 
Urine Enzymatical hydrolysis (pH=7). pH adjustment to 
pH=9-10. Extraction with diethylether and 
anhydrous Na2SO4. Evaporation of organic phase 
and dissolve in water/ACN (5:95 v/v). HRLC-TOF-
MS. 
[56] 
C, M, P, S, T Milk Extraction with ACN. Acidify. Partial evaporation 
of solvent. Ultrafiltration 3 kD. LC-QTOF-MS. 
[41] 
AVM, B, ßA, 
C, CS, L, M, 
NIZ, NSAID, 
P, Q, S, T, 
TMP, TQ, 
others 
Milk Extraction with acidic ACN. Ultrafiltration 3 kD. 
Partial evaporation of organic phase. HRLC-TOF-
MS. 
[43] 
B, C, M, P, 
Q, S, T 
Muscle Extraction with ACN. Immerse tube in liquid 
nitrogen. Evaporation of the organic phase. 
Dissolve in formic acid solution. Filtration. LC-
QqQ-MS. 
[57] 
AVM:avermectins, ßA:ß-agonists, B:benzimidazoles, C:cephalosporins, 
CS:corticosteroids, GCS:glucucorticosteroids, L:lincosamides, M:macrolides, 
NIZ:nitroimidazoles, NSAID:non-steroidal anti-inflammatory drugs, P:penicillins, 
Q:quinolones, S:sulfonamides, T:tetracyclines, TMP:trimethoprim. 
Outlook and future trends 
The trend towards the use of generic sample preparation procedures is not only 
observed in the field of veterinary drug residue analysis in products of animal 
origin, but also in the analysis of pesticides in various matrices [14,58] and 
pharmaceuticals in environmental samples like water, soil and plant material 
[59,60]. It is expected that the trend towards non-selective sample preparation 
continuous parallel to the development of more sensitive full-scan mass 
spectrometers having even higher resolution and scanning speed. Because generic 
sample preparation methods are usually straight-forward, also the trend towards 
further automation of the sample preparation will continue to further increase 
sample throughput [8,9,17] as well as the trend towards green chemistry [8,18].  
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Although a continuing trend towards generic sample clean-up procedures is 
observed, a parallel future trend is expected towards more extensive sample 
clean-up procedures to obtain a precise quantitation at ultra-low levels and to 
provide ultra-high selectivity for unambiguous confirmation of the identity. 
For all regulated compounds [61] quantitative analysis is of crucial importance in 
order to fulfil method requirements and to prove compliance or non-compliance 
versus the MRLs [46]. According to 2005/34/EC [62] for all products entering the 
EU that are analysed for banned veterinary drugs and thus are within the scope 
of 97/78/EC [63], the minimum required performance limit (MRPL) as stated in 
2002/657/EC [46] should be regarded as a reference point of action. In this 
perspective, with the increasing number of provisional MRPL’s, also the 
quantitative analysis of banned substances becomes increasingly important. 
Because in generic methods matrix effects can be pronounced and overall 
analyte recovery is compromised, the precision of the quantitation is 
compromised as well [64,65]. A common way to deal with these matrix effects 
and incomplete analyte recovery is by using appropriate calibration strategies 
[66,67]. 
In the case the detection limits are not sufficiently low due to the presence of 
matrix, the solution is to be found in a more selective (and therefore usually 
more extensive) sample preparation procedure to remove excessive matrix 
interferences. A clear example is the use of a multiple stage SPE procedure in 
the quantitative analysis of antiviral drugs in combination with a column 
switching liquid chromatographic system to overcome excessive matrix effects 
[68], the use of molecular imprinted polymers [69] and immunoaffinity based 
techniques [70]. 
According to criteria concerning the performance of analytical methods and the 
interpretation of results methods used for the analysis of samples taken for 
monitoring residues in animal products have to be validated according to the 
described procedures [46]. In these procedures selectivity is mentioned as a main 
characteristic of an analytical method. Selectivity is defined as “the power of 
discrimination between the analyte and closely related substances like isomers 
(...)”. To obtain sufficient selectivity to be able to comply with this definition 
and to discriminate among different stereo-isomers, selective methods are 
needed, usually involving chiral selectors. Recently, it has been reported that an 
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extensive clean-up procedure is mandatory for the stereo-isomeric selective 
analysis of clevudine in plasma [71] and chloramphenicol in urine [72].  
Nevertheless, from the experience in the authors’ laboratory it is concluded that 
for the analysis of a broad range of veterinary drugs in products of animal origin, 
solvent extraction only or in combination with an SPE clean-up is suitable 
[23,44,48,49,73]. Such methods are considered screening methods that are useful 
for application in a routine situation where high sample throughput is of major 
importance. In this, ACN is the preferred extraction solvent but in case 
tetracyclines are included in the method, EDTA should be added to the 
extraction solvent to prevent complex formation. Although ACE results in higher 
recoveries for especially lipophilic compounds, co-extraction of matrix 
interferences and thus matrix effects increase as well. The use of acidic or 
alkaline conditions during extraction can improve the procedure for specific 
compounds, but overall recoveries are compromised. Even though it was found 
that in some cases QuEChERS approaches are advantageous with regard to sample 
clean-up, from our experience this techniques limits the scope of the method 
especially for very hydrophilic compounds. 
Conclusions 
For the analysis of multi-class compounds, having very different physical and 
chemical properties, very generic procedures should be applied. The first 
challenge is the extraction of the target compounds from the complex matrices 
encountered in food analysis. The selection of the extraction solvent is related to 
the target compounds in order to obtain high extraction efficiency, but also to 
the matrix of interest to prevent excessive matrix effects and to obtain a final 
extract that is compatible with injection into the chromatographic system. 
Although acetonitrile and TCA are frequently used as extraction solvent in 
generic methods, no single extraction solvent is available for the extraction of 
the entire range of veterinary drugs from products of animal origin. Therefore, a 
combination of extraction methods is needed that have to be carried out 
subsequently or in parallel or a compromise has to be made in terms of recovery 
or the number of compounds included in the method. PLE seems more promising 
but data are scarce.  
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SPE procedures can be useful for the clean-up in the analysis of a broad range of 
veterinary drugs, but the scope is limited, especially toward very hydrophilic 
compounds. The advantage in terms of matrix effects is sometimes limited and 
SPE procedures can be quite laborious. In some cases the extraction solvent is 
sub-optimal or additional procedures allowing a solvent change in order to ensure 
compatibility with the SPE procedure are needed. 
QuEChERS is useful for veterinary drug analysis, but its scope is somewhat 
limited. Matrix effects using the QuEChERS procedure are more severe compared 
to PLE, but more data on the matrix effects when using QuEChERS approaches in 
the analysis of veterinary drugs are needed for an adequate comparison with 
solvent extraction, SPE and PLE. 
Besides the continuation of the development of generic non-selective sample 
preparation methods and the automation of these straight forward procedures, 
an expected parallel and opposite future trend is towards highly selective sample 
preparation to produce precise quantitative results at low levels and to be able 
to comply with regulations regarding confirmation of the identity of a 
compounds, e.g. when analysing compounds having a chiral centre like 
chloramphenicol or clenbuterol.  
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Abstract 
In the analysis of food contaminants and residues, sports doping and forensic 
sciences, quantitative and qualitative aspects are involved in declaring a sample 
non-compliant (positive). For the quantitative aspect of a method, validation 
procedures are available on basis of which the measurement uncertainty is 
determined and the quantitative uncertainty is taken into account in the decision 
making process. For the qualitative aspect, criteria for confirmation of the 
identity of a compound using liquid chromatography coupled to tandem mass 
spectrometry (LC-MS/MS) are laid down in several regulations. These criteria 
regard the minimum requirements for the instrumental set-up and criteria for 
retention time (RT) and relative product ion abundances in LC-MS/MS operated in 
the multiple reaction monitoring (MRM) mode. A positive confirmation indicates 
that the result is not against the presumptions made: the compound shows the 
same characteristics as the selected reference compound, but it does not 
exclude the possibility of the presence of another compound showing the same 
characteristics. No validation procedure is described to express this uncertainty 
of a qualitative confirmation result and only limited criteria were set for the 
selection of product ions: in most regulations, all product ions are assumed to 
have similar identification power. A procedure was developed on basis of which 
the identification power of an LC-MS/MS method, which is related to its 
selectivity, can be determined. A measure for the (un)certainty of the selectivity 
is the probability of any compound showing the same precursor ion, product ions 
and RT as the compound of interest. In this work this is calculated based upon 
empirical models constructed from three very large compound databases. Based 
upon the final probability estimation, additional measures to assure unambiguous 
identification can be taken, like the selection of different or additional product 
ions. The reported procedure in combination with criteria for relative ion 
abundances result in a powerful technique to determine the (un)certainty of the 
selectivity of any LC-MS/MS analysis and thus to decrease the risk of false 
positive results. Furthermore, the procedure is very useful as a tool to validate 
method selectivity. 
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Introduction 
In residue analysis of food contaminants, sports doping and forensic sciences two 
criteria exist for declaring a sample as being non-compliant (positive). The first 
criterion is quantitative: does the concentration of the contaminant significantly 
exceed the maximum tolerated limit? The second is a qualitative criterion: is the 
identity of a contaminant confirmed? There is no universally-accepted definition 
of confirmation or identification [1,2]. In this thesis, the term ‘confirmation’ 
presumes knowledge on the identity of the compound present, e.g. from previous 
analysis. A positive confirmation indicates that the result is not against the 
presumptions made: the compound shows the same characteristics as the 
selected reference compound, but it does not exclude the possibility of the 
presence of another compound showing the same characteristics. In contrast, in 
‘identification’ no a priori presumption on the structure of the substance present 
is made and thus identification requires that all other substances are excluded, 
so that the reported substance is the only possible candidate [3]. 
For the quantitative aspect of a method, validation procedures are available, 
stating criteria for trueness, repeatability and within-laboratory reproducibility 
[4]. On basis of the validation results the measurement uncertainty is 
determined, allowing this uncertainty to be applied in the decision making 
process. For the identification of a compound, the main validation parameter is 
selectivity which is defined as “the power of discrimination between the analyte 
and closely related substances…” [4]. Although some regulations have been 
established for the confirmation of the identity of a compound [4-11], these are 
all based on comparison of the hypothesised identity with a single reference 
standard thereby ignoring that another compound on this planet might yield a 
similar result. No validation procedures are described to express this aspect of 
the uncertainty of the qualitative result in LC-MS/MS analysis. 
Guidelines for confirmatory analysis using mass spectrometry with electron 
impact (EI) ionisation were reported for the first time in 1978 [12]. Based on the 
empirical study of product ion spectra databases, using diethyl stilbestrol as a 
model compound, it was concluded that the minimum number of ions in an EI 
mass spectrum needed for identification of a compound is three. This observation 
became known as the “three-ion criterion” [1] and was applied in practice. 
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Although three ions should be sufficient, the choice of ions used for confirmatory 
purposes is critical to prevent false positive findings [12-15].  
Criteria concerning the performance of analytical methods and the interpretation 
of results were established in the European Union in 2002 [4]. In residue analysis, 
mass spectrometry (MS), either in combination with liquid chromatography (LC) 
or gas chromatography (GC), was assigned as the main technique for 
identification of banned and regulated substances [4]. In 2001 the “identification 
point concept” was introduced [16], which was later included in 2002/657/EC 
[4]. This approach was derived from the “selectivity indices approach” in which 
different extraction, clean-up, and detection techniques were assigned a certain 
number of points [17,18], but because in the establishment of 2002/657/EC [4] 
selectivity was predominantly considered a function of the measuring technique, 
the selectivity obtained by the extraction and clean-up were not included in the 
final regulation. 
When using GC- or LC-MS a minimum number of identification points is required 
for ‘unequivocal identification’ [4]. For regulated substances (table 1 of EU 
2010/37 [19]) three identification points are considered adequate and for banned 
substances (table 2 in EU 2010/37 [19]) four identification points are required 
[4,20]. When full scan single MS is used, a minimum number of four ions must be 
present in the spectrum having a relative intensity of > 10 %, which is a more 
stringent criterion compared to the “three-ion criterion” [12]. If low resolution 
MS/MS is used, four identification points are earned for example when monitoring 
one precursor ion and two product ions and five identification points are earned 
when monitoring two precursor ions, each having one product ion. In all cases 
the relative ion abundance of a set of product ions (ion ratio) must comply with 
the criteria established in 2002/657/EC (table 3.1) before the sample can be 
considered non-compliant (positive). Slightly deviating criteria for relative ion 
abundances have been established by other organizations (table 3.1). Previously, 
a quantitative assessment of the probability of false positive results in EI-MS was 
carried out and it was concluded that more stringent criteria are needed to 
prevent false positive results [21]. This underlines that MS/MS criteria do not 
seem to originate from statistically supported data, but are a result of experts’ 
judgment and therefore it cannot be concluded that one criterion is better than 
the other. Moreover, this will depend on the point of view: more stringent 
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criteria result in an increased probability of false negative results whereas less 
strict criteria result in an increased probability of a false positive result [3]. 
A critical review on the ion ratio criteria was presented by Kaufmann et al. 
[22,23] and false positive findings based upon EU criteria have been reported 
[22,24,25]. It was concluded that, although the current criteria are a good 
starting point for confirmation of the identity of a compound, an additional 
procedure is needed to determine the (un)certainty of this qualitative result. 
Table 3.1. Maximum allowed tolerance of relative ion abundance for 
confirmation of the identity based upon LC-MS/MS according to different 
guidelines. 
Guideline Ion ratio (%) Maximum tolerance ion ratio deviation relative 
to the reference standard 
EU [4] > 50  ± 20 % relative 
 > 20 - 50 ± 25 % relative 
 > 10 - 20 ± 30 % relative 
 ≤ 10 ± 50 % relative 
SANCO [5] Equal to EU  
SOFT / AAFS [6] All ± 20 – 30 % relative 
AORC [7] All ± 20 % absolute or ± 40 % relative, whichever is 
larger 
CVM [8] All ± 10 % relative in case of two transition 
± 20 % relative in case of three transition 
IOC [9] All ± 10 % absolute or ± 25 % relative, whichever is 
larger 
UK Drug testing [10] All ± 20 % relative 
WADA [11] > 50 ± 10 % absolute 
 25 – 50 ± 20 % relative 
 5 to < 25 ± 5 % absolute 
 < 5 ± 50 % relative 
SOFT / AAFS = Society of Forensic Toxicologists / American Academy of Forensic 
Sciences 
AORC = Associating of Official Racing Chemists 
CVM = Center for Veterinary Medicine 
EU = European Union 
IOC = International Olympic Committee 
WADA = World Anti-Doping Agency 
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In this chapter a procedure is presented to judge the (un)certainty of the 
selectivity of a method using LC coupled to triple-quadrupole (QqQ) MS based on 
the precursor ion mass, the product ions selected and the RT on a specific 
reversed phase chromatographic system. With this procedure the uniqueness of 
the monitored LC-MS/MS characteristics can be estimated and on the basis of this 
result, it can be decided if additional data, e.g. a third product ion or more 
extensive sample clean-up, are needed for a trustworthy identification of the 
compound present. 
Methods 
Databases 
Three databases were constructed on basis of which the (un)certainty of the 
selectivity of an LC-MS/MS identification procedure was determined.  
Database A contains molecular mass data and was extracted from the eMolecules 
database [26], which contains over 5.3 million commercially available 
compounds. Because residue analysis focusses on small molecules, only the 
compounds having a molecular weight of 100-1000 were taken into account. Of 
these, all compounds containing at least one carbon in combination with at least 
oxygen, nitrogen, sulphur and/or phosphorous were selected because these 
compounds can most likely be ionised by electrospray ionisation. All salts and 
metal containing compounds were removed from the dataset, which resulted in a 
total of over 5.1 million compounds. Of these compounds the mono-isotopic 
nominal mass was calculated. 
Database B contains product ion spectra data and is constructed from the 
product ion spectra of 3629 compounds obtained from our own research, the 
Massbank database [27] and literature [28-35]. Of 3629 compounds, the positive 
ion mode electrospray ionisation (ESI) collision induced dissociation (CID) MS 
spectra were converted to binary spectra with a cut-off level at 5 % relative 
intensity. The combination of precursor ion mass and product ion mass, and the 
corresponding neutral losses, were included in the database, resulting in a total 
of 18314 entries. 
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Database C contains theoretical RT data on a specific high resolution LC system 
and is constructed from the qualitative structure-retention relationship (QSRR) 
model presented in this chapter. For 451 compounds, the relevant physical and 
chemical parameters were used to calculate the theoretical RT.  
Modeling the retention time 
UPLC grade water and methanol were obtained from Biosolve (Valkenswaard, the 
Netherlands). Ammonium formate was obtained from Merck (Darmstadt, 
Germany). Reference standards of 126 model compounds consisting of veterinary 
drugs, growth promoters and pesticides, were obtained from Sigma-Aldrich (St. 
Louis, MO, USA) and Ultra Scientific (North Kingstown, RI, USA). 
The LC system consisted of a vacuum degasser, autosampler, and a Waters 
(Milford, MA, USA) model Acquity binary pump equipped with a Waters Acquity 
HHS-T  analytical column of 2.1 × 100 mm, 1.7 μm placed into a column oven at 
30 °C. The gradient (solvent A, water containing 2 mM ammonium formate, pH 
3.5; solvent B, methanol/water (9:1, v/v) containing 2 mM ammonium formate): 
0 – 1.0 min, 0 % B, 1.0 – 11.0 min, linear increase to 100 % B with a final hold of 
0.5 min, operating at a flow rate of 0.4 mL min-1. The injection volume was 10 
μL. 
Detection was carried out using a Bruker Daltonics (Billerica, MA, USA) Micro-
QTOF MS in the positive electrospray ionisation (ESI) mode. The operating 
parameters were: end plate offset, -500 V; capillary voltage, 3.5 kV; nebulizer, 
2.0 bar; dry gas, 8.0 L min-1; dry temperature, 200 °C. 
Of 126 compounds the RT in the analytical system was determined. Furthermore, 
of each of these compounds 22 physical and chemical parameters were 
determined: Bioconcentration factor (BCF) at pH=5.5, Koc at pH=5.5, 
polarizability and molecular volume were obtained from Chemspider [36]; Log P, 
Log D at pH=3.0 and Log D at pH=5.5 were obtained from SciFinder [37]; total 
energy, Connolly accessible area, Connolly molecular area, Connolly solvent 
excluded volume, molecular mass, ovality, molecular refractivity, partitioning 
coefficient, Balaban index, molecular topological index, polar surface area, 
shape attribute, total connectivity, total valance connectivity and Wiener index 
were calculated from BioChem3D Ultra 12.0 after MM2 energy optimization [38]. 
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Extreme correlations among parameters were studied using GenStat software 
[39] and high correlations were excluded before further analysis. Next, using 
Genstat, the optimal parameters were selected to be included in the QSSR model 
to obtain the best relation between the parameters and the observed RT. Using 
the selected parameters, multiple linear regression was carried out to establish 
an optimal linear model. 
From the constructed model, the theoretical RT of an additional 325 randomly 
selected compounds were calculated. All compounds for which a theoretical RT 
below 0.6 min was calculated, being the dead time of the system and thus 
impossible in practice, were set at 0.6 min. From this data and the theoretical 
RT of the 126 model compounds the probability distribution of the theoretical 
retention time on the selected chromatographic system was constructed.  
Proposed procedure 
A measure for selectivity is the probability of the occurrence of a compound 
showing the same LC-MS/MS characteristics as the compound of interest: the 
probability of an interference, P(I). P(I) is calculated based upon independent 
probability matching: 
)(*))(),(max(*))(),(max(*)()( 2211 RTPMPMPMPMPMPIP nlpdnlpdpc ,  (1) 
in which P(Mpc) is the probability of the occurrence of the precursor ion, P(Mpd) 
the probability of the occurrence of the product ions of transition 1 and 2, P(Mnl) 
the probability of the occurrence of a neural loss of transition 1 and 2, and P(RT) 
the probability of the occurrence of a RT in the chromatographic system. 
Max(P(Mpd),P(Mnl)) is the maximum of P(Mpd) or P(Mnl) to represent a worst case 
situation. These parameters are determined based on the databases and 
empirical models presented in this chapter. Next, P(I) is compared to an a priori 
established criterion to rank the method selectivity, e.g. as sufficient or 
insufficient. Based on the result, corrective measures can be taken to obtain 
additional selectivity like the selection of another or an additional product ion. A 
flow chart of the proposed procedure is presented in figure 3.1. 
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Results and discussion 
An important parameter influencing the (un)certainty of the identification using 
MS, as was already pointed out by Sphon in 1978 [1,12], is the relative 
importance of certain transitions. EU legislation indicates that “the selected 
diagnostic ions should not exclusively originate from the same part of the 
molecule” [4], but even though clear differences in the selectivity of transitions 
were reported in literature [40], in most regulations very non-selective 
transitions like the loss of water or ammonia during CID are considered equally 
selective as compound specific fragmentations. The UK guidelines for urine drugs 
testing mention product ions that are considered insufficiently selective, viz. 
m/z < 50, 58, 86, 91 and 105 [10] and SANCO/12495/2011 states that high m/z 
ions arising from loss of water or from common moieties are of little use [5]. 
McLafferty et al. [41] and Pesyna et al. [42,43] regarded the probability of ions 
to occur in a mass spectrum. From a large collection of GC-EI-MS spectra, the 
occurrence of ions between m/z 29 – 400 were modeled indicating that ions at 
m/z 29, 39, 41, 43, 55, 57, 73, 91 and 105 have a high probability of being a high 
abundant ion in a EI mass spectrum, in contrast to ions at m/z 37, 38, 49 – 53 and 
62 – 66. On the obtained data, they carried out probability matching based upon 
the probability theory which states that if a number of events occur with a 
certain probability, the probability of all these events to occur simultaneously is 
the multiplication of all the individual probabilities. This overall probability was 
considered a measure for the uniqueness of a spectrum and thus for selectivity. 
Probability matching of selectivity 
Selectivity is a parameter that can be expressed in terms of the uniqueness of a 
compounds’ characteristics, in other words in terms of the probability of the 
occurrence of another compound possessing the same characteristics, P(I). If P(I) 
is high, the probability of an incorrect confirmation result is high and thus the 
method selectivity is considered low, whereas if P(I) is low the system used can 
be considered as highly selective. The selectivity for identification purposes using 
low resolution LC-QqQ-MS/MS, and thus the probability of an incorrect 
identification, is primarily determined by: (1) the combination of the selected 
precursor and product ions, (2) the RT of the compound and therefore the 
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probability of co-eluting interfering compounds and (3) the selectivity of the 
sample preparation method [17,18].  
According to EU criteria [4], using low resolution MS/MS, at least two transitions 
from precursor ion to product ion should be monitored to obtain a sufficient 
number of identification points. The selectivity of the monitored transitions is 
directly related to the m/z of the precursor ion(s), Mpc, and the product ions, 
Mpd. In theory, the most exact calculation of the probability of the occurrence of 
a combination of two transitions, P(MS), is given by applying dependent 
probability calculations. In that case P(MS) is the probability of Mpd2, given that 
the Mpd1 occurs and that both originate from the selected precursor ion(s). This 
can only be determined empirically from a very large MS/MS database and the 
final result will be limited by the total number of spectra included in this 
database. For instance if database B, containing 3629 spectra, is used and a 
unique combination of Mpc, Mpd1 and Mpd2 is found, it can be concluded that P(MS) 
is 2.8 10-4, or in other words 1 in 3629. This is a severe underestimation of the 
selectivity of the method and can only be overcome by increasing the total 
number of spectra in the database. However, if a result of e.g. 1 in 5,000,000 is 
considered the minimum to conclude that sufficient selectivity is obtained, at 
least 5,000,000 product ion spectra should be included in the database, which is 
far off reality for the time being. Therefore independent probability matching is 
proposed here, in which the individual probabilities of Mpc, Mpd1 and Mpd2 are 
multiplied. The selectivity of the precursor ion(s) is given by the probability of 
the occurrence of compounds showing the same precursor ion mass: P(Mpc). The 
selectivity of the product ions is related to the product ion mass (Mpd) itself, but 
also to the resulting neutral loss (Mpc-Mpd). For instance a product ion of m/z 400 
has a low probability, but if it origins from a precursor ion of m/z 418, and thus if 
a neutral loss of water (18 Da) is involved, this transition should be considered 
non-selective. In the proposed worst case approach, the selectivity of the 
product ion is determined by selecting the highest of either P(Mpd) or the 
probability of the corresponding neutral loss, P(Mnl). As a result, the probability 
of the occurrence of a compound having the same MS characteristics as the 
compound of interest is given by formula 2. 
))(),(max(*))(),(max(*)()( 2211 nlpdnlpdpc MPMPMPMPMPMSP   (2) 
These parameters can all be derived from the constructed databases A and B. 
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Additional selectivity is obtained from the liquid chromatographic system. From 
the regression model, based on 11 physical and chemical properties, the 
theoretical RT of any compound, including its uncertainty, can be estimated. 
Based on the theoretical RT of 451 compounds included in database C, the 
probability of co-elution with other compounds can be determined. Then the 
total probability of the occurrence of the selected characteristics, P(I) is 
calculated by formula 3.  
)(*)()( RTPMSPIP 
  (3)
 
A disadvantage of the application of independent probability statistics is that 
dependency of the data is assumed not to exist. Obviously, some dependencies 
will exist, for example singly charged precursor ions always result in product ions 
al lower m/z. Therefore no exact quantitation of P(I) is obtained in this work, 
but rather a very good estimate. The result should therefore not be considered as 
a quantitative measure, but as a ranking tool for selectivity, e.g. insufficient, 
sufficient, high. The calculated value of P(I) in relation to the ranking of 
selectivity depends on fitness for purpose [1] and other factors affecting method 
selectivity like the preceding sample preparation procedure. In this work the 
applied sample preparation procedure is not taken into account in calculating 
P(I). A very selective sample preparation procedure, e.g. the use of bio-affinity 
solid phase extraction will decrease the probability of interfering signals and thus 
a higher P(I) could be acceptable, whereas for very generic sample preparation 
techniques, which are increasingly being applied [44], a lower P(I) is needed. 
Furthermore, if a derivatization procedure is used in the sample preparation 
procedure, e.g. a hydrolysis using nitrobenzaldehyde as is common for nitrofuran 
analysis [25], all product ions or neutral losses related to nitrobenzaldehyde 
should be considered less selective than calculated from the method reported 
here, since an excessive number of compounds containing a nitrobenzaldehyde 
moiety will be present in the derivatised solution and thus database B would not 
be representative for this specific case. 
Note that in this approach the relative ion abundances are not taken into 
account, whereas this would usually result in additional certainty on the identity 
of the compound. Therefore, the method presented here is on the safe side and 
gives an overestimation of the true P(I).  
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Precursor ion probability 
The probability distribution of the m/z of the protonated molecules of all entries 
in database A is presented in figure 3.2. It is observed that, in database A, an 
m/z of 387 is most common having a probability of 0.0052. Consequently, 
interfering signals are more likely for compounds in the mass range around m/z 
400 compared to the lower and higher mass range. Therefore, the detection of 
compounds with Mpr around m/z 400 is considered less powerful than detection of 
compounds with an Mpr of e.g. 200 or 600. The obtained probability distribution is 
in good agreement with the distribution reported by Little et al. [45] who used 
Chemspider [36] as a reference. Kind and Fiehn, who used the Pubchem database 
[46] as a reference, found the highest probability at a slightly higher mass and 
reported a longer tail at the high mass range [47]. This might be a result of the 
presence of complexes and compounds containing metal atoms present in the 
Pubchem database, which have been removed from database A. At around m/z 
500 a non-linear transition is observed in the dataset. This is likely a result of the 
content of the eMolecules database, rather than a true lower relative occurrence 
of compounds at this specific mass. 
  
Figure 3.2. Probability distribution of the mass over charge ratio of the 
protonated molecules included in database A (n > 5,000,000). Solid line: fit 
according to equation 4. 
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P(Mpr) can be empirically determined from database A. For application of the 
method without access to the original database, the probability distribution was 
modeled assuming binomial distributed data and using a logit link function. By 
doing so, P(Mpr) can be calculated by formula 4, in which Mpr is the m/z of a 
precursor ion.  
 
 12
12
405000084.0067.08.19exp1
405000084.0067.08.19exp
)(



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Product ion probability 
From database B, the probability distribution of the product ions is presented in 
figure 3.3 for four categories of precursor ions: m/z 100 – 200, m/z 200 – 300, 
m/z 300 – 400 and > 400. These groups were defined to obtain at least 500 
product ion spectra per group. From the data presented in figure 3.3, for each 
precursor ion category a continuous model was constructed assuming binomial 
distributed data using a logit link function, to facilitate calculation of P(Mpd) 
(appendix 3.1). Some product ions show an exceptional high or an exceptionally 
low probability compared to this model (high residual) and for these cases the 
probabilities are presented individually in appendix 3.1.  
In the low mass range (Mpr = 100-200) the probability of the occurrence of a 
product ion around m/z 100 is the highest, in the mass range 200-300 this is m/z 
140 and at the higher mass range (Mpr > 300) this is m/z 170. Overall a product 
ion at m/z 91 has the highest probability and is therefore the least selective, 
followed by 105, 121, 109, 100 and 72. From these, only the product ions at m/z 
91 (tropylium cation) and 105 (benzoyl cation) were previously indicated as being 
insufficiently selective in LC-MS/MS by the UK guidelines for urine drugs testing 
[10]. 
The relation between the product ion probability distribution and the precursor 
ion mass was briefly studied. A clear decrease of the probability of the product 
ion at m/z 91 is observed with increasing precursor ion mass. To less extend this 
decrease is observed for m/z 105. One explanation for this observation is that for 
large precursor ion masses, sometimes only a limited product ion mass range has 
been acquired, missing certain low mass product ions. Therefore, the probability 
of product ions at m/z < 100 originating from large precursor ions can be 
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somewhat underestimated. However, this effect is not apparent for the 
continuous distribution of product ions observed for high mass precursor ions and 
thus it is concluded that this effect is relatively small. The second explanation is 
that in large molecules, more sites are available to dissipate the dissociation 
energy and thus the number of fragment stabilization options increase with the 
molecular mass. As a result, the probability of producing s specific low weight 
product ions decreases. 
Modeling product ion probability for the selected precursor ion mass ranges 
yielded large differences in models compared to the overall product ion 
probability model. The differentiation in the selected precursor ion mass ranges 
was found to be effective in coping with the obvious dependency between 
product and precursor ion mass probabilities. 
 
Figure 3.3. Probability distribution of product ion masses for precursor ions of 
m/z (a) 100 - 200, (b) 200 - 300, (c) 300 - 400 and (d) > 400. Product ions showing 
a high residual from the constructed model are indicated with a cross. n is the 
number of spectra per group. Solid line: fit according to the equations as 
presented in appendix 3.1. 
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Neutral loss probability 
From database B, the neutral losses were calculated (Mpr-Mpd). Although for 
neutral losses it is less obvious, a clear dependency between the neutral loss and 
the precursor ion mass was observed. Therefore, also for the neutral losses four 
product ion mass categories were established. The probability distribution of the 
neutral losses is presented in figure 3.4. 
 
Figure 3.4. Probability distribution of neutral losses for precursor ions of m/z 
(a) 100 - 200, (b) 200 - 300, (c) 300 - 400 and (d) > 400. Neutral losses showing a 
high residual from the model are indicated with a cross. n is the number of 
spectra per group. Note the extended y-axis in (a). Solid line: fit according to 
the equations as presented in appendix 3.2. 
From the data presented in figure 3.4, for each precursor ion category a 
continuous model was constructed assuming binomial distributed data using a 
logit link function to facilitate calculation of P(Mnl) (appendix 3.2). Again, some 
neutral losses show an exceptional high or an exceptionally low probability 
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compared to this model (high residual) and for these cases the individual neutral 
loss probability is presented in appendix 3.2. 
Overall a neutral loss of 18 Da has the highest probability and is therefore the 
least selective (as was reported previously [2]), followed by 46, 17, 45, 60, 73 
and 59. From experience, it was expected that the loss of water (18 Da), 
ammonia (17 Da), formic acid (46 Da) and acetic acid (60 Da), and for larger 
molecules glycoside (162 Da), have a high probability and are thus non-selective. 
However, other observations are not considered general knowledge, like the low 
selectivity of the neutral loss 59 and 73 Da. The neutral losses of 22 – 25 Da have 
an exceptionally low probability (Pnl=0) compared to the empirical model. This 
can be explained because neural losses at these masses are chemically 
impossible; no molecular structure can be drawn that is in agreement with these 
neutral loss masses. 
In a previous version of database B the high probability of neutral loss 162, 176, 
194 and 308 Da were quite dominant. These neutral losses are all to some extend 
related to the loss of glycoside, galactoside and glucuronide moieties. Especially 
the high probability of 176 Da was caused by the inclusion of the data obtained 
from Wissenbach et al. [32], who presented the fragmentation of a large number 
of antidepressant glucuronides. After removal of these data from database B, the 
probability of 176 Da dropped from 0.11 to 0.03, demonstrating that this single 
paper largely biased the dataset. This effect was only limited for the other often 
occurring neural losses, e.g. for 162 Da the probability dropped by 10 %. This 
demonstrates that the construction of the product ion spectra database is crucial 
for correct interpretation of the selectivity. To further improve this procedure 
the database should be extended to equally represent compounds from different 
groups. 
The relation between the neutral loss probability distribution and the precursor 
ion mass was studied. The probability of the smaller neutral losses, e.g. 18, 17 
and 46 Da clearly decreases with increasing precursor ion mass. This might be 
explained by the increasing number of dissociation reactions possible with 
increasing molecular mass, e.g. multiple water losses. As expected, the 
probability of multiple dissociation reactions in a high mass molecule increases, 
together resulting in higher neutral loss values. 
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Chromatographic co-elution probability 
Besides the selectivity provided by the MS detection, the liquid chromatographic 
system adds additional selectivity. To predict the probability of a co-eluting 
compound, the RT of an infinite number of unknown, possibly interfering 
compounds, should be estimated. Because this is impossible, a theoretically 
predicted RT can be used. A QSRR model can be constructed to predict a 
compounds’ RT based upon its physical and chemical properties [48,49]. This 
approach has been applied by Zheng et al. [50] who obtained an excellent 
relation between the true and the predicted RT (r2 > 0.997) for nucleic acids. 
However, they divided the compounds in eight groups that were modeled 
individually, each group containing compounds with similar properties. Baczek, 
et al. [51] and Ghasemi et al. [52] applied QSRR to predict the RT of compounds 
on a previously characterised chromatographic system, resulting in accurate RT 
predictions; r2 > 0.89 and 0.9 respectively.  
In this work a linear regression model was constructed on the basis of the 
experimentally determined RT in a reversed phase LC system of 126 compounds 
and a set of 22 physical and chemical parameters for each of these compounds. 
From the calculations, 10 parameters proved to result in the best prediction of 
the RT. The empirically determined model is: 
WEShape
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P
TBDDRT
tot
mol
pol
pHpHt
*10*8.6*10*1.3*12.0*9.1*19.0
*10*5.9*10*1.2log*61.0log*20.022.4
33
47
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

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 (5) 
in which B is Balaban index, T is molecular topological index, P is partitioning 
coefficient, Apol is polar surface area, Amol is Connolly molecular area, Etot is total 
energy and Wiener is Wiener index. The relation between the experimental RT 
and the calculated RT from the model is presented in figure 3.5; a coefficient of 
correlation (r2) of 0.91 is obtained, which is comparable with previous QSRR 
models that include different compound classes [51,52] . From this model, the 
prediction error was calculated, which is the combination of the residual 
standard error of the model and the standard error of the regression line 
parameters. Because the residual standard deviation of the model is significantly 
larger than the standard deviation of the regression line parameters, the 
prediction error is 0.7 min over the whole RT range. Therefore, using this model 
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the RT of unknown compounds on the reversed phase system tested, can be 
predicted on the basis of its physical and chemical properties with a prediction 
error of ±1.4 min (α = 0.05).  
  
Figure 3.5. Calculated RT from the model as a function of the experimentally 
determined RT on the reverse phase LC system and using a gradient of acidified 
water and methanol as the mobile phase. 
The probability distribution of the theoretical RT of the 126 compounds used to 
construct the model plus 325 randomly selected compounds is presented in figure 
3.6. The largest probability of co-elution is observed for extremely hydrophilic 
compounds that do not show retention on the chromatographic system. Next, the 
highest probability of co-elution is observed for compounds that elute at RT 8.5 
min. A high or low RT (as long as compounds undergo some retention) is less 
probable and therefore more selective. From this, the fraction of compounds 
eluting within a certain RT window can be calculated and the probability of co-
elution of a target compound with other unknown compounds can be estimated. 
According to EU regulations, the maximum deviation of the RT of a compound 
compared to the reference is 5 % in case no internal standard is used [4]. 
Therefore, for a compound of interest that has an experimental RT of x, the best 
estimate of the probability of interference due to co-elution of unknown 
compounds is the probability of compounds with a theoretical RT of x – 5 % and x 
+ 5 %. The fraction of compounds eluting from the presented system between 
these theoretical RTs can be determined from database C and figure 3.6.  
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A prerequisite for obtaining a good estimate for P(RT) is that the used 
chromatographic system is modeled and that an RT probability distribution is 
constructed from a significant number of compounds. If not, a worst case 
approach can be applied. From our data it was found that the highest probability 
for co-elution of interfering compounds within the established RT interval is for 
compounds having an RT of 9.5 min. The corresponding P(RT) is 0.11. To 
challenge the suggested procedure, a second RP chromatographic system using a 
different analytical column and acetonitrile as the organic modifier was 
modeled. For this system the relation between the experimental RT and the 
calculated RT from the model is linear with a coefficient of correlation (r2) of 
0.90. Co-elution showed to be most likely at RT = 8.0 minutes and the 
corresponding P(RT) is 0.16. From this, it was assume that for a high resolution 
RP system using gradient elution, a worst case value of P(RT) = 0.2 can be 
adopted for calculating P(I) in case the used system is not modeled. 
  
Figure 3.6. probability distribution of the theoretical RT (in categories of 0.2 
min) of the compounds in database C (n=451).  
Application of the procedure 
As an illustration of the proposed procedure given in figure 3.1, the calculation 
of P(I) for sebuthylazine, 3[(2-nitrophenyl)-methylene]-amino-2-oxazolidinone 
(NPAOZ), oxolinic acid, 17ß-trenbolone and ceftiofur are presented in table 3.2. 
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The preselected precursor mass and product ion masses for these compounds are 
included in table 3.2. P(Mpr) is empirically determined from the probability 
distribution presented in figure 3.2. P(Mpd) and P(Mnl) of both mass transitions are 
empirically determined respectively from the probability distributions presented 
in figure 3.3 and appendix 3.1, respectively figure 3.4 and appendix 3.2, at the 
corresponding precursor mass category. The theoretical RT is calculated from 
equation 5 and P(RT) is empirically determined from figure 3.6. The results are 
presented in table 3.2.  
Table 3.2. Precursor ion mass, product ion mass and retention time of 
sebuthylazine, NPAMOZ, oxolinic acid,17 ß-trenbolone, and ceftiofur including 
calculation of P(I).  
 Sebuthylazine 
[24] 
NPAMOZ 
[25] 
Oxolinic 
acid [40] 
ß-trenbolone 
[53] 
Ceftiofur 
[54] 
Precursor ion 230 335 262 271 524 
P(Mpr) 7.5*10-4 4.0*10-3 1.5*10-3 1.7*10-3 7.6*10-4 
Product ion 1 
(m/z) 
174 291 244 253 241 
P(Mpd1)
a 0.025 0.019 0.010  0.011 0.024 a 
Neutral loss 1 56 44 18 18 283 
P(nl1)
 a 0.060a b 0.033 a b 0.10a b 0.10 a b 0.012 
Product ion 2 
(m/z) 
104 262 216 199 125 
P(Mpd2)
 a 0.028 0.018 0.013 0.018 0.028 a 
Neutral loss 2 126 73 46 72 399 
P(Mnl2)
 a 0.043 a 0.042 a b 0.062 a b 0.035 a 0.004 
P(MS) 1.9*10-6 5.4*10-6 8.7*10-6 5.6*10-6 5.1*10-7 
Theoretical 
RT (min) 
8.4 0.6 4.8 9.3 10.3 
P(RT) 0.09 0.06 0.04 0.11 0.08 
P(I) 1.7*10-7 3.0*10-7 3.7*10-7 5.9*10-7 4.2*10-8 
1 in… 5,900,000 3,300,000 2,900,000 1,700,000 24,000,000 
a The maximum value of P(Mpd) versus P(Mnl) 
b Probability with high deviation from the constructed model; empirical value taken 
from appendix 3.1 (product ions) or 2 (neutral loss) 
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The proposed procedure was applied for 200 compounds that are routinely 
analysed using LC-MS/MS at the authors’ laboratory, including veterinary drugs, 
pesticides and natural toxins. The cumulative probability distribution versus P(I) 
is presented in figure 3.7 for using one and two MS/MS transitions. It is observed 
that the proposed procedure supports the legal requirement of monitoring at 
least two product ions [4]: P(I) strongly increases when using two products ions, 
as expected. As an example, if for ceftiofur (table 3.2) only one product ion is 
monitored, P(I) is 1.5*10-6 and when considering two product ions, P(I) is 4.2*10-8, 
which is an improvement of method selectivity of approximately 300 times.  
  
Figure 3.7. Cumulative distribution function of the fraction of the compounds 
(n=200) versus P(I) using (dotted line) one product ion and (solid line) two 
product ions.  
Setting a threshold for P(I)  
When is a method sufficiently selective? To be able to answer this question a 
calculated value P(I) should be ranked in terms of method selectivity, e.g. 
insufficient or sufficient. This can be done using a threshold value for P(I). 
However, that would suggest the existence of a sharp boundary between 
‘selective’ and ‘non-selective’, which is not the case. When P(I) is close to any 
set threshold value, other factors should be considered as well, e.g. the sample 
preparation procedure and/or results obtained from orthogonal (screening) 
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analysis which might provide additional information on the compound’s identity. 
In forensic sciences, DNA-matching techniques yield in a probability of 10-9 that 
someone would have the same DNA-profile and thus the probability of an 
incorrect identification is at most 1 in a billion [55]. However, no threshold value 
for DNA-matching probability has been established nor for acceptance of a DNA-
match in court: DNA evidence by itself is usually not considered sufficient for 
conviction [56]. Although it is somewhat arbitrary, we feel that a threshold for 
P(I) can be useful in order to evaluate method selectivity. The threshold should 
be fixed in such a way that it can be concluded that the method is sufficiently 
selective (fit for purpose), i.e. (1) the calculated probability of the occurrence of 
an incorrect identification is low enough to persuade a judge or jury in court and 
(2) an expert scientist would feel comfortable in defending the probability of an 
incorrect identification. 
According to the authors, the certainty needed for satisfactory confirmation 
depends on fitness for purpose [1] and thus the threshold value can differ 
depending on the field of interest, e.g. food safety, sports doping, forensic 
sciences, and the legal framework involved. To support the establishment of a 
threshold value for our laboratory, which focusses on residue analysis of 
registered and banned veterinary drugs, pesticides and natural toxins in food 
products, sebuthylazine and NPAOZ, compounds for which false positive results 
were previously reported [24,25] were studied. Furthermore, oxolinic acid and 
17ß-trenbolone were studied, being compounds that show difficulties in 
confirmatory analysis [40,53] and of which the selected neutral losses, water and 
formic acid for oxolinic acid and water and C4H8O for 17ß-trenbolone are 
considered to be non-selective. The calculated P(I) for NPAOZ, oxolinic acid and 
17ß-trenbolone are respectively 3.0*10-7, 3.7*10-7and 5.9*10-7 (table 3.2). Because 
of the apparent probability of a false identification for these compounds, in our 
opinion, the proposed procedure should indicate insufficient method selectivity 
in these cases and thus we prefer P(I) = 2*10-7 as a threshold value for evaluation 
of the method selectivity. This threshold value was challenged on basis of the 
calculated P(I) of 200 compounds that are routinely analysed at our laboratory by 
LC-MS/MS (figure 3.7). Of these 200 compounds, 20 are routinely analysed using 
neutral losses of ammonia, water and/or formic acid. Because these neutral 
losses are generally considered to be non-selective, the probability of a false 
positive result should be apparent from the proposed procedure. Of these 20 
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compounds, calculated P(I) range from 3*10-8 to 1.6*10-6 and only 10 % are below 
2*10-7 and would therefore be considered sufficiently selective, which is in 
agreement with expectations. This supports the choice of P(I) ≤ 2*10-7 in our 
laboratory as a suitable criterion for sufficient method selectivity. Using this 
criterion, the analysis of sebuthylazine (P(I) = 1.7*10-7) would be considered just 
sufficient, even though false positive findings have been reported [24]. It is 
recalled that P(I) is an estimation of the true probability of interfering 
compounds, therefore it is suggested to critically review all compounds having a 
P(I) around the threshold value.  
From figure 3.7, it is observed that approximately 70 % of the selected 200 
routinely analysed compounds give P(I) ≤ 2*10-7 and thus show sufficient 
selectivity. For the other 30 % additional measures should be taken in case of 
confirmatory analysis to prevent false positive results to occur. For example, if 
for oxolinic acid a product ion of m/z 160 is monitored instead of m/z 244, P(I) 
would be 1.3*10-7, which can be just sufficient and if three product ions are 
monitored P(I) would be 1.3*10-8, which is quite safe. These are clear examples 
of how the calculation of P(I) can assist in selecting product ions and the number 
of product ions to be monitored during method development to assure adequate 
method selectivity and thus a high certainty of the confirmation.  
Conclusions 
In this chapter a procedure is presented that allows the estimation of the 
(un)certainty of the method selectivity of an LC-MS/MS procedure. Based on 
empirical models derived from three databases which include data on the 
precursor ion mass, the product ion mas and a theoretical RT, the probability of 
the co-occurrence of a compound showing the same characteristics in LC-MS/MS 
can be estimated. From this, the selectivity of the procedure can be assessed 
and if found insufficient, corrective measures can be taken like the selection of a 
different, more selective product ion or the inclusion of an additional third 
product ion. Acceptance criteria for the presented procedure are suggested and 
depend on other factors besides LC-MS/MS that possibly influence the method 
selectivity, like the preceding sample preparation procedure. The proposed 
procedure is extremely useful to select sufficiently selective multiple reaction 
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monitoring acquisition parameters during method development. In that way it 
serves as an additional tool to the established relative ion abundance criteria [4-
11] and is a very strong combination for confirmation of the identity of a 
compound because both relative ion abundances as well as the selectivity of the 
monitored product ions is taken into account. Furthermore, the procedure 
reported here can be used as a tool to validate the selectivity of any LC-MS/MS 
method.  
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Appendix 3.1 
Empirical model for calculation of product ion 
probability and extremely deviating values. 
Empirical 
model: 
 
 12
12
exp1
exp
)(





pdpdpd
pdpdpd
pd
dMcMbMa
dMcMbMa
MP   
 precursor ion m/z range  
 100 - 200 200 - 300 300 - 400 > 400  
a -2.22 -2.03 -2.03 -1.66  
b 4.22 10-2 8.38 10-3 1.11 10-2 5.17 10-3  
c -3.12 10-4 -6.62 10-5 -2.43 10-5 -5.13 10-6  
d -159 -181 -197 -235  
Product ions with a significant higher probability than expected from the empirical 
model: 
 
Product 
ion m/z 
probability in precursor ion m/z range Possible product ion 
100 - 200 200 - 300 300 - 400 > 400 
56 0.06 0.03 0.01  C4H8
+● 
57  0.05 0.01  C4H9
+ [33,57] 
58  0.04 0.02  C3H8N
+ [33,57] 
C3H6O
+ 
69 0.10 0.04    
70   0.04  C4H8N
+ [33] 
C3H4N3
+ [33] 
72  0.06 0.03  C4H10N
+ [57] 
74  0.04   C4H12N
+ [33] 
77 0.10    Phenylium ion [57] 
85    0.04 C2H5N4
+ [33] 
86  0.04   C5H12N
+ [33] 
91 0.15 0.08 0.06  
Tropyilium cation 
[29,33,57]  
97   0.04 0.03  
100  0.05 0.04 0.04 C5H12N2
+● [33] 
C6H14N
+ [33] 
105  0.06 0.07  Benzoyl cation [57] 
C7H7N
+● [33] 
C6H5N2
+ [33] 
109  0.05 0.05  C7H5F
+ [33] 
121  0.06 0.05 0.05 Cyclohexatrienecarboxylic 
acid [33] 
C6H5N2O
+ [33] 
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141    0.04 C11H9
+ [33] 
163 0.03     
263    0.04 C20H23
+ [33] 
287    0.04  
303    0.04  
449    0.02  
Product ions with a significant lower probability than expected from the empirical 
model: 
Product 
ion m/z 
probability in precursor ion m/z range  
100 - 200 200 - 300 300 - 400 > 400 
54  0    
62 0.003     
64 0.002 0    
66 0.01 0.001    
75 0.01  0.001   
76 0.02  0.002   
87  0.004    
88  0.006    
89   0.002   
90 0.03  0.003   
94    0  
97      
102  0.005    
103    0.001  
108    0.002  
110    0.001  
188    0.004  
196    0.003  
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Appendix 3.2 
Empirical model for calculation of neutral loss 
probability and extremely deviating values. 
Empirical 
model: 
 
 12
12
exp1
exp
)(





nlnlnl
nlnlnl
nl
dMcMbMa
dMcMbMa
MP   
 precursor ion m/z range  
 100 - 200 200 - 300 300 - 400 > 400  
a -5.21 -5.74 -6.37 -5.83  
b 6.47 10-2 4.14 10-2 3.30 10-2 1.23 10-2  
c -4.75 10-4 -1.80 10-4 -9.87 10-5 -2.47 10-5  
d -7.94 -6.88 1.06 -0.959  
Neutral losses with a significant higher probability than expected from the 
empirical model: 
 
Neutral 
loss (Da) 
probability in precursor ion m/z range Possible loss 
100 - 200 200 - 300 300 - 400 > 400 
15 0.05  0.02  Methyl [57] 
16  0.03 0.03  Methane [57] 
O, e.g. from sulfones [57] 
NH2 
17 0.31 0.06 0.04 0.04 Ammonia 
18 0.23 0.10 0.11 0.07 Water [57] 
27 0.06    Nitrile 
28 0.08 0.05 0.03  CO, e.g. from lactones 
31  0.03 0.03  CH5N, e.g. methylamine 
32  0.05 0.04  CH4O, e.g. methyl ether 
35 0.16 0.03   Water + ammonia 
36 0.07  0.03 0.02 2 x water 
42 0.11 0.05 0.03  C2H2O, e.g. from acetates 
43 0.08    C2H5N, e.g. cyclic amines 
44   0.03  CO2, e.g. from lactones 
45 0.13 0.07 0.04  C3H7N, trimethylamine 
CH3NO, formamide 
46 0.23 0.06 0.06 0.02 CH2O2, e.g. formate 
56  0.06 0.03  C4H8 
C2H2NO, e.g. isocyanate 
57  0.05   C4H9
● 
C3H5O, e.g. from 
cyclopentanol 
59 0.15 0.06   C3H9N, e.g. from amines 
C3H5NO, e.g. from oximes 
C3H7O, e.g. from polyethers  
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60 0.13 0.05 0.05 0.02 42 + water 
43 + ammonia 
C2H4O2, e.g.  
acetate 
61 0.09 0.05   43 + water 
C2H5O2, e.g. from glycols 
C2H5S, e.g. from aliphatic 
thioles 
63 0.16    45 + water 
Chloroethyl 
CH3SO, e.g. from alkyl 
sulfoxides 
64 0.09    46 + water 
SO2, e.g. sulfoned 
73 0.10 0.07 0.04  3 x water + ammonia 
56 + ammonia 
74  0.06 0.04  56 + water 
57 + ammonia 
C2H3O3, e.g. acetic acid + 
water  
C3H6O2, e.g. ethylester 
C4H10O, e.g. tert. Butyl + 
water 
C3H10N2, e.g. diamino propane 
75  0.05   57 + water 
77 0.09     
87   0.04   
91 0.08    Tropylium radical (C7H7
●) [58] 
146    0.05 C11H14 
C5H5O5, e.g. from glucuronide 
[35] 
C6H10O4, e.g. from 
rhamnoside [59] 
 
162 
    
0.08 
 
C10H10O2 
C6H10O5, e.g. from glycoside 
[59] or galactoside 
308    0.05 162 + 146 
454    0.01 162 + 2 x 146 
Neutral losses with a significant lower probability than expected from the 
empirical model: 
Neutral 
loss (Da) 
probability in precursor ion m/z range  
100 - 200 200 - 300 300 - 400 > 400 
22 0 0    
23 0 0    
24 0 0    
25 0 0    
52 0.002     
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4.1. General introduction on chloramphenicol 
analysis 
Chloramphenicol 
Chloramphenicol (CAP; 2,2-dichloro-N-[2-hydroxy-1-(hydroxymethyl)-2-(4-nitro-
phenyl)ethyl]acetamide) is a broad-spectrum antibiotic used as a human 
medicine but also as a veterinary drug in all major food-producing animals. The 
drug is biosynthesised by the soil organism Streptomyces venezuelae and several 
other actinomycetes [1], but is produced for commercial use by chemical 
synthesis [2]. 
CAP has been evaluated by a number of agencies, including the International 
Agency for Research on Cancer [3], the European Committee for Veterinary 
Medicial Products [2], the United States Food and Drug Administration [4] and 
more recently in by JECFA (Joint Expert Committee on Food Additives, FAO) at 
its 62nd meeting [5].  
CAP is a suspected carcinogen and due to its linkages to the development of 
aplastic anemia in humans, the drug is banned for use in food-producing animals 
in the European Union (EU) and in many other countries, including the United 
States of America, Canada, Australia, Japan and China. A minimum required 
performance limit (MRPL) of 0.3 µg kg-1 was assigned by the European 
Commission for the analytical methods testing for CAP in products of animal 
origin [6]. Although CAP is a banned substance, according to 2005/34/EC [7] for 
all products entering the EU that are analysed for veterinary drugs and thus are 
within the scope of 97/78/EC [8], the MRPL as stated in 2002/657/EC [9] should 
be regarded as a reference point of action. In other words, for banned 
substances, only concentration levels above the MRPL are considered being non-
compliant results. However, if the result of an analytical test is below the MRPL 
“the competent authority has to retain a record of the findings in case of 
recurrence” [7]. 
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Complications in chloramphenicol analysis 
Two major complications exist in the analysis of CAP and the subsequent decision 
making process. The first is that eight different isomers of CAP exist. A 
confirmatory method should be able to discriminate among those isomers to 
assign te correct confirmation in case the drug is detected. The second 
complication is that CAP is biosynthesised by soil bacteria, which could result in 
the natural occurrence of the drug. 
Discrimination among isomers 
CAP occurs in the para-configuration and in the meta-configuration and it 
contains two chiral centres (carbon 2 and 3, figure 4.1a), thus in total eight 
different isomeric configurations exist: four (RR, SS, RS, SR) meta-stereoisomers 
and four para-stereoisomers (figure 4.1). If not explicitly mentioned, the name 
chloramphenicol generally refers to RR-p-CAP, which is also called levomycetin. 
SS-p-CAP is also called dextramycin (DEX) and a racemic mixture of the two 
isomers is called synthomycin [10]. All para-stereoisomers are biologically active 
[10-19] but it was reported that only RR-p-CAP has antimicrobial properties 
[10,14]. In contrast, other papers claim < 0.5 % antimicrobial activity for SS-p-
CAP [15,16] and RS-p-CAP [15] compared to RR-p-CAP and 1 to 2 % for SR-p-CAP 
[15]. According to literature the structure of the propanediol moiety is critical 
for the microbial activity whereas the aryl nitro group and the acetamide side 
chain are not that essential [17]. No information is available on the biological 
activity meta-stereoisomers. 
Surprisingly, in the EU regulation [6, 20], no specific configuration of CAP is 
referred to and thus it is unclear if the regulation applies to all individual isomers 
or to RR-p-CAP only. 
In 2002 criteria were established concerning the performance of analytical 
methods [9]. According to this document samples taken for monitoring of 
residues in animal products should be analysed using methods that have been 
validated according to the described procedures [9]. In these performance 
criteria, selectivity is mentioned as a main characteristic of an analytical method 
and is defined as “the power of discrimination between the analyte and closely 
related substances like isomers, metabolites, degradation products, endogenous 
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substances, matrix constituents, etc.”. Only using highly selective methods, the 
identity of a compound can be confirmed with high certainty, which is a 
mandatory in case the analytical result is challenged in court cases. Therefore, 
methods for the analysis of CAP in animal products should be enantioselective in 
order to discriminate the antimicrobially active CAP from its isomers. 
 
Figure 4.1. Molecular structures of chloramphenicol isomers: (a) RR-p-CAP, (b) 
SS-p-CAP, also called DEX, (c) RS-p-CAP, (d) SR-p-CAP, (e) RR-m-CAP, (f) SS-m-
CAP, (g) RS-m-CAP and (h) SR-m-CAP. 
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In section 4.3 a high resolution reversed phase LC-MS/MS system was assessed for 
its ability to separate the eight CAP isomers. In this product ions and the 
fragmentation pathway in collision induced dissociation was studied in detail. In 
section 4.4 a newly developed method is presented that is suited for quantitative 
analysis of eight CAP isomers in urine and which is able to confirm the identity of 
the target compounds according to EU regulations [9] at part-per-trillion levels, 
well below the MRPL. 
Natural occurrence 
In recent years findings of CAP residues in food products such as poultry, honey 
and sheep casings has had a major impact on international trade [21]. Follow-up 
investigations in Asian countries related to the non-compliant findings could not 
identify the origin of CAP residues and no recent history of CAP use was found.  
Various hypotheses have been suggested to explain these results. Residues may 
be caused by the illegal use of the drug in animal production, through 
contamination of the products by processing workers who were using topical 
human medicines containing CAP, or by ingestion of naturally occurring CAP from 
the environment. Due to the fact that recent findings of CAP in several products 
produced in different countries, such as Thailand and Mongolia, could not be 
explained by the use of the drug, the hypothesis of naturally occurring CAP 
warranted scientific investigation. 
Several hypotheses for the contamination of food products by possible natural 
occurring CAP are described by The Joint FAO/WHO Expert Committee on Food 
Additives [5]. The possibility of contamination due to ingestion of naturally or 
externally contaminated soil was evaluated. The final conclusion from the 
evaluation was that the committee could not completely rule out the possibility 
that foods are occasionally contaminated from environmental sources. However, 
due to lack of analytical methods to detect the relevant concentrations of CAP in 
soil, there were no analytical data available to support this suggestion.  
Another hypothesis of the natural occurrence of CAP in food product is the 
production of CAP by Streptomyces venezuelae in a typical poultry production 
environment in poultry litter [21]. The results suggested that residues of CAP on 
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the farms tested were extremely unlikely to have been caused by natural 
biosynthesis of the drug in the production environment. 
In section 4.2 the monitoring results of plant materials and soil from Mongolia are 
presented. Several samples of grass and herbs were collected from Mongolian 
pastures, where the CAP contamination of food products was previously 
identified. Samples of grass and herbs belonging to the Atemisia and Thalictrum 
families were collected. These herbs were selected for collection because it is 
known that these plants are used as traditional medicines by the local 
population. To determine if CAP presence could be detected in herbs grown at 
other locations, samples were purchased from a number of retail outlets in the 
Netherlands. From this work new hypothesis on the natural occurrence of CAP 
were suggested.  
In section 4.5 the work on the research on the natural occurrence of CAP is 
presented. The hypothesis is that crops take up and accumulate CAP, that is 
biosynthesised by soil bacteria, from the soil. If CAP from the soil can 
accumulate in crops, animals might ingest CAP if these crops are used in animal 
feed or as stall bedding. As a consequence products of animal origin might be 
contaminated with CAP residues. 
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4.2. Evidence of the natural occurrence of the 
banned antibiotic chloramphenicol in crops and 
soil 
Abstract 
Chloramphenicol (CAP), a broad spectrum antibiotic, was detected in several 
herb and grass samples from different geographic origins. Due to its suspected 
carcinogenetic properties and linkages with the development of aplastic anemia 
in humans, CAP is banned for use in food producing animals in the EU and many 
other countries. However, products of animal origin originating from Asian 
countries entering the European Market are still found non-compliant (containing 
CAP) on a regular basis, even when there is no history of chloramphenicol use in 
these countries. A possible explanation for the continued detection of these 
residues is the natural occurrence of chloramphenicol in plant material which is 
used as animal feed, with the consequent transfer of the substance to the animal 
tissues. 
Approximately 110 plant, soil and water samples were analysed using liquid 
chromatography coupled to tandem mass spectrometry. In 26 samples the 
presence of CAP was confirmed using the criteria for banned substances defined 
by the EU. Amongst other, plant materials, samples of the Artemisia family 
retrieved from Mongolia and from Utah, USA, and a therapeutic herb mixture 
obtained from local stores in the Netherlands proved to contain CAP at levels 
ranging from 0.1 to 450 µg kg-1.  
These finding may have a major impact in relation to international trade and 
safety to the consumer. The results of this study demonstrate non-compliant 
findings in animal-derived food products may in part be due to the natural 
occurrence of CAP in plant material. This has implications for the application of 
current EU, US and other legislation and the interpretation of analytical results 
with respect to the consideration of CAP as a xenobiotic veterinary drug residue 
and the regulatory actions taken upon its detection in food.  
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Introduction 
Chloramphenciol (CAP) is a broad-spectrum antibiotic with historical veterinary 
uses in all major food-producing animals. CAP is biosynthesised by the soil 
organism Streptomyces venezuelae and several other actinomycetes, but is 
produced for commercial use by chemical synthesis [2]. CAP is a suspected 
carcinogen and due to its linkages with the development of aplastic anemia in 
humans, the drug is banned for use in food-producing animals in the European 
Union (EU) and in many other countries, including the United States of America 
(USA), Canada, Australia, Japan and China. A minimum required performance 
limit (MRPL) of 0.3 µg kg-1 was assigned by the European Commission for the 
analytical methods testing for CAP in products of animal origin [6]. In recent 
years findings of CAP residues in food products such as poultry, honey and sheep 
casings has had a major impact on international trade [21]. Follow-up 
investigations in Asian countries that were related to the non-compliant findings 
could not identify the origin and found no recent history of CAP use. 
Various hypotheses have been suggested to explain these results [5]. Residues 
may be caused by the illegal use of the drug in animal production, through 
contamination of the products by processing workers who were using topical 
human medicines containing CAP, or by ingestion of naturally occurring CAP from 
the environment. Due to the fact that recent findings of CAP in several products 
produced in different countries, such as Thailand and Mongolia, could not be 
explained by the use of the drug, the hypothesis of naturally occurring CAP 
warranted scientific investigation. 
A hypothesis, which to our knowledge has never been investigated, is the 
possibility that grass and herbs (plant materials) absorb and accumulate CAP 
from the soil. The CAP-containing grass and herbs are used as pasture or 
harvested as animal feed or forage and consequently products of animal origin 
are contaminated with residues of CAP. It has been shown that plants are able to 
absorb veterinary drugs such as tetracyclines from soil [22]. To test this 
hypothesis several samples of grass and herbs were collected from Mongolia 
where the contamination of food products with CAP has been identified 
previously. Samples of grass and of herbs belonging to the Atemisia and 
Thalictrum families were collected. To determine if CAP presence could be 
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detected in herbs grown at other locations samples were purchased from a 
number of retail outlets in the Netherlands. 
For the detection, quantitation and confirmation of CAP different analytical 
methods are available based on both gas chromatography and liquid 
chromatography combined with mass spectrometry (GC- or LC-MS) [23-26]. For 
monitoring purposes, the most frequently used technique is the highly selective, 
sensitive and relatively quick LC combined with tandem mass spectrometric 
(MS/MS) detection. This technique is able to detect CAP at the MRPL level of 0.3 
µg kg-1 in various food products. 
In the study reported here plant material and therapeutic herb mixtures were 
analysed for the presence of CAP using an LC-MS/MS method which was validated 
in compliance with the EU guidelines in Commission Decision 2002/657/EC [9] 
and accreditated. However, very recently Schürmann et al. [27] demonstrated 
that for a specific matrix/analyte combination a false non-compliant result is 
obtained by using the EU identification points approach. Therefore, for 
additional selectivity a few representative samples were reanalysed using a 
highly selective high resolution LC system (HRLC) monitoring three selected 
reaction monitoring (SRM) ion transitions. 
The major aim of the present study was to determine if CAP can occur naturally 
in herbs and grass. If confirmed, this observation would help to explain the non-
compliant findings of CAP in products of animal origin even when there is no 
recent history of CAP use. Animals grazing on pasture where such herbaceous 
plants are prevalent, or being fed with feedstuffs containing those plants, may 
become contaminated with CAP, with the subsequent detection of CAP in the 
animal products. 
Experimental 
Chemicals, reagents and solutions 
Methanol (HPLC supra-gradient grade), dichloromethane, ammonia (25 %) and 
toluene were obtained from Biosolve (Valkenswaard, the Netherlands). CAP 
(Sigma-Aldrich, St. Louis, MO, USA) and 37Cl2-CAP (RIVM, Bilthoven, the 
Netherlands) were used as reference standards. The stock solution of the CAP 
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reference standard was prepared in methanol at 100 µg L-1 and were stored at -
18 °C. Dilutions of these stock solution were all prepared in Milli-Q water and 
stored at 4 °C. The stability of CAP stock solution at 4 °C is at least 6 months. A 
solution of ammonia (0.025 %) was prepared by diluting 1 mL ammonia (25 %) in 1 
L of Milli-Q water. 
Samples 
Fifteen plant material samples, among which Artemisia frigida and Thalictrum 
simplex, were collected from local fields in the neighborhood of the State 
Central Veterinary Laboratory, Mongolia (Atar province, Autumn 2007). The first 
set of five samples was transported in May 2008 to RIKILT. A second set of 10 
samples arrived in June of the same year. Six therapeutic herb mixtures, 
including teas claiming an anti-infectious effect, were obtained from a local 
store in the Netherlands (June 2009). One Artemisia frigida sample originating 
from Utah, USA was obtained by Internet order from an retail outlet in the UK 
(June 2009). 
In September 2009 herb samples (Artemisia sieversiana, Artemisia frigida and 
green grass) were collected from five different provinces in Mongolia (Lun 
province, Atar province, Hui doloon xudag, Erdene province, Bayandelger 
province). In each province three different locations were selected and at each 
location three samples of herbs were collected. Each sample of herb was split 
into leaves, roots and, if available, stalk. Furthermore, together with each 
sample of herb two samples of soil were collected (directly below the surface 
and 20 cm below the surface). Finally, a total of five samples of water were 
collected. The total number of samples collected was 192. 
Equipment 
The separation of CAP from the sample components was carried out using liquid 
chromatography (LC) or by high resolution liquid chromatography (HRLC). The LC-
system consists of a vacuum degasser, autosampler and a binary pump (Acquity 
Waters, Milford, MA) equipped - for LC applications - with a X-Bridge C18 
analytical column, 3.0 x 15 mm, 5 µm (Waters) placed in a column oven at 30 °C. 
Isocratic elution was performed with a mobile phase of 0.025 % ammonia / 
acetonitrile (45:55, v/v) at a flow rate of 0.4 mL min-1 and the injection volume 
was 100 µL.  
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For HRLC applications the LC was equipped with an Water acquity UPLC BEH C18 
analytical column of 2.1 x 50 mm, 1.7 µm (Waters) placed in a column oven at 50 
°C. The gradient (solvent A, water (100 %); solvent B, methanol (100 %)) was: 0–
0.5 min, 10 % B; 0.5–3.5 min, linear increase to 100 % B with a final hold of 0.5 
min. Under these conditions CAP eluted after 2.7 min. Injection volume was 100 
µL. 
Detection was carried out using a Waters Quattro Ultima mass spectrometer with 
electrospray ionisation (ESI) operating in negative ionisation mode. The operating 
parameters were: capillary voltage, 2.7 kV; cone voltage, 25 V; source 
temperature, 120 °C; desolvation temperature, 300 °C; cone gas flow, 200 L hr-1; 
and desolvation gas, 500 L hr-1. CAP was fragmented using collision induced 
dissociation (CID) and selected reaction monitoring (SRM) transitions at m/z = 
321.0 > 152.1 and m/z = 321.0 > 194.0 were monitored. In the HRLC-MS/MS an 
additional transition was monitored: m/z = 321.0 > 257.1. 37Cl2-CAP was detected 
by monitoring the transition m/z = 324.8 > 152.0. Data were acquired and 
processed using MassLynx 4.1 software (Waters). 
Sample preparation 
Plant material was cut into small pieces and pulverised using a Moulinex blender. 
Small pieces of plant sample material (1 g) or soil (2 g) were weighed into a 50 
mL tube and internal standard 37Cl2-CAP was added. For the quality control (QC) 
samples, CAP reference standard solution was also added. Next, 10 mL of Milli-Q 
water (or more, with a maximum of 25 mL in cases the water was completely 
absorbed by the sample material) was added to the sample and CAP was 
extracted from the material by shaking (rotary tumbler, 10 min.) after which it 
was centrifuged (15 min., 3500 g). An aliquot (3 mL) of the extract was 
transferred to an Extrelut® NT3 (Merck, Darmstadt, Germany) column. After at 
least 20 min equilibration CAP was extracted from the cartridge using 15 mL 
dichloromethane which was collected in a 12 mm polypropylene centrifuge tube. 
The dichloromethane was evaporated to dryness under a stream of nitrogen at 35 
°C and the residue was dissolved in 0.5 mL milli-Q water. The final extract was 
shaken with 1 mL toluene after which the aqueous layer was transferred into an 
LC-vial. 
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For quantitation, a calibration line was constructed of the response factor (peak 
area of CAP / peak area of the IS) versus the CAP concentration using the least 
squares linear regression method. To take matrix effects into account, blank 
plant (or soil) samples were fortified with different concentrations of CAP (0 - 50 
µg kg-1). The collected samples were analysed together with the matrix matched 
calibration standards (MMS). 
Confirmation of the identity of CAP was carried out according to EU criteria [9]. 
LC-MS/MS monitoring two SRM transitions and comparing the ion ratio of the 
sample with the reference is suitable to obtain the minimal required number of 
identification points. Furthermore, the following criteria were to be applied: 
- The relative retention time of the compound in the sample has to be 
the same as the relative retention time of the reference within a 
margin of 2.5 %. 
- The ion ratio of two SRM transition ions of the compound in the sample 
has to fall within a specified tolerance interval around the reference 
ion ratio (for example: interval of 20 % if the ion ratio is above 50 %). 
Validation  
The LC-MS/MS method used for the determination and identification of CAP was 
validated according to guidelines described for quantitative confirmatory 
methods in Commission Decision 2002/657/EC [9]. Previous full validation was 
performed for the matrices urine and shrimps at the concentration levels of 0.2, 
0.4 and 0.6 µg kg-1. All method characteristics, including linearity, repeatability 
and reproducibility, fulfilled the EU criteria. The CCα an CCβ, established by the 
analysis of 20 blank samples and 20 fortified samples were, respectively, 0.05 
and 0.2 µg kg-1 for urine and 0.05 and 0.15 µg kg-1 for shrimps. Additional 
validation experiments were performed for the matrices milk, animal feed and 
plant material including leaves, stalk, roots and soil. The additional one-day 
validation for plant material was carried out at levels of 0.3 and 0.5 µg kg-1 (n=6 
at each level). From these experiments the repeatability was established and 
compared with the results obtained for the matrices urine and shrimps. In case 
there are no significant differences the CCα for the additional matrices are 
established based on the results obtained during the initial validation study.  
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Sample analysis  
The samples of plant material and soil were analysed in series of a maximum of 
40 samples. Each series of samples started and ended with the analysis of matrix 
matched calibration standards. The samples were analysed by the method and 
the experimental conditions as described above and confirmation of the identity 
was carried out according to 2002/657/EC [9].  
For additional selectivity and confirmation purposes the CAP containing samples 
(confirmed by using LC) and some blank samples were reanalysed by HRLC. As a 
reference the average relative retention time and SRM ion-ratios of blank plant 
material samples spiked with CAP at 2.0 µg kg-1 were used. Three SRM transitions 
were monitored and the ion ratios of the sample and the spiked samples were 
compared. In case the ion ratios fulfilled the EU criteria (ion ratio of sample 
within the tolerance interval of the spiked samples) the identity of CAP was 
considered unambiguous.  
Results and discussion 
Validation 
The trueness obtained for the analyses of six samples of plant material (leaves, 
roots + soil, stalk) at levels of 0.3 and 0.5 µg kg-1 (n=6 at each level) were 
respectively, 100 % and 104 % and the relative standard deviation under 
repeatability conditions 9 % and 6 % at these levels. These results did not 
significantly differ from the results obtained in the initial validation for urine and 
shrimp. Based on these results it was concluded that the CCα for plant material 
was < 0.1 µg kg-1 (second lowest point of the calibration curve). In other words 
the method is suitable to detect CAP in plant material at least at concentration 
levels ≥ 0.1 µg kg-1.  
Sample analysis 
In August 2009 the first set of 22 samples including: (a) the samples collected in 
Mongolia during 2007, (b) the samples obtained from a local store in the 
Netherland, and (c) the Artemisia fridiga obtained from Utah, USA, were 
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analysed for CAP by using LC-MS/MS. The data produced have been presented in 
table 4.1. It can be seen that in all the herb samples from Mongolia, CAP was 
detected at concentrations up to 450 µg kg-1. Furthermore, in one herb mixture 
obtained from a local store in the Netherlands and the sample of Artemisia 
fridiga obtained from a retail outlet, CAP was detected at low µg kg-1 levels. 
Table 4.1. CAP concentrations detected in herb (mixture)s by LC-MS/MS. 
Description Code Sample description Type of plant 
material 
Result 
(µg kg-1)* 
First set Mongolian plants S1 Thalictrum simplex Herb 23 
(collected autumn 2007) S2 Artemisia siversiana Herb 46 
,, S3 Artemisia frigida Herb 175 
,, S4 Thermopsis daurica Herb 21 
,, S5 Thalictrum simplex Herb 0.3 
Second set Mongolian plants S6 Artemisia siversiana Herb 160 
(collected autumn 2007) S7 Thermopsis daurica Herb 25 
,, S8 Artemisia siversiana Herb 20 
,, S9 Thalictrum simplex Herb 40 
,, S10 Thalictrum simplex Herb 450 
,, S11 Thalictrum simplex Herb 15 
,, S12 Artemisia siversiana Herb 8 
,, S13 Thalictrum simplex Herb 50 
,, S14 Artemisia siversiana Herb 4 
,, S15 Artemisia siversiana Herb 5 
Utah, USA**  Artemisia frigida Herb 1.3 
Dutch local store  Kamillebloesem Herb ND 
,,  Bandrek 2 pigeons Herb tea ND 
,,  Parusahaan Jamu Herb mixture 4 
,,  Ge Xian Weng Herb tea ND 
,,  Giju Herb tea ND 
,,  Herb mixture Herb mixture ND 
,,  Echinacea force Herb 
medicine 
ND 
* ND = < 0.1 µg kg-1 
** obtained through a retail outlet in the UK (Internet order) 
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If the concentrations (0.3 - 3 µg kg-1 ) of CAP detected in products of animal 
origin during monitoring in the EU (EU Rapid Alert System for Food and Feed, 
2008) are compared to these findings then the possibility of the sources of some 
of this CAP originating from plant materials must be considered a possibility. The 
data generated also show the accumulation of CAP in plants does not occur at all 
locations and at all times. As a follow up investigation into the variability of CAP 
concentrations found in the first survey, in September 2009 some additional 
samples were collected from Mongolian pastures. In total 192 samples of leaves, 
roots, stalk of Artemisia sieversiana, Artemisia frigida were collected as well as 
samples of green grass, soil and water. From these 192 samples a representative 
set of 87 samples were analysed for CAP. The results for samples containing CAP 
≥ 0.1 µg k-1g are presented in table 4.2.  
Table 4.2. CAP concentrations detected in Mongalian herb samples collected 
September 2009. 
Province Location No. / 
Sample No. 
Name  Part of the plant Result      
(µg kg-1) 
Lun  9/36 Green grass leaves 0.6 
 9/37 Green grass roots 0.3 
Atar  14/59 A. frigida roots 0.3 
 1563 Green grass roots 0.6 
 16/66 A. sieversiana leaves 2.8 
 17/72 A. frigida roots 3.8 
Hui doloon xudag 19/80 A. sieversiana roots 2.0 
 21/86 Green grass leaves 1.2 
 24/100 Soil up* 0.1 
 25/103 A. frigida roots 3.0 
Bayandelger  39/168 A. frigida leaves 0.3 
 43/185 Green grass roots 0.3 
 43/186 Soil up* 0.2 
* soil samples were taken directly under the surface (=up) and in the plant hole (= 
below) 
From the results in table 4.2 it can be observed that only a small selection of the 
samples, 13 out of 87 (= 15 %), contain CAP at detectable concentrations. From 
these 13 samples only five samples contain CAP above 1 µg kg-1 with a maximum 
of 3.8 µg kg-1. No extreme values as found in the first sample set were found 
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CAP (µg kg-1) 
(table 4.1). Furthermore, no specific relationship was found between the 
concentration of CAP in soil and herbs, and concentrations found at a specific 
location. The samples containing CAP appear to be randomly distributed across 
the population of samples. This finding is further demonstrated in figures 4.2a-c.  
Figure 4.2a presents the results of the subset of 87 samples per province. All 
provinces have CAP containing plants except one (Atar province). Figure 4.2b 
illustrates that CAP was found in all three species of plants tested but not in 
every sample. Figure 4.2c points towards the plant roots as having the highest 
concentration of CAP compared to leaves and soil samples. From these data it 
was concluded that the herbs growing on the Mongolian pastures do not always 
contain high concentrations of CAP and also that no single herb family appears to 
be responsible for the presence of the antimicrobial compound.  
 
 
 
Figure 4.2. Results of the analysis of CAP in µg kg-1 for the subset of 87 samples 
collected in Mongolia, autumn 2009, per (a) province 1) Lun province, 2) Atar 
province, 3) Hui doloon xudag, 4) Erdene province, 5) Bayandelger province, (b) 
type of plant and (c) sample material. 
a 
b 
c 
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It is difficult to draw general conclusions from the observations but it is clear 
that a relatively large number of root samples contain CAP. It is therefore 
hypothesised that the CAP originates from the soil and is absorbed through the 
plant roots, regardless of the plant type. The soil organism Streptomyces 
venezuelae, and some other actinomycetes, are known to produce CAP but 
biosynthesis depends on many factors including the external conditions in the 
soil. Consequently, it is proposed that the production of CAP may depend on 
environmental conditions such as the prevailing temperature and the amount of 
rainfall and consequent moisture content of the soil. The year 2007, for example, 
was very dry for Mongolia whereas the year 2009 was a very wet year. It is 
possible (though not proven by our experiments) that the differences in climatic 
conditions have a strong influence on the biosynthesis of CAP by microorganisms 
in the soil and its absorption by the plants’ root system, and therefore on the 
concentration of CAP in the plants. Further research is necessary to confirm the 
biosynthesis of CAP by soil micro-organisms in the vicinity of plants found to 
contain CAP and to elaborate the various factors influencing CAP biosynthesis and 
uptake by plants.  
Confirmatory analysis  
The unambiguous identification of a prohibited compound is of high importance 
due to the financial consequences of a (false) non-compliant finding, which may 
include rejection of consignments of contaminated food products by the 
importing country, increased testing requirements at the expense of the 
exporter, and possibly prosecution and financial penalties for the producers. 
Therefore additional precautions are necessary for the identification of CAP in 
plant materials because of the possible impact the results could have for the 
international market.  
For unambiguous identification of a prohibited (banned) compound the minimum 
required EU criteria, as previously described, have to be fulfilled. The EU criteria 
are set up for products of animal origin but these criteria were also used in this 
study to confirm the identity of CAP in plant material. The results of two 
representative non-compliant (CAP containing) samples analysed using LC-MS/MS 
are presented in table 4.3. From the control samples an average ion ratio of 39.5 
% and a relative retention time (RRT) of 1.008 were calculated. For confirmatory  
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Table 4.3. LC-MS/MS results of two samples including identification 
characteristics. 
Description 
(conc. CAP) 
RRT 
(min) 
Rel. 
deviation 
of RRT (%) 
Response 
SRM*  
321 > 152 
Response 
SRM  
321 > 194 
Ion 
ratio 
(%) 
Rel. deviation 
of ion ratio 
(%)** 
Reference 
(blank+2 µg kg-1) 
1.008  6048 2389 39.5  
Artemisia frigida  
(1.3 µg kg-1) 
1.008 0 3736 1445 38.7 -2.0 
Herb mixture  
(4 µg kg-1) 
1.008 0 82603 31611 38.3 -3.0 
* Response SRM = peak area 
** Max tolerance % according to 2002/657/EC criteria: 25 % 
analysis according to EU criteria [9] the maximum allowed relative deviation of 
the ion ratio is 25 % and thus, in this case the identity of CAP was confirmed if 
the ion ratio was between 29.5 and 49.1 %. The maximum allowed deviation for 
the relative retention time is 2.5 %. This approach results in 4 identification 
points using the approach described in Commission Decision 2002/657/EC [9], 
which is considered adequate for unambiguous identification within the EU. 
The ion ratios obtained for the samples only slightly deviate from the reference 
ion ratio (maximum relative difference is -2.5 %) and the relative retention time 
is 1.008 for all samples. From this it was concluded that the identity of CAP is 
confirmed.  
Table 4.4. HRLC-MS/MS results of three samples including identification 
characteristics. 
Description (conc. CAP) RRT 
(min) 
Rel. 
dev. 
RT 
(%) 
Ion ratio 
194 / 152 
(%) 
Rel. dev. 
ion ratio 
194 / 152 
(%)* 
Ion ratio 
257 / 152 
(%) 
Rel. dev. 
ion ratio 
257 / 152 
(%)** 
Reference (blank+2 µg kg-1) 1.004  37.6  70.2  
Artemisia F. (1.3 µg kg-1) 1.004 0 31.1 -16.4 69.4 -1.1 
Artemisia F. (175 µg kg-1) 1.004 0 36.7 -1.3 66.6 -5.1 
Herb mixture (4 µg kg-1) 1.004 0 35.6 -4.3 68.5 -2.4 
* Max tolerance according to 2002/657/EC criteria: 25 %. 
** Max tolerance according to 2002/657/EC criteria: 20 %. 
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For additional selectivity and thus to obtain additional prove for the identity of 
CAP, the sample extracts were re-injected into an HRLC-MS/MS system to obtain 
a higher chromatographic resolution. Furthermore three transitions were 
monitored resulting in a total of 5.5 identification points demonstrating the high 
selectivity of this method. The results of representative non-compliant samples 
are presented in table 4.4. Chromatograms of a blank herb mixture sample, a 
blank herb mixture sample fortified with 2 µg kg-1 CAP, a non-compliant herb 
mixture sample (4 µg kg-1) and the same herb mixture sample with the addition 
of 2 µg kg-1 are presented in figure 4.3. 
 
Figure 4.3. HRLC-MS/MS chromatograms showing three SRM ion transitions for 
CAP and one for the internal standard of (a) a blank herb sample, (b) a blank 
herb sample with addition of 2 µg kg-1 CAP, (c) a herb mixture form a local shop 
and (d) the same herb sample with addition of 2.0 µg kg-1 CAP. 
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From the control sample an average ion ratio of 37.6 % was calculated for the 
product ions m/z=194 versus 152 and 70.2 % for m/z=257 versus 152. 
Furthermore a relative retention time (RRT) of 1.004 was calculated. For 
confirmative analysis according to EU criteria [9] the maximum allowed relative 
deviation of the ion ratio of m/z = 194 versus 152 is 25 % and thus the presence 
of CAP was confirmed in these samples if this ion ratio was between 28.2 and 
47.0 %. For the ion ratio of m/z = 257 versus 152 this was 20 % and thus the 
identity of CAP was confirmed if this ion ratio was between 56.2 and 84.2 %. The 
ion ratios obtained for the samples were all within these limits and the relative 
retention time was 1.004 for all samples. From this it was concluded that the 
identity of CAP was confirmed with high certainty. The LC results did not deviate 
from the HRLC results. In other words all samples containing CAP based on LC 
results were (re)confirmed by using the HRLC. 
Conclusions 
The LC-MS/MS analysis of plant materials from different origins demonstrate that 
it is possible that plant materials can contain CAP. The concentrations of CAP 
varied from non-detectable up to 450 µg kg-1. In cases of positive quantitative 
CAP results (concentrations above the CCα of 0.1 µg kg-1) the identity of CAP was 
unambiguously confirmed according to EU criteria.  
From the test results it was concluded that plants belonging to different families 
can contain CAP. For example, CAP was detected in plants of the families 
Artemisa and Thalictrum but it was also detected in grass. It is known that the 
soil organism Streptomyces venezuelae and related organisms can biosynthesise 
CAP. Therefore it is suggested, based on the results obtained, that CAP is 
produced in the soil and that the plants absorb CAP through their root systems. 
Further research is required to confirm this hypothesis and to elaborate the 
environmental parameters affecting CAP occurrence in plants. This research is 
presented in section 4.5. 
To the best of our knowledge, this is the first time that findings of CAP in plant 
materials have been reported. These findings make it a much more realistic 
prospect that products of animal origin can contain residues of CAP that are not 
due to (illegal) use of the drug, but rather due the natural occurrence of CAP. 
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The results also have significant implications for the application of legislation 
with respect to the detection of CAP in food products and may imply, if not a 
change in the legislation, at least a change in the interpretation of analytical 
results and in follow-up actions and penalties to producers after the detection of 
CAP. 
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4.3. Discrimination of eight chloramphenicol 
isomer by liquid chromatography tandem mass 
spectrometry in order to investigate the natural 
occurrence of chloramphenicol 
Abstract 
This section describes the discrimination of eight different isomers of 
chloramphenicol (CAP), an antibiotic banned for use in food producing animals, 
by reversed phase and chiral liquid chromatography in combination with tandem 
mass spectrometric detection. In section 4.2, the presence of CAP was confirmed 
in some grass and herb samples collected on Mongolian pastures up to 
concentrations of 450 µg kg-1. It was not possible to establish the cause of CAP 
residues which has initiated research on the natural occurrence of this drug. CAP 
occurs in the para-configuration and in the meta-configuration and contains two 
chiral centers thus eight different isomeric configurations exist, namely four (RR, 
SS, RS, SR) meta-stereoisomers and four para-stereoisomers. It is known that only 
RR-p-CAP has antimicrobial properties. To find out if the CAP detected in the 
plant material samples is the active configuration, a high resolution reversed 
phase LC-MS/MS system was tested for its ability to separate the different 
isomers. This system proved to be able to discriminate among some isomers, but 
not between RR-p-CAP and SS-p-CAP, also called dextramycin. Despite a detailed 
elucidation of the product ions and the fragmentation patterns of all isomers, 
MS/MS did not add sufficient specificity for full discrimination of the isomers. 
Therefore a chiral liquid chromatographic separation with MS/MS detection that 
is able to distinguish all isomers was developed and finally the isomeric ratio of 
non-compliant plant material samples and some CAP formulations was 
determined using this system. This showed that Mongolian grass and herb samples 
only contain the biological active isomer of CAP as do the obtained formulations. 
Therefore the CAP present in the plant material might origin from the production 
by soil organisms or from a manufactured source. 
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Introduction  
Chloramphenicol (CAP; 2,2-dichloro-N-[2-hydroxy-1-(hydroxymethyl)-2-(4-
nitrophenyl)ethyl]acetamide) is a broad-spectrum antibiotic with historical 
veterinary use in all major food-producing animals. The drug is biosynthesised by 
the soil organism Streptomyces venezuelae and several other actinomycetes [28] 
and is chemically synthesised for commercial use [2]. CAP occurs in the meta-
configuration and in the para-configuration and it contains two chiral centers 
(carbon 2 and 3, figure 4.1a) thus in total eight different isomeric configurations 
exist: four (RR, SS, RS, SR) meta-stereoisomers and four para-stereoisomers 
(figure 4.1). If not explicitly mentioned, the name chloramphenicol generally 
refers to RR-p-CAP, which is also called levomycetin. SS-p-CAP is also called 
dextramycin (DEX) and a racemic mixture of the two isomers is called 
synthomycin [10].  
All para-stereoisomers are biologically active [10-19] but it was reported that 
only RR-p-CAP has antimicrobial properties [10,14]. In contrast, other papers 
claim < 0.5 % antimicrobial activity for SS-p-CAP [15,16] and RS-p-CAP [15] 
compared to RR-p-CAP and 1 to 2 % for SR-p-CAP [15]. According to literature the 
structure of the propanediol moiety is critical for the microbial activity whereas 
the aryl nitro group and the acetamide side chain are not essential [17]. No 
information is available on the meta-stereoisomers.  
Chloramphenicol is banned for use in all food producing animals and a minimum 
required performance limit (MRPL) of 0.3 µg kg-1 has been established [6]. 
Surprisingly, in this document, no specific configuration of CAP is referred to and 
thus it is unclear if these regulations apply to all individual isomers. 
During the last decade, findings of CAP residues in food products such as poultry, 
honey, and sheep casings have had a major impact on international trade [21]. 
Follow-up investigations in Asian countries that were related to the non-
compliant findings could not identify the origin of CAP residues and no recent 
history of CAP use was found. Because CAP was also detected in unexpected 
samples, like wine [29] and plant materials [30] it was suggested that products 
are contaminated due to the natural occurrence of CAP. More scientific data are 
needed to be able to support or reject this hypothesis including research on the 
uptake of CAP by plants, the detection of CAP producing soil organisms and the 
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presence of isomeric impurities in plant samples and commercially available CAP 
formulations. The latter is the focus of this section. 
Nowadays for the detection, quantitation, and confirmation of CAP mainly 
reversed phase (RP) LC-MS/MS is used. These RP-LC methods make use of either a 
C8 [31,32] or a C18 [23,24,26,30,33] stationary phase combined with isocratic 
[24,31,32] or gradient [23,26,30,33] elution. Superior resolution is obtained using 
an analytical column containing sub 2 µm particles [23,30] in combination with 
gradient elution. These methods have not been tested for other isomers than RR-
p-CAP and no data are available on the MS/MS detection of CAP isomers. 
There are only a small number of papers available on the use of LC to separate 
CAP isomers. The separation of four para-CAP isomers by RP-LC preceded by a 
derivatization using homochiral isothiocyanate [34] and by addition of 
cyclodextrin to the mobile phase [35] was reported. However both approaches 
did not result in full baseline separation of the stereoisomers and are unfavorable 
because derivatization and complex formation tend to be less robust than direct 
analysis methods. Chiral LC using 4-(3,5-dinitro benzamido)tetrahydrophen-
anthrene covalently bound to silica as the stationary phase was applied to obtain 
a baseline separation for RR-p- and SS-p-CAP [36] and also for the separation of 
RR-p- and SS-p-florfenicol, a compound chemically related to CAP [37]. In 
literature, no methods are reported combining a chiral LC sytem with MS 
detection. 
This is the first time results are reported on the LC-MS/MS confirmatory analysis 
of CAP isomers. The confirmation of the identity of a compound is carried out 
according to EU regulations on basis of the identification points principle [9]. 
When using LC-MS/MS the minimum required number of identification points is 
obtained by selecting one precursor ion and two product ions in Selected 
Reaction Monitoring (SRM). For a positive identification of a compound in an 
unknown sample the relative abundance of the two product ions (the ion ratio) 
should fall within established limits of the ion ratio of the expected compound. 
Thus, to be able to discriminate among the CAP isomers by MS/MS only, for each 
isomer a unique combination of two product ions or two product ions with a 
unique relative abundance are needed. 
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In the research presented in this section it is tested if a high resolution RP-LC 
system is capable of separating all CAP isomers and it is the first time MS/MS 
product ion spectra of CAP isomers are presented and discussed. Furthermore, a 
chiral liquid chromatographic system was developed to achieve separation of the 
relevant isomers. The developed method was used to determine the isomeric 
ratio of CAP isomers in plant material samples obtained from Mongolian pastures 
that were found positive in previous analyses [30]. Furthermore, CAP 
formulations were analysed for isomeric impurities. If the isomeric ratio of CAP 
in plant materials and/or formulations is specific, this could result in tracing the 
origin of the contamination. 
Experimental 
Reagents and equipment 
HPLC grade water, methanol and acetonitrile were obtained from Biosolve 
(Valkenswaard, The Netherlands). Ethanol absolute was obtained from Merck 
(Darmstadt, Germany). Milli-Q water was prepared using a Milli-Q system at a 
resistivity of at least 18.2 MΩ cm-1 (Millipore, Billerica, MA, USA). The reference 
standard of RR-p-CAP was obtained from Sigma-Aldrich (St. Louis, MO, USA). SS-
p-CAP, a mixture of RR-m-CAP and SS-m-CAP, a mixture of RS-m-CAP and SR-m-
CAP and a mixture of RS-p-CAP-d5 and SR-p-CAP-d5 were obtained from Witega 
(Berlin, Germany). The deuterium atoms were substituted at the phenyl ring and 
at carbon 3. Non deuterated RS-p-CAP and SR-p-CAP were not commercially 
available. Stock solutions were prepared in methanol at 100 mg L-1 and all 
dilutions were prepared fresh daily in Milli-Q water. 
The high resolution RP-LC system consists of a vacuum degasser, autosampler, 
and a binary pump (Acquity Waters, Milford, MA, USA) equipped with a Waters 
Acquity UPLC BEH C18 analytical column of 2.1 × 100 mm, 1.7 μm placed in a 
column oven at 50 °C. The gradient (solvent A, water (100 %); solvent B, 
methanol (100 %)) was: 0 – 0.5 min, 10 % B, 0.5 – 4.0 min, linear increase to 100 % 
B with a final hold of 0.5 min, operating at a flow rate of 0.4 mL min-1. The 
injection volume was  5 μl.  
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The chiral LC system consisted of the same equipment but combined with a 
Chromtech Chiral AGP (α1-acid glycoprotein) analytical column of 2.0 × 150 mm, 
5 μm (Chromtech inc, Apple Valley, MN, USA) placed in a column oven at 20 °C. 
The gradient (solvent A, water (100 %); solvent B, methanol/acetonitrile (1:1 
v/v)) was: 0 – 4.0 min, 9 % B, 4.0 – 4.1 min, linear increase to 12 % B with a final 
hold of 4.9 min, operating at a flow rate of 0.5 mL min-1. The injection volume of 
standard solutions was  5 μL and of extracted plant material 5 µL, the latter to 
extend the column lifetime . 
Detection was carried out using a Waters Quattro Ultima mass spectrometer in 
the negative electrospray ionisation (ESI) mode. The operating parameters were: 
capillary voltage, 2.7 kV; cone voltage, 25 V; source temperature, 120 °C; 
desolvation temperature, 300 °C; cone gas flow, 200 L h−1; and desolvation gas, 
500 L h−1. The CAP isomers were fragmented using collision-induced dissociation 
and the Selected Reaction Monitoring (SRM) transitions m/z = 321.0 > 257.1, m/z 
= 321.0 > 152.0 and m/z = 321.0 > 207.0 were monitored. For RS- and SR-p-CAP-
d5 the SRM transitions m/z = 326.0 > 262.1 and m/z = 326.0 > 157.0 were 
monitored. Data were acquired and processed using MassLynx 4.1 software 
(Waters). 
Element compositions of product ions were derived from exact masses 
determined using a MicrOTOF-Q (Bruker Daltonics, Billerica, MA, USA) operating 
in negative ESI mode using the integrated syringe pump to continuously infuse 10 
mg l-1 solutions of RR-p-CAP, SS-p-CAP (DEX), a mixture of d5-RS-p-CAP and d5-SR-
p-CAP, a mixture of RR-m-CAP and SS-m-CAP and a mixture or RS-m-CAP and SR-
m-CAP. Using this instrumentation a resolution of at least 10000 is obtained.  
Proposed fragmentations of the isomers were supported by MSn measurements 
using an LCQ Deca XP (Thermo Scientific, Waltham, MA, USA) ion trap mass 
spectrometer operating in negative ESI mode also by continuous infusion. 
Samples 
CAP formulations seized from farms in the Netherlands were analysed for CAP 
isomers. Plant samples were collected at different Mongolian pastures at 
different points in time. The people collecting the samples did not use hand 
creams (possibly contaminated with CAP) and were made aware of the possibility 
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of contaminating samples due to the use of CAP contaminated gloves to minimise 
the chance of unintended contamination during this stage. These samples were 
monitored for the presence of CAP [30] and five highly contaminated plant 
material samples were selected for analysis of the individual isomers (table 4.5). 
Extraction and sample preparation were carried out as described before [30] and 
of the resulting extract 5 µL was injected into the chiral LC-MS/MS system.  
Two CAP containing formulations were seized from farms in the Netherlands in 
2005. One formulation is a commercially available powder, the other is an 
unidentified liquid. Of the first formulation a solution of 1 µg kg-1 was prepared 
in water and the second was diluted one million times in water. Of both solutions 
20 µL was injected into the chiral LC-MS/MS system. 
MS/MS specificity experiments 
The discriminating power of the triple quadrupole MS was studied by analysing 
the product ions formed and comparing their ion ratios for the different CAP 
isomers. Solutions of RR-p-CAP, SS-p-CAP (DEX), a mixture of d5-RS-p-CAP and d5-
SR-p-CAP, a mixture of RR-m-CAP and SS-m-CAP and a mixture or RS-m-CAP and 
SR-m-CAP were continuously infused in the MS to determine the product ion 
spectrum at different collision energies (0 through 35 eV). For a closer look, the 
abundances of the product ions of RR-p-CAP and SS-p-CAP at each collision 
energy were compared and the product ions showing the largest relative 
differences between the two were selected. These product ions were 
programmed in an SRM experiment and standard solutions of 10 µg L-1 CAP and 
DEX were injected into the LC-MS/MS system alternately (n=8). The ion ratios for 
both stereoisomers were calculated for all combinations of transitions, resulting 
in 21 ion ratios. The corresponding ion ratios for RR-p-CAP and SS-p-CAP were 
compared using a Students t-test (α=0.05) to determine if these stereoisomers 
can be discriminated based on their fragmentation pattern and relative product 
ion intensities. 
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Table 4.5. Mongolian plant materials containing CAP selected for analysis of the 
isomers. 
Sample name Code [30] Level of CAP (µg kg-1) [30] 
Thalictrum simplex S1 23 
Artemisia siversiana S2 46 
Artemisia frigida S3 175 
Artemisia siversiana S6 160 
Thermopsis daurica S7 25 
Thalictrum simplex S9 40 
 
Results & Discussion 
Structure elucidation of product ions 
Tentative molecular structures of product ions were suggested based on the 
presence of chlorine isotopes, the presence of deuterium atoms in RS-p- and SR-
p-CAP-d5 and the elemental composition derived from the determined exact 
mass. The chlorine isotope experiment indicated that the product ion m/z=257 
contains one chlorine atom and that it is the only product ion in which any 
chlorine is present. The presence of the deuterium atoms in the RS-p- and SR-p-
CAP-d5 showed that no fragmentation occurs in the penyl ring nor at carbon 3. 
The exact masses of the major product ions determined using the LC-Q-TOF 
system are presented in table 4.6. From this information elemental compositions 
were suggested (table 4.6) for those ions of which the theoretical exact mass is 
within a 10 ppm error of the experimental asessed value, except for the 
composition suggested for product ion m/z=152 (12 and 35 ppm error for RR-p- 
and SS-p-CAP respectively). For this product ion the most likely elemental 
composition, suggested by the software was selected which is very likely based 
on the presence of all five deuterium atoms. Tentative product ion molecular 
structures in combination with the fragmentation pathways as supported by MSn 
experiments are presented in figure 4.4. Tentative molecular structures for the 
product ions m/z=257 and 152 were reported by Mottier et al. [33] based upon 
the use of 35Cl37Cl-CAP and CAP-d5. These are in agreement with our findings. 
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Table 4.6. Exact masses of relevant product ions. 
Exact mass (m/z) of product ions Suggested 
elemental 
composition of 
product ion 
Theoretical 
exact mass of 
suggested 
formula 
RR-p-CAP SS-p-CAP 
RR-m-CAP / 
SS-m-CAP 
RS-m-CAP / 
SR-m-CAP 
257.0351 257.0333 257.0329 257.0339 C10ClH10N2O4 257.0329 
  249.0512 249.0513 C11H9N2O5 249.0511 
  237.0511 237.0512 C10H9N2O5 237.0511 
   221.0567 C10H9N2O4 221.0562 
  207.0406 207.0440 C9H7N2O4 207.0406 
194.0469 194.0456 194.0452  C9H8NO4 194.0453 
  179.0456 179.0458 C9H9NO3 179.0457 
176.0362 176.0356 176.0350  C9H6NO3 176.0348 
152.0367 152.0402   C7H6NO3 152.0348 
 
The differences in fragmentation pattern might be explained by the three-
dimensional configuration of the CAP isomers. The three-dimensional 
configuration of CAP in solution was extensively studied by X-ray [38], nuclear 
magnetic resonance (NMR) [39,40] and infra-red spectroscopy [40,41]. It is 
reported that RR-p-CAP only occurs in one configuration (figure 4.5a) and that 
the formation of intra-molecular hydrogen bonding between the hydroxyl and the 
methylhydroxyl group occurs [38,39,41]. Furthermore a stabilization of the 
presented configuration was contributed to the dipolar interaction between the 
carbonyl oxygen and the nitroaromatic ring [40,41]. RS- and SR-p-CAP also form 
hydrogen bonds and are mirror images. In that research the interaction of the 
nitrophenyl moiety and the carbonyl oxygen was not discussed. No information is 
available on the meta-CAP isomers.  
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Figure 4.4. Proposed fragmentation pathways for the CAP isomers. 
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Figure 4.5. Configuration of (a) RR-p-CAP in solvent [41] and (b)the [M-H]- ion of 
RR-p-CAP in the gas phase. 
It should be noted that all reported research so far exclusively focused on the 
three-dimensional characterization of CAP in solvent whereas this study focused 
on the fragmentation of the [M-H]- ions of the chloramphenicol isomers in the gas 
phase under vacuum. Therefore, 3D configurations of all isomers were 
determined using BioChem3D 12.0 Ultra software (CambridgeSoft, Cambridge, 
MA, USA). The lowest energetic state of the [M-H]- ion of RR-p-CAP in the gas 
phase was the benzylic anion having a configuration as presented in figure 4.5b. 
All isomers show comparable three-dimensional configurations indicating that all 
isomers form intra-molecular hydrogen bridges between the hydroxyl and 
hydroxymethyl group. Interaction between the carboxyl and the phenyl group is 
unlikely. For the RR- and SS-isomers it is observed that the amide nitrogen is on 
the same plane and within a 3Å distance of the hydroxyl and hydroxymethyl 
group indicating that it could be part of an intra-molecular hydrogen bridging 
system, which might influence the fragmentation pathways of these isomers. The 
presence of the product ion m/z=152 for the para-CAP isomers and the absence 
of this product ion for the meta-CAP isomers is most likely caused by mesomeric 
stabilization of the benzylic anion which only occurs when the nitro group is in 
the para position.   
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Discrimination of CAP isomers by tandem mass spectrometry 
Product ion mass spectra of all CAP isomers were recorded at different collision 
energies. The product ions observed for RR-p-CAP are in agreement with previous 
observations [26,32,33]. From the fragmentation spectra of all isomers obtained 
during continuous infusion at a collision energy ranging from 0 through 35 eV, 
product ions that are at least 5 % of the base peak intensity are graphically 
presented in figure 4.6. 
The first important observation from the product ion spectra shown in figure 4.6 
is that no discrimination can be made between RR- and SS-p-CAP. The 
configuration of para-CAP isomers is the mirror image of SS-p-CAP [39] and thus 
the same fragmentation pattern is expected. RS- and SR-p-CAP are also mirror 
images of each other [39] as is the case for RR- and SS-m-CAP and RS- and SR-m-
CAP. Although these isomers were only fragmented as a mixture, from this it is 
expected that the pairs of enantiomers cannot be distinguished by mass 
spectrometric detection only. 
The second important observation from the product ion spectra shown in figure 
4.6 is that the para- and meta-isomers dissociate in a different way. Especially a 
high abundant product ion m/z=152 and product ion m/z=121 are specific for 
para-CAP stereoisomers whereas the product ions at m/z=237, 207, 179, 86 and 
84 which all origin from a fragmentation pathway via the product ion m/z=237, 
are specific for the meta-CAP isomers. From the product ion mass spectra it is 
concluded that para- and meta-isomers can easily be distinguished by MS/MS 
detection only.  
A third important observation is that different product ion spectra are obtained 
for the RR- and SS-isomers compared to the RS- and SR-isomers. The product ions 
m/z= 194 and 176, originating from a single fragmentation pathway, are solely 
observed for the mixture of RR- and SS-CAP of both the para- and meta-isomers. 
The product ion m/z=221 (observed as m/z=226 for the mixture of RS- and SR-p-
CAP-d5) is only observed for RS- and SR-CAP of both the para- and meta-isomers. 
From this it is concluded that RR- and SS-CAP can be distinguished from RS- and 
SR-CAP for both the para- and meta-isomers by MS/MS detection only.  
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Figure 4.6. Intensity of different product ions recorded at different collision 
energies for the CAP isomers: (a) RR-p-CAP, (b) SS-p-CAP (c) a mixture of SR- and 
RS-p-CAP-d5, (d) a mixture of RR- and SS-meta-CAP and (e) a mixture of SR- and 
RS-m-CAP. 
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From these observations it is concluded that the pure form of all isomers, except 
for the mirror images, can be distinguished by MS/MS detection. The combination 
of product ions m/z=194 and 152 are specific for RR- and SS-p-CAP, m/z=221 and 
152 for RS- and SR-p-CAP, m/z=237 and 194 for RR- and SS-m-CAP and m/z=207 
and 221 for RS- and SR-m-CAP. Of course this will not be the case if several 
isomers are present together in a mixture. 
From the product ion mass spectra RR-p-CAP and SS-p-CAP (DEX) seem to have a 
comparable fragmentation pattern. However, using continuously infusion the 
ionisation conditions (flow and eluent composition) differ from the ionisation 
conditions during LC-MS/MS. To test the possibility to distinguish RR-p-CAP from 
SS-p-CAP based upon the ion ratio concept in relation to Commission Decision 
2002/657/EC [9], the product ions of RR-p-CAP and SS-p-CAP showing a relatively 
high intensity difference in the continuous infusion experiment were selected 
being: m/z=121.0 (20 eV), m/z=151.0 (15 and 30 eV), m/z=152.0 (15 and 25 eV), 
m/z=176.0 (25 eV), m/z=194.0 (10 eV) and m/z=257.1 (10 eV). These product 
ions were monitored for injections (n=8) of RR-p-CAP and SS-p-CAP into the LC-
MS/MS system and all resulting ion ratios were calculated (n=21). The difference 
of the ion ratios of RR-p-CAP and SS-p-CAP were calculated and compared using a 
Students t-test (α=0.05). No significant ion ratio deviations between RR-p-CAP 
and SS-p-CAP were found. From this it is concluded that the pure RR- and SS-p-
CAP cannot be distinguished using MS/MS detection alone. 
Reversed phase-LC-MS/MS 
Because the applied RP-LC method makes use of an analytical column containing 
1.7 µm particles in combination with gradient elution, it is considered a high 
resolution LC-system. From the LC-methods reported in literature [23,24,26,30-
33] it is most likely that this method results in the highest resolution and as a 
consequence in the best isomeric separation. Chromatograms of a mixture of all 
para-stereoisomers, a mixture of all meta-stereoisomers and a mixture of all 
isomers, injected on the high resolution RP-LC-MS/MS system are presented in 
figure 4.7. Only two peaks are observed in the chromatogram of the mixture of 
all isomers: the RS- and SR-isomers of both para- and meta-CAP elute at a 
retention time (RT) of 2.60 min and are separated from the RR- and SS-isomers 
which elute at 2.71 min. As stated RR- and SS-isomers are expected to form an 
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intra-molecular hydrogen bridging system whereas the RS- and SR-isomers do this 
to less extend. Therefore the polar groups in the RS- and SR-isomers are able to 
interact more with the polar mobile phase and therefore they elute from the RP 
column first. The RR- and SS- as well as the RS- and SR-configurations of both 
para- and meta-CAP co-elute using this system. It is expected that the RR- and 
SS- as well as the RS- and SR-isomers cannot be separated using RP-LC because 
these isomeric pairs are mirror images to which RP-LC is non-selective. Further 
optimization was carried out attempting to separate the para- from the meta-
isomers by changing the steepness of the gradient and lowering the injection 
volume (5 instead of 35 µL). These experiments did not result in a visible 
separation of the para- and meta-isomers. 
 
 
Figure 4.7. High resolution RP-LC chromatograms showing three MS transitions 
of (a) a mixture of all para-stereoisomers, (b) a mixture of all meta-
stereoisomers and (c) a mixture of all isomers. For the para-isomers the 
transitions of the non-deuterated and deuterated stereoisomers are combined in 
one chromatogram simulating the use of non deuterated reference standard for 
all isomers. a = RR-p-CAP, b = SS-p-CAP, c = RS-p-CAP-d5, d = SR-p-CAP-d5, e = RR-
m-CAP, f = SS-m-CAP, g = RS-m-CAP and h = SR-m-CAP. 
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Although no chromatographic separation is observed for the para- and meta-
configuration, a mass spectrometric separation based on monitoring different 
product ions is obtained (cf. MS/MS experiments). From the results it is 
concluded that high resolution RP-LC-MS/MS method is not able to separate RR- 
and SS-stereoisomers nor RS- and SR-stereoisomers.    
Chiral LC-MS/MS 
Several mobile phases were tested to obtain a satisfactory separation of all 
isomers. The use of methanol, ethanol, acetonitrile and mixtures of methanol 
and acetonitrile as the mobile phase resulted in a somewhat different selectivity. 
However, for all mobile phases isocratic elution resulted in co-elution of two 
para- or two meta-isomers and in most cases in very broad peaks (> 1 min) for 
the late eluting isomers. A two-step isocratic elution was introduced running at 9 
% methanol/acetonitrile (1:1, v/v) in water for 4 min to obtain satisfactory 
separation of the para-isomers followed by a linear increase of the percentage of 
organic modifier to 12 % during 0.1 minute with a final hold of 4.9 minutes to 
speed up the elution of the retained isomers. This system resulted in the 
chromatographic separation of all eight isomers within eight minutes (figure 4.8).  
MS/MS detection provided additional resolution to the system because the para-
isomers can easily be separated from the meta-isomers by monitoring different 
product ions. The meta-isomers are almost baseline separated but the para-
isomers are not: SS-p-CAP (DEX) with RT=5.57 min shows some overlap with RS- 
or RS-p-CAP eluting at RT=5.02 min. However, the two peaks are clearly 
distinguishable based upon RT. Most important is that RR-p-CAP, the active 
configuration, eluting at RT=3.90 is baseline separated from all other isomers. It 
is concluded that all eight isomers can be distinguished using the chiral LC-MS/MS 
system presented here.  
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Figure 4.8. Chiral LC chromatograms showing three MS transitions of (a) a 
mixture of four para-stereoisomers (b) a mixture of four meta-stereoisomers 
and (c) a mixture of all isomers. The configuration of the isomers is indicated. A 
= RR-p-CAP, b = SS-p-CAP, c = RS-p-CAP-d5, d = SR-p-CAP-d5, e = RR-m-CAP, f = 
SS-m-CAP, g = RS-m-CAP and h = SR-m-CAP. 
Sample analysis 
Using the developed chiral LC-MS/MS system the isomeric ratio of different kind 
of samples was determined. If isomeric impurities are observed, the isomeric 
ratio of the CAP isomers in plant materials and CAP formulations can be 
compared to trace the origin of the contamination. The limit of quantitation of 
the individual isomers in plant material using the chiral LC-MS/MS system is 
relatively high: 2 - 5 µg kg-1 instead of 0.5 µg kg-1 for the high resolution RP-LC-
MS/MS system. Therefore, isomeric impurities can only be detected for highly 
contaminated samples. 
The chromatograms of a blank plant sample spiked at 100 µg kg-1 with all CAP 
isomers and of plant sample S3 are presented in figure 4.9a and b. From the 
chromatograms it is clear that the plant material sample contains RR-p-CAP, the 
active configuration. Especially in sample S3 small signals are observed in the MS  
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Figure 4.9. Chiral LC chromatograms showing three MS transitions of (a) a blank 
plant material sample spiked at 100 µg kg-1 with a mixture of all isomers (b) 
sample S3 and (c) formulation 1. A = RR-p-CAP, b = SS-p-CAP, c = RS-p-CAP-d5, d 
= SR-p-CAP-d5, e = RR-m-CAP, f = SS-m-CAP, g = RS-m-CAP and h = SR-m-CAP. 
transition m/z = 321.0 > 257.1 at RT = 3.09, 5.09 and 6.32 min. The RT of these 
peaks does not correspond to the RT of any of the isomers and furthermore no 
peaks are observed for the other, more specific transitions. It is concluded that 
these signals do not origin from CAP isomers and that only the active 
configuration of CAP was detected in the plant material. This accounts for all 
tested plant materials.  
The analysis of the two seized formulations show very high peaks for RR-p-CAP; 
the chromatogram of the first formulation is presented in figure 4.9c. No 
isomeric impurities were detected in these formulations. Only RR-p-CAP was 
detected in the tested plant materials and formulations and therefore the origin 
of the contamination cannot be traced: the CAP present in the plant material can 
origin from the production by soil organisms or from a manufactured source 
(illegal use).  
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Conclusions 
In this section it is demonstrated that high resolution RP-LC is suitable to 
discriminate RR- and SS-stereoisomers from RS- and SR-stereoisomers. 
Additionally MS/MS detection was found to discriminate meta- from para-
substituted isomers. However, RP-LC methods are unable to discriminate 
between the mirror images (e.g. the antimicrobial active RR-p-CAP and SS-p-
CAP), neither by RP-LC separation nor by MS/MS detection. Because most LC 
methods described in literature are based upon RP-LC it is concluded that 
generally applied methods for the confirmatory analysis of CAP are not specific 
enough and are thus not suited for the control of food products. Alternative 
methods, like chiral LC have to be used to specifically detect the administration 
of the antimicrobial active isomer of CAP. 
A chiral LC-MS/MS system was developed which proved to be able to baseline 
separate RR-p-CAP from the other isomers. This system was applied to analyse 
CAP-containing plant material samples obtained from Mongolian pastures and 
some CAP formulations. This showed that Mongolian grass and herb samples as 
well as the formulations only contain the antimicrobial active isomer of CAP. 
Therefore the CAP present in the plant material can origin from a manufactured 
source indicating illegal use or from the production by soil organisms (natural 
occurrence). Additional research on the uptake and accumulation of CAP isomers 
by plants and herbs, and research on the detection of the presence of CAP 
producing soil organisms is needed to further elucidate this matter.  
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4.4. Quantitative trace analysis of eight 
chloramphenicol isomers in urine by chiral 
liquid chromatography coupled to tandem mass 
spectrometry 
Abstract 
Chloramphenicol is a broad-spectrum antibiotic with, apart from its human 
medicinal use, veterinary abuse in all major food-producing animals. 
Chloramphenicol occurs in four stereoisomers (all para-nitro substituted) and 
furthermore four meta-nitro analogs of chloramphenicol exist. Here, these are 
referred to as eight chloramphenicol isomers. According to EU regulations an 
analytical method should be able to discriminate the analyte from interfering 
substances that might be present in the sample, including isomers. For the first 
time a quantitative method for the analysis of trace levels of eight 
chloramphenicol isomers in urine by chiral liquid chromatography in combination 
with tandem mass spectrometric detection is reported. The separation of the 
isomers on the analytical column, the clean-up of urine and the selectivity of the 
monitored product ions turned out to be critical parameters. To obtain 
reproducible retention isocratic elution on a chiral AGP column was applied. For 
urine samples matrix compounds present in the final extract caused decreased 
retention of the isomers on the chiral stationary phase and a lack of 
chromatographic resolution. Therefore an extended clean-up procedure that 
combines solid phase extraction and liquid-liquid extraction had to be developed. 
The final method was fully validated and showed satisfactory performance for all 
isomers with decision limits (CCα) ranging from 0.005 to 0.0  µg L-1 and within-
laboratory reproducibility of all isomers below 20 % at the minimum required 
performance limit level of 0.3 µg L-1. 
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Introduction 
Chloramphenicol (CAP; 2,2-dichloro-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)-2-
(4-nitrophenyl)ethyl]acetamide) is a broad-spectrum antibiotic used as a human 
medicine but also for veterinary use in all major food-producing animals. 
However, chloramphenicol is banned for use in all food producing animals and a 
minimum required performance limit (MRPL) of 0.3 µg kg-1 has been established 
[6]. 
CAP is a para-nitro substituted compound that contains two chiral centers 
(carbon 2 and 3, figure 4.1a) thus four stereoisomers of CAP exist. Furthermore, 
four meta-nitro substituted analogs exist resulting in a total of eight different 
isomeric configurations (figure 4.1), which are all referred to as CAP isomers in 
this thesis. If not explicitly mentioned, the name chloramphenicol generally 
refers to RR-p-CAP, which is also called levomycetin. SS-p-CAP is also called 
dextramycin (DEX) and a racemic mixture of the two isomers is called 
synthomycin [10]. All para-stereoisomers are biologically active [10-19] but it was 
reported that only RR-p-CAP has antimicrobial properties [10,14]. In contrast, 
other papers claim < 0.5 % antimicrobial activity for SS-p-CAP [15,16] and RS-p-
CAP [15] compared to RR-p-CAP and 1 to 2 % for SR-p-CAP [15]. According to 
literature the structure of the propanediol moiety is critical for the microbial 
activity whereas the aryl nitro group and the acetamide side chain are not that 
essential [17]. No information is available on the meta-analogs. 
Criteria concerning the performance of analytical methods and the interpretation 
of results were established in 2002 [9]. According to this document samples taken 
for monitoring of residues in animal products should be analysed using methods 
that have been validated according to the described procedures [9]. In these 
procedures selectivity is mentioned as a main characteristic of an analytical 
method. Selectivity is defined as “the power of discrimination between the 
analyte and closely related substances like isomers (…)”. Only using an 
enantioselective method, the identity of CAP can be confirmed without any 
doubt, which is a necessity in case the analytical result is challenged in court 
cases. 
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For the quantitation and confirmation of CAP mainly reversed phase (RP) LC-
MS/MS has been used. RP-LC methods make use of either a C8 [31,32] or a C18 
[23,24,26,30,33] stationary phase combined with isocratic [24,31,32] or gradient 
[23,26,30,33] elution. Superior resolution is obtained using an analytical column 
containing sub 2 µm particles [23,30] in combination with gradient elution. 
However, recently the lack of selectivity for enantiomers of these methods was 
demonstrated [42] (section 4.3). 
The analysis of isomeric drugs using chiral stationary phase LC-MS/MS is an 
emerging field. Several methods for the enatioselective analysis of drugs in fungi 
culture medium [43], waste water [44], saliva [45], plasma [46-51], urine [47,48] 
and hair [48] have been reported during the last decade making use of a great 
variety of analytical columns: immobilised α1-acid glycoprotein (AGP) 
[45,46,49,51], chiral cellobiohydrolase (CBH) [44], chiral phenylcarbamate ß-
cyclodextrin (CD-Ph) [48], (R)-1-naphthylglycine and 3,5-dinitrobenzoic acid 
amide linkage [47], teicoplanin [50] or amylose-based analytical columns [43]. 
Only a few papers are on the use of LC to separate CAP isomers. The separation 
of four para-CAP isomers in solvent by RP-LC using pre-column derivatization 
using homochiral isothiocyanate [34] and the addition of cyclodextrin to the 
mobile phase [35] was reported. Both approaches did not result in baseline 
separation of the stereoisomers and are unfavorable because derivatization and 
complex formation is usually less robust than direct analysis [52]. Chiral LC using 
4-(3,5-dinitro benzamido)tetrahydrophenanthrene covalently bound to silica as 
the stationary phase was applied to obtain a baseline separation for RR-p- and 
SS-p-CAP in formulations [36] and also for the separation of RR-p- and SS-p-
florfenicol, a compound chemically related to CAP, in formulations [37]. 
Previously a method was reported combining chiral LC using an AGP column 
material in combination with a two phase isocratic system, with mass 
spectrometry that is able to discriminate among all eight isomers, but that 
method lacked sensitivity for regulatory control of animal products at the MRPL 
level of 0.3 µg L-1 [42] (section 4.3). 
Although chiral separations have found their use in clinical and pharmaceutical 
research [52], to our knowledge no enantioselective LC-MS/MS methods have 
been reported having their application at sup-ppb levels as required for 
veterinary drug residue analysis in products of animal origin. The presented 
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method is suited for quantitative analysis of eight CAP isomers in urine and is 
able to discriminate RR-p-CAP from the other isomers. It is therefore the first 
method reported that is suited to unequivocally confirm the identity of the 
individual CAP isomers according to EU regulations [9] at part-per-trillion levels, 
well below the MRPL. 
Experimental 
Reagents and equipment 
HPLC grade water, methanol (MeOH), acetonitrile (ACN) and ethyl acetate were 
obtained from Biosolve (Valkenswaard, The Netherlands). Ammonium formate, 
acetic acid, formic acid, 25 % ammonia, sodium hydroxide and ß-
glucuronidase/arylsulfatase from helix pomatia were obtained from Merck 
(Darmstadt, Germany). Milli-Q water was prepared using a Milli-Q system at a 
resistivity of at least 18.2 MΩ cm-1 (Millipore, Billerica, MA, USA). The reference 
standard of RR-p-CAP was obtained from Sigma-Aldrich (St. Louis, MO, USA). SS-
p-CAP, a mixture of RR-m-CAP and SS-m-CAP, a mixture of RS-m-CAP and SR-m-
CAP and a mixture of RS-p-CAP-d5 and SR-p-CAP- d5 and a mixture of RR-p-CAP-d5 
and SS-p-CAP-d5 were obtained from Witega (Berlin, Germany). The deuterium 
atoms were substituted at the phenyl ring and at carbon 3 (figure 4.1, page 116). 
Non deuterated RS- and SR-p-CAP were not commercially available and thus were 
the deuterated compounds used as a representative reference. RR- and SS-p-CAP-
d5 were used as the internal standards. Stock solutions were prepared in MeOH at 
100 mg L-1 and all dilutions were prepared fresh daily in Milli-Q water. 
Sample preparation 
5 mL of a urine sample was transferred into a polypropylene centrifuge tube. The 
pH was adjusted to 4.8 using dilutions of acetic acid and sodium hydroxide. 50 µL 
ß-glucuronidase/arylsulfatase were added and the sample was incubated for 16 
hours at 37 °C or for 2 hours at 55 °C. A Phenomenex (Torrance, CA, USA) Strata-
X 200 mg / 6 mL solid phase extraction (SPE) cartridge was conditioned with 5 mL 
MeOH and 5 mL water. The hydrolysed urine sample was applied onto the 
cartridge and washed with 6 mL 40 % MeOH in water containing 1 % acetic acid 
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followed by 6 mL 40 % MeOH containing 1 % ammonia (25 %). The cartridges were 
dried by applying vacuum for 3 minutes. The chloramphenicol isomers were 
eluted from the cartridge using 3 mL MeOH/water (80:20 v/v) followed by 
evaporation of the MeOH under a gentle nitrogen stream at 45 °C. 2 mL of ethyl 
acetate was added to the remaining aqueous extract which was shaken for 5 
minutes using a rotary tumbler. After centrifugation (3500 g, 5 min) the ethyl 
acetate layer was isolated and evaporated under a gentle nitrogen stream at 40 
°C until dry. The residue was redissolved in 500 µL water and transferred into an 
LC-MS/MS sample vial. 
LC-MS/MS analysis 
The LC system consisted of a vacuum degasser, autosampler, and a Waters 
(Milford, MA, USA) model Acquity binary pump equipped with a Chromtech (Apple 
Valley, MN, USA) Chiral AGP (α1-acid glycoprotein) analytical column of 2.0 × 150 
mm, 5 μm placed in a column oven at  0 °C. Isocratic elution was performed 
using a mobile phase consisting of 2 % ACN in 10 mM ammonium formate buffer 
adjusted to pH=4.0 with formic acid at a flow rate of 0.4 mL min-1. The injection 
volume was 10 μL. 
Detection was carried out using a Waters model Xevo TQS mass spectrometer in 
the negative electrospray ionisation (ESI) mode. The operating parameters were: 
capillary voltage, -0.5 kV; cone voltage, 20 V; source offset, 50 V; source 
temperature, 150 °C; desolvation temperature, 550 °C; cone gas flow, 150 L h−1; 
and desolvation gas, 750 L h−1. The CAP isomers were fragmented using collision 
induced dissociation and the selected reaction monitoring (SRM) transitions are 
given in table 4.7. As reported before [42], each product-ion is specific for a 
selected number of CAP isomers. For instance, product ion m/z=257 is observed 
for all isomers, m/z=152 only for para-isomers, m/z=207 only for meta-isomers 
and m/z=194 only for RR/SS-isomers. Therefore, the monitored product ions 
were carefully selected to obtain adequate isomeric selectivity in combination 
with high sensitivity. An overview of the fragmentation pattern for each of the 
isomers including elemental compositions of the product ions was reported 
before [42].  
Because only racemic mixtures of some isomeres are available some 
chromatographically separated peaks could not be specifically asigned to one 
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isomer. Therefore, they are referred to as 1st and 2nd peak. Data were acquired 
and processed using MassLynx 4.1 software (Waters). RR-p-CAP-d5 was used as 
the internal standard for RR-p-CAP and SS-p-CAP-d5 was used as the internal 
standard for all other isomers. 
Method validation 
A full validation was carried out according to 2002/657/EC [9]. The following 
parameters were determined: linearity, trueness, repeatability, within-
laboratory reproducibility, decision limit (CCα), detection capability (CCβ), 
selectivity, robustness and stability. The validation was carried out on three 
different occasions, by two different technicians and including 21 different 
bovine urine samples.  
Table 4.7. SRM transitions of the CAP isomers. 
Code  
(fig. 4.1) 
Compound Precursor Ion 
(m/z) 
Product ion 
(m/z)a 
Collision Energy 
(eV) 
a RR-p-CAP 321.0 152.0 17 
   194.0 10 
b SS-p-CAP 321.0 152.0 
121.0 
17 
28 
c RS/SR-p-CAP-d5 1
st 326.0 157.0 
262.0 
17 
12 
d RS/SR-p-CAP-d5 2
nd 326.0 157.0 
262.0 
17 
12 
e RR/SS-m-CAP 1st 321.0 207.0 
86.0 
14 
15 
f RR/SS-m-CAP 2nd 321.0 257.0 
207.0 
12 
14 
g RS/SR-m-CAP 1st 321.0 257.0 
207.0 
12 
14 
h RS/SR-m-CAP 2nd 321.0 257.0 
207.0 
12 
14 
j RR-p-CAP-d5 326.0 199.0 10 
k SS-p-CAP-d5 326.0 199.0 10 
a The most abundant product ion is mentioned first. 
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Linearity 
On three different days a matrix matched calibration line was prepared including 
the following calibration levels: 0, 0.1, 0.2, 0.3, 0.4 and 0.5 µg L-1, (six data 
points including zero) by adding solutions of the CAP isomers to aliquots of a 
blank urine sample. Calibration lines were constructed by plotting the peak 
areas, normalised using the peak areas of the internal standards, versus the 
added concentration and carrying out least squares linear regression. The 
linearity was considered acceptable if the coefficient of correlation was at least 
0.990. 
Trueness, repeatability and within-lab reproducibility 
On each of the three days seven different blank urine samples were selected and 
analysed as such and spiked at 0.15, 0.3 and 0.45 µg L-1. For each sample the 
level of the CAP isomers was calculated using the calibration line constructed on 
the same day. The trueness was calculated by dividing the average calculated 
level by the nominal concentration. According to 2002/657/EC the trueness at 
the selected validation levels should be between 50 and 120 %. 
The repeatability and within-lab reproducibility were calculated using single 
factor analysis of variance (ANOVA). According to 2002/657/EC [9] the relative 
standard deviation under within-lab reproducibility conditions (RSDRL) and the 
relative standard deviation under repeatability conditions (RSDr) are considered 
acceptable if they are below the value calculated from the Horwitz equation [53] 
respectively two thirds of this value, i.e. below 53.6 % respectively 35.8 % at a 
level of 0.3 µg L-1. Thompson [54] however, demonstrated that the Horwitz 
equation is not applicable to the lower concentration range (< 120 µg kg-1) and 
suggested a complementary model. Based on this model the RSDRL and RSDr are 
acceptable if they are below 22.0 % respectively 14.7 %. The latter, more 
stringent criteria were adopted for this validation study. It is stated that because 
different urine samples were used within one day, the repeatability is not the 
pure repeatability as stated in 2002/657/EC [9]. However, using different urine 
samples a better understanding of the between sample variation is obtained and 
the validation better reflects a routine analysis situation.  
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Decision limit and detection capability 
According to 2005/34/EC [7] for all products entering the EU that are analysed 
for veterinary drugs and thus are within the scope of 97/78/EC [8], the MRPL as 
stated in 2002/657/EC [9] should be regarded as a reference point of action. In 
other words, for banned substances, only concentration levels above the MRPL 
are considered being non-compliant results. However, if the result of an 
analytical test is below the MRPL “the competent authority has to retain a record 
of the findings in case of recurrence” [7]. Therefore, two values for the decision 
limit (CCα) are needed: one based on the MRPL being the reference point of 
action [7] to assign samples that contain CAP with a level exceeding the MRPL (α-
error is 5 %) and one based on zero tolerance in accordance with 2002/657/EC [9] 
to assign samples that contain CAP and thus deviate from the blank population 
(α-error is 1 %). The latter value of CCα indicates the lowest level at which 
detection and confirmation of CAP is possible. 
The CCα and CCβ based on the MRPL being the reference point of action were 
calculated according to the procedure described in 2002/657/EC [9] for MRL 
substances based upon spiked samples at the MRPL level of 0.3 µg L-1 (n=21). 
Because CCα and CCß are calculated from the within-laboratory reproducibility, 
no specific criteria are set for these parameters. 
The CCα and CCβ based on  ero tolerance were calculated based on the band 
width of the signal in blank samples and the height of samples spiked at 0.15 µg 
L-1 at the time window in which the analyte is expected based upon in total 21 
individual blank and spiked samples analysed on three different occasions, 
according to calculations suggested by Antignac et al. [55]. According to 
guidelines on the implementation of 2002/657/EC [56] values for CCß should be 
below or equal to the MRPL and thus the criterion CCß ≤ 0.3 µg L-1 was adopted 
for this validation. 
Selectivity 
The selectivity of the method was studied based on a practical and a theoretical 
study. First, the 21 analysed blank samples were checked for interferences at the 
retention times corresponding to the CAP isomers. Second, databases were 
searched for compounds having a molecular mass equal to CAP that could 
 
 
 
 160 
possibly be present in urine samples. A standard solution of 10 µg L-1 and a blank 
urine sample spiked with 100 µg L-1 of α-zeranol, indicated as a possibly 
interfering compound, were analysed using the developed method. The resulting 
chromatograms were checked for interferences at the retention times 
corresponding to the CAP isomers. Furthermore a blank urine sample spiked with 
both 0.3 µg L-1 CAP isomers and 100 µg L-1 α-zeranol was analysed to check for 
false negative CAP results due to the presence of interfering compounds. 
Robustness 
The robustness of the method became clear during the optimisation of the 
sample preparation, chromatographic conditions and MS parameters. Additionally 
some minor changes to the method were tested in duplicate being: (1) 
evaporation of the eluent until only 200 µL of water remained after which ethyl 
acetate was added, (2) evaporation of the eluent until some methanol was still 
present after which ethyl acetate was added and (3) evaporation of the ethyl 
acetate fraction until dryness plus an additional 10 minutes. The trueness and 
repeatability of these tests were compared to the characteristics of the regular 
method. 
Stability 
The stability of chloramphenicol isomers was tested for 100 µg mL-1 stock 
solutions and for urine extracts. Individual methanolic solutions of 100 µg mL-1 of 
RR-p-CAP and SS-p-CAP, and mixtures of RS- and SR-p-CAP-d5, RR- and SS-m-CAP, 
and RS- and SR-m-CAP were placed at 4 °C and room temperature. After 5 days, 
these solutions were diluted to 100 µg L-1 with water and analysed in duplicate.  
The stability of urine extracts was determined by storing urine extracts at -20 °C 
after analysis. After 7 days, the calibrants and the samples spiked at 0.3 µg L-1 (n 
= 7) were defrosted and injected in the LC-MS/MS system again. The linearity and 
the average and standard deviation of the spiked samples were compared to the 
results of the freshly injected extracts. 
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Application to routine samples 
Subsequent to the full validation, the developed method was compared to the 
routine method that was previously used for the control of CAP residues in animal 
products [30]. In short, that method consisted of a hydrolysis of the urine sample 
followed by a clean-up procedure based on sorbent-assisted liquid-liquid 
extraction using Extrelut NT-3 cartridges (Merck) in combination with 
dichloromethane elution. After evaporation of the solvent, the residue was 
dissolved in 0.5 mL of water and injected onto the RP LC-MS/MS system. 
Two freeze dried bovine urine samples containing CAP glucuronide with an 
assigned value of 0.20 and 0.36 µg L-1 respectively, expressed as free CAP 
originating from a Dutch proficiency study (2008) were selected. The results 
obtained by the chiral LC-MS/MS method were compared to the results previously 
found using the RP LC-MS/MS method. 
Results and discussion 
General considerations 
For the separation of the CAP isomers, the use of an AGP column proved to be 
suitable. In contrast to a high resolution RP-LC system, an AGP column is limited 
in terms of back pressure and organic modifier, and equilibration of the column 
is a relatively slow process. Therefore, the use of isocratic elution at low or 
moderate flow rate is mandatory to obtain a robust and reproducible method. As 
a result, peak widths of approximately 0.5 min are obtained using this column, 
whereas sub-2 µm particle RP-LC generally results in peak widths of about 8 
seconds [23]. This, in combination with the presence of only 2 % organic modifier 
in the mobile phase, which adversely affects the evaporation of the mobile phase 
in the ion source, results in higher detection limits of the chiral stationary phase 
LC-MS/MS system. For the analysis of banned substances, detection limits should 
be as low as reasonably possible and confirmation of the identity of the analyte 
should at least be possible at MRPL level. Therefore, the loss of sensitivity using 
the chiral LC system had to be compensated. 
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Another adverse effect of the chiral LC system was the irreproducibility of the 
CAP isomers’ retention times in urine extracts. If the urine samples were not 
thoroughly cleaned, a decrease in the retention time of the CAP isomers was 
observed every subsequent injection up to 50 % for the last eluting compound, 
resulting in unsatisfactory and irreproducible chromatographic resolution. 
To obtain a robust and reproducible chromatographic separation for urine 
samples and to improve the detection limits, an optimised reversed phase SPE 
procedure combined with a liquid-liquid extraction using ethyl acetate was 
developed to clean and concentrate the urine samples prior to LC-MS/MS 
analysis. Using this sample clean-up a ten-fold concentration of purified urine 
samples was obtained and when injecting 10 µL in the LC-MS/MS system only 
slight effects of the remaining urine matrix were observed.  
Sample preparation 
To optimise the SPE washing and elution procedure 5 mL of a 10 µg L-1 standard 
solution containing all CAP isomers was applied onto conditioned Strata-X RP 200 
mg / 6 mL cartridges. The cartridges were washed in duplicate with two times 6 
mL water-methanol mixtures ranging from 0 to 100 % MeOH. The retained CAP 
isomers were eluted from the cartridge using 1 mL MeOH. The solvent was 
evaporated, the residue reconstituted in 500 µL water and injected into the LC-
MS/MS system. The signal of RS/SR-CAP-d5 1
st peak and RR-p-CAP are presented in 
figure 4.10a. It is observed that only from 50 % MeOH, 78 % of RS/SR-p-CAP-d5 
eluted from the SPE cartridge whereas RR-p-CAP was still fully retained. Because 
the RS/SR-isomers elute slightly before the RR/SS-isomers using a reversed phase 
separation mechanism [42] this is according to expectations. It is concluded that 
the SPE cartridges can be washed twice with 6 mL 40 % MeOH. Because CAP 
remains in the neutral state it was decided to wash the cartridge with 6 mL 
acidic 40 % MeOH in water followed by alkaline 40 % MeOH in water to remove 
additional interferences. For complete (> 95 %) elution of the CAP isomers 6 mL 
of 70 % MeOH is needed. To further optimise the elution the same procedure was 
repeated using 3 mL wash volumes containing 60 - 100 % MeOH. The results are 
presented in figure 4.10b. When using 3 mL of 80 % MeOH, more than 97 % of 
each of the isomers eluted from the SPE cartridge. This condition was considered 
favorable for eluting the CAP isomers over 6 mL of 70 % MeOH because less MeOH 
had to be evaporated. 
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Figure 4.10. Amount of (■) RS/SR-p-CAP-d5 and (■) RR-p-CAP still retained on the 
Strata-X RP SPE cartridge after washing with (a) 6 mL and (b) 3 mL of a mixture 
of MeOH and water.  
LC-MS/MS analysis 
The retention mechanism of an AGP column is based upon hydrophobic 
interaction with amino acids and hydrogen bonding with amides, carbonyl and 
imido groups [57,58]. The AGP column was selected for optimisation of the 
separation of CAP isomers because its selectivity towards analytes that contain a 
ring structure near a chiral center in combination with an alcohol, amide or 
carboxylic acid group [57]. 
Aiming for baseline separation of the eight CAP isomers ACN, MeOH, 2-propanol 
(PrOH), acetone (ACE), tetrahydrofuran (THF) and combinations of these solvents 
were tested as the organic modifiers. Furthermore the pH and the organic 
modifier concentration (0 to 5 %) were optimised. The pH did not significantly 
influence the retention of the isomers but the concentration and the nature of 
the organic modifier showed to be an important parameter for optimising the 
enantioselectivity of the LC system. Chromatograms obtained using different 
organic modifiers are given in figure 4.11. 
From the upper two panels in figure 4.11 it is apparent that the retention time 
decreases with increasing organic modifier concentration, which is comparable to 
RP separations. This was expected, because in both chromatographic systems 
hydrophobic interactions are part of the retention mechanism. The effects of the 
nature of the organic modifier on the isomeric selectivity are not so easily 
a b 
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explained. The elution order of some isomers changes when using a different 
organic modifier (figure 4.11). For instance, if ACN, MeOH or PrOH is used RS/SR-
m-CAP 1st elutes before RS/SR-p-CAP-d5 2
nd, whereas the elution order changes if 
ACE or THF is used. Furthermore, SS-p-CAP and RR/SS-m-CAP 1st co-elute if ACN, 
MeOH or THF are used, whereas a slight separation is obtained using PrOH and 
baseline separation of the two isomers is obtained using ACE. 
Although the nature of the organic modifier in the mobile phase affected the 
enantioselectivity, in all cases, at least two CAP isomers co-eluted. The use of 2 
% ACN in ammonium formate buffer at pH = 4.0 showed optimal chromatographic 
resolution. With this system, still SS-p-CAP and RR/SS-m-CAP 1st peak co-eluted. 
 
 
Figure 4.11. Total ion current chromatograms of 40 µg L-1 mixtures of eight CAP 
isomers. The chromatographic peaks of each isomer are connected by lines. 
Crossing lines indicate changed isomeric selectivity. 
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Because the MS fragmentation pathways of the CAP isomers depend on the 
substitution of the nitro-group [42], it was possible to select specific product ions 
for SS-p-CAP (321 > 121) and RR/SS-m-CAP (321 > 86) allowing discrimination of 
the co-eluting isomers. Examples of the SRM chromatograms of a blank urine 
sample and a blank urine sample spiked at 0.3 µg L-1 are presented in figure 4.12. 
 
Figure 4.12. SRM chromatograms of (a) a blank urine sample and (b) a urine 
sample with addition of 0.3 µg L-1 of all eight CAP isomers. a = RR-p-CAP, b = SS-
p-CAP, c = RS-p-CAP-d5, d = SR-p-CAP-d5, e = RR-m-CAP, f = SS-m-CAP, g = RS-m-
CAP, h = SR-m-CAP. Internal standards: j = RR-p-CAP-d5 and k = SS-p-CAP-d5. 
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Validation 
An overview of the validation results is presented in table 4.8.  
Table 4.8. Summary of the validation study. 
 
Compound 
Validation 
level 
(µg L-1) 
 
Trueness 
(%) 
 
RSDr 
(%) 
 
RSDRL 
(%) 
 
CCαa 
(µg L-1) 
 
CCßa 
(µg L-1) 
 
Linearity 
(r2) 
RR-p-CAP 0.15 
0.3 
0.45 
99 
104 
100 
9.1 
10.2 
11.6 
9.1 
7.4 
7.4 
0.005 
0.36 
0.13 
0.42 
 
> 0.995 
SS-p-CAP 0.15 
0.3 
0.45 
104 
104 
105 
8.9 
6.6 
7.7 
9.0 
7.1 
8.1 
0.04 
0.34 
0.16 
0.37 
> 0.997 
RS/SR-p-CAP-d5 1
st 0.15 
0.3 
0.45 
96 
99 
99 
9.5 
10.9 
10.1 
10.1 
13.1 
15.1 
0.02 
0.36 
0.15 
0.43 
> 0.991 
RS/SR-p-CAP-d5 2
nd 0.15 
0.3 
0.45 
95 
99 
102 
7.7 
11.5 
10.0 
10.2 
14.3 
13.4 
0.02 
0.37 
0.14 
0.44 
> 0.992 
RR/SS-m-CAP 1st 0.15 
0.3 
0.45 
101 
102 
103 
9.7 
6.3 
7.7 
9.9 
6.4 
10.9 
0.01 
0.33 
0.14 
0.36 
> 0.990 
RR/SS-m-CAP 2nd 0.15 
0.3 
0.45 
98 
100 
101 
12.5 
14.5 
12.2 
13.9 
14.9 
12.9 
0.04 
0.37 
0.15 
0.45 
> 0.995 
RS/SR-m-CAP 1st 0.15 
0.3 
0.45 
97 
97 
98 
10.2 
13.4 
14.1 
20.6 
19.9 
20.1 
0.005 
0.39 
0.14 
0.49 
> 0.994 
RS/SR-m-CAP 2nd 0.15 
0.3 
0.45 
90 
91 
93 
9.3 
13.0 
14.1 
9.8 
13.6 
14.2 
0.01 
0.36 
0.13 
0.42 
> 0.991 
a CCα and CCß based on zero tolerance are indicated in italics. 
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The linearity in the range from 0 to 0.5 µg L-1 is above the criterion of 0.990 for 
all compounds and is therefore adequate for quantitative trace analysis. The 
trueness is between 90 and 105 % for all isomers, which is amply within the 
established criterion of 50 to 120 %. The determined RSDr and RSDRL are below 
14.7 % respectively 22 % for all isomers and thus comply with the criteria as well. 
Based on these outcomes it is concluded that the presented method is suitable 
for quantitation of the amount of CAP isomers present in a bovine urine sample.  
The calculated decision limits (CCα) based on  ero tolerance vary from 0.005 µg 
L-1 to 0.04 µg L-1 indicating that part-per-trillion levels of CAP isomers are still 
detectable. The calculated values were verified based upon the signal of the CAP 
isomers in the chromatograms of the lowest calibration level (0.1 µg L-1) and 
were found to be realistic. The calculated detection capabilities (CCß) are 
between 0.13 and 0.16 µg L-1 which is approximately at the lowest validation 
level and therefore the values could easily be verified using the available data 
from the blank urine samples spiked at 0.15 µg L-1. In 100 % of the cases (n=21), 
based upon the ion ratio, CAP was found non-compliant according to EU criteria 
[9] indicating that the calculated levels of CCß are slightly overestimated since 
the criterion is 95 % only. Because this is an initial in-house validation, only 
limited data are available. Over time the band width of the noise of blank 
samples and the peak height of samples spiked at 0.1 µg L-1 will be monitored to 
obtain a more exact estimation of CCß. However, CCß for zero tolerance 
substances is below the MRPL of 0.3 µg L-1 in all cases and therefore it is 
concluded that the method is suitable for detection of chloramphenicol at 
relevant levels. 
No interferences were observed in the chromatograms of the blank samples. 
From the theoretical study α-zeranol, a non-steroidal estrogenic agonist that is 
banned within the EU [59], but approved for the use as a growth promoter in 
cattle in the United States and in Canada [60], was found to have the same 
molecular mass as CAP and might theoretically interfere in the described 
method. A standard solution of 10 µg L-1 and a blank urine sample spiked with 
100 µg L-1 of α-zeranol were prepared and injected into the chiral LC-MS/MS 
system. No interfering signals were observed in the chromatogram indicating that 
the procedure is sufficiently selective for CAP isomers. Furthermore, the 
presence of a severe amount of α-zeranol in the urine sample does not affect the 
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detection and confirmation of the CAP isomers and will therefore not result in 
false negative results for CAP. 
For a few urine samples a slight deformation of the chromatographic peaks was 
observed which was in all cases directly related to the color of the extract 
indicating that occasionally some matrix components can have some influence on 
the chromatographic performance. In these cases the peak top can shift to a 
slightly lower retention time causing a difference in the compound’s retention 
time compared to the compound in the matrix-matched reference standards and 
therefore extra attention should be given to the confirmatory aspect e.g. by 
carrying out multi-level standard addition. Another solution is to further dilute 
the final urine extract in water, but this negatively affects the detection limit 
and therefore the success of this approach depends on the CAP level in the 
specific sample.  
From the method development, the sample clean-up was the most critical step in 
the analysis method. Because the percentage of MeOH in the SPE wash and 
elution procedure are optimised to remove as many interferences as possible, a 
slight difference in the MeOH content can result in breakthrough or incomplete 
elution of the CAP isomers. Therefore, the SPE procedure should be carried out 
accurately for optimum performance. 
Three slight deviations to the procedure that might occur in practice, were 
tested: (1) evaporation of the eluent until only 200 µL of water remained after 
which ethyl acetate was added, (2) evaporation of the eluent until some 
methanol was still present after which ethyl acetate was added and (3) 
evaporation of the ethyl acetate fraction until dryness plus an additional 10 
minutes. The duplicates analysed incorporating these deviations in the method 
showed good trueness and acceptable duplicates, indicating that the tested 
processes are robust. 
When storing methanolic 100 µg mL-1 standard solutions of the isomers (RR-p-CAP 
and SS-p-CAP individually and the others as a racemic mixture) at 4 °C and room 
temperature, no difference in the peak intensities was observed. Furthermore, 
neither conversions to other isomeric forms nor any changes in the relative 
intensities of the isomers in the racemic mixtures were observed. It is concluded 
that solutions of CAP isomers are stable at room temperature for at least 5 days. 
Chapter 4 
 
169 
The results of the stability of urine extracts stored at -20 °C for 7 days are 
presented in table 4.9. Also after 7 days of storage the calibration lines remain 
sufficiently linear having a coefficient correlation above 0.990. Furthermore, no 
significant difference was observed between the average and the RSDr of the 
freshly analysed extracts and the stored extracts. It is concluded that urine 
extracts obtained with the described method are stable for at least 7 days when 
stored at -20 °C.   
Table 4.9. Results of the urine sample spiked at 0.3 µg L-1 analysed directly after 
preparation compared to the results of the same extracts analysed after 7 days 
storage at -20 °C (n=7). 
 Directly After 7 days 
Compound Linearity 
(r2) 
Average 
(µg L-1) 
RSDr 
(%) 
Linearity 
(r2) 
Average 
(µg L-1) 
RSDr 
(%) 
RR-p-CAP 0.995 0.29 18.0 0.999 0.30 12.0 
SS-p-CAP 0.998 0.31 9.9 0.999 0.32 6.8 
RS/SR-p-CAP-d5 1
st 0.992 0.32 12.7 0.995 0.30 13.6 
RS/SR-p-CAP-d5 2
nd 0.992 0.30 10.6 0.994 0.29 12.5 
RR/SS-m-CAP 1st 0.994 0.30 7.6 0.997 0.30 7.1 
RR/SS-m-CAP 2nd 0.998 0.32 15.1 0.999 0.31 10.0 
RS/SR-m-CAP 1st 0.994 0.26 17.5 0.991 0.25 20.3 
RS/SR-m-CAP 2nd 0.993 0.27 10.4 0.995 0.28 12.6 
 
Application to routine samples 
Both proficiency test samples that were found non-compliant in previous analyses 
using the RP LC-MS/MS method were also found non-compliant by the developed 
chiral stationary phase LC-MS/MS method. The quantitative results of both 
methods are in excellent agreement being 0.22 and 0.36 µ L-1 using the RP LC-
MS/MS method and 0.19 and 0.32 µg L-1 using the chiral LC-MS/MS method. If the 
results obtained using the chiral method would have been submitted for the 
proficiency test, z-scores of -0.2 and -0.8 would have been obtained. Note that in 
a proficiency test, quantitative results are considered satisfactory if the z-score 
is between -2 and +2 [61], from which it is concluded that the quantitative 
aspect of the developed method is adequate. From the chiral LC-MS/MS method 
it is clear that both samples contain the RR-p-CAP isomer, the microbial active 
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isomer of CAP. As an example reconstructed SRM chromatograms of the 
proficiency test sample having an assigned value of 0.36 µg L-1 obtained using 
both systems are presented in figure 4.13. In figure 4.13a no discrimination 
among RR-p-CAP, SS-p-CAP, RR-m-CAP and SS-m-CAP (denoted a, b, e and f 
respectively) could be obtained, whereas from figure 4.13b it can be 
unambiguously stated that the sample contains, apart from the internal 
standards (j and k), only the bioactive CAP isomer (denoted a). 
Therefore, a quantitative trace analysis method using chiral stationary phase LC 
in combination with MS/MS detection, which is able to discriminate eight CAP 
isomers at trace level in bovine urine, was successfully developed and fully 
validated according to 2002/657/EC [9] at part-per-trillion levels. Especially the 
sample clean-up procedure proved to be a critical factor for obtaining 
reproducible chromatographic resolution. The validation showed good trueness, 
repeatability and within-lab reproducibility and the selectivity, robustness and 
stability proved to be sufficient to apply the presented method in routine 
analyses. As a result, the microbially active RR-p-CAP can be discriminated from 
its inactive isomers and thus the presented method provides the ultimate 
selectivity in trace evidence, which is expected to survive any legal disputes 
related to CAP abuse.  
Conclusions 
A quantitative trace analysis method using chiral stationary phase LC in 
combination with MS/MS detection, which is able to discriminate eight CAP 
isomers at trace level in bovine urine, was successfully developed and fully 
validated according to 2002/657/EC [9] at part-per-trillion levels. Especially the 
sample clean-up procedure proved to be a critical factor for obtaining 
reproducible chromatographic resolution. The validation showed good trueness, 
repeatability and within-lab reproducibility and the selectivity, robustness and 
stability proved to be sufficient to apply the presented method in routine 
analyses. As a result, the microbially active RR-p-CAP can be discriminated from 
its inactive isomers and thus the presented method provides the ultimate 
selectivity in trace evidence, which is expected to survive any legal disputes 
related to CAP abuse. 
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Figure 4.13. SRM chromatograms of a urine sample containing 0.36 µg L-1 CAP 
obtained using (a) the RP LC-MS/MS method using 37Cl2-CAP as the internal 
standard and (b) using the developed chiral LC-MS/MS method. a = RR-p-CAP, b = 
SS-p-CAP, c = RS-p-CAP-d5, d = SR-p-CAP-d5, e = RR-m-CAP, f = SS-m-CAP, g = RS-
m-CAP, h = SR-m-CAP. Internal standards: j = RR-p-CAP-d5 and k = SS-p-CAP-d5. 
  
37Cl2-CAP 
325 > 152 
248000 
RR/SS-CAP 
321 > 194 
135000 
p-CAP 
321 > 152 
135000 
a/b/e/f 
a/b/e/f 
a 
j 
 
k 
 
j 
 
k 
j 
 
k 
 
CAP-d5 
326 > 262 
93200 
RR/SS-CAP-d5 
326 > 199 
93200 
p-CAP-d5 
326 > 157 
93200 
CAP 
321 > 257 
45000 
m-CAP 
321 > 207 
45000 
RR/SS-CAP 
321 > 194 
45000 
p-CAP 
321 > 152 
45000 
p-CAP 
321 > 121 
45000 
m-CAP 
321 > 86 
45000 
a 
a 
 
b 
a 
a 
 
↓ 
↓ 
g/h 
g/h 
↓ ↓ 
↓ ↓ 
↓ ↓ ↓ 
↓ ↓ ↓ ↓ 
↓ 
↓ 
↓ 
c/d c/d 
c/d c/d 
g/h g/h e/f 
g/h g/h e/f e/f 
b 
b 
e/f 
1511 a
Time
1.00 2.00 3.00 4.00 5.00 6.00 7.00
%
0
100
1.00 2.00 3.00 4.00 5.00 6.00 7.00
%
0
1.00 2.00 3.00 4.00 5.00 6.00 7.00
%
0
100
1.00 2.00 3.00 4.00 5.00 6.00 7.00
%
0
100
1.00 2.00 3.00 4.00 5.00 6.00 7.00
%
0
1.00 2.00 3.00 4.00 5.00 6.00 7.00
%
0
1.00 2.00 3.00 4.00 5.00 6.00 7.00
%
0
100
1.00 2.00 3.00 4.00 5.00 6.00 7.00
%
0
100
1.00 2.00 3.00 4.00 5.00 6.00 7.00
%
0
1511 a
Time
1.00 2.00 3.00 4.00 5.00 6.00 7.00
%
0
100
1.00 2.00 3.00 4.00 5.00 6.00 7.00
%
0
1.00 2.00 3.00 4.00 5.00 6.00 7.00
%
0
100
1.00 2.00 3.00 4.00 5.00 6.00 7.00
%
0
100
1.00 2.00 3.00 4.00 5.00 6.00 7.00
%
0
1.00 2.00 3.00 4.00 5.00 6.00 7.00
%
0
1.00 2.00 3.00 4.00 5.00 6.00 7.00
%
. . . . . . .
%
1.00 2.00 3.00 4.00 5.00 6.00 7.00
%
0
219154
Time
1.50 2.00 2.50 3.00 3.50 4.00 4.50
%
0
1.50 2.00 2.50 3.00 3.50 4.00 4.50
%
1
1.50 2.00 2.50 3.00 3.50 4.00 4.50
%
0
219154
%
1.50 2.00 2.50 3.00 3.50 4.00 4.50
%
0
1.50 2.00 2.50 3.00 3.50 4.00 4.50
%
0
 
 
 
 172 
Acknowledgements 
This project was financially supported by the Dutch Ministry of Economic Affairs. 
Richetti Look is gratefully acknowledged for her assistance in optimising the 
chiral LC separation.  
  
Chapter 4 
 
173 
4.5. The occurrence of chloramphenicol in crops 
through the natural production by bacteria in 
soil 
Abstract 
Due to the unexpected findings of the banned antibiotic chloramphenicol in 
products of animal origin, feed and straw, the hypothesis was studied that the 
drug is naturally present in soil, through production by soil bacteria, and 
subsequently can be taken up by crops. First, the stability of chloramphenicol in 
soil was studied. The fate of chloramphenicol highly depends on soil type and 
showed a half-life of approximately one day in non-sterile topsoil. It was found to 
be more stable in sub-soil and sterile soils. Second, the production of 
chloramphenicol in soil was studied and it was confirmed that Streptomyces 
venezuelae can produce chloramphenicol at appreciable amounts in non-sterile 
soil. Third, a transfer study was carried out using wheat and maize grown on 
three different soils, that were weekly exposed to aqueous chloramphenicol 
solutions at two different levels. Chloramphenicol was taken up by crops as 
determined by chiral liquid chromatography coupled to tandem mass 
spectrometric analysis and the levels in crop were found to be bioavailability 
related. It was concluded that chloramphenicol residues can occur naturally in 
crops as a result of the production of chloramphenicol by soil bacteria in their 
natural environment and subsequent uptake by crops. 
Introduction 
Chloramphencol (CAP) is a broad-spectrum antibiotic that has been used in all 
major food-producing animals. Traditionally, CAP is produced for commercial use 
by chemical synthesis [5] but it is biosynthesised by the soil organism 
Streptomyces venezuelae and several other actinomycetes [1] as well. The drug 
has been evaluated by a number of organizations [2-4], most recently in 2005 by 
the Joint Expert Committee on Food Additives at its 62nd meeting [5]. CAP is a 
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suspected carcinogen and due to its linkage with the development of aplastic 
anemia in humans [5], the drug is banned for use in food-producing animals in 
the European Union (EU) [62] and in many other countries, including the USA, 
Canada, Australia, Japan and China. A minimum required performance limit 
(MRPL) of 0.3 µg kg-1 was set by the European Commission for the analytical 
methods to be used in testing for CAP in products of animal origin [6]. 
In recent years, findings of CAP residues in food products had a major impact on 
international trade [21]. In 2012 non-compliant findings of CAP in the European 
Union were related to casings, meat products and feed [63]. In 2010, the 
detection of chloramphenicol in plants and soil of mainly Mongolian origin [30] 
was reported and a first monitoring of CAP in European straw (n=21) resulted in 
57 % positive samples with concentrations mainly below 1 µg kg-1 but the 
maximum level was as high as 11 µg kg-1 [64]. A more extensive follow-up study 
(n=104) carried out in our laboratories, showed 37 positives (36 %), of which 7 
above 0.3 µg kg-1 and a single result above 1 µg kg-1: 6.8 µg kg-1. All samples 
contained the antimicrobially active isomer of chloramphenicol [42] and no 
correlation between the CAP concentration and the origin or type of straw was 
found. 
Various hypotheses have been proposed to explain these results such as the 
illegal use of the drug in animal production and the natural production of CAP by 
soil bacteria naturally present in the environment [65]. Due to the variety of 
positive samples and the fact that recent findings of CAP in several products 
produced in different countries could not be explained by the use of the drug, 
additional investigations were urgent. A hypothesis, which to our knowledge has 
never been supported by solid scientific evidence is the potential accumulation 
by arable crops of CAP naturally produced in soil by biosynthesis by 
actinomycetes (figure 4.14). If proven correct, the CAP containing crops are 
processed to animal feed or used as stall bedding and consequently animals 
might ingest these products which may result in non-compliant CAP findings in 
products of animal origin. 
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Figure 4.14. Graphical representation of tested hypothesis. 
Two conditions should be fulfilled to confirm the posed hypothesis: (1) soil 
bacteria must be able to produce CAP in soil under natural conditions and (2) 
crops should be able to accumulate CAP from the soil in the above ground 
biomass. The adsorption, stability and production rate of CAP in soil was studied 
long ago under laboratory conditions [65,66]. After inoculation of sterile soils by 
CAP producing bacteria, CAP concentrations up to 1.1 mg kg-1 were found. Upon 
addition of an additional carbon source, CAP production even reached 25 mg kg-1 
after 18 – 31 days of incubation [65]. In non-sterile soils, however, CAP 
production was not detected. In that specific study, the detection limit of the 
applied method was 50 µg kg-1 and thus low, but relevant levels of CAP that may 
have been present could not have been detected at that time [67]. Transfer 
studies confirmed the presence of detectable levels of veterinary drugs in plants, 
among which tetracyclines [68,69], trimethoprim [70], sulphonamides [69-71], 
anticoccidials [72] and florfenicol [22]. A monitoring study, which focused on the 
detection of veterinary drugs in manure, groundwater, soil and plants, confirmed 
the presence of CAP in plants [73]. 
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To verify the posed hypothesis, a series of three experiments were performed 
using state-of-the-art techniques. First, the stability of the antibiotic in soil was 
studied under sterile and non-sterile conditions. Second, the net production of 
CAP by Streptomyces venezuelae in sterile and non-sterile soil was investigated 
and third, the active uptake of free CAP by wheat and maize was quantitated in 
a controlled greenhouse experiment. Wheat and maize were selected because 
these are the major crops used as stall bedding and/or animal feed constituent. 
Results from these three experiments are combined to gain insight regarding the 
hypothesis that CAP contamination in crops can be explained by the natural 
production of CAP by soil bacteria.  
Experimental 
Reagents 
ULC grade water and acetonitrile (ACN), HPLC grade methanol (MeOH) and ethyl 
acetate were obtained from Biosolve (Valkenswaard, The Netherlands). 
Ammonium formate, formic acid, acetic acid and 25 % ammonia were obtained 
from Merck (Darmstadt, Germany). Milli-Q water was prepared using a Milli-Q 
system at a resistivity of at least 18.2 MΩ cm-1 (Millipore, Billerica, MA, USA). The 
reference standard of RR-p-CAP was obtained from Sigma-Aldrich (St. Louis, MO, 
USA) and the internal standard RR-p-CAP-d5 was obtained from Witega (Berlin, 
Germany). Stock solutions were prepared in MeOH at 100 mg L-1 and all dilutions 
were prepared in milli-Q water. 
Transfer study 
Soil used in the transfer study 
The soil used in this study was a sandy soil (Gleyic Podzol, FAO) used for regular 
agriculture and originates from the Droevendaal experimental farm of 
Wageningen University. Fresh soil was collected prior to the experiment on May 
10th 2012 from 2 depth layers, i.e. the 0 - 30 cm layer (topsoil) and the 80 – 120 
cm layer (sub-soil). Two hundred kg of both soil types was transferred to the 
laboratory where it was homogenised and sieved (< 2 mm using stainless steel 
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sieve). The natural moisture content was determined by weight loss at 105 °C. 
To obtain a range in organic matter a third soil was created by mixing dried 
topsoil with an equivalent amount of sub-soil. This resulted in a series of soils 
with similar mineralogical properties and minor differences in pH. The latter 
varied from 5.0 (sub-soil) to 5.2 (topsoil) as determined in a 1:10 (soil:solution) 
extract using 0.01 M CaCl2. The main variable of relevance is the soil organic 
matter (SOM) content which was determined in all soils by Loss on Ignition (LOI) 
at 550 °C. The SOM content ranged from 0.8 % in the sub-soil, 2.1 % in the mixed 
soil and 3.2 % in the topsoil, the latter being representative for normal arable 
sandy soils in the Netherlands.  
Pot experiment to determine CAP transfer 
Approximately 6.5 kilo of air dried top soil, mixed soil and sub-soil was used in 8 
L ceramic pots. To obtain the desired moisture content at the start of the 
experiment, 370 mL of distilled water was added to each pot which is equivalent 
to 80 % of the water holding capacity for this soil type as determined 
experimentally. During the growth of the crops, the moisture content in the pot 
was maintained at 80 % of the water holding capacity by weight loss and 
correction for the total biomass present on the pot. Plants were watered daily 
during the growing season using normal tap water. In order to keep the growing 
conditions in all pots equal, a starting dose of N, P, K and Mg fertilizer was 
initially mixed with the soil. In total 1500 mg of N (25 % as Ca(NO3)2 2M and 75 % 
as NH4NO3), 327 mg P (NaH2PO4), 241 mg Mg (MgSO4) and 1245 mg K (KCL) were 
added to 6.5 kg of soil to overcome nutrient deficiencies. During the growth of 
the crops, aliquots of 50 mL of a nutrient solution based on the same ratio of N, 
P, K and Mg as listed here were added depending on the growing status of the 
plant. Two crops: maize (var. LG 30-208) and wheat (var. Lavett), three soil 
types: sub-soil, mixed soil and topsoil and three CAP treatment levels: blank, low 
and high, were used in the growing study, each carried out in duplicate (table 
4.10). This resulted in a total of 36 pots. In each pot 10 maize or 20 wheat seeds 
were planted. To avoid any salt damage the seeds were placed in a layer of 0.5 
cm of soil that was not amended with fertilizer. After mixing the bulk soil with 
the required amount of fertilizer, filling the pots with soil and installing the 
seeds in the top 0.5 cm layer of unamended soil, the 36 pots were transferred to 
the Nergena greenhouse facilities (Wageningen UR). The temperature and 
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humidity in the greenhouse were kept constant at 20 °C and 80 % respectively 
during the growth of the crop. After germination, the number of plants in each 
pot was reduced to 3 for maize and 10 for wheat. Daylight was maintained for 12 
hours after September 15th 2012 using artificial light. The complete plants were 
harvested after ripening on October 2nd 2012 (wheat) and October 18th 2012 
(maize). Wheat stems and spikes as well as maize stalks and cobs were 
separated. Samples were cut using a knife and subsequently minced under 
cryogenic conditions to obtain homogeneous samples and to improve extraction 
efficiency. Also soil samples, cleared of root material, were taken.  
Table 4.10. Set-up of the pot experiment. Each experiment is carried out in 
duplicate resulting in 36 experiments. 
 Topsoil Mixed soil Sub-soil 
Wheat 0 0 0 
 7.5 mg CAP pot-1 7.5 mg CAP pot-1 7.5 mg CAP pot-1 
 75 mg CAP pot-1 75 mg CAP pot-1 75 mg CAP pot-1 
Maize 0 0 0 
 7.5 mg CAP pot-1 7.5 mg CAP pot-1 7.5 mg CAP pot-1 
 75 mg CAP pot-1 75 mg CAP pot-1 75 mg CAP pot-1 
 
Experimental design of the CAP additions 
CAP was added to the plants after germination and an initial 2-week growth 
phase to avoid any CAP induced effects in the early growing stage. After reaching 
a plant height of approximately 20 cm for both crops, CAP was added weekly via 
100 mL solution gifts containing the appropriate amount of CAP. In total 3 
treatments levels were performed, including a 0-treatment receiving the same 
volume of deionised water, a low dose (7.5 mg CAP total addition per pot) and a 
high dose (75 mg CAP total addition per pot). A CAP stock solution was prepared 
by dissolving 112.5 mg of CAP in 500 mL of deionised water. After mechanical 
stirring for 30 minutes all CAP was dissolved and the solution transferred to 
brown 2L glass flasks. The total volume was brought to 1500 mL. One hundred mL 
of this stock solution equals an addition of 7.5 mg which was added weekly for 10 
consecutive weeks to the 12 pots of the high dose treatment. From this stock 
solution 150 mL was diluted 10 times to a total volume of 1500 mL which served 
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as the low treatment dose. Again, 10 gifts of this solution were added to the low 
dose treatment pots during the growing phase of the plants. To ensure that all 
CAP accumulated by the plants occurred through root action and to avoid direct 
contact between CAP in the water and the above ground plant material, the CAP 
containing solutions as well as the deionised water (0-treatment) were added to 
the pots via a vertical plastic cylinder with a diameter of 4 cm and a total height 
of 10 cm which was installed in each pot. This cylinder was buried in the soil to a 
depth of 3 cm and the solutions could seep into the soil via small holes below the 
soil surface as is illustrated in figure 4.15. To avoid retention or degradation of 
CAP, the cylinder was filled with inert quartz sand with a high infiltration rate. 
After addition of 100 mL of the treatment solutions, 100 mL of deionised water 
was subsequently added to the cylinder to force the CAP into the soil and to 
minimise potential loss of CAP retained in the sand layer. 
   
Figure 4.15. Schematic representation of the pots used in the study. All 
treatment solutions were added via the cylinder to avoid direct contact between 
the solutions and the plant material. 
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Stability study 
Two gram aliquots of the dried soil material from the topsoil and sub-soil were 
transferred into individual polypropylene test tubes (n=24) and 0.5 mL of milli-Q 
water was added. Of both soil types, half of the soil containing test tubes were 
sterilised at 121 °C for 15 minutes during 2 consecutive days, the other tubes 
were stored at room temperature. At t = 0, an aqueous solution (125 µL) of CAP 
was added to two aliquots of each soil type resulting in a nominal concentration 
of 50 µg kg-1. The spiked samples were shaken for 10 sec using a vortex mixer and 
placed at room temperature exposed to daylight. At t = 1, 2, 3 and 4 days this 
spiking procedure was repeated and at day 4, 5 µg kg-1 of internal standard (RR-
p-CAP-d5) was added to all samples as an analytical reference, including the last 
set of blank samples, which were then analysed at random by chiral liquid 
chromatography coupled to tandem mass spectrometry (LC-MS/MS). 
Chloramphenicol production in soil 
To determine the natural production rate of CAP in soil by bacteria, eight 100 g 
batches of dried topsoil were transferred into 250 mL glass containers, which 
were covered with aluminum foil. Half of the containers were sterilised at 121 °C 
for 15 minutes during 2 consecutive days. Streptomyces venezuelae (DSM 40230, 
Leibniz Institute DSMZ, Braunschweig, Germany) was cultured in GYM (4 g L-1 
glucose, 4 g L-1 yeast extract, 10 g L-1 malt extract) for two days at 28 °C (200 
rpm) until OD600 of ~ 2.0 was reached. The culture (650 mL) was harvested by 
centrifugation (10 min. at 10,000 x g) and washed three times with 100 mL PBS (8  
g L-1 NaCl, 0.2 g L-1 KCl, 1.44 g L-1 Na2HPO4, 0.24 g L
-1 KH2PO4, pH 7.4) to remove 
any CAP that might have been produced during culturing. After the last washing 
step, the pellet was taken up in 65 mL of PBS and stored at 4 °C until further 
use. Enumeration of this inoculant yielded 2*109 colony forming units (CFU) mL-1. 
The inoculant was added to the sterile and non-sterile soil in duplicate at two 
concentrations: 2*106 and 2*108 CFU g-1 soil. The moisture concentration was 
adjusted to 20 % for all containers. The beakers were covered with parafilm and 
placed into a humidity chamber at 28 °C. After 1, 8, 15 and 22 days the soil 
samples were homogenised by stirring with a wooden rod and 2.5 g aliquots were 
taken in duplicate. The aliquots were stored at < -70 °C until analysis. 
Chapter 4 
 
181 
Sample preparation for CAP analysis 
The samples were prepared according to a previously reported and validated 
method [74] with minor adjustments making it suitable for plant material and 
soil. An additional validation was carried out for plant materials to ensure good 
method performance. Of the cryogenically minced crop samples, 2.5 g was 
extracted using 20 mL of ACN. After centrifugation (3500 g, 15 min) the organic 
phase was isolated, evaporated until dry (45 °C, N2) and reconstituted in 5 mL of 
water. A Phenomenex (Torrance, CA, USA) Strata-X 200 mg / 6 mL solid phase 
extraction (SPE) cartridge was conditioned with 5 mL MeOH and 5 mL water. The 
sample extract was applied onto the cartridge and subsequently the cartridge 
was washed with 6 mL 40 % MeOH in water containing 1 % acetic acid followed by 
6 mL 40 % MeOH in water containing 0.25 % ammonia. The cartridges were dried 
by applying vacuum for 3 minutes. CAP was eluted from the cartridge using 3 mL 
80 % MeOH in water. The MeOH in the eluent was evaporated (45 °C, N2). 2 mL of 
ethyl acetate was added to the remaining aqueous extract which was shaken for 
1 minute using a rotary tumbler. After centrifugation (3500 g, 5 min) the ethyl 
acetate layer was isolated and evaporated (40 °C, N2) until dry. The residue was 
redissolved in 500 µL water and transferred into an LC-MS/MS sample vial. Soil 
samples were analysed using the same method, but then the samples were 
extracted with 10 mL of water as was proven sufficient from previous 
experiments. 
LC-MS/MS analysis 
Samples of wheat stems and spikes, maize stalks and cobs, and soil were 
analysed separately. Quantitation was carried out by a calibration line in blank 
material, previously found to be free of CAP, ranging from 0 – 200 µg kg-1. 
Internal standard (RR-p-CAP-d5) was added to all individual samples before 
extraction at 10 µg kg-1. All final extracts were injected as such and after 50-fold 
dilution in water to obtain a response within the calibration range. 
The LC system consisted of a vacuum degasser, autosampler, and a Waters 
(Milford, MA, USA) model Acquity binary pump equipped with a Chromtech (Apple 
Valley, MN, USA) Chiral AGP (α1-acid glycoprotein) analytical column of 2.0 × 150 
mm, 5 μm, placed in a column oven at 30 °C [74]. Isocratic elution was 
performed using a mobile phase consisting of 2 % ACN in 10 mM ammonium 
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formate buffer adjusted to pH=4.0 at a flow rate of 0.4 mL min-1. The injection 
volume was 10 μL. Detection was carried out using a Waters model Xevo TQS 
triple quadrupole mass spectrometer in the negative electrospray ionisation (ESI) 
mode. The operating parameters were: capillary voltage, -1.5 kV; cone voltage, 
20 V; source offset, 50 V; source temperature, 150 °C; desolvation temperature, 
550 °C; cone gas flow, 150 L h−1; and desolvation gas, 750 L h−1. CAP and RR-p-
CAP-d5 were fragmented using collision induced dissociation (CID). The selected 
reaction monitoring (SRM) transitions are given in table 4.11. 
Table 4.11. SRM transitions of CAP and the internal standard. 
Compound Precursor Ion (m/z) Product ion (m/z) Collision Energy (eV) 
RR-p-CAP 321.0 152.0 17 
  194.0 10 
  257.0 10 
RR-p-CAP-d5 326.0 199.0 10 
Results and discussion 
Stability in soil 
The results of the stability study are presented in figure 4.16. CAP is rapidly 
degraded in non-sterile topsoil with a half-life of approximately one day. The 
rapid degradation is in line with results reported long ago [75,76] showing 
degradation kinetics depending on the soil composition. In sterilised topsoil, also 
a decrease of CAP concentrations was observed but at a significantly lower rate. 
At least part of the degradation of CAP can therefore be attributed to bacterial 
activity [65]. Sub-soil is expected to contain a much lower bacterial load and 
indeed the reduction of CAP concentrations in non-sterile sub-soil is less. For 
sterilised sub-soil no degradation of CAP seems to have occurred, but high 
standard deviations in the experiment with sterilised sub-soil prevent accurate 
comparison with the non-sterilised samples. 
The instability of CAP in non-sterile soil explains the low number of positive CAP 
findings in soil samples [30]. Note that when CAP is produced in soil, especially in 
close proximity to the plant roots, it may very well be available for uptake by 
crops. This probably explains the relatively high number of positive plant samples 
compared to the number of positive soil samples as previously reported [30].  
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Figure 4.16. Normalised CAP concentration during incubation of CAP in (■) 
topsoil, (■) sub-soil, (■) sterilised topsoil and (□) sterilised sub-soil. Error bars 
represent the standard deviation (n = 2). 
CAP production in soil   
Both the inoculant used for this experiment and the topsoil were found not to 
contain any CAP. The results of the CAP production in sterile and non-sterile soil 
inoculated with Streptomyces venezuelae are presented in figure 4.17. 
Substantial CAP production is observed in the sterile soil samples. The 
concentration level of approximately 500 µg kg-1 that is reached during the first 
week, sustains throughout the incubation period and remarkably appears to be  
independent of the size of the inoculant. In non-sterile soil, inoculation with 
Streptomyces venezuelae yielded significantly lower CAP levels. The samples 
spiked with 2.0 x 108 inoculant showed a remarkable peak concentration at day 1 
(47 and 140 µg kg-1 for the individual containers), suggesting that the presence of 
(competing) microbial flora triggers a specific physiological response. The 
subsequent collapse of the CAP concentration is in agreement with results for 
non-sterilised soil in the stability experiment. Furthermore, if CAP was only 
produced in the beginning of the production experiment, no CAP would be 
detectable after several days. Because also at 22 days of incubation CAP is 
detected, it is concluded that CAP is produced continuously during the 
experiment. 
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Figure 4.17. Average CAP concentration including standard deviation (error bars) 
in soil after incubation at 28 °C of (a) sterilised topsoil containing 2*106 CFU g-1, 
(b) sterilised topsoil containing 2*108 CFU g-1, (c) non-sterile topsoil containing 
2*106 CFU g-1 and (d) non-sterile topsoil containing 2*108 CFU g-1, n = 4 (2 
experiments analysed in duplicate).  
From the stability and production experiments it is concluded that CAP can be 
produced in sterile as well as in natural soils and that biosynthesis and 
biodegradation occur simultaneously. CAP production and Streptomyces 
venezuelae growth rate are strongly related [77] and depend on many 
environmental factors. For instance, Streptomyces venezuelae growth at pH = 
6.0 in MYM (maltose - yeast extract - malt extract) broth is optimal at 28 - 32 °C 
and is slightly lower at 22 °C. At pH = 7.5, the bacterial growth rate is reported 
to be optimal at 22 °C (lowest temperature tested) [78]. It is concluded that CAP 
can also be produced in the soil at lower temperatures, which are common in 
deeper soil layers. Furthermore, soil organic matter is of importance, showing 
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increased CAP production after addition of carbon and nitrogen sources, e.g. in 
fertilised soils [65,79,80]. Because of the simultaneously occurring processes and 
many environmental variables, the production experiment is considered to be 
proof of principle that CAP can be produced in natural soils rather than a precise 
quantitation of the CAP levels that can be produced in soil. Nevertheless, was 
shown that over 100 µg kg-1 CAP can be produced in non-sterile topsoil within a 
single day at high Streptomyces venezuelae inoculation levels. Note that the 
experimental setup was limited to detect free CAP and that the amounts of total 
CAP, e.g. present as conjugate or other metabolite, might be higher. 
Transfer study 
The transfer study was designed to study the influence of the soil, crop type 
(wheat versus maize) and administered CAP concentration. CAP solution was 
administered on a weekly basis so CAP was bioavailable during all stages of the 
growth. The determined average CAP concentrations (n = 4, 2 samples, both 
analysed in duplicate) in the wheat stems and spikes, maize stalks and cobs, and 
soil are presented in figure 4.18.  
 
Figure 4.18. Average free CAP concentration including standard deviation (error 
bars) determined in the transfer study for (a) wheat: (□) stems, (■) spikes and 
(■) soil, and (b) maize: (□) stalks, (■) cobs and (■) soil at low and high level 
administration, n = 4 (2 samples, both analysed in duplicate). No CAP was 
detected in the soils used for wheat cultivation. 
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The fate of CAP in the system was assessed by adding up the absolute amounts of 
free CAP detected per pot (sum of soil and plant). This then was compared to the 
total amount of CAP administered over 10 weeks (7.5 mg pot-1 at the low level 
and 75 mg pot-1 at the high level). Thus calculated, the total amount of free CAP 
recovered was at < 0.5 %, indicating that over 99 % of free CAP disappeared 
during the experiment. The major cause of CAP loss is most likely the microbial 
degradation in soil. Also CAP conjugation, metabolism or degradation in the crops 
may occur, which may account for another part of the CAP loss. 
The free CAP concentration in the wheat stems and the maize stalks is 
significantly higher than that in the wheat spikes or maize cobs. The average 
difference is approximately a factor 30 for wheat and 15 for maize which 
suggests a relatively higher transfer into maize cobs compared to wheat spikes. 
The data were studied in more detail using analysis of variance (ANOVA) in which 
the total amount of administered CAP and the soil type were considered as the 
factors under investigation. Although severe bio-variability is observed (variation 
between pots was significantly higher than variation between duplicate analyses 
of the same pot), for all plant materials, the effect of the administered CAP 
level, the soil type and the interaction of both were statistically significant (α < 
0.001). The administered CAP concentration and the soil type are both related to 
the theoretical bioavailability of the antibiotic and thus, it is most likely that the 
observed effects are related to a single parameter of importance, being the 
bioavailability of the antibiotic. The effects were more significant for wheat 
spikes and stems compared to maize stalks and cobs. As an example, the 
difference in CAP concentration in wheat grown on topsoil and sub-soil is a factor 
20, whereas this is a factor 4 for maize.  
For all experiments, the absolute amount of free CAP in the plants (total of 
stems and spikes for wheat, and stalks and cobs for maize) was divided by the 
total administered amount of CAP. The results for each experiment are 
presented in table 3. Note that the calculated transfer rates strongly depend on 
the experimental set-up, e.g. if CAP is administered continuously instead of 
weekly, the bioavailability of CAP would increase and a higher uptake is 
expected. Furthermore, only free CAP is taken into account, so if CAP is 
metabolised or conjugated in the crops, the actual transfer of CAP is higher than 
calculated here. 
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Table 4.12. Detected amount of free CAP in wheat and maize grown on topsoil, 
mixed soil and sub-soil versus administered CAP (n = 2). 
Soil type CAP administration Detected CAP vs administered CAP (%) 
(mg pot-1) Wheat (n=2) Maize (n=2) 
 Pot 1 Pot 2 Pot 1 Pot 2 
Topsoil 7.5 0.007 0.001 0.02 0.02 
 75 0.02 0.009 0.02 0.02 
Mixed soil 7.5 0.02 0.006 0.04 0.07 
 75 0.006 0.07 0.04 0.05 
Sub-soil 7.5 0.17 0.06 0.19 0.10 
 75 0.19 0.10 0.05 0.07 
 
A final observation from the transfer study is that CAP was detected in two of the 
wheat samples (up to 7 µg kg-1) and two of the maize samples (up to 2 µg kg-1) 
belonging to the untreated population. External contamination in the greenhouse 
was excluded by the set-up of the experiment and contamination in the 
laboratory was excluded by repeated analyses on another occasion and thus it 
was concluded that this most probably must have been the result of natural 
production of CAP in the pots. 
Can CAP production in soil yield residues in crop? 
The production and degradation of CAP in soil occur simultaneously, and both 
processes depend on many environmental parameters. Therefore, it is not 
possible to determine the total amount of free CAP produced in non-sterile soil 
that is available for uptake by the crops. Consequently it is also not possible to 
calculate what level of free CAP in crops can still be explained through natural 
CAP production by soil bacteria and subsequent uptake by crops. Based on the 
experimentally determined uptake rates (table 4.12) however, calculations were 
made to obtain an estimate of the required magnitude of CAP production in soil 
to explain the observed non-compliant findings in crops. Here it is calculated 
what level of CAP should be produced by soil bacteria to result in detection of 
0.1 µg kg-1 free CAP in crops.  
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The average mass of a single full grown wheat plant as determined in the 
transfer study is 16 g (fresh weight). Therefore, 0.1 µg kg-1 equals 1.6 ng CAP per 
wheat plant. Considering an average transfer rate for a wheat plant growing on 
topsoil of 0.009 % (average transfer rate using topsoil, table 4.12), a single plant 
should be exposed to 17 µg CAP during its lifetime. A regular field contains 200 
wheat plants per square meter and thus on this square meter 3.4 mg of CAP 
should be produced to yield a level of 0.1 µg kg-1 of CAP in all of these wheat 
plants. Considering the availability of nutrients in a 30 cm layer of soil, having a 
density of 1.4 kg L-1 these crops have 420 kg of soil available and therefore CAP 
production should be 8 µg kg-1 soil in total during the growing period of the crops 
to yield 0.1 µg kg-1 of CAP in wheat. For maize a level of 2 µg kg-1 in the topsoil is 
required assuming a plant density of 10 maize plants per square meter and an 
average maize plant mass of 185 g (fresh weight). CAP levels as high as 10 µg kg-1 
in wheat, being the highest concentration detected, can be explained if in total 
800 µg of CAP is produced per kg soil when considering topsoil. Note that these 
levels do not indicate the level that should be present in soil at a certain time, 
but rather the total amount of CAP that should be produced per kg of soil during 
the whole crop production time of approximately 10 weeks. 
Conclusions 
The results from the CAP production experiment described here, showed that 
over 100 µg kg-1 CAP can be produced by Streptomyces venezuelae in non-sterile 
topsoil within a single day. This suggests that the low-ppb concentrations of CAP, 
and possibly also the high concentrations observed in crops in monitoring studies 
can be explained by the natural production of CAP by soil bacteria and the 
subsequent uptake of the drug by crops. 
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5.1. General introduction on ß-lactam antibiotic 
analysis 
ß-lactam antibiotics 
ß-lactams are highly effective antibiotics in the treatment of bacterial infections 
[1]. The ß-lactam antibiotics consist of several groups of which the penicillins, 
cephalosporins and carbapenems are the most important due to their activity and 
the number of compounds included. 
The first penicillin was isolated from bacteria in 1928 [1,2]. Later many  
chemically altered semi-synthetic penicillins were developed. The penicillins 
derive their activity from the 6-aminopenicillinic acid nucleus which is effective 
against mainly Gram positive bacteria [1,3,4]. Amoxicillin, ampicillin, penicillin G 
(benzylpenicillin), penicillin V (phenoxymethylpenicillin), cloxacillin, 
dicloxacillin, oxacillin and nafcillin (figure 5.1) are registered for the treatment 
of food-producing animals: in fact penicillins are the most frequently used 
antibiotic in poultry production [5]. Maximum residue limits (MRLs) are 
established for the mayor species, including poultry (table 5.1) [6].  
Cephalosporins were first isolated from bacteria in 1956 [7-9]. The six membered 
dihydrothiazine ring fused with a four membered ß-lactam ring (figure 5.2) is 
responsible for the biological activity of this group of compounds. Cephalosporins 
are highly effective antibiotics in the treatment of bacterial infections of the 
respiratory tract [10]. As for the penicillins, many semi-synthetic cephalosporins 
were developed and in this four generations are distinguished based upon their 
time of discovery and their range of activity [11]. Cefacetril, cefalonium, 
cefazolin, cefalexin and cefapirin (all 1st generation), cefoperazone and ceftiofur 
(3rd generation), and cefquinome (4th generation) are all approved for treatment 
of mastitis infections in dairy cattle. Cefazolin is approved for the treatment of 
other ruminants (sheep and goat) as well. Furthermore, cefalexin and cefapirin 
are approved for the treatment of respiratory disease and foot rot in cattle, 
cefquinome is approved for the treatment of cattle, swine and horses, and 
ceftiofur for all food producing mammals [6,11]. For these species, MRLs are 
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established (Table 5.1). For cefapirin the MRL is defined as the sum of cefapirin 
and deacetylcefapirin and for ceftiofur as the sum of all active ceftiofur 
metabolites [6]. Molecular structures of these cefalosporins are presented in 
figure 5.2. 
Table 5.1. Maximum residue limits for ß-lactam antibiotics in muscle. 
Compound  Species MRL (µg kg-1) 
Amoxicillin All food producing species 50 
Ampicillin All food producing species 50 
Penicillin G All food producing species 50 
Penicillin V Porcine, poultry 25 
Cloxacillin All food producing species 300 
Dicloxacillin All food producing species 300 
Nafcillin All ruminants 300 
Oxacillin All food producing species 300 
Ceftiofura All mammalian food producing species 1000 
Cefapirinb Bovine 50 
Cefquinome Bovine, ovine, caprine No MRL required 
Cefalexin Bovine 200 
Cefazolinc Bovine No MRL required 
Cefaloniumd Bovine No MRL required 
Cefacetrile Bovine No MRL required 
Cefoperazonee  Bovine No MRL required 
a Sum of all residues retaining the ß-lactam structure expressed as desfuroylceftiofur. 
b  Sum of cefapirin and desacetylcefapirin. 
c For intra-mammary use, except if the udder may be used as food for human 
consumption. 
d  For intra-mammary use and eye treatment only. 
e  For intra-mammary use in lactating cows only. 
The first carbapenem was isolated from bacteria in 1971 [12]. The carbapenems 
are structurally very similar to the penicillins: the sulfur atom has been replaced 
with a carbon atom and an unsaturation has been introduced (figure 5.3) [13]. As 
a result the carbapenems possess the broadest antimicrobial activity amongst the 
ß-lactams [13]. The most common carbapenems are imipenem, meropenem, 
ertapenem, doripenem and biapenem. The carbapenems are not registered for 
use in food-producing animals and are used off-label in companion animals [4]. A 
 
 
 
 196 
ß-lactam substance, related to the carbapenems is faropenem (figure 5.3). As the 
carbapenems, faropenem is active against ESBL producing bacteria [14]. 
 
Figure 5.1. Molecular structure of the penicillins registered for use in animal 
practice. 
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Figure 5.2. Molecular structure of the cephalosporins registered for use in 
animal practice. 
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Figure 5.3. Molecular structure of the carbapenems: meropenem, imipenem, 
ertapenem, doripenem and biapenem and the penem faropenem.  
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ß-lactam resistance 
During the last decades, antimicrobial resistant bacteria like methicillin-resistant 
Staphylococcus aureus (MRSA) and extended-spectrum- ß-lactamase (ESBL) 
producing bacteria are emerging [1,15] which has become an important public 
health threat [15-19]. Most penicillins are found to be ineffective against ESBL 
producing bacteria [1,20-22]. Cephalosporins are more effective and, therefore, 
in 2007 they were assigned as critically important antimicrobials for human 
health [23]. Even though these compounds should only be used sparingly, 
resistance towards cephalosporins is emerging [1,16-18,22,24-29]. In contrast to 
penicillins and cephalosporins, carbapenems have proven to be highly effective in 
severe infections due to ESBL producing bacteria. As a result, due to the rising 
resistance to cephalosporins, carbapenem use has increased in the treatment of 
humans [30]. It is alarming that also carbapenem resistance is emerging 
[13,16,29-31].  
Not only the antibiotic usage in humans contributes to rising bacterial resistance, 
also the regular use of antibiotics in veterinary practice contributes to the 
occurrence of resistant bacteria that can be transferred from animals to humans 
[32]. Furthermore, due to irresponsible or off-label use of antibiotics in 
veterinary practice, residues of these antibiotics can end up in the human food 
chain which contributes to increasing bacterial resistance as well [33]. ß-lactams 
are among the most frequently sold antibiotics for animal breeding in The 
Netherlands [5] and their use in veterinary practice is likely to contribute to the 
emergence of resistant bacteria [15-19]. Penicillins are the most frequently sold 
antibiotics for treatment of broilers [34] and even though cephalosporins and 
carbapenems are not registered for use in animal production, due to their high 
effectiveness their veterinary use, including broilers, cannot be ruled out.  
To prevent off-label use of ß-lactams in animal breeding and thus to limit the 
dissemination of bacterial resistance, an effective control strategy for ß-lactam 
usage in food-producing animals is needed including penicillins, cephalosporins 
and carbapenems. Therefore, the control of poultry muscle for penicillins at MRL 
level, and cephalosporins as well as carbapenems at levels as low as possible is of 
importance. 
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Cephalosporins in food products 
The occurrence of residues of cephalosporins in the food chain due to their use 
as veterinary drug is not considered to be a potential risk, because levels of 
cephalosporins including known metabolites in edible tissues have been found to 
be low [35]. However, off-label use of cephalosporins should be restricted 
because of the risk of the development of bacterial resistance. Therefore the use 
of cephalosporins should be monitored and thus detection of these compounds at 
levels as low as reasonably possible is mandatory. 
Ceftiofur and cefapirin are known to rapidly metabolise after intramuscular 
administration. For ceftiofur, reported metabolites include desfuroylceftiofur 
(DFC, figure 5.4a)), desfuroylceftiofur cysteine disulfide (figure 5.4b) and protein 
bound DFC [36-38] so the ceftiofur maximum residue limit (MRL) was defined as 
the sum of all residues retaining the ß-lactam structure, expressed as DFC 
[39,40]. For cefapirin (figure 5.2), The main metabolite reported to date is 
desacetylcefapirin (DAC) [41] so the MRL was defined as the sum of cefapirin and 
DAC [39,42]. This is a complicating factor in cephalosporin analysis.  
 
Figure 5.4 Molecular structure of DFC and DCCD. 
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In section 5.2 a combination of triple-quadrupole mass spectrometry, time of 
flight mass spectrometry and nuclear magnetic resonance is used to study the 
degradation of ceftiofur and cefapirin under different conditions. Based on the 
results a new approach was developed for the analysis of the total residue levels 
of ceftiofur and cefapirin in kidney. 
In section 5.3 the new approach was incorporated in a new analytical procedure. 
To study the applicability of this new method it was compared to routinely 
applied methods for the analysis of ceftiofur in poultry tissues. 
Other ß-lactam antibiotics were included in the newly developed procedure 
which resulted, after some alterations of the method, in a multi-ß-lactam 
method that includes penicillins, cephalosporins and carbapenems. This work is 
described in section 5.4. 
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5.2. Newly identified degradation products of 
ceftiofur and cefapirin impact the analytical 
approach for the quantitative analysis of kidney 
Abstract  
This section describes the research on the degradation of ceftiofur and cefapirin 
at physiological temperatures in kidney extract and in alkaline and acidic 
solution, conditions that regularly occur during sample preparation. Degradation 
products were identified using liquid chromatography combined with Time of 
Flight mass spectrometry, NMR and microbiological techniques. Additionally 
kinetics of the degradation processes were studied. A slight instability of 
cefapirin and desfuroylceftiofur was observed at elevated temperatures. 
Ceftiofur and cefapirin degraded immediately and completely in an alkaline 
environment, resulting in inactive degradation products. Ceftiofur and cefapirin 
also degraded immediately and completely in kidney extract resulting in both 
formerly reported metabolites as well as not previously reported products.  
Our research shows that conditions often occurring during the analysis of 
ceftiofur or cefapirin result in rapid degradation of both compounds. From this it 
is concluded that underestimation of the determined amounts of ceftiofur and 
cefapirin is likely to occur when using conventional methods for the quantitative 
analysis of these compounds in tissue. Therefore, a new approach is needed for 
the analysis of both compounds including their degradation products. 
Introduction 
Cephalosporins, including ceftiofur and cefapirin (figure 5.2), are semi-synthetic 
antibiotics, consisting of a six membered dihydrothiazine ring fused with a four 
membered ß-lactam ring which is responsible for the biological activity of the 
compounds. Because cephalosporins are highly effective antibiotics in the 
treatment of bacterial infections of the respiratory tract [10], the common use of 
cephalosporins in veterinary practice is expected. An effective monitoring of 
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cephalosporin use in animal breeding is mandatory to prevent excessive use, 
which will contribute to the emergence of bacterial resistance. 
In monitoring food products, it is not clear that all relevant metabolites and 
degradation products, such as those produced by the degradation of ceftiofur and 
cefapirin during sample preparation, are taken into account when current 
methods are used to test for ceftiofur and cefapirin in tissue samples. The main 
causes of such degradation can be (1) the use of elevated temperatures, (2) the 
presence of tissue extract [43] and (3) an acidic or alkaline environment [44]. If 
degradation caused by these three aspects is not taken into account it is possible 
that ceftiofur and cefapirin residues are underestimated.  
Ceftiofur and cefapirin are known to rapidly metabolise after intramuscular 
administration. For ceftiofur, reported metabolites include desfuroylceftiofur 
(DFC), desfuroylceftiofur cysteine disulfide and protein bound DFC [36-38] so the 
ceftiofur maximum residue limit (MRL) was defined as the sum of all residues 
retaining the ß-lactam structure, expressed as DFC [6]. For cefapirin, The main 
metabolite reported to date is desacetylcefapirin (DAC) [41] so the MRL was 
defined as the sum of cefapirin and DAC [6].   
Cephalosporin multi-methods that include both ceftiofur and cefapirin are 
lacking, although methods to detect cetiofur and cefapirin in tissue separately or 
in combination with a limited number of other cephalospirins have been reported 
[35,43,45-47].  
Methods for the analysis of ceftiofur in tissue include a deconjugation and 
extraction of all protein bound DFC in slightly alkaline buffer (pH=9) using 
dithioerythritol followed by a derivatization of the resulting free DFC at pH=2.5 
using iodoacetamide [35,45] and an extensive Solid Phase Extraction (SPE) 
procedure in which alkaline solutions are used. This method is not very robust so 
the procedure has to be closely followed to obtain good results and it is limited 
to the analysis of a few cephalosporins and thus unsuitable as a multi-method. 
Other methods focus only on one or a few metabolites of ceftiofur [43,46]. 
Methods for the analysis of cefapirin are based on the complete conversion of 
cefapirin to DAC within 5 minutes in kidney extract [43,47]. The degradation 
processes possibly occurring after this time are not taken into account. 
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Degradation of ceftiofur and cefapirin under three circumstances: physiological 
temperatures, the presence of kidney extract and acidic or alkaline environment, 
is reported in this section. Degradation products are detected and identified 
using liquid chromatography coupled to Time of Flight mass spectrometry (LC-
ToF/MS) which is a high resolution ‘full scan’ technique. This means that by 
ToF/MS all ions are detected in contrary to triple quadrupole techniques in which 
only a predefined selection of ions is monitored [48,49]. Accurate mass 
determination and calculated elemental composition data can be used for 
structure elucidation. This makes ToF/MS very useful for the detection and 
identification of ‘unknown’ compounds. LC-Tof/MS is not previously reported for 
the identification of cephalosporin metabolites and degradation products. 
Additional structural information was obtained by NMR and microbiological 
experiments. Combining information from LC-ToF/MS, NMR and microbiological 
experiments made it possible to identify new degradation products of ceftiofur 
and cefapirin. The new identified products indicate that currently applied 
methods are likely to underestimate the residue levels of ceftiofur and cefapirin 
found in kidney samples. Furthermore, this research resulted in a new approach 
for the quantitative analysis of ceftiofur, cefapirin and other cephalosporins in 
tissue. 
Experimental  
Material 
LC-MS grade water and methanol and HPLC grade methanol, HPLC grade 
acetonitrile, 2-propanol (Biosolve, Valkenswaard, The Netherlands), 25 % 
ammonia, acetic acid, 99.8 % methanol-d4, sodium hydroxide, sodium formate, 
ortho-phosphoric acid (85 %), sodium hydrogendiphosphate, disodium 
hydrogenphosphate, trisodium phosphate (Merck, Darmstadt, Germany) and 
leucine-enkephalin (Sigma, St. Louis, MO, USA) were used. Milli-Q water was 
prepared using a Milli-Q system at a resistivity of at least 10 MΩ∙cm (Millipore, 
Billerica, MA, USA). Cefapirin, desacetylcefapirin (DAC) and cefalothin lacton 
were a kind gift of Intervet (Boxmeer, The Netherlands). Ceftiofur was obtained 
from Pfizer (Capelle aan den IJssel, The Netherlands) and desfuroylceftiofur 
(DFC) was obtained from Toronto Research Chemicals (North York, Canada). 
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Stock solutions of ceftiofur, DFC, cefapirin and DAC were prepared in methanol 
at 100 µg/L. Sodium phosphate buffer 0.2 M at pH=2.5; 5.0; 7.0; 7.5; 9.0; 10.0; 
11.0 and 12.0 was prepared by mixing 0.2 M aqueous solutions of ortho-
phosphoric acid, sodium hydrogendiphosphate, disodium hydrogenphosphate and 
trisodium phosphate while determining the pH using a Schott CG840 pH-meter 
(Mainz, Germany) calibrated using certified pH 4.0, 7.0 and 10.0 buffers (Merck). 
Preparation of kidney extract  
A blank bovine kidney sample was defrosted and homogenised at room 
temperature, after which 5 g was transferred to a 50 mL test tube. An extract 
was made by adding 25 mL of Milli-Q water. After mixing for 15 min by using a 
rotary tumbler the extract was centrifuged at 3500 × g using a Falcon 6/300 
centrifuge (London, UK). The supernatant was decanted in a new 50 mL test 
tube. Fresh kidney extracts were prepared daily. 
LC–QqQ/MS  
The LC instrumentation consisted of two Shimadzu (Nakagyo-ku, Kyoto, Japan) 
LC-20AD high pressure liquid delivery pumps, a SIL-HTc autosampler combined 
with a CTO-20A column oven. A chromatographic separation was established 
using a Symmetry C18 analytical column, 150 x 3 mm, 5 µm (Waters, Manchester, 
UK). The gradient (mobile phase A, 0,05 % ammonia in water, pH adjusted to 8 
with acetic acid; mobile phase B, 0.05 % ammonia in water/methanol (1:9, v/v), 
pH adjusted to 8 with acetic acid; flow rate 0.4 mL min-1) was: 0 - 3 min, 15 % B; 
3 - 8 min, linear increase to 100 % B; 8 - 9 min, 100 % B; 9 - 9.5 min, return to 15 
% B. The flow was split 1:1 (MS:waste). Under these conditions, ceftiofur eluted 
after 8.3 minutes and cefapirin after 7.8 minutes. 
Detection was carried out using a Waters Quattro Ultima mass spectrometer 
operating with electrospray ionisation (ESI) in positive mode. The operating 
parameters were: capillary voltage, 1.5 kV; cone voltage, 25 V; source 
temperature, 120 °C; desolvation temperature, 300 °C; cone gas flow, 200 L hr-1; 
and desolvation gas, 500 L hr-1. Ceftiofur, DFC, cefapirin and DAC were 
fragmented using collision induced dissociation (CID) with the settings presented 
in table 5.2. Data were acquired and processed using MassLynx 4.1 software 
(Waters). 
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Table 5.2. Precursor ions, collision energy and product ions of ceftiofur, DFC, 
cefapirin and DAC.  
Compound  Precursor ion 
(m/z)  
Collision energy 
(eV)  
Product ion 
(m/z)  
Ceftiofur  524  45  125  
    17  241  
DFC  430  25  126  
    15  241  
Cefapirin  424  13  292  
    22  152  
DAC  382  25  152  
    15  292  
LC–ToF/MS  
The LC instrumentation used was an Acquity UPLC system and the separation was 
established on a Symmetry C18 analytical column, 150 x 3 mm, 5 µm (Waters).  
The gradient (mobile phase A, 0.05 % ammonia in LC-MS quality water, pH 
adjusted to 8 with acetic acid; mobile phase B, 0.05 % ammonia in LC-MS quality 
water/methanol (1:9, v/v), pH adjusted to 8 with acetic acid; flow rate 0.4 mL 
min-1) was: 0 - 3 min, 15 % B; 3 - 13 min, linear increase to 100 % B; 13 - 18 min, 
100 % B; 18 - 18.5 min, return to 15 % B. The flow was split 1:1 (MS:waste). Under 
these conditions ceftiofur eluted after 9.7 minutes and cefapirin after 8.6 
minutes. 
Detection was carried out using a Waters LCT Premier equipped with ESI. The 
instrument was operated in the positive W-mode (resolution ≥ 10,000) and was 
calibrated spanning a range of 90 to 1050 using a solution of sodium formate in 2-
propanol to obtain a mass error below 5 ppm. Scans were performed in the 
continuum mode using a scan time of 0.2 seconds. The operating parameters 
were: capillary voltage, 2.7 kV; cone voltage, 20 V; source temperature, 150 °C; 
desolvation temperature, 300 °C; cone gas flow, 30 L hr-1; desolvation gas, 400 L 
hr-1; and aperture 1 voltage, 4. A solution of 1 µg mL-1 leucine-enkephalin in 
water/acetonitrile (1:2), infused at a flow rate of 10 µL min-1 was used as a 
reference, resulting in a lock mass of m/z = 557.2802 and an attenuated lock 
mass of m/z = 556.2771. The reference scan frequency was set at 10 scans, the 
reference cone voltage at 20 V and the reference aperture 1 voltage at 8. Data 
were acquired and processed using MassLynx 4.1 software (Waters).  
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Methods 
Stability study 
The stability of solutions of ceftiofur, DFC, cefapirin and DAC at elevated 
temperature was tested. Stock solutions were diluted to 200 ng mL-1 in water of 
which 20 mL was transferred to a test tube and placed into a Julabo 25 water 
bath (Julabo, Seelbach, Germany) set at a temperature of 37 °C. After 0; 0.5; 1; 
2; 4; 6; 24; 48; 72 and 144 hours, 1 mL of the solutions was transferred to an LC-
MS vial and stored at < -70 °C. All solutions were defrosted at room temperature 
and 50 µL was injected onto the LC-QqQ/MS system to monitor ceftiofur, DFC, 
cefapirin and DAC.  
The stability of solutions of ceftiofur, DFC, cefapirin and DAC at different pHs 
was also tested. Stock solutions were diluted in each of the phosphate buffer 
solutions to obtain 10 µg mL-1 solutions at different pHs in the range of 2.5 
through 12. After 0, 30, 60, 120 and 180 minutes at room temperature, 100 µL of 
these solutions was combined with 4.9 mL sodium phosphate buffer, 0.2 M, pH=7, 
conditions at which the compounds were considered stable, to quench possible 
degradation, after which 50 µL was injected onto the LC-QqQ/MS system to 
monitor ceftiofur, DFC, cefapirin and DAC. The compounds were considered 
unstable when the peak intensity decreased over 10 %. 
Fractionation  
The LC instrumentation used for fractioning was a 1200 Series HPLC system 
(Agilent Technologies, Santa Clara, CA, USA) consisting of a G1312B binary pump 
solvent delivery system, a G1322A degasser, a G1329A auto sampler with a 
G1330B thermostat and a G1316A column oven combined with a G1314B UV-
detector and a G1364B fraction collector with a G1330B thermostat. A separation 
was established using an X-Bridge C18 analytical column, 150 x 3 mm, 5 µm 
(Waters). The gradient (mobile phase A, 0,05 % ammonia in water; mobile phase 
B, 0.05 % ammonia in water/methanol (1:9, v/v); flow rate 0.4 mL min-1) was: 0 - 
3 min, 5 % B; 3 - 43 min, linear increase to 100 % B; 43 - 44 min, 100 % B; 44 - 
44.5 min, return to 5 % B.  
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Concentrated solutions of 500 µg mL-1 cefapirin and 1 mg mL-1 ceftiofur were 
prepared in methanol. Both solutions and pure methanol were diluted tenfold in 
water to obtain solutions containing 10 % methanol after which 2 mL was 
transferred to different test tubes in duplicate, resulting in two identical sets, 
each set consisting of one blank tube, one containing 100 µg cefapirin, and one 
containing 200 µg ceftiofur. To the first set, 0.5 mL of 25 % ammonia was added. 
To the second set, 2.5 mL of kidney extract was added. Both sets were incubated 
for four hours in a water bath at 37 °C. Of each of the incubates, 20 times 100 µL 
was injected on the fractioning system. Fractions of 30 sec were taken from a 
retention time of 6 min through 34 min. The different fractions of each of the 20 
injections were combined in test tubes resulting in 4 mL fractions. From the 
collected fractions the methanol was evaporated at room temperature under a 
stream of nitrogen, 200 µL was transferred to an LC-MS vial and the remaining 
aqueous solvent in the test tubes was evaporated overnight at room temperature 
under nitrogen. The resulting residues were diluted in 700 µL deuterated 
methanol and subjected to analysis by NMR. From the LC-MS vials 25 µL was 
injected on the LC-ToF/MS system to identify the fractions containing relevant 
degradation products. Of the relevant fractions, the remaining solution in the LC-
MS vial was subjected to the microbiological test.  
Identification by LC-ToF/MS  
Stock solutions of ceftiofur and cefapirin were diluted to 10 µg mL-1 in water. 
Four sets of five test tubes were prepared, each set consisting of a test tube 
containing 5 mL 10 µg mL-1 ceftiofur, 5 mL 10 µg mL-1 DFC, 5 mL 10 µg mL-1 
cefapirin, 5 mL 10 µg mL-1 DAC and 5 mL 10 % methanol in water. The sets were 
treated according to the conditions presented in table 5.3. After the incubation 
time the solutions were stored at < -70 °C. All solutions were defrosted at room 
temperature and shaken by hand after which an aliquot of each solution was 
filtered using a 30 kD ultrafilter (3500 G, 15 minutes), transferred to an LC-MS 
vial and analysed by LC-ToF/MS. 
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Table 5.3. Incubation conditions for the identification experiment. 
Set Addition Incubtation temperature (°C) Incubation time (h) 
1 - 37 72 
2 62.5 µL 25 % ammonia Room temperature 2 
3 2.5 mL kidney extract 37 72 
4 2.5 mL kidney extract + 
62.5 µL 25 % ammonia 
37 72 
 
MetAlign Software (www.metalign.nl, RIKILT Wageningen UR, The Netherlands) 
was used to detect degradation products. This software aligned chromatograms 
of the blank solution with the chromatograms of the ceftiofur and cefapirin 
spiked solutions, after which the differences between the two sets of 
chromatograms were determined. This procedure resulted in chromatograms 
containing accurate mass full scan data showing mainly degradation products. For 
each degradation product, the most likely molecular formulas was selected, 
using the elemental composition option in MassLynx 4.1, combining the 
determined accurate mass and isotope ratio. The molecular formula of the 
degradation products was determined with a high certainty because ceftiofur and 
cefapirin contain sulfur atoms having a very specific isotope [M+2] and several 
nitrogen atoms. From these molecular formulas, possible molecular structures 
were generated.  
NMR  
1H NMR experiments were performed on a Bruker Avance 400 MHz spectrometer. 
Presaturation was performed on the residual HDO resonance. A 90° pulse was 
used; the total relaxation delay was 3.7 s; the spectral width was 5000 Hz. The 
data were acquired in 16 K data points. Before Fourier transformation and 
phasing, a 1/3 shifted sine squared window multiplication was applied and a 
zero-filling to 128 K data points were applied. Calibration of spectra was 
achieved by setting the HCD2 resonance of deuterated methanol to 3.27 ppm.  
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Microbiology  
Antimicrobial activity was determined using a modified Bacillus 
stearothermophilus var. calidolactis C953 disk assay method. Aliquots of 6 mL 
Plate Count Agar (Difco) inoculated with approximately 106 CFU mL-1 spores were 
allowed to set in petri dishes with a diameter of 9 mm. Samples of 100 μL were 
pipetted on filter paper sample disks (diameter 12.7 mm, Whatman, Schleicher & 
Schuell) and transferred to the center of a test plate using tweezers. The plates 
were incubated for 3.5 to 5 hours at 55 °C. Antimicrobial activity becomes visible 
as a zone of growth inhibition around the paper disk. 
Kinetics  
The kinetic experiment was carried out for ceftiofur and cefapirin separately. 
Stock solutions of ceftiofur and cefapirin were diluted to 10 µg mL-1 in water, and 
10 mL of each was transferred into four 14 mL test tubes. Nothing further was 
added to the first test tube, 5 mL kidney extract was added to the second test 
tube, 125 µL 25 % ammonia was added to the third test tube and 5 mL kidney 
extract and 125 µL 25 % ammonia were added to the fourth test tube. The test 
tubes were placed in a water bath at 37 °C. After 0; 0.5; 1; 2; 4; 8; 24; 50; 72 
and 144 hours, 1 mL of each of the solutions was transferred to a clean test tube 
and stored at < -70 °C. Just before analysis, all solutions were defrosted at room 
temperature, shaken by hand, filtered using a 30 kD ultrafilter (Millipore) (3500 
G, 15 minutes), transferred to an LC-MS vial and analysed by LC-ToF/MS. 
From the data obtained, the formation of the degradation products was studied 
in a qualitative way using the MetAlign Software. These data were unsuited for 
quantitation purposes, because no reference standards are available and because 
different degradation products do not necessarily show the same ionisation 
efficiency, resulting in a different sensitivity on the LC-MS system. In the figures 
displaying kinetic results the highest signal obtained is set at 100 % and all other 
signals are related to this without suggesting a quantitative relation exists. 
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Results & Discussion  
An overview of suggested1 degradation products is presented in table 5.4 (page 
215) including retention time, accurate mass, molecular formula and suggested 
compound name. Molecular structures of the most relevant products are 
presented in figure 5.5 for ceftiofur and figure 5.6 for cefapirin. 
 
Figure 5.5. Overview of the suggested degradation products of ceftiofur (k) in 
kidney extract, (NH3) after addition of ammonia and (inc.) after prolonged 
incubation at 37 °C. The corresponding retention times and molecular formulas 
are presented in table 5.4 (page 215). 
  Footnote 
1 All structures proposed for unknown degradation products are suggested based on 
the combination of data obtained from different techniques (LC-ToF, NMR and/or 
microbiological methods). Because of the lack of reference standards for the proposed 
degradation products, none of these structures can be considered as 100 % identified. 
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Physiological temperature 
Stability  
A representative LC-QqQ/MS chromatogram as obtained during the stability study 
is presented in figure 5.3. Due to the QqQ/MS technique applied, which is a 
targeted technique, only predefined compounds are monitored; possible other 
compounds, like degradation products, are not detected. 
The stability of ceftiofur, DFC, cefapirin and DAC in aqueous solutions of 200 µg 
L-1 at a temperature of 37 °C is presented in figure 5.7. Ceftiofur and DAC were 
stable for 24 hours at 37 °C, showing decreases in the signal of 2 % (ceftiofur) 
and 4 % (DAC), which are considered not to be significant. 
Cefapirin is relatively unstable at 37 °C, showing 40 % degradation after 24 
hours. DFC shows 25 % degradation after 24 hours and during incubation an 
additional peak appears in the DFC transition 430 > 126 eluting 0.3 minutes 
before DFC. The two peaks likely represent the syn- and anti-oxyimino isomers of 
DFC [50] for two reasons. First, the sum of the isomer and DFC results in 100 % of 
the initial amount of DFC. Second, from the results it is extrapolated that after 9 
days of incubation 50 % of DFC is converted into the isomer and equilibrium is 
established. 
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Figure 5.7. MRM chromatogram of a mixture of 200 µg L-1 ceftiofur, DFC, 
cefapirin and DAC. 
 
 
 
 
 
cefapirin 
desfuroylceftiofur 
ceftiofur 
desacteylcefapirin 
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Table 5.4. Overview of suggested degradation products of cefapirin under several 
conditions including retention time on LC-ToF/MS system, accurate mass and 
proposed molecular formula. Proposed structures are given in figure 5.5 and 5.6. 
 
Code RT 
(min) 
Accurate 
mass 
[M+H]+ 
Mol. Formula 
[M+H]+ 
Suggested compound name 
Ceftiofur 9.9 524.036 C19H18N5O7S3  
DFC 7.8 430.031 C14H16N5O5S3  
Cef-1 6.5 549.036 C17H21N6O7S4 DFC-cysteine disulfide 
Cef-2 8.0 412.021 C14H14N5O4S3 DFC-thiolacton 
Cef-3-NH3 6.5 413.070 C14H17N6O5S2 Ammoniated 
desthiofuroylceftiofur 
Cef-4 2.7 201.045 C6H9N4O2S 2-amino-α-(methoxyimino)-4-
thiazoleacetamide (AMTA) 
Cefapirin 8.8 424.064 C17H18N3O6S2  
DAC 7.4 382.053 C15H16N3O5S2  
Cefp-1a 8.4 396.068 C16H18N3O5S2 Methoxy DAC 
Cefp-1b 9.3 396.068 C16H18N3O5S2 DAC methyl ester 
Cefp-2 8.1 364.043 C15H14N3O4S2 Desacetoxy cefapirin 
DAC-NH3 6.6 399.080 C15H19N4O5S2 Ammoniated DAC 
Cefp-2-NH3 7.6 381.069 C15H17N4O4S2 Ammoniated desacetoxy cefapirin 
DAC-NH3d 7.3 397.064 C15H17N4O5S2 Ammoniated desacetyl 
dehydrocefapirin 
Cefp-2-NH3d 8.2 379.054 C15H15N4O4S2 Ammoniated desacetoxy cefapirin 
Cefp-3 6.5 169.044 C7H9N2OS 2-(pyridine-4-ylthio)acetamide 
(PTA) 
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Figure 5.8. The kinetics for (●) ceftiofur, (■) DFC, (□) a conformational isomer of 
DFC, (▲) cefapirin and (♦) DAC during incubation at 37 °C.  
 
Figure 5.9. LC-ToF/MS chromatogram of (a) 10 % methanol + 62.5 µL 25 % 
ammonia, (b) 10 µg L-1 cefapirin + 62.5 µL 25 % ammonia and (c) the resulting 
MetAlign output. 
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Kinetics  
An example of a typical LC-ToF/MS chromatogram including the MetAlignTM 
output as obtained during the identification of unknown degradation products is 
presented in figure 5.9. Because ToF/MS was used, which is a non-targeted 
technique, all products, including interferences and new degradation products, 
are detected. 
Ceftiofur remains stable during incubation at 37 °C. For cefapirin at 37 °C in 10 % 
methanol, three major degradation products, including DAC were detected. The 
accurate masses of the other products were 396.068 (cefp-1), showing two peaks 
and 364.043 (cefp-2) (table 5.4, page 215). The formation of these degradation 
products and the decay of cefapirin during incubation at 37 °C are presented in 
figure 5.6. DAC is immediately produced and the concentration increases during 
24 hours. For cefp-1 two peaks are found at retention times of 8.4 and 9.3 min 
which might be caused by the presence of two different forms (a and b). The 
production of cefp-1a and b is complete after 75 hours. Cefp-2 reaches a 
maximum intensity after 4 hours of incubation, after which it remains constant.  
 
Figure 5.10. The kinetics for (▲) cefapirin, (x) DAC, (•) cefp-1 and (■) cefp-2 
during incubation of an aqueous cefapirin solution at 37 °C. 
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Kidney extract  
Kinetics  
For ceftiofur, three major degradation products were detected, with accurate 
masses of 430.031 (DFC), 549.035 (cef-1) and 412.021 (cef-2). DFC is produced 
immediately after addition of kidney extract but is unstable under these 
conditions. The products cef-1 and cef-2 show a maximum intensity after 4 hours 
of incubation (figure 5.11a).  
For cefapirin, three major degradation products were detected: DAC, cefp-1b 
and cefp-2. DAC is produced immediately after addition of kidney extract as has 
also been reported [43,47] but is unstable and therefore not the only degradation 
product (figure 5.11b). Cefp-1b and cefp-2 are also produced during degradation 
at elevated temperature only. However, for both cefp-1b and cefp-2 effects of 
the kidney extract are observed. In contrast to the process in aqueous solution at 
physiological temperature, in kidney extract both cefp-1b and cefp-2 are 
produced immediately after addition. Furthermore, cefp-1b is detected at a 
relatively high intensity.  
   
Figure 5.11. (a) The kinetics for (□) DFC, (○) cef-1 and (∆) cef-2 during 
incubation at 37 °C after addition of ceftiofur to of kidney extract. Ceftiofur 
was not detected. (b) The kinetics for (x) DAC, (•) cefp-1b and (■) cefp-2 during 
incubation at 37 °C after addition of cefapirin to kidney extract. Cefapirin was 
not detected. 
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Identity1  
For each of the unknown degradation products of ceftiofur and cefapirin a 
molecular formula and possible molecular structures were determined from the 
accurate mass and isotope ratio (table 5.4 (page 215), figures 5.5 and 5.6 (page 
211 and 212)).  
For cef-1, one likely structure is proposed: DFC cysteine disulfide reported in 
milk and plasma of lactating cows [38] and in swine tissues [35,46]. For cef-2 one 
likely structure is proposed: ceftiofur thiolacton. The presence of ceftiofur 
thiolacton was first reported in acidified plasma and urine of ceftiofur-treated 
cows [37] and was reported as a hydrolysis product of ceftiofur [51]. To the best 
of our knowledge, this is the first time ceftiofur thiolacton has been reported in 
kidney extract.  
For cefp-1b suggested structures are methoxy DAC and DAC methyl ester. A third 
candidate structure which does not obtain an intact ß-lactam ring, was ruled out 
because the microbiological experiment indicated antimicrobial activity for this 
product, showing that it contains an intact ß-lactam ring. Methoxy DAC is a 
somewhat more polar compound compared to DAC methyl ester and therefore 
elutes first. It is proposed that cefp-1a is methoxy DAC and cefp-1b is DAC methyl 
ester. No NMR spectrum was obtained for cefp-1b due to its low concentration. In 
the standard solution of cefapirin a trace (0.5 %) of cefapirin methyl ester was 
detected which could have degraded to DAC methyl ester in analogy to the 
degradation of cefapirin to DAC. However, the production of the cefp-1b cannot 
be fully explained by the degradation of a trace of cefapirin methyl ester, 
because in the kinetic experiment the signal of cefp-1b is higher than the signal 
of DAC. This is very unlikely to be caused by a difference in sensitivity only. It is 
concluded that cefp-1b is a major degradation product of cefapirin in the 
presence of kidney extract and is suggested to be DAC methyl ester. It is stated 
that the presence of methanol in the solution could result in esterfication of 
cefapirin or degradation products of cefapirin. 
For cefp-2 three suggested structures are cefapirin lacton, formerly reported by 
Heller et al. [52] to occur in milk of cefapirin treated cows, DAC methyl ester 
and desacetoxy cefapirin. Unfortunately no NMR spectrum was obtained for this 
compound due to its low concentration. However, this product shows analogy 
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with the product cefp-2-NH3 detected for cefapirin in the presence of ammonia 
of which NMR signals were observed. Therefore it is suggested that cefp-2 is 
desacetoxy cefapirin.  
Impact  
During incubation at 37 °C in aqueous kidney extract, ceftiofur immediately 
degrades to several products including the unstable DFC. The main products 
formed are DFC-cysteine disulfide and DFC-thiolacton. To the best of our 
knowledge, DFC-thiolacton has not been previously reported in kidney extract.  
Possibly DFC-thiolacton is not taken into account when applying the 
derivatization procedure using dithioerythritol and iodoacetamide to produce 
DFC from all active metabolites present [35], because it does not contain the 
complete DFC structure. In the kinetic experiment the intensity of DFC thiolacton 
was rather low. However, in the LC-ToF/MS identification experiment the 
intensity of DFC-thiolacton was found to be 40 % of DFC and therefore it is 
concluded that the derivatization procedure can result in an underestimation of 
the total amount of active ceftiofur compounds present in kidney.  
During incubation at 37 °C in aqueous kidney extract cefapirin immediately 
degrades into several products among which the unstable DAC. The main 
products formed are cefp-1b which is likely DAC methyl ester and cefp-2 which is 
likely desacetoxy cefapirin. To the best of our knowledge these products have 
not been formerly reported. Using the generally applied method in which the 
sum of cefapirin and DAC is determined [43,47], cefapirin methyl ester as well as 
desacetoxy cefapirin which are both antimicrobially active products are not 
taken into account.  
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pH  
Stability  
Ceftiofur is unstable in alkaline phosphoric buffer showing complete degradation 
within 30 min at pH = 12, 80 % degradation within 3 hours at pH = 11 and no 
degradation between pH = 2.5 through 10 (figure 5.12a). Surprisingly, compared 
to ceftiofur, DFC is more stable at high pH but less stable at low pH (figure 
5.12b). At pH = 12, about 70 % of DFC is degraded after 3 hours, at pH = 11 this is 
30 % and no degradation occurs between pH = 5 and 10. At pH = 2.5, 60 % of DFC 
degrades within 3 hours. In this experiment ceftiofur was less unstable than 
stated by Sunkara et al. [44] who reported a stable pH range for ceftiofur from 
5.0 through 6.8 and complete degradation of ceftiofur within 10 min at pH = 10. 
The present study shows a stable pH range from 2.5 through 10 expanding the 
applicable pH range. These differences could be caused by a difference in ionic 
strength or quenching procedure. 
  
  
Figure 5.12. The degradation of (a) ceftiofur, (b) DFC, (c) cefapirin and (d) DAC 
in aqueous solution at pH (●) 2.5, (■) 5.0, (▲) 7.5, (x) 10.0, (♦) 11.0 and (○) 12.0.  
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Cefapirin and DAC show similar results to ceftiofur and DFC. Cefapirin is unstable 
in alkaline solution showing complete degradation within 30 min at pH = 12, 
complete degradation within 3 hours at pH = 11, slight degradation at pH 10 and 
no degradation between pH = 2.5 through 7.5 (figure 5.12c). Compared to 
cefapirin, DAC is more stable at high pH but less stable at low pH (figure 5.12d). 
DAC completely degrades within 30 min at pH = 12, but at pH = 11 degradation is 
slower compared to cefapirin: 80 % within 3 hours. DAC is stable from pH= 5 
through 10 and at pH = 2.5 it degrades for 40 % within 3 hours.  
Kinetics  
After addition of ammonia to a ceftiofur solution two major degradation products 
were detected with accurate masses of m/z = 413.070 (cef-3-NH3) which shows a 
maximum intensity after 4 hours of incubation, and 201.045 (cef-4) which is 
produced slowly at 37 °C (figure 5.13a). 
For cefapirin two major degradation products were detected with accurate 
masses of m/z = 399.080 (DAC-NH3) and 381.069 (cefp-2-NH3). DAC-NH3 and cefp-
2-NH3 are immediately produced after addition of ammonia and show maximum 
intensity after 2 and 24 hours of incubation respectively (figure 5.13b). 
  
Figure 5.13. (a) The kinetics of (□) cef-3-NH3 and (◊) cef-4 produced from 
ceftiofur in diluted ammonia during incubation at 37 °C. No ceftiofur was 
detected. (b) The kinetics of (x) DAC, (+) DAC-NH3, (▲) and cefp-2-NH3 produced 
from cefapirin in alkaline environment during incubation at 37 °C. No cefapirin 
was detected.  
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Identity1 
For each of the detected degradation products of ceftiofur and cefapirin in 
ammonia a molecular formula and possible molecular structures were 
determined (table 5.4 (page 215), figures 5.5 and 5.6 (page 211 and 212)) from 
the accurate mass and isotope ratio.  
The isolated ceftiofur degradation products obtained after addition of ammonia 
showed slight microbiological activity which is explained by the occurrence of 
low amounts (< 1 %) of compounds containing an intact ß-lactam ring in these 
fractions. The isolated cefapirin degradation products do not show any 
antimicrobial acitivty and thus it is concluded that the degradation products 
become antimicrobially inactive by addition of ammonia. This is in agreement 
with the NMR data in which no ß-lactam ring structure (geminal protons at both 
4.9 and 5.6 ppm) was observed for any of the products after addition of 
ammonia. By combining the LC-ToF/MS, NMR and microbiological data it is 
concluded that the ß-lactam ring, responsible for the antimicrobial activity is 
ammoniated at the carbonyl group producing an amide moiety.  
For cef-3-NH3 two possible molecular structures are ammoniated ceftiofur lacton 
and ammoniated desthiofuroylceftiofur that can be produced because DFC 
contains a sulfide group, which is a good leaving group [53]. The production of 
ammoniated desthiofuroylceftiofur is more likely, since for ceftiofur lacton, two 
sets of geminal protons would be expected in the NMR spectrum which were not 
observed. For this product two chromatographic peaks were observed, suggesting 
the formation of conformational isomers, e.g. the syn- and anti-oxyimino 
isomers. 
Cef-4 is likely the inactive part of ceftiofur containing the aromatic ring, the 
oxyimino moiety and an amide group: 2-amino-α-(methoxyimino)-4-
thiazoleacetamide (AMTA). From the LC-Tof/MS data and the knowledge that 
ammonia causes opening of the ß-lactam ring, it is suggested that DAC-NH3 is 
ammoniated DAC.  
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Figure 5.14. The NMR spectrum of cefp-2-NH3. 
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Figure 5.15. Spectra of (a) ammoniated cefalothin lacton and (b) cefp-2-NH3, 
including proposed molecular formulas and structures. 
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For cefp-2-NH3 three possible molecular structures are ammoniated cefapirin 
lacton, ammoniated DAC methyl ester and ammoniated desacetoxy cefapirin. 
The NMR spectrum (figure 5.14) does not show the expected couple of geminal 
protons that would be observed for cefapirin lacton. An NMR signal that is likely 
to originate from the methyl group in ammoniated desacetoxy cefapirin is 
observed at 2.2 ppm. The LC-MS/MS fragmentation pattern of cefp-2-NH3 and 
ammoniated cefalothin lacton, obtained by adding ammonia to a standard 
solution of cefalothin lacton, were compared (figure 5.15) to obtain additional 
information. Cefalothin lacton was used because of the lack of a reference 
standard of cefapirin lacton. The fragmentation pattern of cefp-2-NH3 consists of 
the loss of CO2 (m/z = 337), the loss of both CO2 and NH3 (m/z = 320) and the loss 
of CO2, NH3 and CO (m/z = 292). Ammoniated cefalothin lacton (m/z = 354) did 
show the loss of NH3 (m/z = 337), but did not show an abundant peak 
corresponding with the loss of CO2. This indicates that, in contrast to cefalothin 
lactone, cefp-2-NH3 does not contain a lactone ring. Based on the combination of 
LC-ToF/MS, NMR, microbialogical and LC-MS/MS data it is likely that cefp-2-NH3 
is ammoniated desacetoxy cefapirin.  
For both DAC-NH3 and cefp-2-NH3 four chromatographic peaks were observed 
indicating the presence of several conformational isomers. After isolation of a 
specific isomer by fractionation and injection on the LC-ToF/MS system, again 
four peaks were observed, indicating the slow formation of an equilibrium among 
the isomers. 
Impact 
From these results it is concluded that for ceftiofur and cefapirin high alkaline 
conditions result in immediate degradation. When using ammonia the main 
process occurring is ammoniation of the ß-lactam ring resulting in 
microbiologically inactive products. DFC and DAC are stable in the pH range from 
3 - 10. At more extreme conditions severe degradation of both compounds 
occurs. Therefore, for analysis involving ceftiofur, DFC, cefapirin and DAC, the 
pH during sample preparation and analysis should be well controlled. If the pH 
gets below 3 or above 12, as might occur during adjustment of the pH, rapid 
degradation occurs resulting in an underestimation of the residue level of 
ceftiofur and cefapirin.  
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Alkaline kidney extract 
Kinetics 
When ammonia is added to ceftiofur spiked kidney extract, DFC and cef-2, found 
in aqueous kidney extract at neutral pH, are not detected. Cef-1 is detected but 
degrades almost completely within 4 hours (figure 5.16a). This is expected 
because high levels of ammonia immediately ammoniate the ß-lactam ring. By 
comparing the processes in the presence and absence of kidney extract (figure 
5.13a vs 4.16a) it is concluded that the degradation of cef-3-NH3 is accelerated in 
kidney extract. Cef-4, found in alkaline solutions, is also found in alkaline kidney 
extract, showing the same kinetics obtaining a stable concentration after 60 
hours of incubation at 37 °C.  
When ammonia is added to cefapirin spiked kidney extract, DAC and cefp-1b 
found in aqueous kidney extract at ambient pH, are detected but degrade rapidly 
due to the ammoniation of the ß-lactam ring. Cefp-2 was not detected in this 
experiment. Cefp-2-NH3, found in the presence of ammonia, is also found in 
alkaline kidney extract showing comparable kinetics to the degradation process 
in absence of kidney extract (figure 5.16b). DAC-NH3 was detected in this 
experiment but decreased more rapidly compared to the degradation process in 
absence of kidney extract. It is concluded that the degradation of DAC-NH3 is 
catalysed by active compounds in kidney extract.  
Some unknown products with accurate masses of m/z = 397.064 (DAC-NH3d), 
379.054 (cefp-2-NH3d) and 169.044 (cefp-3) are formed in alkaline kidney extract 
during incubation. After about 50 hours of incubation at 37 °C the production of 
these products is complete after which the intensity remains stable.  
Identity1 
For each of the unknown degradation products of ceftiofur and cefapirin a 
molecular formula and possible molecular structures were determined (table 5.4 
(page 215), figures 5.5 and 5.6 (page 211 and 212)) from the accurate mass and 
isotope ratio.  
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Figure 5.16. (a) The kinetics of (○) cef-1, (□) cef-3-NH3 and (◊) cef-4 produced 
from ceftiofur in alkaline kidney extract during incubation at 37 °C. No ceftiofur 
was detected.(b) The kinetics of (x) DAC, (•) cefp-1b, (+) DAC-NH3, (▲) cefp-2-
NH3, (○) DAC-NH3d, (∆) cefp-2-NH3d and (□) cefp-3 produced from cefapirin in 
alkaline kidney extract during incubation at 37 °C. 
It is noteworthy that DAC-NH3 and DAC-NH3d as well as cefp-2-NH3 and cefp-2-
NH3d only differ two hydrogen atoms. This indicates that these products are 
related and differ only one double bond. It is suggested that during incubation an 
aromatic system is formed in the six membered thiazine ring resulting in a more 
unsaturated compound.  
The products cef-4 and cefp-3 are suggested to be analogs being AMTA and 2-
(pyridine-4-ylthio)acetamide) (PTA). 
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Impact  
From these results it is concluded that both active compounds in kidney extract 
and ammonia influence the degradation process of ceftiofur and cefapirin. For 
ceftiofur, the highly polar cef-4 is the only detected stable product in alkaline 
kidney extract. For cefapirin, DAC-NH3d, cefp-2-NH3d and the polar cefp-3 are 
found to be stable products. The formation of these products is only complete 
after 50 hours of incubation at 37 °C. At 80 °C the formation of AMTA is 
complete after 8 hours and the formation of the PTA after 2 hours. Further 
research is needed to determine if these products can result in a new approach 
for the quantitative analysis of ceftiofur and cefapirin in kidney.  
Conclusions 
Ceftiofur and cefapirin are stable in aqueous solution within a pH range 2.5 - 10. 
Above pH = 10, the ceftiofur and cefapirin ß-lactam ring is degraded and at pH = 
12 this is almost an immediate proces. It is concluded that the pH has to be well 
controlled during analysis to prevent the occurrence of such degradation. 
In kidney extract as well, ceftiofur and cefapirin are highly unstable. For 
ceftiofur the suggested main degradation products are DFC, DFC-cysteine 
disulfide and DFC-thiolacton. For cefapirin the main degradation product is DAC 
which degrades further to a product that is suggested to be DAC methyl ester and 
a product that is suggested to be desacetoxy cefapirin. To the best of our 
knowledge DFC-thiolacton, DAC methyl ester and desacetoxy cefapirin have not 
been previously reported to be found in kidney extract. 
Due to the processes occurring in kidney extract and the fact that the pH has to 
be well controlled, severe degradation during sample preparation is likely to 
occur. Furthermore, the identification of the degradation products indicate that 
reported methods do not include all relevant analytes. Both aspects result in an 
expected underestimation of the residue levels of ceftiofur and cefapirin. 
Additional research to determine whether newly identified degradation products 
can result in a new approach for the quantitative determination of ceftiofur, 
cefapirin and other cephalosporins in tissue is reported in section 5.3.  
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5.3. Assessment of liquid chromatography 
tandem mass spectrometry approaches for the 
analysis of ceftiofur metabolites in poultry 
muscle 
Abstract 
The use of cephalosporin antibiotics in veterinary practice is likely to play an 
important role in the development of ß-lactam resistant bacteria. To detect off-
label cephalosporin antibiotic usage an analytical method is needed that, besides 
the native compound, also detects their active metabolites. In this section the 
applicability of three approaches for the quantitative analysis of ceftiofur using 
liquid chromatography coupled to tandem mass spectrometry is assessed, viz. (A) 
the analysis of ceftiofur, desfuroylceftiofur and/or desfuroylceftiofur cystein 
disulfide, (B) the derivatization of ceftiofur metabolites to desfuroylceftiofur 
acetamide and (C) the chemical hydrolysis using ammonia in order to produce a 
marker compound for ceftiofur. It was found that approach A is not suited for 
quantitative analysis of total ceftiofur concentration nor for effectively detecting 
off-label use of ceftiofur. Approach B resulted in adequate quantitative results, 
but is considered to be a single compound method because it depends on the 
cleavage of a thioester group which is present in only a limited number of 
cephalosporin antibiotics. Approach C showed adequate quantitative results as 
well. In contrast to approach B, this approach is applicable to a range of 
cephalosporin antibiotics and therefore applicable as a broad quantitative 
screening of cephalosporin compounds in poultry tissue samples to indicate off-
label use of cephalosporins in poultry breeding. Based on the research presented 
here, it is concluded that the multi-method following approach C is the most 
suited to detect off-label use of a range of cephalosporin antibiotics. 
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Introduction  
Cephalospirins are semi-synthetic ß-lactam antibiotics, consisting of a six 
membered dihydrothiazine ring fused with a four membered ß-lactam ring which 
is responsible for the biological activity of the compounds. Nowadays, five 
generations of cephalosporins are distinguished reflecting their spectrum of 
activity, structural similarity and time of introduction [11]. Ceftiofur (figure 
5.17a) is a third generation cephalosporin which is highly effective in the 
treatment of bacterial infections of the respiratory tract [10]. Ceftiofur is 
registered for use in food-producing mammals [6] but occasionally off-label use 
occurs in poultry breeding. This is likely to contribute to the emergence of 
resistant bacteria like extended-spectrum-ß-lactamase (ESBL) producing bacteria 
[15-19]. Cephalosporins are assigned as critically important antimicrobials for 
human health [23] and should therefore be used sparingly in veterinary practice 
to prevent the occurrence of bacterial resistance [24-27,54]. 
 
Figure 5.17. Molecular structure of (a) ceftiofur, (b) desfuroylceftiofur (DFC), 
(c) desfuroylceftiofur cysteine disulfide (DCCD), (d) desfuroylceftiofur 
acetamide (DCA) and (e) 2-amino-α-(methoxyimino)-4-thiazoleacetamide 
(AMTA). 
a 
b 
c 
d 
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Ceftiofur is known to metabolise rapidly after intramuscular administration. 
Reported metabolites include desfuroylceftiofur (DFC, figure 5.17b), 
desfuroylceftiofur cysteine disulfide (DCCD, figure 5.17c), protein bound DFC and 
desfuroylceftiofur thiolacton [36-38,55]. Although no maximum residue limit 
(MRL) has been established for poultry muscle, it is important to realise that 
ceftiofur MRLs for other species are defined as the sum of all residues retaining 
the ß-lactam structure, expressed as DFC [6]. This implies that all active 
metabolites should be included in the analysis of ceftiofur in food products. 
Two main approaches for the analysis of ceftiofur residues in animal tissue and 
plasma have been reported. The first approach focuses on the analysis of one or 
more ceftiofur metabolites. LC-UV methods for the analysis of ceftiofur itself 
were reported [56,57] as well as an LC-UV method including ceftiofur and DFC 
[58] and one including ceftiofur, DCCD and DFC dimer [46]. Furthermore, a very 
straightforward LC-MS/MS method monitoring DCCD as the marker compound in 
kidney was reported [59].  
The second approach includes an extraction and deconjugation of all protein 
bound DFC using dithioerythritol (DTE) followed by a derivatization of the 
resulting free DFC using iodoacetamide to obtain desfuroylceftiofur acetamide 
(DCA) as a marker residue (figure 5.17d). This approach was first introduced for 
the analysis of plasma in combination with UV detection [60] and was later 
optimised for the analysis of muscle [35,61]. This second approach was validated 
by a multi-laboratory trial demonstrating its applicability [62]. However, these 
methods are very laborious including several solid phase extraction (SPE) steps. 
Simplified methods applying the same approach were reported for the analysis of 
plasma and synovial fluid [63] and for the analysis of several matrices among 
which serum and endometrial tissue [45,64].  
Based on the results presented in section 5.2, it is expected that currently 
applied methods are likely to underestimate the residue levels of ceftiofur and 
cephapirin found in kidney samples because they do not include all active 
metabolites. Furthermore, it is noted that cephalosporin multi-methods that 
include unstable cephalosporins (like ceftiofur and cefapirin) and are able to 
detect the active metabolites of these compounds, are still lacking. Therefore, a 
new approach for the analysis of ceftiofur including its metabolites was 
suggested [55]. This third approach is based on an alkaline hydrolysis of ceftiofur 
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and its metabolites to produce 2-amino-α-(methoxyimino)-4-thiazoleacetamide 
(AMTA, figure 5.17e) as a marker residue for the total amount of active ceftiofur 
metabolites. This method is also applicable for other cephalosporins, including 
cefcapene, cefapirin and cefquinome.  
Based on incurred ceftiofur poultry muscle material a critical assesment of the 
three approaches is presented in this section: (A) the analysis of ceftiofur, DFC 
and DCCD using the method reported by Mastovska et al. [59], (B) the 
derivatization of ceftiofur metabolites to DCA as reported by Witte et al. [45] 
and (C) a newly developed method applying an alkaline hydrolysis of ceftiofur, of 
which the preliminary concept was reported in section 5.2.  
Experimental 
Reagents 
HPLC grade methanol, HPLC grade acetonitrile, hexane (Biosolve, Valkenswaard, 
The Netherlands), 25 % ammonia, 99 % acetic acid, sodium chloride, sodium 
hydroxide, ammonium acetate, 85 % phosphoric acid (Merck, Darmstadt, 
Germany), disodium tetraborate , dithioethrytol (DTE) and iodoacetamide (IAA) 
(Sigma-Aldrich, St. Louis, MO, USA) were used. Ceftiofur, DFC, DCCD and 
ceftiofur-d3 were obtained from Toronto Research Chemicals (North York, 
Ontario, Canada).  
Milli-Q water was prepared using a Milli-Q system at a resistivity of at least 18.2 
MΩ∙cm (Millipore, Billerica, MA, USA). Bakerbond® Octadecyl 40 µm was obtained 
from J.T. Baker (Phillisburg, NJ, USA). The solid phase extraction (SPE) cartridges 
used were Mega Bond-Elut C18 1 g / 6 mL, Bond Elut SCX 100 mg / 3 mL (Agilent 
Technologies, Santa Clara, CA, USA) and Oasis HLB 60 mg / 3 mL (Waters, 
Milford, MA, USA).  
Borate buffer pH 9 was prepared by dissolving 10.0 g disodium tetraborate and 
29.2 g sodium chloride in 1 L of water. A 1 M ammonium acetate solution was 
prepared by dissolving 7.71 g of ammonium acetate in 100 mL water. This was 
diluted tenfold in water to obtain a 0.1 M ammonium acetate solution. A 17 % 
phosphoric acid solution was prepared by diluting 10 mL 85 % phosphoric acid to 
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50 mL with water. A 2 % acetic acid solution was prepared by diluting 10 mL 99 % 
acetic acid to 500 mL with water. A 5 M sodium hydoxide solution was prepared 
by dissolving 20 g sodium hydroxide in 100 mL water. A 20 mg mL-1 DTE solution 
was prepared by dissolving 2.0 g of DTE in 100 mL borate buffer pH 9. A 0.2 M IAA 
solution was prepared by dissolving 3.7 g IAA in 100 mL 0.1 M ammoniumacetate 
buffer. Individual stock solutions of ceftiofur and ceftiofur-d3 were prepared in 
methanol and stock solutions of DFC and DCCD in water at 100 µg L-1. 
Methods 
Three sample preparation methods (described below) were implemented and 
tested at our laboratory for the analysis of ceftiofur and its metabolites in 
poultry muscle. All final extracts were analysed using the LC-MS/MS system 
described.  
Method A: individual analysis of ceftiofur, DFC and DCCD 
This method focuses on the individual analysis of ceftiofur, DFC and DCCD and 
was based on Mastovska et al. [59]. One gram of poultry muscle was weighed into 
a centrifuge tube and ceftiofur-d3 was added as the internal standard. 2 mL of 
water and 8 mL of acetonitrile was added to the sample and the tube was shaken 
using a rotary tumbler (5 min). After centrifugation (3500 g, 15 min) the 
supernatant was decanted into a new centrifuge tube containing 0.5 g of 
octadecyl sorbent. After vortex shaking (30 s) and centrifugation (3500 g, 5 min) 
5 mL of the extract was transferred into a 12 mm centrifuge tube and evaporated 
(45 °C, N2) until the volume was below 1 mL. The concentrated extract was 
transferred into an autosampler vial. 
Method B: derivatization to DCA 
This method includes a deconjugation and derivatization of ceftiofur metabolites 
to DCA and was based on Witte et al. [45]. One gram of poultry muscle was 
weighed into a centrifuge tube and ceftiofur-d3 was added as the internal 
standard. Deconjugation of DFC conjugates resulting in free DFC was carried out 
by adding 5 mL of DTE solution followed by shaking using a rotary tumbler (15 
min). The extract was incubated in a water bath set at 50 °C for 15 minutes and 
afterwards DFC was stabilised by adding 5 mL IAA solution followed by shaking 
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using a rotary tumbler (15 min) resulting in DCA. The derivatization was 
completed by incubating the extract for 30 min at room temperature. After the 
derivatization the pH of the extract was adjusted to pH 3 by adding droplets of 
17 % phosphorous acid solution. After centrifugation of the extract (4000 g, 30 
min) the supernatant was isolated and the pH was adjusted to pH 5 by adding 
droplets of a 5M sodium hydroxide solution. A 1g, 6 mL Mega Bond Elut C18 SPE 
cartridge was conditioned using 5 mL of methanol followed by 5 mL 0.1M 
ammonium acetate solution. The entire extract was applied onto the SPE 
cartridge which was subsequently washed with 5 mL 0.1 M ammonium acetate 
solution and 5 mL 2 % acetic acid in water. DCA was eluted from the SPE 
cartridge using 5 mL 2 % acetic acid in water : acetonitrile (8:2, v/v). A 100 mg, 
3 mL SCX SPE cartridge was conditioned with 3 mL of methanol followed by 3 mL 
2 % acetic acid in water. The eluent of the C18 cartridge was applied onto the SCX 
cartridge which was subsequently washed with 2 mL of methanol. After drying 
the cartridge under vacuum for 5 min, DCA was eluted using 1 mL 1M ammonium 
acetate in water : acetonitrile (85:15, v/v). The extract was transferred into an 
autosampler vial. 
Method C: hydrolysis to AMTA 
This method includes an alkaline hydrolysis of ceftiofur metabolites to AMTA and 
was derived from Berendsen et al. [55]. 2.5 grams of poultry tissue was weighed 
into a centrifuge tube and ceftiofur-d3 was added as the internal standard. 10 
mL of borate buffer pH 9 and 250 µL of 25 % ammonia were added to the sample. 
After shaking using a rotary tumbler (5 min) the extract was incubated in a water 
bath of 60 °C for 20 hours. After hydrolysis, 10 mL hexane was added and the 
extract was shaken using a rotary tumbler (5 min) and centrifuged (3500 g, 15 
min). A 60 mg, 3 mL OasisTM HLB SPE cartridge was conditioned by subsequently 
5 mL of methanol and 5 mL of water. 5 mL of the clear aqueous layer of the 
extract was transferred onto the SPE cartridge, which was subsequently washed 
with 3 mL of water. After drying the cartridge under vacuum for 5 min, the 
derivate AMTA was eluted using 5 mL methanol:acetonitrile (1:1, v/v). The 
eluent was evaporated until dryness (45 °C, N2) and the residue was redissolved 
in 500 µL of water, filtered using a 0.45 µm acrodisc® PVDF membrane filter (Pall 
corporation, Port Washington, NY, USA) and transferred into an autosampler vial.  
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LC-MS/MS 
The LC instrumentation consisted of a vacuum degasser, autosampler and a 
binary pump (Acquity Waters, Milford, MA, USA) equipped with a Waters X-Bridge 
C18 (3.5 µm) analytical column of 2.1 × 100 mm placed in a column oven at 50 °C. 
The gradient (solvent A, 0.2 % ammonia in water adjusted to pH 8 using acetic 
acid; solvent B, 0.2 % ammonia in water adjusted to pH 8 using acetic acid : 
methanol (1:9, v/v)) was: 0 – 1.0 min, 0 % B, 1.0 – 5.0 min, linear increase to 50 
% B, 5.0 – 6.0 min, linear increase to 100 % B with a final hold of 0.5 min, 
operating at a flow rate of 0.4 mL min-1. The injection volume was 20 μL.  
Detection was carried out using a Waters Quattro Ultima mass spectrometer 
operating with electrospray ionisation (ESI) in positive mode. The operating 
parameters were: capillary voltage, 2.7 kV; cone voltage, 20 V; source 
temperature, 120 °C; desolvation temperature, 450 °C; cone gas flow, 200 L hr-1; 
and desolvation gas, 550 L hr-1. Ceftiofur, ceftiofur-d3, DFC, DCCD, DCA, DCA-d3, 
AMTA and AMTA-d3 were fragmented using collision induced dissociation (CID) 
with the settings presented in table 5.5. Data were acquired and processed using 
MassLynx 4.1 software (Waters). 
Table 5.5. Precursor ions, product ions and collision energy of ceftiofur, DFC, 
DCCD, DCA, AMTA and the internal standards. 
Compound  Precursor ion (m/z)  Collision energy (eV)  Product ion (m/z)  
Ceftiofur  524  40  125 
    17  241  
DFC  430  45 125 
    17 241 
DCCD 549 25 183 
  20 241 
DCA 487 25 167 
  20 241 
AMTA 201 23 125 
  15 126 
Ceftiofur-d3 527 17 244 
DCA-d3 490 20 244 
AMTA-d3 204 15 126 
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Controlled treatment study 
Following ethical approval, ceftiofur incurred poultry tissue samples were 
obtained from Schothorst feed research (Lelystad, The Netherlands). Fifteen one 
day old broilers were held under controled conditions (water, feed and housing) 
for 22 days. At day 22, the broilers were weighed and 12 broilers were injected 
in the breast with a 4 mg mL-1 solution of Excenel (Pfizer Animal Health, New 
York, NY, USA). The other three animals were considered the untreated control 
group. The volume of the injected solution was adapted to the body weight in 
such a way that each animal received 3 mg ceftiofur per kg. The animals were 
euthanised via cervical dislocation, three animals each at 1, 2, 4 and 8 hours 
after injection. From each animal breast and thigh muscle, liver and kidneys 
were removed and stored at -80 °C. After transportation to the laboratory on dry 
ice, the samples were thawed, minced using a laboratory mincer and stored at -
80 °C immediately afterwards to prevent degradation. 
Derivatization/hydrolysis yield  
For method B and C the efficiency of the conversion of ceftiofur, DFC and DCCD 
to DCA and AMTA respectively were tested. Ceftiofur, DFC and DCCD were each 
added to six aliquots of blank poultry muscle at a concentration of 1000 µg kg-1. 
The poultry muscle samples were analysed according to method B and C and the 
peak areas of DCA and AMTA were determined. Peak areas of ceftiofur and DCCD 
were corrected to 1000 µg kg-1 DFC to facilitate a correct comparison of the 
results by: (Y/MDFC)*M, in which Y is the response of DCA or AMTA of the samples 
spiked with ceftiofur or DCCD, MDFC is the molecular mass of DFC and M is the 
molecular mass of ceftiofur or DCCD. The corrected areas of the samples 
fortified with the different metabolites were compared using a Students’ t-test 
(α = 0.05).  
Quantitative analysis 
First, the limit of detection (LOD) of the methods were determined by 
extrapolation of the chromatogram of the lowest calibration point (10 µg kg-1) of 
the least abundant product ion monitored to a signal to noise ratio of 3. Next, all 
of the incurred poultry breast muscle samples were analysed in duplicate using 
the three described methods. The samples were quantitated using a matrix 
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matched calibration line. For method A, blank samples were spiked with 0 to 500 
µg kg-1 ceftiofur, DFC and DCCD. For method B and C blank samples were spiked 
with 0 to 3000 µg kg-1ceftiofur only. For all methods the total amount of ceftiofur 
metabolites was calculated and expressed in µg kg-1 DFC by: (X/M)*MDFC, in which 
X is the calculated concentration of ceftiofur or DCCD in the samples, M is the 
molecular mass of ceftiofur or DCCD and MDFC is the molecular mass of DFC. For 
each animal the results obtained by applying different methods were compared 
using a Students’ t-test (α = 0.05). 
Applicability to other matrices.  
The applicability of the hydrolysis approach (method C) was additionally tested 
for other matrices than poultry breast muscle by studying the concentration of 
total ceftiofur residues in the thigh muscle, kidney and liver samples obtained 
from the ceftiofur treated broilers. The ceftiofur metabolites in each matrix 
were quantitated using matrix matched standards prepared from the materials 
obtained from the broilers in the control group.  
Results and discussion  
General considerations 
Method A and B were adopted from literature and method C was based upon the 
concept of the alkaline hydrolysis of ceftiofur to AMTA as reported previously 
[55] (section 5.2). To study the applicablity of this method C concept, a 
straightforward extraction and sample clean-up procedure was developed. It was 
found to be crucial to carry out the hydrolysis during extraction (in the presence 
of the muscle matrix) to obtain good hydrolysis yields for ceftiofur, DFC and 
DCCD. If ammonia in pure water (without addition of salts) is used as the 
extraction solvent, muscle proteins denaturate during incubation, resulting in 
extreme gelation of the extract. To prevent gelation, sodium borate buffer pH=9 
and sodium chloride had to be used as the extraction solvent to facilitate 
alkaline hydrolysis in the presence of the muscle matrix. 
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Critical assessment of approaches 
Linearity and detection limits 
For method A, B and C a chromatogram of a blank poultry muscle sample, spiked 
at 10 µg kg-1 with the relevant compounds and internal standard ceftiofur-d3, is 
presented in figure 5.18. 
In the range from 0 to 3000 µg kg-1 good linearity (r > 0.998) was observed for all 
three methods indicating that they are suited for the quantitation of ceftiofur 
and (the selected) metabolites in poultry muscle. Method A resulted in an LOD of 
1 µg kg-1 for ceftiofur, 2 µg kg-1 for DFC and 3 µg kg-1 for DCCD. Method B resulted 
in an LOD of 1 µg kg-1 for the total ceftiofur content which is superior to 
previously reported LODs for this approach (10 µg kg-1 for swine muscle [35], 100 
µg kg-1 for endometrial tissue [45] and uterine tissue [64]). Method C resulted in 
an LOD of 0.5 µg kg-1 for the total ceftiofur content indicating that this method is 
very adequate for detecting residues of ceftiofur metabolites. 
Derivatization/hydrolysis yield 
For a method that includes the production of one marker compound from several 
individual compounds, the conversion is important: each metabolite should be 
converted to the marker compound with the same yield to obtain a correct total 
concentration. The average response and the standard deviation of six poultry 
muscle samples spiked at 1000 µg kg-1 with ceftiofur, DFC and DCCD individually, 
analysed using both method B and C, were calculated. The results are presented 
in figure 5.19a and b. 
From the results it is observed that, when using method B, the derivatization of 
ceftiofur and DCCD to DCA occurs with the same yield. However, the 
derivatization of DFC only results in 20 % DCA compared to ceftiofur and DCCD. 
DFC is the most reactive metabolite having a free sulfide group and quickly 
degrades under the formation of e.g. protein bound DFC [65] and DFC thiolactone 
[55] and might therefore not be effectively derivatised to DCA. From this, it is 
concluded that when using DFC for preparation of matrix matched calibrants, an 
incorrect quantitation of the total amount of ceftiofur metabolites is obtained. 
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Figure 5.19. Average peak area including standard deviation (n=6) of poultry 
muscle samples spiked at 1000 µg kg-1 with ceftiofur, DFC and DCCD individually, 
analysed using (a) method B and (b) method C. 
From figure 5.19b it is observed that the hydrolysis of ceftiofur, DFC and DCCD 
results in the same amount of AMTA: no significant differences among the groups 
is observed. It is concluded that the yield of the hydrolysis of various ceftiofur 
metabolites to AMTA is comparable and an accurate quantitation of the total 
amount of ceftiofur metabolites is realistic using the method C approach. 
Quantitative analysis of incurred poultry samples 
The individual levels of ceftiofur, DFC and DCCD found in the incurred poultry 
breast muscle samples using method A are presented in table 5.6. It is observed 
that a significant concentration of ceftiofur is present 1 hour after 
administration, whereas it is not detectable 5 hours after treatment. DFC is the 
main metabolite observed, but also this metabolite is metabolised/excreted 
rapidly and from extrapolation it is estimated that it will no longer be detectable 
24 hours after administration of a single dose of ceftiofur. DCCD, which is 
suggested to be a suitable biomarker for detecting ceftiofur [43] is present at 
concentrations lower than DFC and is excreted rapidly as well: it is no longer 
detectable approximately 24 hours after administration.  
The determined levels of total ceftiofur metabolites, expressed as DFC, using 
method A, B and C are presented in figure 5.20. Method A clearly results in the 
lowest concentration of ceftiofur metabolites for all broilers. It is previously 
reported that a significant amount of protein-bound metabolites are formed after 
a b 
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ceftiofur administration [36,65,66]. This is in agreement with the observation 
that when using method A, which only detects selected metabolites, a lower 
total ceftiofur concentration is found compared to methods B and C, which do 
include protein-bound metabolites. It is concluded that method A results in an 
underestimation of the total amount of ceftiofur metabolites. From this and the 
observation that ceftiofur cannot be detected approximately 24 hours after 
administration of a single dose it was concluded that the analysis of individual 
metabolites of ceftiofur is not a suitable approach for detecting the off-label use 
of ceftiofur in the poultry-breeding. 
For 10 out of the 12 samples, method C results in an average higher total 
ceftiofur concentration compared to method B, however, except for animal 
number 4 and 8 no statistically significant difference was found between method 
B and C using a Students’ t-test. Note that method C also includes the minor 
metabolite desfuroylceftiofur thiolacton [55]. It is concluded that method C is 
comparable to or better than method B regarding its quantitative aspect and that 
the method C approach is adequate for the quantitative analysis of ceftiofur 
metabolites in poultry muscle. 
Table 5.6. Concentration of ceftiofur, DFC and DCCD, expressed as DFC, 
detected in poultry breast muscle samples from a single dose controlled 
treatment using method A. Data between brackets: standard deviation (n=2). 
Broiler no. Time after administration 
(h) 
Ceftiofur  
(µg kg-1) 
DFC 
(µg kg-1) 
DCCD 
(µg kg-1) 
1 1 167 (2) 386 (31) 246 (22) 
2 1 267 (42) 561 (147) 187 (10) 
3 1 157 (41) 349 (58) 115 (36) 
4 2 2 (1) 78 (68) 79 (47) 
5 2 13 (2) 121 (61) 69 (32) 
6 2 4 (1) 53 (13) 70 (2) 
7 4 ND 26 (5) 14 (0) 
8 4 ND 41 (3) 12 (3) 
9 4 ND 24 (17) 34 (7) 
10 8 ND 17 (2) 11 (1) 
11 8 ND 15 (6) 6 (2) 
12 8 ND 11 (6) 15 (4) 
ND = Not detected 
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Figure 5.20. The determined levels of total ceftiofur metabolites (expressed as 
DFC) in poultry breast muscle samples from a single dose controlled treatment 
using method (□) A, (■) B and (■) C (n=2).  
Applicability to cephalosporin antibiotics other than ceftiofur 
The approach applied in method B depends on the cleavage of a thioester bond 
using DTE. None of the other registered cephalosporins (for use in cattle and 
swine breeding) contains the thioester bond and therefore it is expected that 
method B is only applicable to a very small range of cephalosprins. This was 
confirmed by Beconi-Barker et al. [35] who demonstrated that cefquinome, 
cefacetrile and cefoperazone (figure 5.21) were not detectable using method B, 
when applying UV detection, whereas a signal possibly corresponding to cefapirin 
(figure 5.21b) was detected. In this work this derivatization procedure was tested 
for cefcapene, a cephalosporin antibiotic being an ester instead of a thioester 
(figure 5.21a). After applying the derivatization procedure used in method B, 
neither cefcapene acetamide nor any other representative marker for cefcapene 
was found by direct infusion analysis. It is concluded that method B is not a 
suitable approach for detecting a broad range of cephalosporins as was also 
stated by Fagerquist et al. [67]. 
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Figure 5.21. Molecular structure of (a) cefcapene, (b) cefapirin, (c) cefquinome, 
(d) cefacetrile and (e) cefoperazone. The AMTA analogue is indicated by the 
dotted square. 
In theory, the approach used in method C is more generic and should be 
applicable to a broad range of cephalosporin antibiotics. Previously it was 
reported that an AMTA analogue was detected after hydrolysis of cefapirin [55] 
(section 5.2). The broad applicability was further demonstrated by derivatization 
of cefcapene in the presence of poultry muscle, resulting in the marker 
compound analogous to AMTA. A chromatogram of a blank poultry muscle sample 
spiked with 1 mg kg-1 of ceftiofur and cefcapene is presented in figure 5.22. From 
this it is concluded that, in contrast to method B, the method C hydrolysis 
approach is applicable as a multi-cephalosporin method that includes active 
metabolites, provided that not only AMTA but also the AMTA analogues are 
recovered during the sample clean-up and detected by selected reaction 
monitoring (SRM). 
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Figure 5.22. A blank poultry muscle sample spiked at 1 mg kg-1 with ceftiofur 
and cefcapene analysed using method C. Cefcapene* indicates the hydrolysis 
product of cefcapene. 
The broad applicability of the new approach might also be considered as a 
weakness. Only a minor moiety of ceftiofur is used as the marker compound and 
therefore the selectivity of AMTA as a bio-marker for ceftiofur metabolites might 
be quenstioned. The Pubchem database [68] was searched for molecules 
containing the AMTA substructure resulting in many hits, amongst which 18 
antibacterial substances, all being cephalosporines (eg. cefquinome, figure 
5.21c). This demonstrates that the new approach is not specific for ceftiofur. 
However, if the AMTA analogues are analysed as well, the new approach is very 
useful as a broad quantitative screening of cephalosporin compounds in tissue 
samples to effectively indicate off-label use of cephalosporins in poultry 
breeding. Subsequently, for the determination of the identity of the actual 
cephalosporin administered, another method is needed monitoring intact 
cephalosporins or metabolites thereof. 
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Application to other matrices 
The applicability of the method C hydrolysis approach was tested for other 
matrices than poultry breast muscle. This was done by studying the 
concentration of total ceftiofur residues in the thigh muscle, kidney and liver 
samples obtained from the ceftiofur treated broilers. For each of the matrices a 
calibration line with a coefficient of correlation above 0.991 was obtained, 
indicating that the quantitative aspect of the method is adequate for the analysis 
of different kinds of tissue matrix. The total amount of ceftiofur metabolites, 
expressed as DFC, in thigh muscle, kidney and liver, determined using method C, 
is presented in table 5.7.  
Table 5.7. Concentration of total ceftiofur, expressed as DFC, detected in 
poultry thigh muscle, kidney and liver samples from a single dose controlled 
treatment using method C. Data between brackets: standard deviation (n=2), 
not duplicate value available for kidney because of the lack of sample material. 
Broiler 
number 
Time after 
administration (h) 
Thigh muscle  
(µg kg-1) 
Kidney 
(µg kg-1) 
Liver 
(µg kg-1) 
1 1 488 (20) 3042 1906 (97) 
2 1 595 (9) 2722 1755 (286) 
3 1 458 (27) 2894 1855 (24) 
4 2 442 (77) 1802 821 (1) 
5 2 545 (10) 2240 796 (44) 
6 2 476 (8) 2111 797 (28) 
7 4 475 (22) 1277 524 (109) 
8 4 300 (20) 854 285 (39) 
9 4 392 (5) 1123 356 (91) 
10 8 145 (8) 705 221 (8) 
11 8 196 (29) 942 317 (77) 
12 8 222 (5) 939 358 (3) 
 
The results indicate that ceftiofur metabolites are rapidly distributed throughout 
the body. Levels of ceftiofur metabolites in the breast muscle are equal to the 
concentrations in liver following intramuscular breast injection. Levels in the 
thigh muscle were lower, whereas the highest concentrations were detected in 
the kidneys. This is in agreement with previous findings after intramuscular 
treatment of swine [36,66] and subcutaneous injection of ducks [69]. It is 
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concluded that, from an analytical point of view, poultry kidney is potentially 
better suited for detecting off-label use of ceftiofur. However, only a very 
limited amount of kidney (approximately 5 g per broiler) is available 
complicating its use for monitoring purposes. From the results it is concluded 
that the hydrolysis approach is applicable to different kinds of poultry tissues 
illustrating its versatility and ruggedness. 
Conclusions 
Three LC-MS/MS approaches for the analysis of ceftiofur and its active 
metabolites in poultry muscle were critically compared. The first approach 
focused on the analysis of ceftiofur, DFC and DCCD. The detection limits of this 
method are 1 µg kg-1 for ceftiofur, 2 µg kg-1 for DFC and 3 µg kg-1 for DCCD. 
Although this approach is the simplest one to apply, it results in a serious 
underestimation of the total ceftiofur residue concentration and off-label use of 
ceftiofur is only detectable for approximately 24 hours after a single dose 
treatment. Therefore, it is concluded that the analysis of ceftiofur, DFC and/or 
DCCD is inadequate for detecting off-label use of ceftiofur in the poultry-
breeding sector. The second approach included a derivatization to produce DCA, 
as a marker for ceftiofur and its metabolites. The LOD of this method was 1 µg 
kg-1 and this approach resulted in significantly higher total ceftiofur 
concentrations compared to the first approach. However, this second method 
should be considered a single compound method. The third approach included a 
hydrolysis using ammonia to produce AMTA as a marker for ceftiofur including its 
metabolites. The detection limit was 0.5 µg kg-1, and this approach included 
protein-bound ceftiofur and the minor metabolite desfuroylceftiofur thiolacton, 
resulting in comparable or slightly higher total ceftiofur concentrations compared 
to the second approach. Only the third approach is applicable to a broad range of 
cephalosporin antibiotics. It is fair to state that the third approach is not entirely 
specific for ceftiofur because some chemicals, other than ceftiofur, might yield 
the same AMTA marker. Nevertheless, the method can be very useful as a broad 
quantitative screening of any cephalosporin compound in poultry tissue samples 
to indicate off-label use of cephalosporins in poultry breeding. It is expected that 
such a multi-method that includes the active metabolites of all unstable 
cephalosporins will help to detect off-label use of cephalosporin antibiotics. 
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5.4. Comprehensive analysis of ß-lactam 
antibiotics including penicillins, cephalosporins 
and carbapenems in poultry muscle using liquid 
chromatography coupled to tandem mass 
spectrometry 
Abstract 
A comprehensive method for the quantitative residue analysis of trace levels of 
22 ß-lactam antibiotics, including penicillins, cephalosporins and carbapenems in 
poultry muscle by liquid chromatography in combination with tandem mass 
spectrometric (LC-MS/MS) detection is reported. The samples analysed for ß-
lactam residues are hydrolysed using piperidine, in order to improve compound 
stability and to include the total residue content of the cephalosporin ceftifour. 
The reaction procedure was optimised using a full experimental design. Following 
detailed isotope labeling tandem mass spectrometry studies and exact mass 
measurements using high resolution mass spectrometry reaction schemes could 
be proposed for all ß-lactams studied. The main reaction occurring is the 
hydrolysis of the ß-lactam ring under formation of the piperidine substituted 
amide. For some ß-lactams multiple isobaric hydrolysis reaction products are 
obtained, in accordance with expectations, but this did not hamper quantitative 
analysis. The final method was fully validated as a quantitative confirmatory 
residue analysis method according to Commission Decision 2002/657/EC and 
showed satisfactory quantitative performance for all compounds with trueness 
between 80 and 110 % and within-laboratory reproducibility below 22 % at target 
level, except for biapenem. For biapenem the method proved to be suitable for 
qualitative analysis only.   
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Introduction  
ß-lactams are highly effective antibiotics in the treatment of bacterial infections 
[1]. The ß-lactam antibiotics consist of several groups of which the 8 penicillins, 
8 cephalosporins and 6 carbapenems were selected because of their important 
(biological) activity. 
The first penicillin was isolated from bacteria in 1928 [2]. Later, many chemically 
altered semi-synthetic penicillins were developed. The penicillins derive their 
activity from the 6-aminopenicillinic acid nucleus which is effective against 
mainly Gram positive bacteria [3,4]. Amoxicillin, ampicillin, penicillin G 
(benzylpenicillin), penicillin V (phenoxymethylpenicillin), cloxacillin, 
dicloxacillin, oxacillin and nafcillin (chemical structures included in online 
resource 1) are registered for the treatment of food-producing animals: in fact 
penicillins are the most frequently used antibiotics in poultry production [33]. 
Maximum residue limits (MRLs) are established for the major species, including 
poultry (table 5.8) [6].  
Cephalosporins were first isolated from bacteria in 1956 [8]. The six membered 
dihydrothiazine ring fused with a four membered ß-lactam ring is responsible for 
the biological activity of this group of compounds. As for the penicillins, many 
semi-synthetic cephalosporins were developed. Several generations of 
cephalosporins are distinguished based upon their time of discovery and their 
range of activity [11]. Cefacetril, cefalonium, cefazolin, cefalexin and cefapirin 
(all 1st generation), cefoperazone and ceftiofur (3rd generation), and cefquinome 
(4th generation) are all approved for treatment of mastitis infections in dairy 
cattle (chemical structures included in online resource 2). Cefazolin is approved 
for the treatment of other ruminants (sheep and goat) as well. Furthermore, 
cefalexin and cefapirin are approved for the treatment of respiratory disease and 
foot rot in cattle, cefquinome is approved for the treatment of cattle, swine and 
horses, and ceftiofur for all food producing mammals [6,11]. For cefapirin the 
MRL is defined as the sum of cefapirin and deacetylcefapirin and for ceftiofur as 
the sum of all active ceftiofur metabolites (table 5.8) [6].  
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The first carbapenem was isolated from bacteria in 1971 [12]. The carbapenems 
are structurally very similar to the penicillins: the sulfur atom has been replaced 
by a carbon atom and an unsaturation has been introduced [13]. As a result the 
carbapenems possess the broadest antimicrobial activity amongst the ß-lactams 
[13]. The most common carbapenems are imipenem, meropenem, ertapenem, 
doripenem and biapenem (chemical structures included in online resource 3). 
The carbapenems are not registered for use in food-producing animals and are 
used off-label in companion animals [4]. Another ß-lactam substance, related to 
the carbapenems is faropenem (chemical structures included in online resource 
3). As the carbapenems, faropenem, a related compound, is active against ESBL 
producing bacteria [14].  
During the last decades, antimicrobial resistant bacteria like methicillin-resistant 
Staphylococcus aureus (MRSA) and extended-spectrum- ß-lactamase (ESBL) 
producing bacteria are emerging [15,19] which has become an important public 
health threat [15-19]. Most penicillins are found to be ineffective against ESBL 
producing bacteria [20-22]. Cephalosporins are more effective and, therefore, in 
2007 they were assigned as critically important antimicrobials for human health 
[23]. Even though these compounds should only be used sparingly, resistance 
towards cephalosporins is emerging [16-18,22,24-29]. In contrast to penicillins 
and cephalosporins, carbapenems have proven to be highly effective in severe 
infections due to ESBL producing bacteria. As a result, due to the rising 
resistance to cephalosporins, carbapenem use has increased in the treatment of 
humans [30]. It is alarming that also carbapenem resistance is emerging 
[13,16,29,30]. 
Not only the antibiotic usage in humans contributes to rising bacterial resistance, 
also the regular use of antibiotics in veterinary practice contributes to the 
occurrence of resistant bacteria [15-19,24] that can be transferred from animals 
to humans [32]. Furthermore, due to off-label use of antibiotics in veterinary 
practice, residues of these antibiotics can end up in the human food chain which 
contributes to increasing bacterial resistance as well [33]. Penicillins are the 
most frequently sold antibiotic group for treatment of broilers [34]. 
Cephalosporins and carbapenems are not registered for use in poultry production 
within Europe, but due to their high effectiveness, their use in broilers cannot be 
ruled out. To prevent off-label use of ß-lactams in animal breeding and thus to 
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limit the dissemination of bacterial resistance, an effective monitoring strategy 
is needed for ß-lactam usage analysis in food-producing animals. Therefore, the 
monitoring of poultry muscle for penicillins, cephalosporins as well as 
carbapenems at levels as low as reasonably possible is of importance. 
Table 5.8. MRLs and target values for the validation of the ß-lactams included in 
the develop dmethod.  
Component MRL (µg/kg) [6] Study’s target level (µg kg-1)1 
 Poultry 
muscle 
Beef Milk Poultry muscle 
Amoxicilline 50   50 
Ampicilline 50   50 
Penicilline G 50   50 
Penicilline V 25   25 
Cloxacilline 300   300 
Dicloxacilline 300   300 
Nafcilline 300   300 
Oxacilline 300   300 
Ceftiofur n.a. 1000 100 10 
Cefquinome n.a. 50 20 10 
Cefapirine n.a. 50 60 10 
Cefalexin n.a. 200 100 10 
Cefalonium n.a.  20 50 
Cefazolin n.a.  50 25 
Cefacetrile n.a.  125 50 
Cefoperazone n.a.  50 50 
Biapenem n.a.   100 
Doripenem n.a.   50 
Ertapenem n.a.   50 
Imipenem n.a.   100 
Meropenem n.a.   25 
Faropenem n.a.   25 
1 Target value is the MRL or in case no MRL has been established, as low as 
reasonably possible. 
n.a.: not available, substance not registered for use in poultry. 
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Many multi-analyte methods for the analysis of ß-lactams in muscle using liquid 
chromatography coupled to tandem mass spectrometry (LC-MS/MS) have been 
reported [70]. Most of them include penicillins only [71-75] or a combination of 
penicillins and some cephalosporins [43,47,59,67,74]. The multi-analyte methods 
that include ceftiofur, an important member of the cephalosporin group, target 
for ceftiofur itself or include desfuroylceftiofur (DFC) and/or DFC cysteine 
disulfide (DCCD) [43,59,67] but do not detect protein bound metabolites, which 
is the largest fraction of the ceftiofur related metabolites after intra-muscular 
administration. As a result, these methods result in an underestimation of the 
total amount of active ceftiofur metabolites [76] (section 5.3). To the best of our 
knowledge, no methods for the analysis of carbapenems in food products have 
been reported at all. In other words, methods that comprehensively cover the 
broad range of ß-lactam antibiotics and that do offer an effective monitoring 
strategy for ceftiofur are lacking.  
In this section a comprehensive ß-lactam LC-MS/MS method is presented that is 
suitable for the simultaneous analysis of eight penicillins, eight cephalosporins, 
five carbapenems and faropenem in poultry muscle that does include the active 
metabolites of ceftiofur. 
Experimental 
Reagents and equipment 
ULC/MS grade water and acetonitrile (ACN), and HPLC grade methanol (MeOH) 
were obtained from Biosolve (Valkenswaard, The Netherlands). Acetic acid, 
formic acid, 25 % ammonia, 32 % ammonia (GPR Rectapur), sodium chloride and 
n-hexane were obtained from VWR International (Darmstadt, Germany). 
Piperidine (99 %)and disodium tetraborate were obtained from Sigma-Aldrich (St. 
Louis, MO, USA). Piperidine-d11 was obtained from CDN Isotopes (Pointe-Claire, 
Quebec, Canada). Milli-Q water was prepared using a Milli-Q system at a 
resistivity of at least 18.2 MΩ cm-1 (Millipore, Billerica, MA, USA). The reference 
standard of amoxicillin, ampicillin, penicillin G Na, penicillin V K, cloxacillin Na 
H2O, dicloxacillin Na H2O, nafcillin Na H2O, oxacillin Na H2O, ceftiofur HCl, 
cefapirin HCl, cefalonium H2O and cefoperazone Na were obtained from Sigma-
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Aldrich. Cefalexin H2O, cefazolin Na, cefacetrile, ampicillin-d5, dicloxacillin-
13C4 
Na H2O, cefalexin-d5 H2O, cephapirin-d4, ceftiofur d3 HCl and meropenem-d6 
were obtained from Toronto Research Chemicals (Toronto, ON, Canada). 
Cefquinome sulphate was obtained from AK scientific (Union City, CA, USA). 
Biapenem, ertapenem Na, imipenem H2O, faropenem and meropenem were 
obtained from Ontario Chemicals (Guelph, ON, Canada). Doripenem, penicillin-V-
d5, amoxicillin-d4 and cefazolin-
13C2-
15N were obtained from Cachesyn 
(Mississauga, ON, Canada). Penicillin-G-d7 ethylpipiridinium was obtained from 
Witega (Beril, Germany). Imipenem-d4 and ertapenem-d4 were obtained from 
Alsachim (Illkirch Graffenstaden, France).  
Stock solutions of the penicillins, ceftiofur, cefapirin, cefalonium, cefacetrile 
and the corresponding isotopically labeled analogues were prepared in MeOH at 
100 mg L-1. Stock solutions of cefquinome, cefalexin, cefazolin, cefoperazone, 
the carbapenems, faropenem and the corresponding isotopically labeled 
analogues were prepared in water at 100 mg L-1. All dilutions were prepared fresh 
daily in Milli-Q water. 
Borate solution was prepared by dissolving 10 g disodium tetraborate (0.05 M) 
and 29.2 g sodium chloride (0.5 M) in 1 L of water, stirred using a magnetic bar 
for 30 min (this is a saturated solution). 
Sample preparation 
The poultry muscle samples were homogenised using a laboratory blender, 2.5 g 
was weighted into a 50 mL poly propylene (PP) centrifuge tube and 200 µL 
internal standard solution was added to obtain a concentration of the internal 
standard of 2 * target level (table 5.8). 10 mL of borate solution and 500 µL 
piperidine were added to the sample. The sample was vigorously shaken by hand 
for 5 sec and next incubated in a water bath (1 h, 60 °C). After incubation the 
samples were cooled at room temperature for 10 min and next 10 mL of n-
hexane was added to the reaction mixture. After shaking using a rotary tumbler 
(5 min) and centrifugation (3500 g, 15 min) the aqueous layer was transferred 
into a clean test tube and neutralised (pH 7.2) by adding acetic acid (25 %) 
and/or ammonia (2.5 %) and the sample was centrifuged again (3500 g, 15 min). 
A Phenomenex (Torrance, CA, USA) Strata-X 200 mg / 6 mL reversed phase solid 
phase extraction (SPE) cartridge was conditioned with 5 mL MeOH and 5 mL 
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water. The clear neutralised extract was applied onto the SPE cartridge which 
was subsequently washed with 5 mL of MeOH/water (1:9 v/v) and dried by 
applying vacuum for 5 min. The ß-lactam hydrolysis products were eluted from 
the cartridge using 5 mL MeOH/ACN (50:50, v/v) followed by evaporation of the 
solvent (45 °C, N2). The residue was redissolved in 500 µL 1 % piperidine in water 
and transferred into an LC-MS/MS sample vial. 
Liquid chromatography – tandem mass spectrometry 
The LC system consisted of a Waters (Milford, MA, USA) model Acquity with a 
Waters Acquity UPLC CSH C18 analytical column of 2.1 × 100 mm, 1.7 μm, placed 
in a column oven at 50 °C. The gradient (solvent A, 0.0032 % ammonia in water; 
solvent B, 0.0032 % ammonia in water/acetonitrile (1:9 v/v)) was: 0 – 1.0 min, 0 
% B, 1.0 – 9.0 min, linear increase to 40 % B, 9.0 – 10.0 min, linear increase to 
100 % B with a final hold of 0.5 min, operating at a flow rate of 0.4 mL min-1. The 
injection volume was 10 μL. Detection was carried out by LC-MS/MS using a 
Waters Xevo TQS or a AB Sciex (Ramingham, MA, USA) Q-Trap 6500 mass 
spectrometer in the positive electrospray ionisation (ESI) mode. All compounds 
were analysed on both instruments. The operating parameters of the Xevo TQS 
were: capillary voltage, 2.0 kV; cone voltage, 25 V; source offset, 20 V; source 
temperature, 150 °C; desolvation temperature, 550 °C; cone gas flow, 150 L h−1; 
and desolvation gas, 600 L h−1. The selected ß-lactam hydrolysis products were 
fragmented using collision induced dissociation (argon) and the Selected Reaction 
Monitoring (SRM) transitions are presented in table 5.9. Data were processed 
using QuanLynx software V4.1 (Waters). The operating parameters of the QTrap 
6500 were: capillary voltage, 2.0 kV; cone voltage, 25 V; source offset, 20 V; 
source temperature, 150 °C; desolvation temperature, 550 °C; cone gas flow, 
150 L h−1; and desolvation gas, 600 L h−1. The selected ß-lactam hydrolysis 
products were fragmented using collision induced dissociation (nitrogen) and the 
Selected Reaction Monitoring (SRM) transitions are presented in table 5.9. Data 
were processed using Multiquant software V2.1.1 (AB Sciex). 
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Table 5.9. SRM transitions of the selected ß-lactam hydrolysis products using the 
Xevo TQS and the QTrap 6500.  
 
Product of 
 
Precursor 
ion (m/z) 
 
Product 
ion (m/z) 
Xevo TQS QTrap 6500 
Cove (V) Collision 
energy (eV) 
DP Collision 
energy (eV) 
Penicilline G 420.2 261.2b 25 15 40 15 
  176.0 25 20 40 20 
  160.0a 25 20 40 20 
Penicilline G-d7 427.2 160.0 25 20 40 20 
Ampicilline 435.2 286.0a b 15 20 40 20 
  276.2 15 20 40 20 
Ampicilline-d5 440.2 291.0 25 20 40 20 
Penicilline V 436.0 277.0a b 25 115 40 20 
  192.0 25 20 40 20 
  160.0 25 20 40 20 
Penicilline-V-d5 441.0 160.0 25 20 40 20 
Amoxicilline 451.2 275.2a 25 15 40 15 
  302.2b 25 15 40 15 
Amoxicilline-d4 455.2 279.2 25 15 40 15 
Oxacilline 487.0 160.0a 25 20 40 17 
  328.2b 25 15 40 15 
  243.1 25 20 40 20 
Nafcilline 500.0 256.2a b 16 15 40 15 
  199.1 16 22 40 22 
Cloxacilline 521.2 160.0a 25 20 40 20 
  362.2b 25 15 40 15 
Dicloxacilline 555.0 160.0a 25 20 40 20 
  396.0b 25 15 40 15 
Dicloxacilline-13C4 559.0 160.0 25 20 40 20 
Cefalexine 276.2 143.1 58 12 40 22 
  259.1a b 58 10 40 22 
  231.2 58 16 40 22 
Cefalexine-d5 281.2 264.1 58 10 40 22 
Cefapirine 294.1 152.0a b 25 22 40 24 
  181.0 25 20 40 22 
  143.1 25 22 40 22 
Cefapirine-d4 298.1 156.0 25 22 40 24 
 
 
 
 256 
Ceftiofur / 
cefquinome 
326.1 169.0a b 25 20 40 19 
 241.0 25 15 40 17 
  213.0 25 20 40 22 
Cefquinome by-
product 
134.0 106.0 25 25 40 37 
 78.0a 25 35 40 49 
Ceftiofur-d3 329.1 169.0 25 20 40 17 
Cefacetrile 468.2 339.2a 20 15 20 19 
  424.2b 20 15 20 17 
Cefazolin 493.2 294.1a 25 20 40 22 
  336.2b 25 20 40 22 
Cefazolin-13C2-
15N 496.2 296.1 25 20 40 22 
Cefalonium 507.2 378.2 20 16 45 24 
  463.4a b 20 10 45 19 
Ceforperazone 718.3 386.3a 50 25 40 27 
  630.4b 50 20 40 22 
Imipenem 358.1 314.1a b 25 10 35 17 
  172.1 25 20 35 24 
  154.2 25 25 35 37 
Imipenem-d4 362.1 318.1 25 10 35 17 
Faropenem 371.1 154.2a b 25 15 55 21 
  172.1 25 15 55 17 
  257.1 25 15 55 23 
Biapenem 399.2 154.1a b 25 25 50 35 
  172.1 25 20 50 31 
Meropenem 469.2 207.1a 25 18 20 27 
  425.2b 25 10 20 13 
Meropenem-d6 475.2 207.1 25 18 20 27 
Doripenem 506.0 207.1 25 20 30 29 
  462.2a b 25 10 30 19 
Ertapenem 560.9 517.1b 25 20 40 23 
  207.2a 25 25 40 31 
Ertapenem-d4 564.9 207.2 25 25 40 31 
a Most abundant product ion in Xevo TQS 
b Most abundant product ion in QTrap 6500 
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LC-Orbitrap-MS 
The LC system consisted of a Thermo Fisher Scientific (San Jose, CA, USA) Accela 
HPLC system. The LC conditions and column were the same as for the triple 
quadrupole MS analysis. Detection was carried out using a Thermo Fisher 
Scientific Exactive single-stage Orbitrap MS operating with a heated electrospray 
ionisation (HESI) II source in positive mode. The operating parameters were: 
electrospray voltage, 2.8 kV; sheath gas, 19 arbitrary units; auxiliary gas, 7 
arbitrary units; source heater, 300 °C; heated capillary, 360 °C. Data were 
acquired in full scan from m/z 55 – 1000 (scan time 0.5 sec) at a resolving power 
of at least 50,000. Internal mass calibration within each scan was done using an 
ion that is always present in the background (m/z 218.1387, not identified). Data 
were processed using Xcalibur software V2.2 (Thermo Fisher Scientific).  
Identification of reaction products upon piperidine treatment 
All ß-lactams were hydrolysed by adding 250 µL piperidine to 5 mL of an aqueous 
standard solution of the individual ß-lactams (10 µg mL-1). After incubation in a 
water bath (60 °C, 1 h) the solution was transferred onto a conditioned Strata-X 
RP 200 mg / 6 CC SPE cartridge (Phenomenex). The cartridge was washed with 3 
mL water to remove excessive piperidine and dried by applying vacuum for 5 
min. The ß-lactam reaction products were eluted with 5 mL MeOH/ACN (1:1 v/v) 
followed by evaporation of the solvent (45 °C, N2). The residue was redissolved 
in 2 mL water. The same procedure was followed using piperidine-d11 and, if 
available, isotopically labeled analogues of the ß-lactams. These solutions were 
infused into the triple quadrupole MS at a rate of 20 µL min-1 and full scan 
spectra were obtained in the range of m/z 50 – 1000. All selected reaction 
products were subjected to collision induced dissociation (CID) to obtain 
information on their identity. The exact mass of the marker compounds was 
determined by injecting the solutions into the LC-Orbitrap-MS system.  
Optimization of the reaction conditions in poultry muscle 
The hydrolysis was optimised using a full experimental design consisting of three 
factors: temperature at 40, 60 and 80 °C; piperidine concentration at 2.5, 5 and 
10 %; and time at 10, 20, 30 and 60 min. The experiment consisted of 36 poultry 
muscle samples, spiked at 500 µg kg-1 with all ß-lactams. Data were evaluated 
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using single factor analysis of variance (ANOVA) in Genstat (VSN International, 
Hemel Hempstead, UK). 
Method Validation 
A full validation was carried out according to Commission Decision 2002/657/EC 
[77]. The following parameters were determined: linearity, trueness, 
repeatability, within-laboratory reproducibility, decision limit (CCα), detection 
capability (CCβ), selectivity, ruggedness and stability. For each compound a 
target level was set: for the penicillins this was the MRL [6] and for the other 
compounds this was as low as reasonably possible using the presented method 
(table 5.8). The validation was carried out at three different levels (0.5, 1.0 and 
1.5 * target level), on three different occasions, by two different technicians, 
including two different mass spectrometers and including poultry muscle samples 
from different origin (n=21). For the penicillins, an additional validation was 
carried out at a target level of 10 µg kg-1 on a single day, including seven 
different poultry muscle samples to determine the performance of the method 
for the quantitation of penicillins at levels well below the MRL. Because ceftiofur 
and cefquinome result in the same hydrolysis product, they interfere in each 
other’s quantitation. To be able to determine method characteristics for both 
compounds, separate samples for ceftiofur and cefquinome were prepared. 
Quantitative results were obtained using isotopically labelled internal standards. 
If available correction were carried out using the corresponding labelled internal 
standard. Nafcillin, cloxacillin and oxacillin were all corrected using dicloxacillin-
13C4, cefquinome using ceftiofur-d3, cefacetrile, cefazolin, cefalonium and 
cefoperazone were all corrected using cefazolin-13C2
15N, faropenem using 
penicillin G-d7, biapenem using ertapenem-d4 and doripenem using amoxicillin-d4. 
Linearity 
On four different days a matrix matched calibration line was prepared including 
0, 0.5, 1, 2, 3 and 5 * target level by adding solutions of the ß-lactams to blank 
poultry muscle sample aliquots. Calibration lines were constructed by plotting 
the peak areas, corrected by the corresponding internal standard, versus the 
added level and carrying out least squares linear regression. The linearity was 
considered acceptable if the coefficient of correlation was at least 0.990. 
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Trueness, repeatability and within-lab reproducibility 
On each of the days seven different blank poultry muscle samples were selected 
and analysed as such and spiked at 0.5, 1.0 and 1.5 * target level. For each 
sample the ß-lactams concentration was calculated using the calibration line 
constructed on the same day. The trueness was calculated by dividing the 
average calculated level by the nominal concentration. According to 
2002/657/EC [77] the trueness should be between 70 and 110 % for validation 
levels between 1.0 and 10.0 µg kg-1 and between 80 and 110 % for validation 
levels exceeding 10.0 µg kg-1. 
The repeatability and within-lab reproducibility were calculated using ANOVA. 
According to 2002/657/EC [77] the relative within-lab reproducibility (RSDRL) and 
relative repeatability (RSDr) are considered acceptable if below the value 
calculated from the Horwitz equation [78] respectively two thirds of this value, 
i.e. below 31.7 % and 21.1 % respectively at a validation level of 10 µg kg-1. 
Thompson [79] however, demonstrated that the Horwitz equation is not 
applicable to the lower concentration range (< 120 µg kg-1) and suggested a 
complementary model. Based on this model the RSDRL and RSDr are acceptable if 
below 22 % and 14.7 % respectively. The latter, more stringent criteria were 
adopted for this validation study for all validation levels < 120 µg kg-1. Note that 
because different muscle samples were used within one day, the repeatability is 
not the pure repeatability as stated in 2002/657/EC [77]. However, using 
different muscle samples a better understanding of the between sample variation 
is obtained and the validation better reflects a routine analysis situation.  
Decision limit and detection capability 
For the penicillins CCα and CCβ were calculated according to the procedure 
described in 2002/657/EC [77] for MRL substances. Because CCα and CCß are 
calculated from the within-laboratory reproducibility, no specific criteria are set 
for these parameters. In addition, for all compounds, CCα and CCβ were 
calculated based upon the zero tolerance approach using the linearity approach 
as stated in ISO 11843 [80], to reflect the lowest levels that can still be 
determined. This approach tends to give correct results only if the spiking levels 
are near the CCß of the method. Because the validation levels of the penicillins 
are far above the detection limit, additional blank poultry muscle samples (n=7) 
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were spiked at 5, 10 and 15 µg/kg with the penicillins and analysed according to 
the presented procedure. The results were assessed using the results of the 
samples spiked at the lowest validation level. In at least 95 % of these samples a 
peak for the ß-lactams should be observed for the least abundant product ion. 
Selectivity 
The selectivity of the method was studied based on a practical and a theoretical 
study. First, the 21 analysed blank samples were checked for interferences at the 
retention times corresponding to the ß-lactam hydrolysis reaction products. 
Second, the procedure previously described for validation of selectivity was 
applied to estimate the probability of interfering substances [81] (chapter 3). 
Ruggedness 
The ruggedness became clear during the optimisation of the method. Additionally 
some minor changes to the method were assessed in triplicate being: (1) 
hydrolysis for an additional 60 min, (2) evaporation of the eluent until dryness 
and leaving the test tubes in the evaporator for 30 min, and (3 and 4) adjustment 
of the pH of the extract to pH 6.0 and 8.0. The trueness and repeatability of 
these tests were compared to the characteristics of the method as described. 
Stability 
Stability data for the ß-lactams in solutions and final extracts were obtained 
from literature for the penicillins [82] and studied for the cephalosporins and 
carbapenems. The stability was tested for 10 mg L-1 academic solutions in 
methanol according to a previously described procedure [82]. Mixed reference 
solutions of 10 mg L-1 of the studied compounds were placed at < -70 °C, -18 °C 
and 4 °C. After 1and 2 months two containers of both -18 °C and 4 °C were 
placed at < -70 °C. At the day of analysis, all solutions were defrosted, 
hydrolysed and analysed in quadruplicate in random order. 
The stability of final extracts was determined by storing these extracts at -18 °C 
after analysis. After 7 days, the matrix matched calibration standards and the 
samples spiked at target level (n=7) were defrosted and injected in the LC-MS/MS 
system again. The linearity, the trueness and the repeatability of this series was 
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evaluated based on the established validation criteria to determine whether 
quantitative analysis is still possible after storing the sample extracts at -18 °C 
for one week.  
Application to routine samples 
The method was assessed by analysing ceftiofur incurred poultry muscle samples 
obtained from ceftiofur treated chicks obtained 4h, 8h and 24h after treatment 
(n=3). These samples were analysed using the presented method and the method 
previously presented using a hydrolysis with ammonia which was found to have 
comparable results to other routinely applied methods for ceftiofur analysis [76] 
(section 5.3). The results were compared using a Students’t-test. Finally the 
presented method was used to monitor 25 poultry muscle samples obtained from 
different local super markets. 
Results & Discussion 
Characterization of the hydrolysis reaction products 
The penicillins all react in the same way with piperidine as was previously 
reported [53,71]. A reaction product is produced by hydrolysis of the ß-lactam 
ring under formation of the substituted amide (figure 5.23, appendix 5.1). The 
reaction product is, in contrast to the penicillin itself [59,82], a stable molecule 
and therefore the hydrolysis procedure is beneficial with regard to method 
ruggedness.  
The cephalosporin hydrolysis is more complicated and results in multiple reaction 
products. The proposed reaction scheme is presented in figure 5.24 and the 
proposed reaction products in appendix 5.2. A first nucleophillic substitution 
occurs in which the ß-lactam ring is hydrolysed and the leaving group at the C ’ 
position is removed resulting in the exo-methylene compound as reported 
previously [53,83]. This intermediate was detected in the continuous infusion full 
scan mass spectra for all cephalosporins, except for cefalexin. Cefalexin showed 
the intermediate at two mass units higher, which is explained by the absence of 
a leaving group on position 3: only the hydrolysis of the ß-lactam ring occurs and 
no double bond can be produced at this position.  
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Figure 5.23. Hydrolysis of the penicillin amoxicillin after addition of piperidine. 
Two additional reaction pathways are proposed. First, because the exo-
methylene group is highly reactive, a second nucleophillic substitution occurs at 
the  ’ position (figure 5.24, pathway 1) [84,85]. This results in a reaction product 
containing two piperidine moieties (cefazolin, cefalonium, cefacetrile and 
cefoperazone), which was confirmed by a mass increase of 20 Da when carrying 
out the reaction using piperidine-d11. A peak at the m/z corresponding with this 
reaction product was observed for all cephalosporins in the continuous infusion 
mass spectra. The cefalexin intermediate does not contain an exo-methylene 
group and thus it cannot undergo a second nucleophillic attack at position  ’. 
Because a reaction product is observed at the corresponding m/z, another 
reaction must occur that results in an isomeric reaction product. It is proposed 
that, instead of a nucleophillic attack at position  ’, this could also occur at 
position 4, although this seems less likely at forehand. This would result in a 
second reaction product containing two piperidine moieties. The formation of 
multiple isomeric reaction products is confirmed by the observation of several 
peaks in the chromatogram when monitoring the SRM mass transitions of these 
reaction products that contain two piperidine moieties.  
Second, it is proposed that the nucleophillic attack at position  ’, after electron 
rearrangement, can result in a piperidine amide compound, which was only 
observed for ceftiofur, cefquinome, cefalexin, cefapirin and cefalonium (figure 
5.24, pathway 2). The presence of one piperidine moiety and the side chain on 
position 7 in this reaction product was confirmed by carrying out the reaction 
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using piperidine-d11 and, if available, cefalosporins containing an isotopically 
labeled side chain at position 7. 
For each cephalosporin a single reaction product was selected for effectively 
monitoring the presence of ß-lactam residues in poultry muscle (appendix 5.2). 
For ceftiofur, cefquinome, cefalexin and cefapirin the final reaction product 
containing one piperidine moiety was the most abundant and therefore those 
were selected as the marker compounds. For cefalonium and cefazolin the 
reaction product containing two piperidine moieties were the most abundant 
products and therefore, those were selected as the marker compounds. For 
cefacetrile and cefoperazone reaction products containing two piperidine 
moieties were observed, but additionally hydrolysis of the nitrile group in the 
side chain of cefacetrile and hydrolysis of the amide in the side chain of 
cefoperazone occurred [86-88]. 
Also the carbapenems and faropenem show several reaction products, but it is 
observed that, as for the penicillins, the hydrolysis of the ß-lactam ring was the 
major reaction occurring (figure 5.25, appendix 5.3). Additional hydrolysis 
reactions in the side chain were observed for imipenem (comparable to the 
hydrolysis of amitraz [89]) and biapenem. For all compounds, the proposed 
reaction products were supported by the exact mass data (error < 1 ppm, table 
5.10) and the fragmentation pattern in MS/MS using collision induced 
dissociation.  
According to the MRL of ceftiofur [6] all metabolites containing the intact ß-
lactam ring should be taken into account. As was previously demonstrated [76] 
(section 5.3) by using an alkaline hydrolysis also DFC, DCCD and protein bound 
ceftiofur are taken into account. Another advantage of the presented method is 
that the hydrolysis reaction products are more stable molecules compared to the 
intact ß-lactams. Therefore, a more robust method is obtained.  
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Figure 5.24. Proposed hydrolysis reaction of the cephalosporins in the presence 
of piperidine. 
 
Figure 5.25. Proposed hydrolysis reaction of the carbapenem imipenem in the 
presence of piperidine. 
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Table 5.10. Exact mass data for the cephalosporin and carbapenem hydrolysis 
reaction products. 
Product of Determined exact 
mass [M+H]+ 
Molecular formula Exact mass 
[M+H]+ 
Error 
(ppm) 
Amoxicillin 451.2012 C21H31N4O5S+ 451.2010 0.3 
Ampicillin 435.2063 C21H31N4O4S+ 435.2061 0.3 
Penicillin G 420.1948 C21H30N3O4S+ 420.1952 -0.4 
Penicillin V 436.1906 C21H30N3O5S+ 436.1901 0.5 
Cloxacillin 521.1618 C24H30ClN4O5S+ 521.1620 -0.2 
Dicloxacillin 555.1234 C24H29Cl2N4O5S+ 555.1230 0.4 
Oxacillin 487.2013 C24H31N4O5S+ 487.2010 0.3 
Nafcillin 500.2214 C26H34N3O5S+ 500.2214 0.1 
Ceftiofur 326.1288 C13H20N5O3S+ 326.1281 0.7 
Cefquinome 326.1285 C13H20N5O3S
+ 326.1281 0.3 
Cefapirine 294.1273 C14H20N3O2S
+ 294.1271 0.2 
Cefalexin 276.1711 C15H22N3O2
+ 276.1707 0.5 
Cefalonium 507.2104 C24H35N4O4S2
+ 507.2094 1.0 
Cefazolin 493.2338 C21H33N8O4S
+ 493.2340 -0.2 
Cefacetrile 468.2280 C21H34N5O2S
+ 468.2275 0.5 
Cefoperazone 718.3237 C33H48N7O9S
+ 718.3229 -0.4 
Biapenem 399.2066 C18H31N4O4S
+ 399.2061 0.6 
Doripenem 506.2109 C20H36N5O6S2
+ 506.2102 0.7 
Ertapenem 561.2385 C27H37N4O7S
+ 561.2377 0.7 
Faropenem 371.1643 C17H27N2O5S
+ 371.1635 0.8 
Imipenem 358.1801 C16H28N3O4S
+ 358.1795 0.6 
Meropenem 469.2484 C22H37N4O5S
+ 469.2479 0.5 
Ceftiofur and cefquinome have the same side chain at position 7 and thus they 
result in the same hydrolysis reaction product. As a consequence, based on this 
reaction product only, ceftiofur and cefquinome cannot be distinguished. 
However, a by-product of the cefquinome hydrolysis is the 5,6,7,8-
tetrahydroquinoline moiety (the ring structure in the position  ’ side chain, 
appendix 5.2), showing a clear peak in the continuous infusion mass spectrum at 
m/z 134. By additionally monitoring this reaction product the presence of 
cefquinome can be distinguished from ceftiofur (figure 5.26). Because the two 
compounds interfere in each other’s quantitation process they can only be 
quantitated by using separate calibration standards. A molecular structure search 
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in SciFinder [90] shows 53 substances besides ceftiofur and cefquinome having a 
comparable molecular structure with variation in the position  ’ side chain only. 
From a theoretical perspective these might all result in the same reaction 
product. Because a complete side chain group is removed in the hydrolysis of the 
cephalosporins, the presented method cannot be considered an unequivocal 
confirmation of the presence of the cephalosporins. However, in the analysis of 
21 blank samples no interferences were observed and in practice it is unlikely to 
find the 53 theoretically interfering compounds in poultry muscle. 
 
 
Figure 5.26. SRM chromatograms for three ion transitions of ceftiofur and 
cefquinome (m/z=326) and one ion transition of the cefquinome by-product 
(m/z=134) for a blank poultry muscle sample spiked at 10 µg kg-1 with (a) 
ceftiofur and (b) cefquinome. 
Optimization of the hydrolysis kinetics 
The main factors that possibly influence the hydrolysis reaction were 
temperature, incubation time and piperidine concentration. From the 
experimental design ANOVA, it was observed that none of the selected factors 
affected the hydrolysis of the penicillins and the carbapenems. These reactions 
were all instantaneous and no significant further degradation of the selected 
reaction products was observed during the incubation. For the cephalosporins, all 
three factors and the interaction of temperature with time proved to have a 
significant effect (α < 0.05) on the formation of the selected reaction products. A 
high piperidine concentration proved to be beneficial for especially the 
hydrolysis of cephalexin (+ 100 %). At 80 °C the cefalexin reaction product 
a b 
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showed an optimal response after 20 min followed by a decrease, which is most 
likely caused by degradation of the reaction product at this temperature. Over 
all, the highest response of the reaction products was observed after 1 h 
incubation at 60 °C using 5 % piperidine. 
Optimization of sample extraction 
The piperidine has to be added to the raw aqueous extract, in the presence of 
the muscle matrix in order to hydrolyse protein bound metabolites of ceftiofur. 
Because a relatively high concentration of piperidine is necessary for the 
hydrolysis of the cephalosporins, severe gelation caused by the hydrolysis of 
extracted collagen occurs when the extraction was carried out in pure water. 
The use of a saturated solution of disodium tetraborate and sodium chloride 
proved successful in the prevention of gelation. This is most likely caused by 
inhibiting excessive hydrogen bridge formation by the extracted collagen.  
LC-MS/MS analysis 
The LC separation of especially the carbapenem hydrolysis products is 
challenging. Under acidic LC conditions extreme peak tailing is observed for 
especially imipenem, meropenem and doripenem. Only at a mobile phase pH > 7, 
the peak tailing decreased but still remained sub-optimal. The addition of 1 % 
piperidine to the aqueous purified sample extract improved the peak width and 
shape and thus chromatographic resolution of the isomeric reaction products. A 
chromatogram of a blank sample spiked at target level with all ß-lactams is 
presented in figure 5.27. As a result of the hydrolysis reaction, the 
chromatograms of most compounds show multiple peaks. The chromatograms of 
the penicillins and the carbapenems (except imipenem) show a major and a 
minor peak whereas imipenem shows two peaks of approximately equal height. It 
is suggested that stereoisomers are produced during the incubation under the 
extreme alkaline conditions. For the cephalosporin reaction products that 
contain two piperidine moieties, up to four peaks are observed. This might be a 
combination of stereoisomers and structural isomers, due to a variation in the 
position of the second nucleophillic attack. In most cases, baseline separated 
peaks are observed, but especially in the case of cefoperazone the resolution of 
the peaks is limited. In such cases, the combination of peaks is integrated to 
obtain reproducible peak areas. 
 
 
 
 268 
 
 
 
Figure 5.27. Representative reconstructed ion chromatograms of a blank poultry 
muscle sample spiked at target level with the ß-lactams showing the least 
abundant product ion of each compound’s hydrolysis reaction product. 
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Validation results 
An overview of the validation results is presented in table 5.11.  
Table 5.11. Summary of the validation study results. 
 
Compound 
Validation 
level 
(µg kg-1) 
Trueness 
(%)  
n=21 
RSDr 
(%) 
 n=21 
RSDRL 
(%) 
n=21 
CCα1 
(µg kg-1) 
CCß1 
(µg kg-1) 
Linearity 
(r2) 
 
Amoxicillin 25 
50 
75 
97 
98 
100 
3.4 
4.7 
4.5 
4.7 
4.9 
4.5 
1.1 
53.9 
2.2 
57.9 
> 0.999 
Ampicillin 25 
50 
75 
106 
102 
99 
7.4 
7.2 
7.9 
8.8 
11.4 
9.1 
1.7 
59.5 
3.5 
69.0 
> 0.997 
Penicillin G 25 
50 
75 
100 
98 
100 
4.6 
3.5 
5.2 
4.8 
3.5 
5.5 
1.1 
52.9 
2.2 
55.7 
> 0.998 
Penicillin V 12.5 96 4.4 5.4 0.7 1.5 > 0.993 
 25 97 6.0 6.1 27.4 29.9  
 37.5 98 4.8 5.0    
Cloxacillin 150 100 6.8 11.9 1.7 3.4 > 0.995 
 300 106 4.2 10.1 353 405  
 450 103 3.6 6.5    
Dicloxacillin 150 
300 
450 
101 
103 
104 
3.5 
2.6 
2.7 
5.4 
2.8 
2.7 
1.6 
314 
3.2 
328 
> 0.993 
Oxacillin 150 
300 
450 
98 
101 
100 
6.1 
5.2 
6.5 
7.5 
5.9 
6.7 
1.4 
329 
2.8 
358 
> 0.997 
Nafcillin 150 
300 
450 
99 
102 
104 
7.7 
6.1 
8.8 
7.8 
6.1 
8.8 
2.0 
331 
4.1 
361 
> 0.996 
Ceftiofur 5 
10 
15 
95 
97 
101 
6.5 
6.9 
4.1 
8.6 
7.3 
5.0 
1.3 
 
2.7 
 
> 0.998 
Cefquinome 5 
10 
15 
92 
98 
96 
10.7 
9.4 
8.8 
11.2 
9.5 
10.1 
1.9 3.9 > 0.996 
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Cefapirin 5 
10 
15 
88 
97 
94 
10.2 
9.4 
8.5 
13.3 
9.5 
8.7 
2.4 4.8 > 0.995 
Cefalexin 5 
10 
15 
102 
96 
91 
10.9 
7.8 
7.0 
13.9 
8.4 
10.4 
2.5 5.0 > 0.993 
Cefalonium 25 
50 
75 
101 
108 
115 
12.6 
12.4 
7.1 
12.7 
13.0 
8.4 
5.5 11 > 0.998 
Cefazolin 12.5 
25 
37.5 
93 
98 
96 
9.9 
8.4 
7.0 
10.0 
8.7 
7.9 
5.1 10 > 0.998 
Cefacetrile 25 
50 
75 
98 
98 
104 
12.0 
14.5 
6.0 
12.4 
19.0 
15.2 
10 20 > 0.995 
Cefoperazone 25 
50 
75 
100 
106 
110 
8.8 
10.0 
6.6 
17.3 
12.6 
10.5 
9.3 19 > 0.996 
Biapenem 50 111 27.1 45.1 - 50 > 0.993 
 100 118 29.7 46.5    
 150 91 20.7 33.8    
Doripenem 25 
50 
75 
101 
106 
109 
11.3 
11.1 
7.0 
15.9 
11.9 
9.2 
12 25 > 0.999 
Ertapenem 25 
50 
75 
91 
94 
95 
7.3 
11.0 
7.7 
7.6 
12.9 
10.7 
12 24 > 0.990 
Imipenem 50 
100 
150 
102 
107 
103 
11.2 
9.7 
5.4 
14.6 
14.9 
9.3 
20 41 > 0.995 
Meropenem 12.5 
25 
37.5 
86 
97 
96 
8.9 
6.3 
5.4 
12.8 
7.0 
5.6 
3.6 7.2 > 0.994 
Faropenem 12.5 
25 
37.5 
88 
91 
94 
12.3 
10.2 
6.9 
14.8 
10.8 
7.1 
5.6 11 > 0.995 
1 CCα and CCß based on MRL are presented in regular font, CCα and CCß based on zero 
tolerance are presented in italics. 
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For cloxacillin, dicloxacillin, nafcillin and oxacillin, for which the calibration line 
ranges from 0 – 1500 µg/kg-1 in some cases a clear signal saturation was observed 
at the highest calibration level. Therefore, these are best calibrated over a range 
from 0 – 3 * target level. Taking this into account, the linearity over the 
calibration range is above the criterion of 0.990 for all compounds and does 
comply with the established criterion. The trueness is between 91 and 110 % for 
all compounds except cefalonium at 1.5 * target level and biapenem at all levels. 
From the linear calibration lines, it is concluded that the within-sample variation 
is limited and thus it is most likely that the observed deviations are caused by 
matrix effects and could be resolve if an isotopically labeled internal standard 
would be available. The RSDr and RSDRL are all below 13.3 % respectively 17.3 % 
except for biapenem. Based on these outcomes it is concluded that the 
presented method is suitable for quantitation of the amount of ß-lactams present 
in poultry muscle at relevant levels except for biapenem. The method is suitable 
for qualitative analysis of biapenem and thus for monitoring biapenem use in 
poultry breeding.  
The calculated decision limits (CCα) based on  ero tolerance, indicating the limit 
of detection, vary from 0.7 – 20 µg kg-1. CCα was found to be of the same 
magnitude for both mass spectrometers used. Based on the samples spiked at the 
lowest level included in the validation, the calculated values of CCα are realistic. 
The penicillins have detection limits in the low ppb range demonstrating that the 
method is suitable for the detection of penicillins at levels well below the MRL 
enabling the monitoring of extra-label penicillin use. The method also proved 
suitable for the detection of cephalosporins and carbapenems at relevant levels. 
The calculated detection capabilities (CCß) are between 1.5 and 50 µg kg-1 which 
is approximately at the lowest level included in the validation. Therefore the 
calculated values could easily be verified using the available data. In over 95 % of 
the cases, based upon the ion ratio, the ß-lactams were found positive according 
to EU criteria [77] indicating that the calculated levels of CCß are realistic. 
Because this is an initial in-house validation, only limited data are available. 
Over time the within-laboratory reproducibility should be determined more exact 
to obtain a more precise estimation of CCß. 
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Selectivity 
A hydrolysis upon addition of piperidine is carried out and as a consequence an 
excessive number of compounds containing a piperidine moiety can be expected 
in the hydrolysed sample extract. Therefore, protonated piperidine as the 
product ion (m/z 86) and a piperidine neutral loss (-85 Da) were considered non-
selective and were discarded in the selection of ion transitions for confirmatory 
LC-MS/MS analysis. For each ß-lactam reaction product, two product ions were 
selected and based on those the probability of an interfering signal (P(I)) was 
calculated [81]. If P(I) was above 2 * 10-7, being a suitable criterion for selectivity 
as previously proposed [81], as was the case for penicillin G, penicillin V, 
oxacillin, cefapirin, ceftiofur, cefquinome, imipenem and faropenem, an 
additional product ion was selected for confirmatory analysis to assure sufficient 
selectivity. Only for ceftiofur and cefquinome a neutral loss of piperidine was 
included as the third transition, not to compromise sensitivity too much. Using 
these ion transitions, no interferences at the retention times of the ß-lactam 
reaction products were observed in the chromatograms of the blank samples 
(n=21).  
Ruggedness 
Some slight deviations to the procedure that might occur in practice were tested 
in triplicate: (1) hydrolysis for an additional 60 min, (2) evaporation of the eluent 
until dryness and leaving the test tubes in the evaporator for 30 min, and (3 and 
4) adjustment of the pH of the extract to pH 6.0 and 8.0. Adjusting the pH of the 
extract to 6.0 resulted in statistically significant deviating results for penicillin V 
(-12 %), cephalexin (-85 %) , cefoperazone (-49 %), biapenem (-92 %), nafcillin 
(+75 %) and cefalonium (+40 %). Adjusting the pH to 8.0 only showed a 
statistically significant change in the results of cefoperazone (-16 %) and 
ertapenem (+34 %). The deviating results can be explained by the break-through 
occurring during SPE due to ionisation of the compounds and it was concluded 
that adjustment of the pH of the extracts to pH = 6.8 – 7.3 should be carried out 
with care. For some penicillins (e.g. nafcillin +60 %) and some cephalosporins 
(e.g. cefapirin +40 %) prolonged incubation results in an increase in peak 
response. For faropenem and ertapenem a decrease in peak response is observed 
of approximately 30 %. An incubation time of 60 min was found to be a good 
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compromise and because internal standards are used for quantitation, slight 
deviations of the incubation time are acceptable. No degradation of the 
compounds was observed during prolonged evaporation, except for cefacetrile 
which showed a drop in the signal of 15 % when left in the evaporator unit 30 
min. after dryness. It is concluded that for this specific compound, the 
centrifuges tubes should be removed from the evaporator unit directly after 
dryness. 
Stability 
Stability data on penicillin solutions were previously reported [82]. It was found 
that penicillin solutions in methanol are stable for at least 3 months at < -18 °C 
with the exception of ampicillin and penicillin G, which are stable for 2 months 
under these storage conditions.  
The stability results of 10 mg L-1 academic solutions cephalosporins and 
carbapenems are presented in table 5.12. As the penicillins, the the 
cephalosporins and carbapenems are unstable in methanolic solutions, stored at 
4 °C during 2 months, with exception of ceftiofur. When storing the solutions at -
18 °C the cephalosporins and faropenem remain stable during at least two 
months. The carbapenems seem to drop in response for 10 – 30 % and remain 
stable afterwards. To prevent degradation of the stock solutions it was decided 
to store them at < -70 °C. 
The stability of poultry muscle extracts showed that even if extracts are stored 
at -18 °C for 7 days, results similar to those for fresh extracts are obtained. It is 
concluded that muscle extracts obtained with the described method are stable 
for at least 7 days when stored at -18 °C.  
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Table 5.12. Stability of 10 mg L-1 methanolic solutions of cephalosporins and 
carbapenems during storage at -18 and +4 °C. 
Compound Relative response compared with t=0 (%) 
 +4 °C -18 °C 
 t = 1 month t = 2 months t = 1 month t = 2 months 
Cefalexin 87 65 96 98 
Cefapirin 85 66 99 99 
Cefquinome 89 68 99 100 
Ceftiofur 99 97 100 99 
Cefacetrile 81 55 97 93 
Cefazolin 83 62 96 94 
Cefalonium 44 13 97 95 
Cefoperazone 85 63 99 98 
Imipenem 31 14 85 82 
Biapenem 12 2 72 75 
Meropenem 50 25 87 87 
Doripenem 43 19 86 89 
Ertapenem 59 34 86 91 
Faropenem 85 81 99 98 
 
Application to routine samples 
Ceftiofur incurred tissue samples, obtained from chicken that were slaughtered 
four, eight and 24 hours after intramuscular injection of ceftiofur, were analysed 
using the presented method (n=3 per group). The results were compared to the 
results of a previously presented method which was found to give comparable 
results to a routinely applied method [76]. For the samples obtained four hours 
after treatment the average ceftiofur concentration of the presented method 
was 625 µg kg-1 and 587 µg kg-1 for the other method. For the samples taken eight 
hours after treatment this was 273 respectively 247 µg kg-1, and 24 hours after 
treatment 42 respectively 52 µg kg-1. In all three cases, no statistically significant 
differences were observed between the results of both methods. From this it is 
concluded that the method presented here is suitable for detection of incurred 
poultry muscle samples. No ß-lactam antibiotics were detected in the 25 poultry 
samples obtained from local supermarkets.  
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Conclusions 
A comprehensive quantitative trace analysis method for the analysis of 22 ß-
lactam antibiotics including penicillins, cephalosporins and carbapenems was 
successfully developed and fully validated according to 2002/657/EC [77]. In 
order to stabilise the penicillins and to be able to carry out an effective 
monitoring for ceftiofur use by including its protein-bound metabolites, a 
hydrolysis using piperidine is included. Reaction products, which are used as 
markers for the ß-lactams are proposed. The validation showed good trueness, 
repeatability and within-lab reproducibility for all compounds except for 
cefalonium at 75 µg kg-1 and biapenem, for which the method is considered 
qualitative. The ruggedness and stability proved to be sufficient to apply the 
presented method in routine analyses. The method is the most appropriate 
method available today for detection and quantitation of a broad range of ß-
lactam antibiotics in poultry muscle.  
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Appendix 5.1 
Molecular structure of 6-aminopenicillinic acid 
nucleus, the piperidine hydrolysis product, and 
penicillins registered for use in animal practice. 
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Appendix 5.2 
Molecular structure of the cephalosporins registered 
for use in animal practice including their hydrolysis 
product. 
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Appendix 5.3 
Molecular structure of the carbapenems and their 
hydrolysis product. 
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Introduction 
What selectivity is adequate in residue analysis of antibiotics and other drugs? 
There is no general answer to this question, because this highly depends on the 
purpose of the method in question. 
In chapter 2 it was elaborated that selectivity is related to the sample clean-up 
and that usually a tradeoff between selectivity and the number of compounds 
included in the method occurs. 
In chapter 3 it was demonstrated that the selectivity obtained by liquid 
chromatography coupled to tandem mass spectrometry (LC-MS/MS) can be graded 
based upon modeled empirical data. The result can be compared to a threshold 
value but no sharp boundary between ‘selective’ and ‘non-selective’ exists. As a 
starting point, according to European Union Commission Decision 2002/657/EC 
[1] the selectivity for detection of banned substances (group A) should be higher 
than for registered substances (group B). Because consequences of a non-
compliant result for banned substances are higher than for a non-compliant 
finding of a registered substance, this is an acceptable concept.  
A second consideration in the selectivity needed is the kind of interferences that 
can be expected. A clear example thereof is the analysis of chloramphenicol 
(CAP) as presented in chapter 4. A non-compliant finding of CAP has huge 
consequences that might include farmers’ bankruptcy, bad reputation of certain 
branches, destruction of shipments of perfect quality food products, and 
affecting the economy and international relations. Beforehand, it is known that 
CAP has two chiral centers and that its nitro-group can be substituted at the 
para- and meta-position. Because ‘unequivocal identification’ is mandatory, a 
method for the analysis of CAP should be able to discriminate CAP from its 
stereo-isomers. Therefore, to prevent false positive results to occur, a method 
for the analysis of CAP should be extremely selective. The same accounts for 
other banned compounds having enantiomers, like ß-agonists [2,3] and to less 
extend for regulated compounds like some fluoroquinolone antibiotics [4], some 
non-steroidal anti-inflammatory drugs (NSAIDs) [5] and albendazole sulphoxide, 
an anthelmintic drug [6,7]. Enantiomeric separations have usually been carried 
out using chiral liquid chromatography (LC) [4-6] as also demonstrated for CAP 
Chapter 6 
 
289 
and/or capillary electrophoresis (CE) [2-4,7], but also new techniques to enhance 
selectivity have become available. These are further discussed from page 290. 
A third consideration in the selectivity needed is the purpose of the analysis. In 
monitoring programs, usually a broad screening is carried out first, followed by a 
confirmatory analysis of suspect samples. Ideally, a screening analysis focusses 
on a broad range of compounds, which compromises selectivity as was discussed 
in chapter 2. A confirmatory method should by definition result in an unequivocal 
identification and thus a high selectivity is mandatory. Future perspectives on 
monitoring programs and their effects on selectivity are further discussed in this 
chapter. 
An example of a method in which selectivity is intentionally compromised is the 
analysis of ß-lactams as presented in chapter 5. Because, ceftiofur metabolises 
rapidly, off-label use is best detected if protein-bound residues are included. To 
facilitate this, a hydrolysis of the protein-bound residues is mandatory. By 
definition, when applying a derivatization, selectivity is compromised: instead of 
the drug focused at, a derivative is detected and thus the method is not able to 
differentiate the parent drug from other drugs that result in the same derivative. 
It is concluded that selectivity should be fit for purpose and therefore remains a 
matter of experts’ judgment. Nevertheless, it is important to be able to grade 
selectivity, e.g. in terms of bad, good or extreme, which is facilitated by the 
method presented in chapter 3. The obtained result is the basis for determining 
if selectivity is adequate and thus the described procedure is highly valuable 
when the selectivity of the confirmatory method is challenged in a court case. 
When selectivity is considered inadequate, additional methods or techniques can 
be applied to increase method selectivity.  
In this chapter 6, future perspectives are discussed. First techniques that in my 
view are highly valuable to further increase selectivity are presented and 
discussed. Next, future perspectives on monitoring strategies for regulatory 
control are elaborated upon and finally additional options to further investigate 
the natural occurrence of CAP are presented. 
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Enhancing selectivity 
As described in chapter 2, during the last decade many developments in state-of-
the-art instruments for the analysis of antibiotics in products of animal origin 
occurred. As a result, instead of aiming for the detection of just one compound 
or compounds from a single antibiotic group, multi-compound methods are being 
developed that include different antibiotic groups. As a result extraction and 
sample-clean-up procedures have become more generic and selectivity is 
compromised. To obtain a trustworthy confirmatory result additional ion 
transitions can be monitored in LC-MS/MS to improve the information on the 
compounds’ functional groups and structure. However, in my opinion some other 
techniques have become available to further increase selectivity, being high-
resolution mass spectrometry (HRMS), ion mobility spectrometry (IMS), two-
dimensional LC and supercritical fluid chromatography (SFC).  
High resolution mass spectrometry 
In HRMS, co-eluting compounds are much better separated compared to low 
resolution MS and, provided target ions are fully separated from background ions, 
the exact mass is determined more accurate [8]. Quadrupole instruments operate 
at a resolution of approximately 5000 full width at half maximum (FWHM) [9] 
which results in nominal mass data. As was presented in chapter 3 (figure 3.2) at 
nominal mass, the probability of a compound having the same mass (P(Mpc)) is at 
most 0.0052. Nowadays, Fourier transform-ion cyclotron resonance (FTICR) [10] 
and orbitrap [11] MS instruments are commercially available operating at a 
resolution of 100,000 FWHM with a mass accuracy below 3 ppm [10,12-16]. Using 
specific software tools and applying an additional internal calibration, mass 
accuracy is enhanced to even sub-ppm errors [12,17-19]. 
Selectivity in low resolution MS (LRMS) and HRMS has been assessed previously 
[20-22]. Kaufmann et al. [20] reported that single stage MS analysis at a 
resolution of 100,000 FWHM permits selectivity which exceeds that provided by 
currently used unit resolving MS/MS instruments. Quenzer et al. [23] 
demonstrated that the number of possible elemental compositions that fit the 
accurate mass result increases with increasing m/z. For instance, only a few 
elemental compositions are possible for a compound at m/z = 100.0000 ± 2 ppm, 
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whereas much more options are available for compounds with m/z = 900.0000 ± 2 
ppm. It was concluded that at a higher mass range, a better mass accuracy is 
required for unequivocal identification compared to the lower mass range. 
However, this conclusion was based upon the theoretical mathematical number 
of elemental compositions possible, instead of upon the number of existing 
molecules or chemically possible elemental compositions. Furthermore, the 
seven golden rules for filtering molecular formulas obtained from HRMS 
measurements were not applied [24]. These rules include (1) restriction of 
element numbers, (2) LEWIS and SENIOR check, (3) isotopic pattern filtering, (4) 
a hydrogen/carbon element ratio check, (5) a heteroatom ratio check, (6) an 
element probability check and (7) a TMS check (only if derivatised using N-
methyltrimethylsilyltrifluoro-acetamide (MSTFA)). When applying these rules, the 
number of optional molecular formulas can be severely limited. 
Another theoretical assessment of the selectivity in LRMS and HRMS was recently 
reported by Stoev et al. [22]. In this the maximum number of m/z peaks fitting a 
mass spectrum was calculated. Logically the number of peaks fitting in a 
spectrum is proportional to the mass resolution. As a result a 10,000-fold 
increase in selectivity was reported going from nominal mass resolution to HRMS 
at 100,000 FWHM resolution. It was concluded that confirmatory analysis using 
LC-MS/MS according to Commission Decision 2002/657/EC [1], monitoring one 
precursor ion and two product ions thereof, was more selective than full scan 
exact mass measurement of the precursor ion only at 100,000 FWHM resolution. 
The reported approach is highly theoretical and some important issues are 
overlooked. First, the chance of the occurrence of precursor masses is unequally 
distributed over the mass range as demonstrated in chapter 3. In HRMS these 
differences can be very extreme, because in the low mass range, the majority of 
exact masses has a zero probability of occurrence. Second, as was also presented 
in chapter 3, not all product ions are as likely, as a matter of fact some product 
ion masses are impossible. Third, it is suggested that selectivity is related to the 
selected scan range, which is not the case. A more practical approach for the 
assessment of LRMS versus HRMS is needed. 
To assess the selectivity in full scan HRMS analysis, the database containing over 
5,000,000 entries of commercially available compounds [25], as introduced in 
chapter 3, can be used. This information is highly valuable to assess the 
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selectivity of confirmatory methods in which additionally to LC-MS/MS analysis, a 
HRMS measurement is used to determine the exact mass of the compound 
present to obtain additional selectivity. The probability distribution of the 
precursor ion m/z at 2 ppm mass accuracy is presented in figure 6.1a showing 
that with high resolving power a precursor m/z of 351.1592 is the most probable, 
having a probability of 3.8*10-4. This is over a factor 10 improved compared to 
nominal mass resolution. Looking at the details of the distribution (figure 6.1b) it 
is clear that the distribution, in contrary to nominal mass resolution, is not 
continuous and thus the selectivity highly depends on the elemental composition 
of the compound: e.g. at m/z = 351.1592 the probability is 3.8*10-4 and at m/z = 
351.2421 the probability is only 8.9*10-6.  
 
Figure 6.1. Probability distribution of the precursor ion m/z at 2 ppm mass 
accuracy over a m/z range of (a) 100 – 1000 and (b) 350 – 353. 
This approach is valuable when the precursor ion is detected at high resolution, 
but it does not cover the LC-MS/MS analysis using currently available hybrid 
instruments like Q-TOF and linear ion-trap-Orbitrap instruments [26] in which the 
precursor is determined at nominal mass resolution and the product ion(s) at high 
resolution. To assess the selectivity of these LC-MS/MS measurements, exact 
mass data on product ions is needed for a high number of compounds. Then, as 
was done for LRMS, the selectivity in high resolution LC-MS/MS can be calculated 
and compared to low resolution LC-MS/MS. Because HRMS is nowadays used more 
frequently for confirmatory analysis, in my opinion, this work should be carried 
out urgently, so that statistically supported criteria for confirmatory analysis in 
HRMS can be established.  
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Ion mobility 
Ion mobility spectrometry (IMS) was developed to separate volatile and semi-
volatile compounds in the gas phase. The separation is based on different drift 
velocities (mobility) of compounds in low and high electric fields and enables 
differentiation by mass, charge and collision cross section (derived from 
structural parameters of size, shape, and the charge location or distribution) 
[27]. Therefore it is a separation mechanism that is orthogonal to liquid 
chromatography and mass spectrometry [28,29]. 
In conventional IMS, after ionisation of the sample compounds, a cloud of sample 
ions is introduced into a drift region via an electronic shutter. The ions in the 
drift region move toward a detector down a voltage gradient through a gas 
atmosphere. Velocities in electric fields of 300 V cm−1 are often 2 m s−1, so a 
spectrum can be generated every 5 to 25 ms. The velocity of the ions (drift 
velocity, vd) is proportional to the strength of the electric field (E) with the 
mobility (K) of the ions being constant: K=
vd
E
 [27,30-33]. 
In addition to conventional IMS, the desire for further miniaturization has 
prompted the introduction of other methods for ion separation. Two IMS devices 
are commercially available for coupling to LC-MS: traveling-wave (T-wave) ion 
mobility spectroscopy (TWIMS) [29,31] as applied in the Waters SYNAPT, and 
differential mobility spectrometers (DMS), also called field asymmetric waveform 
ion mobility spectrometers (FAIMS) [27] as applied in the AB Sciex SelexIONTM. 
In TWIMS (figure 6.2a) the drift cell is placed in the vacuum of the instrument 
and is made of a series of ring electrodes. In conventional IMS a low electric field 
is uniformly applied on the cell, whereas in TWIMS a high electrical field is swept 
sequentially from one electrode to the next in the direction of ion migration 
[27,34,35]. As for conventional IMS, a pulsed method is used for ion injection 
with the duty cycle time depending on the speed of separation. While waiting for 
previously injected ions to separate, many ions are being discarded. This can be 
prevented by including a trap device in front of the drift tube [34]. 
In DMS/FAIMS (figure 6.2b) the ion mobility device is placed in the ion source 
region and ions are separated under ambient conditions. DMS/FAIMS 
differentiates ions by their difference in ion mobilities in high and low electric 
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fields, induced asymmetrically and orthogonal to the ion path. The different ion 
mobility during the application of high and low electric fields causes the ions to 
drift toward one of two electrodes. A compensation voltage is applied to correct 
the trajectory of targeted ions along the radial axis and thus to avoid ion 
discharge. DMS and FAIMS instruments are based on the same principle, but their 
instrumental design differs: two plate electrodes are used in DMS, whereas 
cylindrical electrodes are used in FAIMS [27,32]. 
 
 
Figure 6.2. Principles of ion mobility separation of ions in (a) traveling-wave ion 
mobility spectrometry (TWIMS, per example only V1 – V3 are depicted) and (b) 
field-asymmetric waveform ion mobility spectrometry (FAIMS). 
a 
b 
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A clear example of additional selectivity obtained using IMS is the ability to 
separate closely related compounds. Direct injection electrospray-IMS has been 
applied for the analysis of different antibiotics, including CAP and some 
penicillins for the analysis of aquatic environmental samples [36]. Corona 
discharge IMS has been applied for the analysis of three antibiotics, including 
CAP, in poultry muscle [37]. IMS in combination with MS detection was recently 
reviewed [38] and has been applied for the analysis of pharmaceuticals [39-41] 
and was found extremely useful for the discrimination of positional isomers [41]. 
LC-IMS-MS has recently been applied for antibiotic analysis showing increased 
overall resolving power as a result of IMS [42]. 
Diastereomeric separation of ephedrine, pseudoephedrine and their metabolites 
using FAIMS without addition of a chiral selector was reported [43]. The 
separation of carotenoids diastereomers [44] and small pharmaceutical 
diastereomeric compounds [45] using TWIMS was also reported. Chiral 
separations are more complicated: IMS is not capable of carrying out chiral 
separation by itself, because m/z, shape and the collision cross section are 
identical. Using IMS, chiral molecules in the gas phase can be separated as a 
result of differences in their stereospecific interaction with a chiral gas (e.g. (S)-
(+)-2-butanol) that is brought into the drift tube [46,47]. As a drawback, the 
addition of the chiral modifier to the drift gas reduced the mobility of both 
enantiomers and thus cycle times severely increase [34]. Another option to 
obtain a chiral separation is to add a chiral selector to the injected sample 
solution to produce diastereomeric complexes that can be separated by IMS [48] 
or to carry out a complexation reaction prior to injection as has been reported 
for terbutaline enantiomers analysed using electrospray-IMS-MS [40]. 
In my opinion, IMS is a valuable addition to residue analysis, because it is simple 
to apply, it is commercially available and it increases selectivity. In the analysis 
of CAP isomers (chapter 4) and ß-lactam antibiotics (chapter 5) IMS may have a 
clear added value. In the analysis of CAP isomers, the chromatographic resolution 
of the isomers is critical. As was presented in chapter 4.3, using reversed phase 
LC SS-p-CAP was not chromatographically separated from RR/SS-m-CAP which 
excludes the use of the product ions that origin from the RR/SS-isomers. Most 
likely, the different pairs of stereoisomers show different drift times in IMS, 
resulting in better (or even completely) resolved peaks. As a result the selection 
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of product ions used for quantitation and confirmation becomes less critical and 
more abundant product ions can be selected for monitoring. Furthermore, if the 
isomers are separated by IMS, another LC separation may be used speeding up 
the chromatographic separation and thus sample throughput. 
In the analysis of ß-lactams (section 5.4) it was found that for some 
cephalosporin and carbapenem drugs several isomers were formed during 
derivatization. In some cases these are not baseline separated, which negatively 
influences the automatic peak integration performance. As a result, the 
integration should be checked carefully and additional manual integration is 
usually mandatory. Most likely, IMS will discriminate among the isomers, 
facilitating baseline separation of the isomeric compounds. As a result, besides 
the gain in selectivity, the quantitation process is simplified and more robust. 
Furthermore, by using IMS, information on the type of isomers present is 
obtained (e.g. stereoisomers versus enantiomers, cf. above). 
Two-dimensional LC 
Two-dimensional (2D) LC, either off-line or on-line, is a useful tool to improve 
the peak capacity and is especially useful for the separation of compounds in 
complex mixtures [29]. In the off-line mode two chromatographic systems with 
orthogonal separation principles are used of which the first chromatogram is 
fractionated using a fraction collector and each fraction is subsequently injected 
in the second chromatographic system. In this way superior selectivity is 
obtained. Examples of off-line 2D LC are presented in table 6.1. 
Table 6.1. Applications reported for off-line 2D-LC. 
Analysis Dimension Detection Ref. 
 First Second   
Triacylglycerol 
samples of plant oils 
Non-aqueous 
reversed-phase 
Silver-ion APCI-MS [55] 
Pharmaceutical 
samples 
Cyano Reversed-phase ESI-MS [56] 
Lipidomic profiling of 
biological tissues 
HILIC Reversed-phase ESI- and 
APCI-MS 
[57] 
HILIC: Hydrophilic lipophilic interaction chromatography 
APCI: Atmospheric pressure chemical ionisation 
ESI: Electrospray ionisation 
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In the on-line mode two chromatographic systems with orthogonal separation 
principles are coupled by one or more multi-port valves. Two fundamental 
challenges to realise the full potential of 2D-LC are (1) coupling two orthogonal 
separation mechanisms and (2) retaining the first dimension separation [49]. The 
first challenge mainly relates to solvent incompatibility, which is usually caused 
by solvent immiscibility or because a strong solvent in one mode is a weak 
solvent in the other [49]. The second challenge relates to interfacing the two 
dimensions. A fraction from the first dimension (e.g. of 30 sec) is trapped 
(usually in a loop or trap column) and subsequently injected on the second 
dimension. While the second dimension separation takes place, a new fraction is 
collected in the first dimension. In theory, peak capacity of the 2D-LC system 
would be the product of the peak capacities of the individual dimensions. 
However, this is not the case due to inefficient transfer of separated compounds 
from one dimension to the other resulting in remixing of the compounds [50]. 
Therefore, a prerequisite of on-line 2D-LC is a fast separation in the second 
dimension, so the trapping cycles in the first dimension remain limited in time to 
obtain sufficient chromatographic resolution in the first dimension [51]. Two 
parallel columns can be used for the second dimension to limit the fractions 
collected in the first dimension [52]. Clearly, the separation mechanisms in both 
dimensions should be selected with care and interface dead volume should be 
limited to benefit most from the advanced peak capacity that can be achieved 
with 2D-LC. Another consideration is that total analysis time severely increases 
using 2D-LC which is disadvantageous in a routine situation. Comprehensive 2D-
LC (LCxLC) was reviewed [50,53,54] and examples, relevant to residue analysis of 
antibiotics, are presented in table 6.2. 
In my opinion, because LCxLC can further enhance the selectivity of a 
chromatographic separation, it should be the method of choice for confirmatory 
analysis. It may be possible to develop a single system that is able to analyse all 
major antibiotic groups (including the highly polar aminoglycosides) within a 
single run. Furthermore, the increased selectivity of LCxLC would tremendously 
add to the identification of unknowns and to profiling strategies. The application 
of LCxLC as a confirmatory method and as a tool in profiling are discussed in 
more detail in the paragraph ‘monitoring strategies’. 
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Table 6.2. Applications reported for on-line 2D-LC. 
Analysis interface Dimension Detection Ref. 
  First Second   
Sulfonamide and 
steroid mixture 
2 10-port 
valves 
Diol Reversed-phase APCI-MS [55] 
Antiviral compounds 
in poultry muscle 
2 6-port 
valves 
Hypercarbon Reversed-phase ESI-MS [58] 
Drug mixture 12-port 
valve 
Reversed-phase Phenyl ESI-MS [52] 
Chinese medicines 8-port 
valve 
Cyano Reversed-phase APCI-MS [51] 
Corn metabolites 2 6-port 
valves 
Reversed-phase Reversed-phase UV [59] 
Triacylglycerols in 
vegetables oil 
10-port 
valve 
Silver ion Reversed-phase UV [60] 
Oxygen heterocyclic 
components of a 
lemon essential oil 
10-port 
valve 
Silica normal-
phase 
Reversed-phase 
monolithic 
Diode 
array 
[61] 
  
Supercritical fluid chromatography 
SFC was first introduced in 1962 [62]. In packed column SFC regular LC columns 
can be used, but instead of a liquid mobile phase, supercritical fluids are used. 
The supercritical state occurs when pressure and temperature are both above the 
thermodynamic critical point. A supercritical fluid has a higher density compared 
to the gas state and a lower viscosity and higher diffusivity relative to the liquid 
state. These unique characteristics result in a higher solvation power and lower 
backpressures across a packed column [63-65].  
CO2 is the most commonly applied eluent because its critical pressure and 
temperature are relatively low (respectively 73 atm and 31 °C) and thus the 
instrumental requirements are limited and thermo-labile compounds can be 
analysed. Furthermore, when the pressure is decreased to atmospheric pressure, 
the CO2 converts to the gaseous state and is easily removed [65]. As a result SFC 
is a technique with an extremely low waste production and a low environmental 
impact [66-68]. Note that often organic modifiers like alcohols, acetonitrile or 
hexane are added to the mobile phase to change the polarity of the mobile phase 
to allow tuning of the mobile phase polarity [69,70]. Besides the advantage of 
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less organic waste production, the sample-throughput [71] and chromatographic 
resolution [71-73] (all using 5 µm particle size) in SFC were reported to be 
increased relative to LC. The advantage of the high throughput in SFC is clearly 
observed from the increased linear velocity, u, at optimal (low) plate height, H, 
in the Van Deemter curves of SFC compared to LC (figure 6.3) [74]. In this 
specific study, the separation efficiency, expressed by a low value of H, in SFC 
when using 3.5 µm particles was slightly better than in LC using the same particle 
size. However, when using particles of 1.7 µm internal diameter, LC shows 
slightly better separation efficiency compared to SFC using the same particle 
dimension. This is explained by the occurrence of an inverted radial temperature 
gradient (the wall region of the column is warmer than the center) inducing an 
endothermic mobile phase decompression in SFC [74]. 
 
Figure 6.3. Plate height (H) as a function of linear velocity for 1.7 and 3.5 μm 
particles in HRLC and HRSFC. Van Deemter curves for butylparaben on 2 systems 
equipped with 1.7 or 3.5 μm particles columns. LC conditions: H2O/ACN (60/40, 
v/v), 30 °C, 1 μL injected. SFC conditions: CO2/MeOH (96/4, v/v), 40 °C, 150 bar 
backpressure, 1 μL injected. Reproduced with permission of the author [74]. 
 
LC: XTerra RP18 
50 mm × 4.6 mm, 3.5 μm 
LC: Acquity Shield C18 
50 mm × 2.1 mm, 1.7 μm  
SFC: Acquity UPC2 BEH 2-EP 
100 mm × 3.0 mm, 3.5 μm 
SFC: Acquity UPC2 BEH 2-EP 
100 mm × 3.0 mm, 1.7 μm 
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Due to the high efficient separations when using > 3 µm particles, SFC is 
becoming more popular for chiral separations [70,75,76]. Note that, as for chiral 
LC, in chiral SFC a chiral selector is used, either bonded to the stationary phase 
(e.g. α-acid glycoprotein or polysaccharide) or in the mobile phase (e.g. 
cyclodextrins) [70]. Several chiral applications of SFC were previously reported 
[70] of which the majority aim for impurity separation in pharmaceuticals. 
Applications of SFC in veterinary drugs analysis include the separation of 
benzimidazole sulphoxide enantiomers in academic solutions [77-79], ketoprofen 
enantiomers in human plasma [80], ibuprofen [81], naproxen [82] and ß-agonist 
[83] enantiomers in academic solutions. 
In my opinion, now SFC bench-top equipment, compatible to MS instruments, has 
become commercially available, it will become more popular for the analysis of 
small-molecules. When using > 3 µm particle sizes, chromatographic resolution is 
increased by SFC and thus this technique is especially beneficial for chiral 
separations for which no sub-2 µm particle size materials are commercially 
available. Furthermore, the low environmental impact and high sample 
throughput serve well in a routine situation. Also because of its flexibility in 
separation mechanisms, solvent compatibility, high efficiency and speed, SFC 
would be an excellent option for SFCxSFC [84] (comparable to LCxLC), SFCxLC or 
LCxSFC. 
Concluding remarks on selectivity 
Several new techniques are available on the market today to further enhance the 
selectivity in residue analysis. The use of HRMS is becoming increasingly popular 
in a routine situation, especially for screening analysis but it is also increasingly 
applied for confirmatory analysis. In my opinion HRMS has added value in the 
screening of antibiotics in products of animal origin (e.g. the low detection 
limits) but the benefits of this technique are not fully exploited yet. Because 
databases are used for data evaluation this technique remains a targeted 
approach. New software tools may improve the process of data evaluation 
making HRMS applicable for fast non-targeted screening analysis. Until then, the 
use of microbial inhibition tests [85,86] should be maintained (in parallel to 
HRMS), because this is a fully orthogonal technique and is able to detect all 
compounds showing antimicrobial activity. 
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IMS, LCxLC and SFC all contribute to a certain extend to an increased selectivity 
in the analysis of veterinary drugs in product of animal origin. I expect that many 
MS instruments will be equipped with IMS during the upcoming years, because it 
is easy to implement. IMS will be used in a research environment as well as in 
routine analyses and it will be applied in combination with both nominal mass MS 
and HRMS. The implementation of SFC is less obvious. For many applications the 
increase in chromatographic power compared to HRLC is expected to be limited 
and thus SFC is primarily beneficial for decreasing the environmental impact and 
to increase the sample-throughput which is primarily of interest for routine 
analyses. Furthermore, unless an MS system is exclusively used in combination 
with SFC, flexibility is needed. Many currently applied methods use LC-MS/MS, 
and if the same MS equipment is used (as is likely, especially during the SFC 
implementation phase) the SFC equipment should be easily disconnected from 
(and later reconnected to) the MS. This practical issue might hamper the 
implementation of SFC-MS. LCxLC can easily be implemented in the laboratory by 
purchasing a complete LCxLC system or by constructing a system using a couple 
of multi-port valves and LC pumps, which are usually already present in the 
laboratory. However, before this technique can be fully operational, research is 
needed to develop an easy to use LCxLC system that is widely applicable. Also 
the use of SFC in multi-dimensional applications should be considered. 
Monitoring strategies 
Regulatory monitoring of antibiotic residues has focused on the analysis of 
products of animal origin based upon 96/23/EC [87]. Due to the economic 
situation a cut down on budgets is a realistic scenario, and thus there is a need 
for a more efficient design of the monitoring strategy. In my opinion this will 
result in changes in the regulatory control of antibiotics in food products: 
- Due to the advances in biochemical analysis techniques, parts of the 
regulatory monitoring will move from the laboratory to the farms, fields 
and slaughter houses and become part of the self-control policy. 
- More generic methods will be applied for the screening of regulatory 
control samples to increase sample-throughput. Because in this selectivity 
is compromised, highly selective confirmatory methods are needed as a 
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follow up. For sake of efficiency the development of a single highly 
selective confirmatory method would be of interest. 
- The monitoring programs will become more risk based, thereby limiting 
the number of regular monitoring samples and increasing the number of 
irregular samples being other matrices and/or containing compounds not 
routinely included in the monitoring plan. Methods should be available to 
detect antimicrobial activity at relevant levels and procedures should be 
developed to determine the identity of the ‘unknown’ compound present. 
Monitoring plans aim for detection of banned substances at levels as low as 
reasonably possible and at least at the minimum required performance limit 
(MRPL). For registered substances, screening and confirmatory methods are 
implemented aiming for detection and quantitation of antibiotic residues at and 
around the maximum residue limit (MRL). It is important to realise that “in order 
to protect public health, MRLs should be established in accordance with generally 
recognised principles of safety assessment, taking into account toxicological 
risks, environmental contamination, as well as the microbiological and 
pharmacological effects of residues” [88]. More specifically, MRLs are established 
based on pharmacological and toxicological data, immunotoxicity, 
microbiological properties and their effects on the human gut flora [89,90]. The 
possible occurrence of bacterial resistance as a result of antibiotic usage is not 
specifically mentioned in the establishment of MRLs. Because of emerging 
antibiotic resistance the government policy focuses on the decrease of antibiotic 
treatment and therefore additional requirements for the registration of 
antibiotics usage in animal breeding were established [91]. To enforce this 
requirement, I expect that the focus of monitoring plans will broaden: 
- Instead of only aiming at MRL level, monitoring programs will focus on 
antibiotic usage in general and thus on levels as low as reasonably 
possible.  
- The focus will extend from monitoring the levels of antibiotics in food 
products to other matrices, like manure, feathers, hair and swap samples. 
By analysing these noninvasive samples antibiotic usage can possibly be  
monitored effectively. Monitoring programs should also include 
environmental samples to study the role of antibiotic residues in the 
dissemination of bacterial resistance.  
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Efficient monitoring strategies 
For the regulatory control of products of animal origin aiming at MRL level, the 
current trend observed is towards the use of more generic methods as presented 
in chapter 2. This compromises selectivity and therefore, most of these methods 
are considered screening methods. I expect that, in the near future a few 
screening methods, be it microbiological, biochemical or instrumental, that 
include a broad range of compounds will be applied to monitor the complete 
range of antibiotic, anthelmintic and coccidiostat drugs. In current practice, 
suspect samples are re-analysed using confirmatory methods that focus on a 
single compound group and if instrumental screening techniques are used it is 
common to re-inject samples on the same LC system after adjusting the MS 
settings to focus on a single compound using two or more ion transitions. These 
confirmatory methods run within the quality system’s scope and as a result, 
operationality of all of these methods has to be demonstrated. Because only a 
relatively low number of samples are found suspect, these methods are applied 
sparingly and thus additional effort is needed to demonstrate operationality to 
keep accreditation for these methods. This is extremely inefficient. 
In my opinion, a solution to this problem would be to use a single, highly 
selective confirmatory method that replaces all individual confirmatory methods. 
To facilitate this, a detection system should be developed that is able to 
sufficiently retain and separate antibiotics from all relevant antibiotic classes 
including the tetracyclines, sulfonamides, (fluoro)quinolones, macrolides, ß-
lactams and aminoglycosides. Especially including the latter compound group is 
challenging because these antibiotics are highly polar and are not retained in 
reversed phase chromatography.  
A promising technique to fulfill this challenging task is 2D chromatography like  
LCxLC, SFCxSFC or the combination of LC with SFC. Such a system yields superior 
chromatographic resolution and thus is high selectivity. Because these systems 
are more complicated than regular LC systems, for the upcoming years, these 
will not function within a routine situation. Until then, I advise to carry out the 
screening analysis using generic screening methods at the official laboratories 
and that all suspect samples are transferred to the national reference laboratory 
(NRL) in order to carry out confirmatory analysis using a comprehensive two-
dimensional technique. A huge advantage of this approach is that samples are 
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analysed by two different laboratories and using two different systems, which 
enhances the selectivity and trustworthiness of the result. Furthermore, this 
approach is more efficient for the official laboratories because they can focus on 
broad screening methods under a fixed scope whereas the NRL can assure 
accreditation under a flexible scope which is an additional strain on the 
laboratory’s quality system. For this approach to be successful, a high degree of 
collaboration between the official laboratories and the NRL is mandatory. A 
disadvantage of this approach is that the NRL cannot carry out the counter- 
analysis of the non-compliant samples, because of a conflict of interest. 
Therefore, also collaboration with other laboratories, e.g. the European 
Reference Laboratories (EURL) is mandatory. 
Risk based monitoring 
Currently, the implemented monitoring programs are relatively fixed and only 
slight changes occur from one year to the next. Therefore, also the scope of 
methods of analysis needed for regulatory control is relatively fixed. In my 
opinion monitoring programs should become more risk based. The prescribed part 
in the monitoring program should become more limited and each member state 
should carry out a risk assessment regularly on basis of which the national 
monitoring programs are adjusted. This will result in a focus on different 
antibiotic compounds, different matrices and different levels and as a result, 
additional compounds and matrices will have to be analysed. As an example of a 
risk based approach, national legislation will be enforced stating that, to prevent 
further dissemination of antimicrobial resistance, third and fourth generation 
cephalosporins and (fluoro)quinolones are only to be used in veterinary practice 
after it has been demonstrated that the aimed bacteria are resistant towards 
other, more common drugs like tetracyclines [91]. A more stringent monitoring 
on the use of third and fourth generation cephalosporins and (fluoro)quinolones is 
then inevitable. This should not focus on the detection of these compounds at 
MRL level, but at the use of these compounds in general. As a result, instead of 
determining the concentration of these compounds in animal tissue, the control 
should focus on the use of these compounds in general and thus be able to detect 
these antibiotics at levels as low as reasonably possible. Furthermore, the focus 
should be extended from species for which a certain antibiotic is registered, to 
species for which the use of these compounds is to be expected. Cephalosporins 
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are registered for use in pork and cattle, but because the use of these 
compounds is likely in poultry breeding as a result of penicillin resistance, 
monitoring should include different matrices.  
This development demands a highly flexible approach from official laboratories 
and NRLs. Furthermore, fast development of robust methods and efficient 
validation and method implementation is of importance. Also a more flexible 
quality control system is needed to be able to report results under accreditation. 
Another effect of a more risk based monitoring strategy is that methods are 
applied to monitor if new ‘unknown’ antibiotics are being used in veterinary 
practices. Therefore methods focusing on the detection of microbial activity are 
needed and as a follow up, highly selective methods are needed to be able to 
identify such compounds. A method for the identification of antimicrobially 
active compounds in feed is currently being developed within RIKILT. Samples 
showing antimicrobial activity are extracted and fractionated on an LC system 
with a subsequent microbial inhibition test to determine the fraction that 
contains the antimicrobially active compound. This fraction is further analysed 
by HRMS and the data were evaluated using a large compound database. This 
procedure is highly successful if the antimicrobially active compound is present 
at relatively high concentration, but especially when the antimicrobially active 
compound is present at low level, this procedure results in a long list of possible 
molecular formulas, each having several structural isomers. The possible 
candidates might not be false positive finding but could be other compounds 
present in the sample, like vitamins, flavones and plant hormones. So these can 
be eliminated because they do not show antimicrobial activity, but still it 
remains difficult to assign the identity of the antimicrobially active compound 
present. There are several options to further improve this procedure and limit 
the number of possible candidates: (1) using a database of compounds that all 
show antimicrobial activity, (2) modeling the LC system to eliminate false 
positive results based on retention time, (3) the use of a second fractionation 
system to limit the number of candidates, (4) the application of fragmentation or 
neutral loss trees for identification and (5) the application of IMS-HRMS. 
The first option is to only include antimicrobially activity compounds in a 
database. This would be highly beneficial, even though it might be possible that 
not all biological data on the possibly relevant compounds are available in 
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literature. Furthermore, it is an immense task to create a database that includes 
all antimicrobially active compounds and some natural (herbal) antibiotics might 
be missed. 
Second, the analytical LC system can be modeled according to the procedure 
described in chapter 3. With this, for each possible candidate reported, the 
retention time found can be related to the chemical characteristics of the 
compound. If these are not in agreement, the suggested compound can be 
eliminated from the list of possible candidates. Because for each possible 
candidate a number of physical and chemical properties have to be determined, 
this procedure can be quite laborious when the number of possible candidate 
compounds is high. Furthermore, other compounds that are truly present but are 
not responsible for the antimicrobial inhibition are not eliminated using this 
procedure. Therefore, other procedures to limit the number of possible 
candidates might be preferred.   
A third option is the use of an additional, and preferably orthogonal, 
fractionation system, e.g. using alkaline conditions, that is used in parallel to the 
acidic LC fractionation system. By correlating the list of determined possible 
candidates found by HRMS in the antimicrobially active fraction of both 
fractionation systems, the number of possible candidates can be limited 
severely. Furthermore, by comparing the retention time of the fraction 
containing the antimicrobially active compounds for both systems, information is 
obtained on the chemical properties of the compound (acidic, neutral, basic) 
that may not always be obtained by comparing the data of positive and negative 
ionisation in MS.  
A fourth option is to identify unknown compounds based upon multi stage (MSn) 
fragmentation and/or neutral loss trees. Related compounds result in similar 
fragmentation patterns in tandem MS (MS/MS) showing similar product ions or 
neutral losses. As an example, for all penicillins included in the method as 
presented in section 5.4, a product ion at m/z 160 is found (not in all cases 
among the two most abundant ions). The observation of a product ion of m/z 160 
for an unknown compound could indicate it is related to the penicillins. The use 
of fragmentation and neutral loss trees has been reported in literature as a tool 
to elucidate sub-structures of unknown compounds [92-95]. Problems related to 
this technique are the complexity of the data and therefore the need of 
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expertise [92], the reproducibility of the data from one instrument to the other 
and the limitation of this approach to the use of multi-stage MSn mass 
spectrometric equipment (ion trap). 
Last, the use of IMS-HRMS can aid in the structure elucidation of the 
antimicrobially active compound. Besides the higher separation power obtained, 
using IMS, the collision cross section of the candidate compounds can be 
determined, which is valuable information for structural characterization of the 
compound [45,96]. 
Sub-MRL detection 
It is recognised only recently that antibiotic usage in veterinary practice and the 
presence of low levels of antibiotics in food products and the environment 
contribute to the emergence of antibiotic resistance [97]. Therefore, instead of 
only monitoring the level of antibiotic residues present in food products, the use 
of antibiotics in animal breeding in general should be monitored. Due to 
increasing antibiotic resistance, the Dutch government emphasised on the 
development of new antibiotics and on lowering antibiotic usage in humans [98] 
and veterinary practice [99]. In 2011, a reduction of 32 % of antibiotic usage 
compared to 2009 was reported. However, these figures are based on official 
sales data rather than usage data and might thus not fully reflect the use of 
antibiotics. In my opinion, to be able to determine the true antibiotic usage in 
veterinary practice, on-farm antibiotic usage registration data should be used 
that are enforced by a monitoring program.  
This program should not focus on monitoring antibiotic residues in food products 
aiming at MRL levels as is current practice, but instead on the control of the on-
farm registration data itself. For this purpose non-traditional matrices should be 
sampled including manure, hair, feathers and surfaces (e.g. by methanolic 
swaps). These samples are non-invasive and can easily be taken from any farm. 
Next, methods should be developed for the analysis of these samples aiming at 
detection limits as low as possible and the results of the analyses using these 
methods should be correlated to the on-farm registration system. Especially for 
the analysis of swap samples, if detection limits allow, ambient ionisation mass 
spectrometry might be a valuable technique as was previously demonstrated for 
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the analysis of explosives and drugs on fabrics [100,101] and surfaces [102], and 
pesticides on vegetable and fruit surfaces [103,104].  
Because no information is available on the levels of antibiotics that can 
contribute to the emergence of bacterial resistance, analytical methods should 
be able to detect antibiotics at levels far below the MRL. Many analytical 
methods, especially the ones based on LC-MS/MS are already capable of doing 
this of which the method for analysis of ß-lactams as described in section 5.4 is a 
clear example. However, for routine monitoring, quick, easy, cheap and reliable 
screening methods are beneficial. Unfortunately, microbial screening tests, as 
routinely applied in the monitoring of antibiotics in food products, are unsuited 
because of their relative high detection limits [105]. Therefore, cheap, easy and 
reliable screening tests, that are able to detect a broad range of antibiotics at 
levels well below the MRL, are required. Besides generic instrumental methods, 
immunoassay biosensors based on (imaging) surface plasmon resonance (SPR) 
[106-113], electrochemical immunosensors using magnetic beads [114] and 
luminescent bacteria biosensors [115,116] are promising techniques. 
Antibiotic-free animal breeding 
Especially when outbreaks of resistant bacteria get more common, from a 
producer’s commercial perspective it could be of interest to introduce a quality 
label indicating antibiotic-free animal breeding practices. But is it possible to 
distinguish between for instance broilers that were raised without antibiotics and 
broilers that were treated, even if it was in the first days after hatching? 
Antibiotics are excreted from the body and a few days or weeks after treatment, 
residue levels in body tissues and manure are usually too low to be detected (as 
was also shown in section 5.3) [117]. Therefore, regular testing of food products 
aiming at the MRL level or well below, are insufficient and thus new approaches 
are needed.   
The first option could be monitoring unconventional matrices, e.g. bones, legs, 
feathers or hair. Antibiotics may be excreted from tissue, they might accumulate 
in other matrices. In a study enrofloxacin was administered to broilers and 
kidney, muscle, liver and feather samples were analysed until nine days after 
treatment. It was found that nine days after treatment enrofloxacin and its 
metabolite ciprofloxacin were present at higher levels in feathers compared to 
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tissues [118]. Furthermore, it was reported that chlortetracycline binds to bones 
and can be released under acidic conditions [119]. This could be of interest to 
detect the use of tetracycline antibiotics long after administration. 
The second option is the use of an untargeted metabolomics approach [120-124] 
to distinguish treated animals from untreated animals. A first step would be to 
study the applicability of this approach based on one antibiotic substance. 
Samples of a large and highly diverse group (species, age, region, etc.) of treated 
and non-treated animals (preferably treated at different time points in their 
lives) should be analysed using a generic sample preparation procedure and a full 
scan detection technique (e.g. LC-Orbitrap-MS). Using multivariate data analysis 
(e.g. principal component analysis), the treated and untreated group should be 
distinguished [125,126]. As a second step, animals treated with a different 
antibiotic from the same compound group and, later, animals treated with 
entirely different antibiotics can be added to the data set. The main 
disadvantage of this approach to be successful is the need of a blank population 
that fully covers all natural variation and thus an extreme number of animals is 
needed to set up the method. As an alternative, biomarkers for antibiotic usage 
may be found. 
Concluding remarks on monitoring strategies 
Due to the current economic situation and the renewed attention for bacterial 
resistance, changes will occur in the monitoring strategies for veterinary drugs in 
products of animal origin. There is a clear need for more efficient methods and 
new monitoring strategies have to be developed to be able to control farmers’ 
administration. This includes the detection of antibiotics at levels as low as 
reasonably possible and research to determine what samples are suitable for this 
purpose, e.g. manure, swaps, feathers (all non-invasive) and bones. 
The analysis of chloramphenicol 
In this thesis the analysis of CAP, a banned antibiotic compound which is 
frequently detected in products of animal origin [127], corn silage and straw 
[128] was studied. Findings of CAP have had a huge impact on farmers’ lives and 
international trade [129,130]. 
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Confirmatory analysis 
A first step in the analysis of CAP is to confirm the identity of the compound 
present. Because CAP occurs in eight different stereoisomers, of which only one 
is biologically active, the confirmatory method should be able to discriminate 
among these eight isomers. As described in section 4.4 a method was developed 
based on chiral LC coupled to MS/MS which is able to confirm the presence of the 
individual isomers at levels well below the minimum required performance limit 
(MRPL) of 0.3 µg kg-1 in urine. This method also proved to be applicable for the 
analysis of animal feed and plant samples. 
The reported method consists of an extensive sample clean-up procedure which 
limits the sample throughput. Furthermore, relatively large amounts of toxic 
chemicals are used. Therefore, it would be advisable to study new ways to 
discriminate the CAP isomers. Possibilities would be to use ion mobility 
spectrometry in line with (HR)MS detection. A second option would be to use 
supercritical fluid chromatography (SFC) instead of chiral LC as discussed above. 
Natural occurrence 
A second important aspect is the study of the possible natural occurrence of CAP 
residues. CAP was first isolated from the soil bacteria Streptomyces venezuelae 
[131,132] and can therefore occur naturally. In section 4.2 it is shown that CAP 
was detected in plant material, mainly obtained from Mongolian pastures. Later 
the detection of CAP in straw samples from different origins within Europe was 
reported [128], indicating the natural occurrence of CAP. In the meantime, also 
in other European countries unexpected findings of CAP have been reported. The 
possible natural occurrence of CAP was studied by (1) comparing isomeric profiles 
in positive samples and CAP formulations, (2) studying the possibility of CAP 
production when exposing corn silage to air and (3) investigating the possibility 
of crops to take up CAP from the soil. 
In section 4.3 it was shown that no differences in isomeric profiles of CAP were 
observed in positive samples and CAP formulations: in all cases only the active 
isomer was detected. It was concluded that naturally occurring CAP and 
chemically synthesised CAP cannot be discriminated on basis of the isomeric 
profiles. Furthermore, it was found (results not presented in this thesis) that 
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during corn silage preparation and after exposing corn silage to air, conditions 
are unfavorable for CAP production. Therefore it is unlikely that CAP is naturally 
produced in the corn silage production process. In section 4.5 it is shown that 
wheat and corn can take up CAP from the soil with the uptake rate primarily 
depending on the type of soil cultivated on. It was also demonstrated that CAP 
can be produced by Streptomyces venezuelae in non-sterile soil and, on the 
other hand, that CAP is biodegraded in soil. This might explain why no or only 
very low levels of CAP have been detected in soil samples. Nevertheless, it was 
shown that CAP can be produced by soil bacteria in non-sterile soil in appreciable 
amounts, allowing the transfer to crops and the subsequent detection of free CAP 
residues in crops. This is considered evidence of the natural occurrence of CAP in 
crops and animal feed.  
If such crops are consumed by animals, CAP residues in products of animal origin 
may occur via this route. To support this, transfer studies of CAP in animal feed 
products (corn and wheat straw) to products of animal origin, including muscle, 
casings and urine, are needed. A preliminary oral dosing study in veal calves 
showed that direct oral administration of CAP corresponding to at least 3 µg kg-1 
CAP in feed is needed to obtain non-compliant findings of CAP (> MRPL) in urine 
and that CAP levels drop well below the MRPL within one day after consumption. 
Because no contaminated feed was available, this study was carried out, as a 
worst case scenario, by applying CAP preparations directly into the calves’ 
mouths. In this way the exact administered amount of CAP is known and no cross-
contamination among the calves can occur. However, it may not be fully 
representative with the intake of CAP through contaminated feed or stall 
bedding. Therefore, a transfer study using contaminated feed is urgently needed 
to confirm the preliminary results and to study other matrices like muscle and 
casings. 
Another study that is scientifically relevant is the investigation of the fate of CAP 
in soil and crops. The transfer study presented in section 4.5 solely focused on 
free CAP and it was observed that over 99 % of the CAP administered to the soil 
was undetectable. Besides microbial degradation, it may be possible that CAP is 
conjugated in soil or in crops and that it is reactivated after ingestion by animals. 
Therefore, the determined transfer of free CAP is the bare minimum of CAP that 
is transferred. To study the fate of CAP, HRMS could be applied searching for CAP 
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conjugates and degradation products. Furthermore the mass balance of CAP 
could be studied in a transfer study in which the biodegradation of CAP in soil is 
eliminated. This could be done by cultivating crops on sterile soil or in the 
absence of soil (e.g. on water). If biodegradation in soil was the primary process 
that lead to the loss of CAP, a severely higher percentage of CAP should be 
recovered in this experiment. In parallel, the presence of CAP conjugates and 
metabolites in plant and soil samples should be studied by analysing these 
samples using HRMS. 
Because it is likely that CAP can occur naturally in crops, this affects the 
enforcement of legislation. Therefore, for CAP, either the status of banned 
antibiotic should be abandoned and a threshold level should be established based 
upon low-level toxicological data [130] or methods should be developed that are 
able to discriminate between naturally produced and chemically synthesised 
CAP. The latter might be possible in two ways. The first option is to study if 
intermediates and/or by-products of the naturally occurring CAP biosynthesis are 
detectable in contaminated samples. Several intermediates and by-products are 
produced in the biosynthesis of CAP among which N-dichloroacetyl-p-
aminophenylserinol, p-amino-phenylserine and chorismic acid (figure 6.4) [133-
136]. If one or more of these intermediates or by-products is detectable besides 
CAP itself, these compounds might be useful markers in the discrimination of 
biosynthesised and chemically synthesised CAP. Chemical CAP preparations are 
purified to obtain the highest possible purity. Nevertheless, to prevent the 
selection of a marker compound that could also be the result of chemical 
synthesis, the chemical synthesis of CAP should be taken into account as well. 
The main route for chemical synthesis seems to deviate severely for the 
biosynthesis, having 2-amino-1-(4-nitrophenyl)-1,3-propanediol as the 
intermediate [137-139], whereas in the biosynthesis the intermediate products 
contain an aminophenyl moiety. 
Another option is to study the ratio of naturally occurring isotopes (e.g. 12C 
versus 13C) in CAP using isotope ratio MS (IRMS) [140] in order to determine the 
origin of the compound. This technique has been used in authenticity control of 
food products [141,142], the detection of production fraud [143], the 
differentiation of exogenous from endogenous steroids [144-147] and in the 
determination of the origin of cyanide in forensic investigations [148]. 
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Figure 6.4. Chloramphenicol biosynthesis including other primary and secondary 
aromatic metabolites in the shikimic acid pathway [134].  
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Concluding remarks on chloramphenicol analysis 
As a result of my research a highly selective method for the analysis of CAP is 
available and evidence was found for the natural occurrence of CAP in crops and 
animal feed. Because CAP is a banned substance, it is of main importance to 
discuss the European regulations. Should the banned status of CAP be remained 
or should a tolerance limit be implemented? In my opinion additional research is 
needed. First, transfer studies from CAP contaminated feed or crops to products 
of animal origin are needed to determine if naturally contaminated samples can 
result in positive findings in such samples. Second, research on the possibility to 
discriminate biosynthesised from chemically synthesised CAP is needed. Third, 
toxicity studies based on sub-ppb concentrations of CAP in products of animal 
origin should be carried out. If naturally contaminated samples are not likely to 
result in positive findings in products of animal origin or if biosynthesised and 
chemically synthesised CAP can be discriminated, the banned status of CAP can 
be maintained. If CAP turns out not to be toxic at residue levels, an MRL could be 
established. Up until then, I advise to take straw and feed samples when taking 
regular samples for CAP analysis. If this is not possible, e.g. because samples are 
taken in the slaughter house, conclusions based on positive CAP findings should 
be drawn with utmost care. 
Concluding recommendations 
To summarise, the following recommendations for future research are made: 
- The selectivity of HRMS compared to MS operating at nominal mass 
resolution should be studied. Based on the outcomes, regulations on the 
use of HRMS in confirmatory analysis should be assessed. 
- The use of IMS, LCxLC and SFC to further enhance selectivity in 
confirmatory analysis should be studied. Also the applicability of these 
techniques in research studies, e.g. coupled to HRMS should be 
investigated. 
- Efficient screening methods that include a broad range of compounds in 
combination with highly selective, broadly applicable confirmatory 
methods should be developed in order to efficiently carry out the (fixed 
and risk based) national monitoring plan. 
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- Monitoring strategies should be developed to effectively control farmers’ 
antibiotic usage registration. This includes method development to further 
decrease detection limits of regulated antibiotics and studying the use of 
other matrices for antibiotic residue detection, e.g. hair, feathers, swaps, 
manure (non-invasive) and bones. 
- The transfer of CAP from naturally contaminated crops or feed to 
products of animal origin (e.g. urine, muscle and casings) should be 
studied to determine if naturally contaminated crops and feed can result 
in non-compliant finding of CAP in products of animal origin. 
- The mass balance of CAP in a transfer study from soil to crops should be 
studied in which the biodegradation of CAP in soil is eliminated. In this 
way it is studied if only free CAP is present in crops or if other forms of 
CAP, e.g. conjugated CAP, is formed in the crop and/or non-sterile soil. In 
parallel, the presence of CAP conjugates and metabolites in plant and soil 
samples should be studied by analysing these samples using HRMS. 
- It should be studied if the biosynthesis of CAP by soil organisms can be 
discriminated from chemically synthesised CAP. This may be possible by 
studying biosynthesis by-products or by applying IRMS.  
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Summary 
In animal breeding the use of antibiotics has become common practice. 
Antibiotics are used to treat bacterially infected animals but are also 
administered as a preventive measure. From an animal and human health 
perspective, responsible use of antibiotics is of importance. Therefore, 
regulatory monitoring programs are in place. In residue analysis of antibiotics in 
products of animal origin, quantitative and qualitative aspects are involved in 
declaring a sample non-compliant (positive). The quantitative aspect regards the 
determination of the amount of the compound present in the sample. The 
qualitative aspect regards the confirmation of the identity of the compound 
present. In this, selectivity is the main parameter of importance which is defined 
as the ability of a method to distinguish the analyte being measured from other 
substances. In chapter 1, the background on antibiotics usage in animal breeding 
and the legal framework of antibiotic analysis are discussed. 
In chapter 2, the observed trends in sample preparation of veterinary drug 
analysis using liquid chromatography coupled to mass spectrometry (LC-MS/MS) 
are discussed. Due to recent advances in LC-MS instrumentation the detection of 
many compounds within one run became possible and methods for the 
simultaneous analysis of different compound groups were developed. To be able 
to simultaneously analyse compounds having different physical and chemical 
properties, generic sample preparation procedures are applied. The most 
frequently reported generic sample preparation methods are a solvent extraction 
only, solid phase extraction and a QuEChERS (Quick, Easy, Cheap, Effective, 
Rugged, Safe) approach. These multi-analyte methods - sometimes including over 
150 different compounds – are of much interest for analytical laboratories due to 
the reduction of costs. A clear drawback of generic sample preparation 
procedures is the occurrence of abundant matrix effects which compromise 
detection limits, quantitative aspects, maintenance frequency and method 
selectivity.  
In chapter 3 the concept of selectivity of qualitative LC-MS/MS methods is 
discussed. Validation procedures are available to determine the uncertainty of 
the quantitative result, which is taken into account in the decision making 
process. For the qualitative aspect, criteria for confirmation of the identity of a 
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compound using LC-MS/MS are laid down in several regulations. These criteria 
concern the minimum requirements for the instrumental set-up and criteria for 
retention time and relative product ion abundances in LC-MS/MS systems 
operated in the multiple reaction monitoring mode. Procedures to determine the 
uncertainty of the qualitative aspect of a method of analysis are lacking and, as a 
result, whether or not a method is adequately selective is a matter of experts’ 
judgment. A procedure was developed on basis of which the selectivity of an LC-
MS/MS method can be graded. A measure for the (un)certainty of the selectivity 
is the probability of any compound showing the same precursor ion, product ions 
and retention time as the compound of interest. In the developed procedure this 
is calculated based upon empirical models constructed from three large 
compound databases. Based upon the final probability estimation, additional 
measures to assure unambiguous identification can be taken, like the selection of 
different or additional product ions. The reported procedure in combination with 
criteria for relative ion abundances result in a powerful technique to determine 
the (un)certainty of the selectivity of any LC-MS/MS analysis and thus to decrease 
the risk of false positive results. 
To demonstrate the importance of selectivity, in this thesis two analytical 
challenges are presented in which selectivity plays an important role. One in 
which selectivity is extreme to be able to discriminate between a banned 
antibiotic and its antimicrobially inactive isomers. Second a method in which 
selectivity is deliberately compromised to obtain an effective monitoring strategy 
in which not only the parent drugs are detected, but also their protein bound 
metabolites. 
In chapter 4, the analysis of the broad spectrum antibiotic chloramphenicol 
(CAP) is discussed. Due to its suspected carcinogenetic properties and linkages 
with the development of aplastic anemia in humans, CAP is banned for use in 
food producing animals in the EU and many other countries. This topic is 
introduced in detail in section 4.1. In section 4.2 it is reported that CAP was 
detected in several herb and grass samples from different geographic origin. The 
results of this study demonstrate that non-compliant findings in animal-derived 
food products may in part be due to the natural occurrence of CAP in plant 
material. If so, this has implications for the application of current legislation and 
the interpretation of analytical results with respect to the consideration of CAP 
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as a xenobiotic veterinary drug residue and the regulatory actions taken upon its 
detection in food and feed.  
CAP occurs in the para-configuration and in the meta-configuration and contains 
two chiral centers, thus eight different isomeric configurations exist, namely four 
(RR, SS, RS, SR) meta-stereoisomers and four para-stereoisomers. It is known that 
only RR-p-CAP has antimicrobial properties. To find out if the CAP detected in 
the plant material samples is the active configuration, in section 4.3 a high 
resolution reversed phase LC-MS/MS system was tested for its ability to separate 
the different isomers. After a detailed elucidation of the product ions and the 
fragmentation patterns of all isomers, reversed phase LC-MS/MS proved to be 
able to discriminate among some isomers, but not between the enantiomeric 
pairs, including RR-p-CAP (the active isomer) and SS-p-CAP. A chiral LC 
separation with MS/MS detection that is able to distinguish all isomers was 
developed. Using this new method it was demonstrated that the CAP present in 
the plant materials was indeed the antimicrobially active isomer. 
In section 4.4 a quantitative method for the analysis of ultra-trace levels of 
eight chloramphenicol isomers in urine by chiral LC-MS/MS is reported. The 
separation of the isomers on the analytical column, the selectivity of the 
monitored product ions and the clean-up of urine turned out to be critical 
parameters. To obtain reproducible retention times, isocratic elution on a chiral 
α-acid glycoprotein column was applied. For urine samples, matrix compounds 
present in the final extract caused decreased retention of the isomers on the 
chiral stationary phase and a lack of chromatographic resolution. Therefore an 
extensive clean-up procedure that combines solid phase extraction and liquid-
liquid extraction had to be developed. The final method was fully validated and 
showed satisfactory performance for all isomers with decision limits (CCα) 
ranging from 0.005 to 0.03 µg L-1 and within-laboratory reproducibility of all 
isomers below 20 % at the minimum required performance limit of 0.3 µg L-1. 
In section 4.5 the natural occurrence of CAP is studied in more detail. The 
hypothesis is that CAP can occur in crops and animal feed through the production 
of the drug by soil bacteria and the subsequent uptake by crops. Two conditions 
should be fulfilled to accept the posed hypothesis: (1) soil bacteria must be able 
to produce CAP in soil under natural conditions and (2) crops should be able to 
take up CAP from the soil. It is shown that the soil bacteria Streptomyces 
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venezuelae can produce CAP in appreciable amounts in non-sterile soil. Even 
though CAP is biodegraded in non-sterile soil, it is taken up by plants in relatively 
small amounts, where it might accumulate. Based on the observations it is stated 
that CAP can occur in crops, and therefore in animal feed, through the natural 
production of CAP in soil by soil bacteria. 
In chapter 5, the analysis of ß-lactam antibiotics is presented. ß-lactam 
antibiotics include the penicillins, cephalosporins and carbapenems. Especially 
penicillins are frequently applied in animal breeding and human medicine. 
Nowadays, antibiotic resistance against the penicillins is extremely high. Also 
resistance against cephalosporins and even carbapenems has been reported, 
which is a major threat to human health. This subject is introduced in detail in 
section 5.1. The main challenges in ß-lactam analysis are (1) the instability of 
some of the analytes and (2) the fast metabolism ceftiofur and cefapirin and the 
protein binding of ceftiofur residues.  
In section 5.2 the research on the degradation of ceftiofur and cefapirin is 
presented. A slight instability of cefapirin and desfuroylceftiofur was observed at 
elevated temperatures. Ceftiofur and cefapirin degraded immediately and 
completely in an alkaline environment, resulting in antimicrobially inactive 
degradation products. Ceftiofur and cefapirin also degraded immediately and 
completely in kidney extract resulting in both formerly reported metabolites as 
well as not previously reported products. It is shown that conditions often 
occurring during the analysis of ceftiofur or cefapirin can result in rapid 
degradation of both compounds. From this, on a theoretical basis, it is concluded 
that underestimation of the determined amounts of ceftiofur and cefapirin is 
likely to occur when using conventional methods for the quantitative analysis of 
these compounds in tissue, and that a new approach is needed that takes the 
metabolism and degradation into account. 
To effectively detect off-label ceftiofur usage an analytical method is needed 
that, besides the native compound, also detects its active metabolites. In 
section 5.3 the applicability of three approaches for the quantitative analysis of 
ceftiofur using LC-MS/MS is assessed, viz. (A) the analysis of ceftiofur, 
desfuroylceftiofur and/or desfuroylceftiofur cystein disulfide, (B) the hydrolysis 
of ceftiofur metabolites to desfuroylceftiofur acetamide and (C) a new method 
based on the chemical hydrolysis of ceftiofur metabolites using ammonia in order 
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to produce a single marker compound that is representative for the sum of all for 
ceftiofur metabolites. It was found that approach A is not suited for quantitative 
analysis of total ceftiofur concentration nor for effectively detecting off-label 
use of ceftiofur. Approach B resulted in adequate quantitative results, but is 
considered to be a single compound method. Approach C showed adequate 
quantitative results as well, but in contrast to approach B, this approach is 
applicable to a range of cephalosporin antibiotics and therefore applicable as a 
broad quantitative analysis method for cephalosporin compounds in poultry tissue 
samples. 
In section 5.4 a comprehensive method is reported based on hydrolysis using 
piperidine, for the quantitative analysis of a broad range of ß-lactam antibiotics 
including penicillins, cephalosporins and carbapenems. The hydrolysis was 
optimised using a full experimental design. Using isotopically labeled analogues 
and high resolution mass spectrometry (HR-MS), molecular structures of the 
derivatization products were proposed. The method was fully validated showing 
satisfactory method performance. It was shown that this method is suitable for 
the quantitative analysis of 21 out of 22 compounds included and that it is 
effective for the detection of off-label ceftiofur use, because protein bound 
metabolites are included. 
In chapter 6 future perspectives on antibiotic analysis are discussed. The use of 
HR-MS is one of the main trends observed. A study comparable to the work 
described in chapter 3 is needed to assess the selectivity of that technique. 
Based upon the outcome, regulations on the use of HR-MS for confirmatory 
analysis should be assessed. Other methods have become available to further 
enhance the selectivity of a method. In ion mobility spectrometry compounds can 
be separated based on their size, shape and collision cross section and therefore 
it is orthogonal to LC-MS/MS. If IMS is coupled to LC-MS/MS the selectivity is 
enhanced. The use of comprehensive LC (LCxLC) would also severely increase 
selectivity. Research is needed to determine optimal and compatible conditions 
for both dimensions and to effectively couple the two chromatographic systems. 
Next, supercritical fluid chromatography (SFC) is a promising technique. Due to 
the fast diffusion rate and the limited back pressure, fast separation at high 
resolution can be obtained. Also combinations of these techniques, e.g. IMS-HR-
MS or LCxSFC should be considered. 
Summary 
 
331 
In chapter 6 also some expected changes in monitoring strategies are discussed. 
The national monitoring plan will become more risk based and therefore, a more 
generic and flexible approach is needed. The most efficient would be to use 
generic screening methods that include a broad range of compounds in 
combination with highly selective confirmatory methods. Also, due to the 
increasing bacterial resistance, the focus of regulatory control will be more on 
antibiotic usage in general next to the control of food products itself. In this, 
detection limits should be as low as reasonably possible and the use of other 
matrices should be investigated, e.g. manure, hair, feathers, swap (all non-
invasive) and bone samples. 
Finally, future research regarding CAP analysis is discussed. Because it is shown 
that CAP can occur naturally in crops and feed, transfer studies from 
contaminated crops and feed to products of animal origin, including urine, meat 
and casings are needed to determine if the natural levels in crops and feed can 
result in non-compliant results in animal products. Furthermore, a study on the 
possibility to discriminate biosynthesised CAP from chemically synthesised CAP is 
needed. Based on the outcome of these studies, the banned status of the drug 
should be reconsidered. 
Based on the findings in this thesis we can now answer the question: “What 
selectivity is adequate?” Unfortunately, there is no general answer to this 
question, because this highly depends on the purpose of the method in question. 
Usually there is a trade-off between selectivity and the number of compounds 
that can be included in a method. For a screening method a low selectivity is 
acceptable (as long as the number of false positives remains limited), whereas 
selectivity should be high for a confirmatory method. Furthermore, the 
selectivity needed depends on the interferences that can be expected. In some 
cases high selectivity is needed as in the case of CAP, in other cases, like in 
ceftiofur analysis, selectivity has to be compromised to obtain an effective 
monitoring strategy. To conclude, whenever developing or validating a method, 
it is of extreme importance to consider the parameter selectivity in detail. 
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Samenvatting 
In de veehouderij is het gebruik van antibiotica gangbaar geworden. Antibiotica 
worden gebruikt om bacterie-infecties te behandelen, maar worden ook 
toegepast als preventief middel. Het verantwoordelijk gebruik van antibiotica is 
van belang vanuit het oogpunt van dierlijk welzijn en humane gezondheid. Om 
antibioticumgebruik in de veehouderij te controleren bestaan er wettelijke 
monitoringsprogramma’s. In de residuanalyse van antibiotica in producten van 
dierlijke oorsprong spelen kwantitatieve en kwalitatieve aspecten een rol in het 
bepalen of een monster conform de regelgeving is. Het kwantitatieve aspect 
betreft de bepaling van de hoeveelheid van het aanwezig antibioticum en het 
kwalitatieve aspect betreft het vaststellen van de identiteit van het 
antibioticum. Hierbij speelt de parameter ‘selectiviteit’ een belangrijke rol. 
Selectiviteit wordt gedefinieerd als ‘het vermogen van een methode om 
onderscheid te maken tussen de te analyseren component en andere aanwezige 
componenten’. In hoofdstuk 1 wordt de achtergrond van antibioticumgebruik in 
de veehouderij en de wetgeving omtrent de monitoring hiervan besproken. 
In hoofdstuk 2 worden de trends in de monstervoorbewerking in de analyse van 
dierbehandelingsmiddelen met behulp van vloeistofchromatografie gekoppeld 
aan tandem-massaspectrometrie (LC-MS/MS) bediscussieerd. Ten gevolge van de 
laatste instrumentele ontwikkelingen is het mogelijk geworden een groot aantal 
verschillende componenten tegelijkertijd te detecteren. Om componenten met 
verschillende fysische en chemische eigenschappen tegelijkertijd te kunnen 
analyseren, dient een generieke monstervoorbewerking toegepast te worden. Het 
meest frequent toegepast zijn vloeistofextractie, vastefase-extractie en 
QuEChERS (Quick, Easy, Cheap, Effective, Rugged, Safe). Deze multi-
componentmethoden, die soms meer dan 150 componenten bevatten, leiden tot 
een verlaging van de analysekosten, maar een nadeel is dat de kans op 
matrixeffecten groot is, waardoor ingeleverd wordt op detectielimieten, 
kwantitatieve aspecten, de onderhoudsfrequentie en de selectiviteit.  
In hoofdstuk 3 wordt de selectiviteit van kwalitatieve methoden besproken. 
Validatierichtlijnen voor het bepalen van de onzekerheid van het kwantitatieve 
resultaat van een methode, dat wordt meegenomen in de besluitvorming, zijn 
voorhanden. Wat het kwalitatieve aspect betreft zijn criteria voor bevestiging 
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van de identiteit van een component, gebruikmakend van LC-MS/MS vastgelegd. 
Deze criteria betreffen de minimaal toe te passen instrumentele techniek, de 
retentietijd en relatieve ion-intensiteit. Procedures om de onzekerheid van het 
kwalitatieve resultaat te bepalen zijn niet voorhanden. Daarom is het vaststellen 
of een methode voldoende specifiek is een kwestie van de inschatting van 
experts. Er is een methode ontwikkeld op basis waarvan de selectiviteit van een 
LC-MS/MS meting kan worden beoordeeld. Een maat voor de (on)zekerheid van 
de selectiviteit is de kans dat een component eenzelfde precursor-ion, product-
ionen en retentietijd heeft als de component die van belang is. In de ontwikkelde 
procedure wordt dit bepaald op basis van empirische modellen, opgesteld aan de 
hand van drie stofdatabanken. Op basis van de verkregen schatting kunnen 
aanvullende maatregelen genomen worden om te komen tot een eenduidige 
bevestiging van de identiteit, zoals de selectie van andere product-ionen of de 
selectie van een additioneel product-ion. De gerapporteerde procedure in 
combinatie met de gestelde wettelijke criteria voor relatieve ion-intensiteiten 
resulteert in een krachtige techniek om de onzekerheid van de 
bevestigingsanalyse te bepalen, zodat het risico op een vals-positief resultaat 
beperkt wordt. 
Om het belang van selectiviteit te illustreren, zijn in dit proefschrift twee 
uitdagingen gepresenteerd waarin selectiviteit een belangrijke rol speelt. Ten 
eerste een methode waarin de selectiviteit extreem hoog moet zijn om verschil 
te kunnen maken tussen een verboden antibioticum en haar antimicrobiologisch 
inactieve isomeren. Ten tweede een methode waarbij de selectiviteit bewust 
wordt gecompromitteerd zodat een effectieve monitoringsstrategie wordt 
verkregen waarbij niet alleen het antibioticum zelf wordt gedetecteerd, maar 
ook eiwitgebonden metabolieten daarvan. 
In hoofdstuk 4 wordt de analyse van het breedspectrumantibioticum 
chlooramfenicol (CAP) bediscussieerd. Doordat dit antibioticum verdacht 
carcinogeen is en geassocieerd wordt met aplastische anemie bij de mens, is het 
verboden voor gebruik bij voedselproducerende dieren. Dit onderwerp is in 
sectie 4.1 geïntroduceerd. In sectie 4.2 wordt gerapporteerd dat CAP 
gedetecteerd is in diverse kruiden en grassen van verschillende geografische 
oorsprong. Dit resultaat laat zien dan positieve bevindingen van CAP in dierlijke 
producten mogelijk een natuurlijke oorsprong kunnen hebben. Als dat zo is, 
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heeft dit mogelijk invloed op de bestaande wetgeving en de interpretatie van 
analytische resultaten.  
CAP komt voor in de para- en in de meta-configuratie en bevat twee chirale 
centra, waardoor acht verschillende isomeren bestaan, namelijk vier (RR, SS, RS, 
SR) para- en vier meta-stereo-isomeren. Het is bekend dat alleen RR-p-CAP 
antimicrobieel actief is. Om te onderzoeken of de CAP gedetecteerd in de gras- 
en kruidenmonsters de actieve isomeer is, is in sectie 4.3 getest of 
hogeresolutie-reversed-phase-LC-MS/MS onderscheid kan maken tussen de 
verschillende isomeren. Na een uitgebreide opheldering van de structuur van de 
product-ionen en de fragmentatiepaden, blijkt reversed-phase-LC-MS/MS 
geschikt om enkele isomeren te onderscheiden, maar niet de 
spiegelbeeldisomeren zoals RR-p-CAP en SS-p-CAP (dextramycine). Daarom is een 
chiraal LC-systeem ontwikkeld waarmee alle isomeren wel onderscheiden kunnen 
worden. Met dit scheidend systeem is aangetoond dat de gras- en 
kruidenmonsters de antimicrobieel actieve vorm van CAP bevatten. 
In sectie 4.4 is een kwantitatieve methode voor de analyse van de acht CAP-
isomeren in urine met behulp van chirale LC-MS/MS gerapporteerd. De 
isomeerscheiding op de analytische kolom, de selectiviteit van de gemonitorde 
product-ionen en de monstervoorbewerking zijn kritische parameters. Om 
reproduceerbare retentietijden te verkrijgen wordt isocratische elutie toegepast 
op een α-zuurglycoproteïnekolom. In het geval van urinemonsters zijn 
matrixcomponenten in het eindextract aanwezig die ervoor zorgen dat de 
retentietijden van alle isomeren afnemen, waardoor onvoldoende 
chromatografische resolutie wordt verkregen. Om dit te voorkomen is een 
intensieve opschoning van de monsterextracten ontwikkeld, bestaande uit een 
vaste fase extractie met daarna een vloeistof-vloeistofextractie. De ontwikkelde 
methode is volledig gevalideerd en voldoet aan de gestelde criteria voor alle 
isomeren. De beslisgrens (CCα) varieert van 0.005 tot 0.03 µg L-1 en de binnen-
laboratoriumreproduceerbaarheid van alle isomeren ligt lager dan 20 % op niveau 
van de minimaal vereiste prestatielimiet van 0.3 µg L-1. 
In sectie 4.5 is het natuurlijk voorkomen van CAP onderzocht. De hypothese is 
dat CAP van nature voor kan komen in gewassen en diervoeders doordat het in de 
grond geproduceerd wordt door bodembacteriën en vervolgens wordt opgenomen 
door gewassen. Om deze hypothese te kunnen accepteren dient aan twee 
Samenvatting 
 
335 
voorwaarden voldaan te worden: (1) bodembacteriën moeten CAP kunnen 
produceren in natuurlijke grond en (2) gewassen moeten CAP vanuit de grond 
kunnen opnemen. Er is gedemonstreerd dat Streptomyces venezuelae CAP in 
voldoende mate kan produceren in onbehandelde grond. Ondanks dat CAP in 
niet-gesteriliseerde grond degradeert, wordt het in beperkte mate opgenomen 
door gewassen. Op basis van deze observaties is geconcludeerd dat CAP in 
gewassen en voeders kan voorkomen ten gevolge van de natuurlijke productie 
van CAP door bodembacteriën. 
In hoofdstuk 5 wordt de analyse van ß-lactamantibiotica besproken. ß-
lactamantibiotica omvatten de penicillines, cefalosporines en carbapenems. Met 
name penicillines worden veelvuldig gebruikt in de veehouderij en als humaan 
medicijn. Dit heeft geleid tot een extreem hoge bacteriële resistentie voor 
penicillines. Resistentie voor cefalosporines en in minder mate carbapenems 
komt tevens voor, wat een gevaar vormt voor de volksgezondheid. Dit onderwerp 
wordt in detail geïntroduceerd in sectie 5.1. De uitdagingen voor de analyse van 
ß-lactams zijn (1) de instabiliteit van enkele componenten behorende tot deze 
groep en (2) het metabolisme van ceftiofur en cefapirine, en eiwitbinding van 
ceftiofurresiduen.  
In sectie 5.2 is het onderzoek naar de degradatie van ceftiofur en cefapirine 
gepresenteerd. Een beperkte instabiliteit van cefapirine en desfuroylceftiofur is 
waargenomen bij verhoogde temperatuur. Ceftiofur en cefapirine degraderen 
meteen en volledig in basisch milieu, resulterend in antimicrobieel inactieve 
producten. Ceftiofur en cefapirine degraderen tevens in de aanwezigheid van 
nierextract resulterend in eerder gerapporteerde en nog niet eerder 
gerapporteerde producten. Condities die vaak voorkomen bij de analyse van 
ceftiofur en cefapirine kunnen leiden tot snelle afbraak van deze componenten. 
Daarom wordt op theoretische gronden geconcludeerd dat het waarschijnlijk is 
dat een onderschatting van het ceftiofur- en cefapirinegehalte plaatsvindt bij 
toepassing van de conventionele methoden voor de analyse van deze 
componenten en dat een nieuwe methode, die rekening houdt met het 
metabolisme en deze degradatie noodzakelijk is.  
Om effectief off-label gebruik van ceftiofur aan te kunnen tonen dient een 
analysemethode naast ceftiofur zelf ook de actieve metabolieten daarvan te 
kunnen detecteren. In sectie 5.3 is de toepasbaarheid van drie kwantitatieve 
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methoden onderzocht, namelijk (A) de analyse van ceftiofur, desfuroylceftiofur 
en/of desfuroylceftiofur-cysteïne-disulfide, (B) de derivatisering van 
ceftiofurmetabolieten naar desfuroylceftiofur-acetamide en (C) een binnen 
RIKILT ontwikkelde methode gebaseerd op de basische hydrolyse van 
ceftiofurmetabolieten met ammonia ter verkrijging van een markerresidu dat 
representatief is voor de totale hoeveelheid ceftiofurmetabolieten. Er is 
vastgesteld dat methode A niet geschikt is voor de kwantitatieve analyse van de 
totale hoeveelheid ceftiofurmetabolieten, noch voor de effectieve detectie van 
off-label gebruik van ceftiofur. Methode B resulteert in goede kwantitatieve 
resultaten, echter deze methode is uitsluitend geschikt voor de analyse van 
ceftiofur, niet voor andere cefalosporines. Methode C geeft tevens goede 
kwantitatieve resultaten en deze methode lijkt geschikt voor toepassing van de 
analyse van diverse cefalosporines in kippenvlees.  
In sectie 5.4 is de ontwikkeling van een methode gerapporteerd, gebaseerd op 
de basische hydrolyse met piperidine, voor de kwantitatieve alomvattende 
analyse van ß-lactamantibiotica, inclusief penicillines, cefalosporines en 
carbapenems. De hydrolyse is geoptimaliseerd met een ‘full experimental 
design’. Gebruikmakend van isotoopgelabelde componenten en hoge resolutie 
massaspectrometrie (HR-MS) zijn voorstellen gedaan voor de molecuulstructuur 
van de gevormde reactieproducten. De methode is volledig gevalideerd en de 
bepaalde methodekarakteristieken zijn acceptabel bevonden voor de 
kwantitatieve analyse van 21 van de 22 ß-lactams. Daarnaast is aangetoond dat 
de ontwikkelde methode effectief is voor het opsporen van off-label gebruik van 
ceftiofur, omdat met deze methode ook eiwitgebonden residuen worden 
gedetecteerd. 
In hoofdstuk 6 zijn toekomstperspectieven betreffende antibioticumanalyse 
besproken. Het toenemend gebruik van HR-MS is één van de meest opvallende 
trends over de afgelopen jaren. Een onderzoek, vergelijkbaar aan het werk 
gepresenteerd in hoofdstuk 3, moet uitgevoerd worden om de selectiviteit van 
HR-MS-analyses te bepalen. Op basis van de uitkomsten hiervan dient wetgeving 
op het gebied van het gebruik van HR-MS voor bevestigingsanalyse heroverwogen 
te worden. Enkele andere methoden voor het verbeteren van de selectiviteit zijn 
voorhanden. Ion-mobiliteitspectrometrie (IMS) scheidt componenten op basis van 
grootte, vorm en botsingsdoorsnede, en is daarmee orthogonaal aan LC-MS/MS. 
Samenvatting 
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De koppeling van IMS met LC-MS/MS resulteert in een verhoogde selectiviteit. 
Het gebruik van tweedimensionale chromatografie (LCxLC) verhoogt de 
selectiviteit aanzienlijk. Er is onderzoek nodig om de optimale condities voor 
beide dimensies te bepalen en om een goede koppeling te maken tussen beide 
dimensies. Ook superkritischefasechromatografie (SFC) is een veelbelovende 
techniek. Door de hoge diffusiesnelheid en de lage tegendruk kunnen zeer snelle 
scheidingen met hoge resolutie verkregen worden. Als laatste zijn combinaties 
van deze technieken mogelijk zeer interessant, zoals bijvoorbeeld IMS-HR-MS en 
LCxSFC.  
In hoofdstuk 6 worden ook de verwachte ontwikkelingen in de monitoring van 
residuen besproken. Het nationaal monitoringsplan zal meer risicogebaseerd 
worden en daardoor is een flexibelere aanpak vereist. Het meest efficiënt is het 
gebruik van generieke, veel componenten omvattende, screeningsmethoden in 
combinatie met enkele zeer selectieve bevestigingsmethodes. Daarnaast zal, 
door de verregaande ontwikkeling van bacteriële resistentie, monitoring steeds 
meer gericht worden op het testen van antibioticumgebruik in het algemeen 
naast de monitoring van antibiotica in voedselproducten. Hierbij moeten 
detectiegrenzen zo laag mogelijk zijn en is het gebruik van andere matrices 
mogelijk relevant, zoals mest, haar, veren, veegmonsters (alle niet-invasief) en 
botten. 
Als laatste wordt toekomstig onderzoek gerelateerd aan CAP voorgesteld. Omdat 
aangetoond is dat CAP van nature kan voorkomen in gewassen en diervoeder, zijn 
overdrachtsstudies van natuurlijk gecontamineerde gewassen en voeders naar 
producten van dierlijke oorsprong (urine, vlees, darmen) noodzakelijk om vast te 
stellen of de niveaus in gewassen en voeders kunnen leiden tot detecteerbare 
CAP-residuen in producten van dierlijke oorsprong. Daarnaast dient onderzoek 
gedaan te worden naar de mogelijkheid om gebiosynthetiseerd CAP te 
onderscheiden van chemisch gesynthetiseerd CAP. Op basis van de uitkomsten 
van dat onderzoek moet de wettelijk verboden status van CAP opnieuw tegen het 
licht gehouden worden.  
Op basis van het onderzoek gepresenteerd in dit proefschrift, kunnen we de 
volgende vraag beantwoorden: “Hoeveel selectiviteit is vereist?” Helaas is er 
geen eenduidig antwoord op deze vraag, omdat dit afhangt van het doel van de 
betreffende methode. Normaal gesproken bestaat er een wisselwerking tussen 
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selectiviteit en het aantal componenten dat met één methode geanalyseerd kan 
worden. Voor screeningsmethoden zou derhalve een lagere selectiviteit volstaan, 
terwijl de selectiviteit van bevestigingsmethoden hoog moet zijn. Daarnaast 
hangt de vereiste selectiviteit af van de verwachte interferenties. In het geval 
van CAP-analyse is hoge selectiviteit nodig, maar in andere gevallen, zoals 
ceftiofuranalyse, dient de selectiviteit doelbewust verlaagd te worden om een 
effectieve monitoringsstrategie te verkrijgen. Hieruit wordt geconcludeerd dat 
bij methodeontwikkeling en –validatie, het van groot belang is de parameter 
selectiviteit in detail te bestuderen. 
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Het is algemeen bekend dat het uitvoeren van een PhD-traject stressvol is. 
Deadlines, mislukte experimenten, lastige reviewers… Gelukkig heb ik de 
afgelopen jaren de druk die ik voelde enigszins weten te beperken. Echter, zodra 
de promotiedatum bekend werd, ontstond toch een licht gevoel van spanning in 
mijn onderbuik. Het gaat nu echt gebeuren… 
Zoals zo vaak de laatste maanden, zit ik weer eens in de voorkamer achter de 
laptop aan tafel. Het is alweer donker buiten, de gordijnen dicht. De hond ligt 
snurkend op de bank en op de achtergrond hoor ik zacht het geluid van de 
televisie. Een documentaire of zoiets… Het grootste deel van het proefschrift ligt 
gelukkig al lang klaar, de opmaak is gedaan. Alles is geregeld. Op tafel liggen 
verschillende proefschriften, alle opengeslagen op één van de laatste pagina’s. Ik 
kijk ernaar, de pendule tikt confronterend op de achtergrond. Terwijl ik 
inspiratie probeer te krijgen herinner ik me ineens de woorden van Ingrid: “Het 
dankwoord mag best met een beetje humor geschreven worden”. Ik voel ineens 
die enorme last op mijn schouders; meer druk dan ik tijdens het gehele 
onderzoek en het schrijven van dit proefschrift heb ervaren. Ik kijk op en zie dat 
de hond echt eerst nog even naar buiten moet en ik loop een rondje dat net iets 
langer is dan normaal. Eenmaal terug, de hond weer op de bank, tuur ik 
afwisselend naar het scherm en naar de opengeslagen proefschriften. Ik lees nog 
eens vluchtig een dankwoord door. Eerst een kop thee. Ik sta op, loop naar de 
keuken en zet de waterkoker aan. Onderweg zie ik de modderpoten en haren van 
de hond op de vloer; daar moet toch echt eerst iets aan gebeuren, anders kan ik 
me niet concentreren. Een kwartier later zit ik weer aan tafel, een kop thee 
rechts en een handje rozijnen links van de laptop. Inspiratieloos. Het 
belangrijkste is dat ik niemand vergeet te noemen en iedereen in passende 
volgorde laat passeren, wat dat dan ook moge  ijn. Maar humor… Ingrid bedankt! 
En ineens is zomaar de kop eraf. 
Natuurlijk wil ik in het bijzonder Michel en Linda bedanken. Hoe snel kan het 
gaan? Toen ik in januari 2008 aan mijn MSc-traject aan de Universiteit van 
Amsterdam begon, was de steun en het vertrouwen al enorm. Toen Michel na het 
behalen van mijn diploma informeerde of ik interesse had in een PhD-traject, 
vond ik dat een grote eer. Vanaf dat moment hebben Michel en Linda zich 
volledig ingezet om mij in dit traject te ondersteunen. Wat misschien nog wel 
het belangrijkste is, is dat jullie beiden altijd hebben uitgestraald vertrouwen in 
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mij te hebben. Jullie hebben me alle ruimte gegeven mijn onderzoek zelfstandig 
uit te voeren, maar waren er altijd als ik reflectie nodig had. Michel, ik moet 
eerlijk  eggen dat ik even moest wennen aan jouw kritische blik en je ‘advocaat-
van-de-duivel-aanpak’, maar ik ben er wel veel verder mee gekomen. Het heeft 
me gedwongen beter na te denken over keuzes die ik maakte en me geleerd mijn 
standpunten helderder te beargumenteren. Dat is iets wat ik in mijn verdere 
loopbaan zeker mee zal nemen. Ook wil ik jullie beiden bedanken voor jullie 
feedback op manuscripten en teksten voor dit proefschrift. Ondanks dat jullie 
enorm druk zijn, kreeg ik toch altijd onverwacht snel een uitgebreide reactie op 
mijn concepten. Altijd eerlijk en zonder er doekjes om te winden; althans, dat 
denk ik.  
Dan wil ik mijn collega’s bedanken. Allereerst degenen die een belangrijke 
bijdrage geleverd hebben aan het onderzoek dat in dit proefschrift beschreven 
staat. Ik vind het leuk dat er  o veel collega’s meegewerkt hebben aan mijn 
onderzoek; het blijkt toch maar weer dat je samen veel verder komt. Wat 
hebben we lopen zoeken naar een goede opwerking om die isomeerpieken op hun 
plek te houden. Martien, bedankt voor je hulp bij het optimaliseren van de 
opwerking van de urinemonsters. Jouw jarenlange ervaring heeft uiteindelijk tot 
de oplossing geleid. Robin, door jouw inzet en enthousiasme heb ik me altijd 
extra gemotiveerd gevoeld. Jij wilde altijd precies weten wat er binnen het 
onderzoek speelde, zodat je je eigen ideeën kon vormen. Echt jammer dat we 
niet hebben kunnen aantonen dat chlooramfenicol in maïskuil gevormd wordt, 
maar dank ij ‘jouw’ maïskuil konden we de e hypothese met grote 
waarschijnlijkheid verwerpen. Dat is ook een belangrijk resultaat. Ook bedankt 
voor je hulp in de begeleiding van Mathilde en Ralph, leuk dat je paranimf wilt 
zijn en nogmaals dank dat je  52 pagina’s door bent gegaan op  oek naar fouten. 
Henk, jij ook bedankt voor je hulp in de begeleiding van Ralph en je bijdrage aan 
de ß-lactammethode. Jouw kennis van de Q-Trap 6500 heeft ervoor gezorgd dat 
we last-minute de overstap konden maken en dat we toch tijdig de validatiedata 
konden produceren. Daarnaast was het altijd prettig even met jou en Robin te 
sparren en ook als ik niet aanwezig was op RIKILT wist ik dat de studenten en het 
onderzoek in goede handen waren. Tina, jij ook bedankt. Je hebt er zeker aan 
bijgedragen dat er weer financieel draagvlak kwam voor vervolgonderzoek naar 
chlooramfenicol en de ß-lactamanalyse. Zonder dat had ik het onderzoek 
überhaupt niet kunnen doen. Ingrid, bedankt dat je er altijd bent om even 
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inhoudelijk mee te sparren en om af en toe wat persoonlijke zaken te bespreken. 
Hoe eenvoudig deze gesprekken misschien lijken, ze helpen wel om zaken wat te 
relativeren. Echt heel fijn om jou als collega te hebben en top dat jij als 
routinier paranimf wilt zijn. Ook jij bedankt dat je de proefversie van dit 
proefschrift hebt gecontroleerd; knap dat je nog zoveel kleine inconsistenties en 
taalfoutjes hebt weten te vinden. Mariël, bedankt voor je ondersteuning in het 
chlooramfenicolproject. Je was er door je zwangerschapsverlof lange tijd niet bij 
betrokken, maar toen je eenmaal weer terug op RIKILT was, heb je je er 
enthousiast ingestort. Met jouw expertise zijn we echt een stuk verder gekomen. 
Sabrina en Alexander, ook bedankt voor jullie hulp. Sinds ik erachter kwam dat 
we zelf ook een Streptomyces venezuelae kunnen opkweken, hebben jullie je 
enorm flexibel opgesteld (een preparaat stond klaar wanneer ik maar wilde) en 
waren jullie enorm betrokken bij het onderzoek. Toch jammer dat het zo 
verdomd lastig is ervoor te zorgen dat die bacterie chlooramfenicol gaat 
produceren. Ooit gaat het ons lukken… Het is erg leuk om met jullie samen te 
werken, juist omdat onze achtergronden zo verschillend zijn. 
Dan al mijn overige RIKILT-collega’s. Jullie dragen er allemaal aan bij dat de 
sfeer heel open en vertrouwd is. Mede daardoor ga ik iedere dag (nou ja, bijna 
iedere dag) met plezier naar mijn werk. Iedereen is altijd bereid om bij te 
springen waar nodig en  o klaren we met  ’n allen toch steeds weer iedere klus. 
Iedereen enorm bedankt daarvoor. 
Ook wil ik alle studenten bedanken die een bijdrage hebben geleverd aan het 
werk in dit proefschrift. Jullie hebben met  ’n allen  o ont ettend veel werk 
verzet dat ik niet anders kan dan concluderen dat dit proefschrift zonder jullie 
een stuk dunner was geweest. Ik heb het altijd leuk gevonden jullie te 
begeleiden en te zien hoe jullie je ontwikkelden. Richetti, bedankt voor het 
uitzoeken van goede condities om die nare chlooramfenicolisomeren op de 
chirale kolom te scheiden. Vooral de reproduceerbaarheid viel in het begin nogal 
tegen, maar het is toch gelukt. Cynthia, super dat je de methode voor de analyse 
van ceftiofur met behulp van de hydrolyse met ammoniak hebt geoptimaliseerd. 
Later is weliswaar overgestapt op piperidine, maar jij hebt de basis van de 
monstervoorbewerking. Sven, bedankt voor het implementeren van de 
verschillende methodes voor de analyse van ceftiofur en de analyse van al die 
vleesmonsters. Mathilde, bedankt voor het onderzoek naar de invloed van de 
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maalprocedure op de vorming van degradatieproducten van ceftiofur. Hoewel 
jouw werk niet direct in dit proefschrift is opgenomen (ik zou het misschien nog 
eens moeten publiceren), vormt het wel een heel belangrijke basis van het 
onderzoek. Ik ben blij dat je hebt kunnen aantonen dat er wel degelijk 
metabolieten gevormd worden na injectie van kippen met ceftiofur. Steven, 
bedankt voor de ontwikkeling van de ß-lactam-multimethode. Jouw werk vormde 
een mooie basis om de uiteindelijk gerapporteerde methode op te zetten. Ralph, 
bedankt voor de validatie van deze methode. Het was een enorme klus: ik denk 
dat het je nog steeds duizelt als je bedenkt dat je meer dan 15000 pieken hebt 
geïntegreerd gedurende je stage. Ik schrik er  elf een beetje van… 
In dit dankwoord uiteraard ook een mooie plek voor Freek. Nog steeds gaat 
binnen jouw familie de ronde dat je zonder mij nooit je MSc zou hebben gehaald. 
Iedereen weet wel dat dat niet waar is, maar uiteraard houd ik dat gerucht graag 
in stand. Voor mijn MSc-traject, en in iets mindere mate mijn PhD-traject, geldt 
wél dat ik het zonder jou niet had kunnen doen. Met name tussen 2008 en 2010, 
de jaren waarin ik hele avonden en weekenden heb gestudeerd, heb jij alle 
andere taken uit handen genomen, zodat ik me op mijn opleiding kon 
concentreren. Hele weekenden zat ik opgesloten in de voorkamer te werken en 
ik heb jou daar niet één keer over horen mopperen. Hetzelfde geldt voor de 
laatste fase van mijn PhD: ik kon me volledig focussen op mijn proefschrift, 
omdat jij altijd voor me klaar staat en me steunt.  
Als laatste een woord van dank aan familie en vrienden. Gelukkig heb ik tijdens 
mijn promotietraject meer tijd voor jullie gehad dan tijdens mijn MSc-studie; dat 
was echt een twee jaar durende sociale stop. Als ik na mijn promotie in het 
bekende zwarte gat val, zal ik jullie allemaal weer wat vaker gaan vervelen. 
Hoewel, de puzzel die ik van Sinterklaas heb gekregen met duizend stukjes 
uitsluitend grijskleurige olifant houdt me nog wel even van de straat (moet ik dat 
als subtiele hint van Sinterklaas beschouwen?). Als die af is, heb ik weer tijd voor 
iedereen. Ik kijk er al naar uit. 
Bjorn 
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